CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: vitamin E
Accession: CHEBI:33234
browse the term
Definition: Any member of a group of fat-soluble chromanols that exhibit biological activity against vitamin E deficiency. The vitamers in this class consists of a chroman-6-ol core which is substituted at position 2 by a methyl group and (also at position 2) either a saturated or a triply-unsaturated hydrocarbon chain consisting of three isoprenoid units. The major function of vitamin E is to act as a natural antioxidant by scavenging free radicals and molecular oxygen.
Synonyms: related_synonym: vitamin E vitamer; vitamin E vitamers; vitamins E
alt_id: MESH:D014810
xref_mesh: MESH:D024502
xref: MetaCyc:Vitamin-E; PMID:33684201; PMID:33847203; PMID:33896432; PMID:34277234; PMID:34278890; PMID:7898412; PMID:7901680; Wikipedia:Vitamin_E
G
1110038F14Rik
RIKEN cDNA 1110038F14 gene
increases expression
ISO
Vitamin E results in increased expression of C8ORF33 mRNA
CTD
PMID:19244175
NCBI chr15:76,832,453...76,835,179
Ensembl chr15:76,832,706...76,835,179
G
5031439G07Rik
RIKEN cDNA 5031439G07 gene
increases expression
ISO
Vitamin E results in increased expression of KIAA0930 mRNA
CTD
PMID:19244175
NCBI chr15:84,828,137...84,872,503
Ensembl chr15:84,828,137...84,872,752
G
5730409E04Rik
RIKEN cDNA 5730409E04Rik gene
increases expression
ISO
Vitamin E results in increased expression of C1ORF216 mRNA
CTD
PMID:19244175
NCBI chr 4:126,503,638...126,508,164
Ensembl chr 4:126,503,611...126,508,164
G
Aamp
angio-associated migratory protein
increases expression
ISO
Vitamin E results in increased expression of AAMP mRNA
CTD
PMID:19244175
NCBI chr 1:74,318,999...74,324,833
Ensembl chr 1:74,318,999...74,323,897
G
Aass
aminoadipate-semialdehyde synthase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AASS mRNA Vitamin E results in decreased expression of AASS mRNA
CTD
PMID:19244175
NCBI chr 6:23,072,172...23,132,985
Ensembl chr 6:23,072,172...23,132,985
G
Abcb11
ATP-binding cassette, sub-family B member 11
decreases expression
ISO
Vitamin E results in decreased expression of ABCB11 mRNA
CTD
PMID:34767876
NCBI chr 2:69,068,626...69,172,960
Ensembl chr 2:69,068,626...69,172,958
G
Abcc2
ATP-binding cassette, sub-family member 2
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ABCC2 mRNA
CTD
PMID:11444866
NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179
G
Abhd14a
abhydrolase domain containing 14A
decreases expression
ISO
Vitamin E results in decreased expression of ABHD14A mRNA
CTD
PMID:19244175
NCBI chr 9:106,317,250...106,328,402
Ensembl chr 9:106,317,253...106,324,877
G
Abhd2
abhydrolase domain containing 2
decreases expression increases expression
ISO
Vitamin E results in decreased expression of ABHD2 mRNA Vitamin E results in increased expression of ABHD2 mRNA
CTD
PMID:19244175
NCBI chr 7:78,923,002...79,015,257
Ensembl chr 7:78,922,947...79,015,256
G
Abhd4
abhydrolase domain containing 4
increases expression
ISO
Vitamin E results in increased expression of ABHD4 mRNA
CTD
PMID:19244175
NCBI chr14:54,491,586...54,506,626
Ensembl chr14:54,491,645...54,508,094
G
Acaa2
acetyl-CoA acyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of ACAA2 mRNA
CTD
PMID:19244175
NCBI chr18:74,912,283...74,939,278
Ensembl chr18:74,912,268...74,939,279
G
Acads
acyl-Coenzyme A dehydrogenase, short chain
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ACADS mRNA Vitamin E results in increased expression of ACADS mRNA
CTD
PMID:19244175
NCBI chr 5:115,248,358...115,257,405
Ensembl chr 5:115,248,358...115,257,405
G
Ache
acetylcholinesterase
multiple interactions
EXP ISO
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of ACHE protein] [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [sodium arsenite results in increased activity of ACHE protein]; Vitamin E inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of ACHE protein]; Vitamin E inhibits the reaction [Scopolamine results in decreased activity of ACHE protein]
CTD
PMID:11814146 PMID:20663516 PMID:23619517 PMID:29233033
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Aco2
aconitase 2, mitochondrial
increases expression
ISO
Vitamin E results in increased expression of ACO2 mRNA
CTD
PMID:19244175
NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334
G
Acot2
acyl-CoA thioesterase 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ACOT2 mRNA Vitamin E results in increased expression of ACOT2 mRNA
CTD
PMID:19244175
NCBI chr12:84,034,635...84,040,651
Ensembl chr12:84,034,635...84,040,647
G
Acp1
acid phosphatase 1, soluble
decreases expression
ISO
Vitamin E results in decreased expression of ACP1 mRNA
CTD
PMID:19244175
NCBI chr12:30,943,325...30,961,616
Ensembl chr12:30,943,325...30,961,588
G
Acta2
actin alpha 2, smooth muscle, aorta
decreases expression
ISO
Vitamin E results in decreased expression of ACTA2 mRNA
CTD
PMID:19244175
NCBI chr19:34,217,736...34,232,985
Ensembl chr19:34,218,490...34,232,990
G
Actb
actin, beta
increases expression
ISO
Vitamin E results in increased expression of ACTB mRNA
CTD
PMID:19244175
NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509
G
Actn4
actinin alpha 4
increases expression
ISO
Vitamin E results in increased expression of ACTN4 mRNA
CTD
PMID:19244175
NCBI chr 7:28,592,673...28,661,799
Ensembl chr 7:28,592,673...28,661,765
G
Actr1a
ARP1 actin-related protein 1A, centractin alpha
increases expression
ISO
Vitamin E results in increased expression of ACTR1A mRNA
CTD
PMID:19244175
NCBI chr19:46,365,252...46,384,180
Ensembl chr19:46,365,250...46,384,187
G
Actr1b
ARP1 actin-related protein 1B, centractin beta
increases expression
ISO
Vitamin E results in increased expression of ACTR1B mRNA
CTD
PMID:19244175
NCBI chr 1:36,737,195...36,749,051
Ensembl chr 1:36,737,195...36,753,503
G
Acvr2a
activin receptor IIA
decreases expression
ISO
Vitamin E results in decreased expression of ACVR2A mRNA
CTD
PMID:19244175
NCBI chr 2:48,704,121...48,793,276
Ensembl chr 2:48,704,121...48,793,281
G
Acvr2b
activin receptor IIB
decreases expression
ISO
Vitamin E results in decreased expression of SCGB2A2 mRNA
CTD
PMID:15084515
NCBI chr 9:119,231,081...119,271,214
Ensembl chr 9:119,231,184...119,264,061
G
Adam17
a disintegrin and metallopeptidase domain 17
decreases expression
ISO
Vitamin E results in decreased expression of ADAM17 mRNA
CTD
PMID:19244175
NCBI chr12:21,373,510...21,423,633
Ensembl chr12:21,373,510...21,423,633
G
Adamts5
ADAM metallopeptidase with thrombospondin type 1 motif 5
decreases expression
ISO
Vitamin E results in decreased expression of ADAMTS5 mRNA
CTD
PMID:19244175
NCBI chr16:85,655,045...85,698,013
Ensembl chr16:85,653,061...85,698,716
G
Adap1
ArfGAP with dual PH domains 1
increases expression
ISO
Vitamin E results in increased expression of ADAP1 mRNA
CTD
PMID:19244175
NCBI chr 5:139,257,631...139,311,516
Ensembl chr 5:139,257,631...139,311,377
G
Adarb1
adenosine deaminase, RNA-specific, B1
decreases expression
ISO
Vitamin E results in decreased expression of ADARB1 mRNA
CTD
PMID:19244175
NCBI chr10:77,126,561...77,254,125
Ensembl chr10:77,126,560...77,254,104
G
Adcy2
adenylate cyclase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ADCY2 mRNA
CTD
PMID:19244175
NCBI chr13:68,768,162...69,147,719
Ensembl chr13:68,768,162...69,147,660
G
Adcy6
adenylate cyclase 6
increases expression
ISO
Vitamin E results in increased expression of ADCY6 mRNA
CTD
PMID:19244175
NCBI chr15:98,484,982...98,508,119
Ensembl chr15:98,487,854...98,507,957
G
Add1
adducin 1
increases expression
ISO
Vitamin E results in increased expression of ADD1 mRNA
CTD
PMID:19244175
NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652
G
Add3
adducin 3
decreases expression
ISO
Vitamin E results in decreased expression of ADD3 mRNA
CTD
PMID:19244175
NCBI chr19:53,128,874...53,235,518
Ensembl chr19:53,128,874...53,235,830
G
Adgrb1
adhesion G protein-coupled receptor B1
increases expression
ISO
Vitamin E results in increased expression of ADGRB1 mRNA
CTD
PMID:19244175
NCBI chr15:74,388,045...74,461,314
Ensembl chr15:74,388,044...74,461,314
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of ADH7 mRNA
CTD
PMID:19244175
NCBI chr 3:137,903,828...137,937,803
Ensembl chr 3:137,923,521...137,939,143
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of ADIPOQ protein]
CTD
PMID:20404018
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Adissp
adipose secreted signaling protein
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ADISSP mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ADISSP mRNA
CTD
PMID:19244175
NCBI chr 2:130,988,235...131,002,001
Ensembl chr 2:130,988,244...131,002,001
G
Adra2c
adrenergic receptor, alpha 2c
increases expression
ISO
Vitamin E results in increased expression of ADRA2C mRNA
CTD
PMID:19244175
NCBI chr 5:35,435,910...35,439,107
Ensembl chr 5:35,435,663...35,439,107
G
Adrm1
adhesion regulating molecule 1 26S proteasome ubiquitin receptor
increases expression
ISO
Vitamin E results in increased expression of ADRM1 mRNA
CTD
PMID:19244175
NCBI chr 2:179,813,381...179,818,076
Ensembl chr 2:179,813,278...179,818,079
G
Aebp1
AE binding protein 1
increases expression
ISO
Vitamin E results in increased expression of AEBP1 mRNA
CTD
PMID:19244175
NCBI chr11:5,806,085...5,822,248
Ensembl chr11:5,811,947...5,822,088
G
Aen
apoptosis enhancing nuclease
increases expression
ISO
Vitamin E results in increased expression of AEN mRNA
CTD
PMID:19244175
NCBI chr 7:78,545,675...78,560,957
Ensembl chr 7:78,545,602...78,560,957
G
Agpat2
1-acylglycerol-3-phosphate O-acyltransferase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA
CTD
PMID:19244175
NCBI chr 2:26,483,069...26,494,429
Ensembl chr 2:26,483,069...26,494,429
G
Agrn
agrin
decreases expression
ISO
Vitamin E results in decreased expression of AGRN mRNA
CTD
PMID:19244175
NCBI chr 4:156,249,747...156,281,997
Ensembl chr 4:156,249,747...156,281,945
G
Agtpbp1
ATP/GTP binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of AGTPBP1 mRNA
CTD
PMID:19244175
NCBI chr13:59,597,348...59,705,184
Ensembl chr13:59,593,556...59,733,041
G
Ahnak
AHNAK nucleoprotein
increases expression
ISO
Vitamin E results in increased expression of AHNAK mRNA
CTD
PMID:19244175
NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278
G
Ahnak2
AHNAK nucleoprotein 2
increases expression
ISO
Vitamin E results in increased expression of AHNAK2 mRNA
CTD
PMID:19244175
NCBI chr12:112,738,631...112,766,278
Ensembl chr12:112,738,628...112,766,277
G
Ahr
aryl-hydrocarbon receptor
decreases expression
ISO
Vitamin E results in decreased expression of AHR mRNA
CTD
PMID:19244175
NCBI chr12:35,547,978...35,584,988
Ensembl chr12:35,547,973...35,585,037
G
Ahsa1
AHA1, activator of heat shock protein ATPase 1
increases expression
ISO
Vitamin E results in increased expression of AHSA1 mRNA
CTD
PMID:19244175
NCBI chr12:87,313,189...87,320,772
Ensembl chr12:87,313,253...87,320,772
G
AI837181
expressed sequence AI837181
increases expression
ISO
Vitamin E results in increased expression of C11ORF68 mRNA
CTD
PMID:19244175
NCBI chr19:5,475,172...5,477,345
Ensembl chr19:5,475,172...5,477,341
G
Aimp1
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of AIMP1 mRNA Vitamin E results in decreased expression of AIMP1 mRNA
CTD
PMID:19244175
NCBI chr 3:132,366,259...132,390,151
Ensembl chr 3:132,366,242...132,390,131
G
Ak1
adenylate kinase 1
increases expression
ISO
Vitamin E results in increased expression of AK1 mRNA
CTD
PMID:19244175
NCBI chr 2:32,511,770...32,525,070
Ensembl chr 2:32,511,770...32,525,070
G
Ak3
adenylate kinase 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of AK3 mRNA
CTD
PMID:19244175
NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361
G
Akap13
A kinase anchor protein 13
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of AKAP13 mRNA Vitamin E results in decreased expression of AKAP13 mRNA
CTD
PMID:19244175
NCBI chr 7:75,105,271...75,404,357
Ensembl chr 7:75,105,282...75,404,357
G
Akr1b1
aldo-keto reductase family 1 member B
increases expression
ISO
Vitamin E results in increased expression of AKR1B1 mRNA
CTD
PMID:19244175
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akr1b10
aldo-keto reductase family 1, member B10
increases expression
ISO
Vitamin E results in increased expression of AKR1B10 mRNA
CTD
PMID:34767876
NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885
G
Akr1c21
aldo-keto reductase family 1, member C21
increases expression
ISO
Vitamin E results in increased expression of AKR1C2 mRNA
CTD
PMID:19244175
NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540
G
Akt1
thymoma viral proto-oncogene 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of AKT1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of AKT1 protein]
CTD
PMID:19244175 PMID:21911000
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Alad
aminolevulinate, delta-, dehydratase
multiple interactions
ISO
Vitamin E inhibits the reaction [lead acetate results in decreased activity of ALAD protein]
CTD
PMID:2604901
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Alb
albumin
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [Ethanol results in decreased expression of ALB protein] [Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in decreased expression of ALB protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased expression of ALB protein] Vitamin E inhibits the reaction [Oleic Acid results in decreased secretion of ALB protein]
CTD
PMID:17927767 PMID:21086752 PMID:23348005
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Aldh6a1
aldehyde dehydrogenase family 6, subfamily A1
decreases expression
ISO
Vitamin E results in decreased expression of ALDH6A1 mRNA
CTD
PMID:19244175
NCBI chr12:84,477,491...84,497,798
Ensembl chr12:84,477,491...84,497,778
G
Alg3
ALG3 alpha-1,3- mannosyltransferase
increases expression
ISO
Vitamin E results in increased expression of ALG3 mRNA
CTD
PMID:19244175
NCBI chr16:20,424,208...20,429,515
Ensembl chr16:20,424,124...20,430,485
G
Alg9
ALG9 alpha-1,2-mannosyltransferase
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ALG9 mRNA
CTD
PMID:19244175
NCBI chr 9:50,686,570...50,754,939
Ensembl chr 9:50,686,319...50,754,842
G
Alkbh1
alkB homolog 1, histone H2A dioxygenase
decreases expression
ISO
Vitamin E results in decreased expression of ALKBH1 mRNA
CTD
PMID:19244175
NCBI chr12:87,474,847...87,490,609
Ensembl chr12:87,472,610...87,490,787
G
Alox5
arachidonate 5-lipoxygenase
decreases activity multiple interactions
ISO
Vitamin E results in decreased activity of ALOX5 protein [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of ALOX5 protein
CTD
PMID:11325678 PMID:12200813 PMID:22223226
NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139
G
Alpl
alkaline phosphatase, liver/bone/kidney
multiple interactions
ISO
Vitamin E inhibits the reaction [Doxorubicin results in decreased activity of ALPL protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of ALPL protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of ALPL protein]
CTD
PMID:30064338 PMID:31618080 PMID:32810592
NCBI chr 4:137,469,042...137,523,695
Ensembl chr 4:137,469,044...137,523,695
G
Ambra1
autophagy/beclin 1 regulator 1
increases expression
ISO
Vitamin E results in increased expression of AMBRA1 mRNA
CTD
PMID:19244175
NCBI chr 2:91,560,464...91,749,194
Ensembl chr 2:91,560,479...91,749,194
G
Amy1
amylase 1, salivary
decreases expression
ISO
Vitamin E results in decreased expression of AMY2A mRNA
CTD
PMID:19244175
NCBI chr 3:113,349,601...113,371,399
Ensembl chr 3:113,349,359...113,400,348
G
Anapc15
anaphase promoting complex C subunit 15
increases expression
ISO
Vitamin E results in increased expression of ANAPC15 mRNA
CTD
PMID:19244175
NCBI chr 7:101,530,508...101,551,056
Ensembl chr 7:101,512,922...101,551,056
G
Angpt1
angiopoietin 1
decreases expression
ISO
Vitamin E results in decreased expression of ANGPT1 mRNA
CTD
PMID:19244175
NCBI chr15:42,288,063...42,540,373
Ensembl chr15:42,288,119...42,540,373
G
Ank3
ankyrin 3, epithelial
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ANK3 mRNA Vitamin E results in decreased expression of ANK3 mRNA
CTD
PMID:19244175
NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268
G
Ankrd12
ankyrin repeat domain 12
decreases expression
ISO
Vitamin E results in decreased expression of ANKRD12 mRNA
CTD
PMID:19244175
NCBI chr17:66,272,698...66,386,242
Ensembl chr17:66,272,693...66,384,084
G
Anp32b
acidic nuclear phosphoprotein 32 family member B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ANP32B mRNA Vitamin E results in decreased expression of ANP32B mRNA
CTD
PMID:19244175
NCBI chr 4:46,450,926...46,472,657
Ensembl chr 4:46,450,902...46,472,657
G
Anxa6
annexin A6
increases expression
ISO
Vitamin E results in increased expression of ANXA6 mRNA
CTD
PMID:19244175
NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271
G
Ap1m2
adaptor protein complex AP-1, mu 2 subunit
increases expression
ISO
Vitamin E results in increased expression of AP1M2 mRNA
CTD
PMID:19244175
NCBI chr 9:21,206,753...21,223,617
Ensembl chr 9:21,205,571...21,223,633
G
Ap2a2
adaptor-related protein complex 2, alpha 2 subunit
increases expression
ISO
Vitamin E results in increased expression of AP2A2 mRNA
CTD
PMID:19244175
NCBI chr 7:141,142,093...141,212,924
Ensembl chr 7:141,142,086...141,212,924
G
Ap2m1
adaptor-related protein complex 2, mu 1 subunit
increases expression
ISO
Vitamin E results in increased expression of AP2M1 mRNA
CTD
PMID:19244175
NCBI chr16:20,354,230...20,363,659
Ensembl chr16:20,354,228...20,363,659
G
Ap2s1
adaptor-related protein complex 2, sigma 1 subunit
increases expression
ISO
Vitamin E results in increased expression of AP2S1 mRNA
CTD
PMID:19244175
NCBI chr 7:16,472,369...16,483,215
Ensembl chr 7:16,472,335...16,483,219
G
Ap3s2
adaptor-related protein complex 3, sigma 2 subunit
increases expression
ISO
Vitamin E results in increased expression of AP3S2 mRNA
CTD
PMID:19244175
NCBI chr 7:79,525,073...79,570,388
Ensembl chr 7:79,525,073...79,570,397
G
Apbb2
amyloid beta precursor protein binding family B member 2
decreases expression
ISO
Vitamin E results in decreased expression of APBB2 mRNA
CTD
PMID:19244175
NCBI chr 5:66,456,068...66,779,189
Ensembl chr 5:66,456,046...66,776,127
G
Apex1
apurinic/apyrimidinic endonuclease 1
increases expression
ISO
Vitamin E results in increased expression of APEX1 mRNA
CTD
PMID:19244175
NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596
G
Aplp2
amyloid beta precursor-like protein 2
increases expression
ISO
Vitamin E results in increased expression of APLP2 mRNA
CTD
PMID:19244175
NCBI chr 9:31,060,853...31,123,144
Ensembl chr 9:31,060,853...31,123,111
G
Apoa1
apolipoprotein A-I
increases expression
ISO
Vitamin E results in increased expression of APOA1 protein
CTD
PMID:18458655
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apob
apolipoprotein B
multiple interactions
ISO
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of APOB protein; Vitamin E promotes the reaction [Flavonoids inhibits the reaction [Copper results in increased oxidation of APOB protein]]; Vitamin E promotes the reaction [Quercetin inhibits the reaction [Copper results in increased oxidation of APOB protein]]
CTD
PMID:17237316 PMID:17475462
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
G
Apoe
apolipoprotein E
multiple interactions
EXP
Vitamin E inhibits the reaction [APOE mutant form results in increased abundance of 8,12-iso-isoprostane F2alpha-VI]
CTD
PMID:16303615
NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113
G
Apol7b
apolipoprotein L 7b
increases expression
ISO
Vitamin E results in increased expression of APOL3 mRNA
CTD
PMID:19244175
NCBI chr15:77,306,409...77,331,660
Ensembl chr15:77,306,409...77,331,692
G
Apom
apolipoprotein M
increases expression
ISO
Vitamin E results in increased expression of APOM mRNA
CTD
PMID:19244175
NCBI chr17:35,347,973...35,350,777
Ensembl chr17:35,347,973...35,351,026
G
App
amyloid beta precursor protein
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of APP mRNA Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3] Vitamin E inhibits the reaction [Aluminum results in increased cleavage of APP protein]
CTD
PMID:12039845 PMID:12117551 PMID:15223066 PMID:19244175
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Appbp2
amyloid beta precursor protein binding protein 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of APPBP2 mRNA Vitamin E results in increased expression of APPBP2 mRNA
CTD
PMID:19244175
NCBI chr11:85,082,134...85,125,946
Ensembl chr11:85,078,088...85,125,956
G
Aqp1
aquaporin 1
increases expression
ISO
Vitamin E results in increased expression of AQP1 mRNA
CTD
PMID:19244175
NCBI chr 6:55,313,284...55,325,540
Ensembl chr 6:55,313,417...55,325,540
G
Aqp3
aquaporin 3
increases expression multiple interactions
ISO
Vitamin E results in increased expression of AQP3 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of AQP3 mRNA
CTD
PMID:19244175
NCBI chr 4:41,092,724...41,098,183
Ensembl chr 4:41,092,722...41,098,183
G
Aqp4
aquaporin 4
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [manganese(III) acetate dihydrate results in increased expression of AQP4 protein] Vitamin E inhibits the reaction [[ferrous chloride results in increased abundance of Iron] which results in increased expression of AQP4 protein]
CTD
PMID:20648640 PMID:30914277
NCBI chr18:15,522,451...15,544,039
Ensembl chr18:15,522,553...15,544,039
G
Araf
Araf proto-oncogene, serine/threonine kinase
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ARAF mRNA
CTD
PMID:19244175
NCBI chr X:20,663,946...20,726,760
Ensembl chr X:20,664,053...20,726,758
G
Arf3
ADP-ribosylation factor 3
increases expression
ISO
Vitamin E results in increased expression of ARF3 mRNA
CTD
PMID:19244175
NCBI chr15:98,635,505...98,660,999
Ensembl chr15:98,634,515...98,661,095
G
Arf5
ADP-ribosylation factor 5
increases expression
ISO
Vitamin E results in increased expression of ARF5 mRNA
CTD
PMID:19244175
NCBI chr 6:28,423,603...28,426,601
Ensembl chr 6:28,423,559...28,426,601
G
Arhgap10
Rho GTPase activating protein 10
increases expression
ISO
Vitamin E results in increased expression of ARHGAP10 mRNA
CTD
PMID:19244175
NCBI chr 8:77,976,995...78,244,628
Ensembl chr 8:77,976,995...78,244,582
G
Arhgap8
Rho GTPase activating protein 8
increases expression
ISO
Vitamin E results in increased expression of ARHGAP8 mRNA
CTD
PMID:19244175
NCBI chr15:84,604,214...84,657,058
Ensembl chr15:84,604,253...84,656,408
G
Arhgdia
Rho GDP dissociation inhibitor alpha
increases expression
ISO
Vitamin E results in increased expression of ARHGDIA mRNA
CTD
PMID:19244175
NCBI chr11:120,468,925...120,472,450
Ensembl chr11:120,468,930...120,472,450
G
Arih1
ariadne RBR E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of ARIH1 mRNA
CTD
PMID:19244175
NCBI chr 9:59,295,837...59,395,469
Ensembl chr 9:59,295,541...59,393,901
G
Arl4d
ADP-ribosylation factor-like 4D
increases expression
ISO
Vitamin E results in increased expression of ARL4D mRNA
CTD
PMID:19244175
NCBI chr11:101,556,367...101,558,658
Ensembl chr11:101,556,367...101,558,658
G
Arl6ip4
ADP-ribosylation factor-like 6 interacting protein 4
increases expression
ISO
Vitamin E results in increased expression of ARL6IP4 mRNA
CTD
PMID:19244175
NCBI chr 5:124,254,171...124,256,258
Ensembl chr 5:124,254,152...124,256,259
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
increases expression
ISO
Vitamin E results in increased expression of ARPC1A mRNA
CTD
PMID:19244175
NCBI chr 5:145,020,679...145,045,566
Ensembl chr 5:145,020,640...145,045,571
G
Arpc4
actin related protein 2/3 complex, subunit 4
increases expression
ISO
Vitamin E results in increased expression of ARPC4 mRNA
CTD
PMID:19244175
NCBI chr 6:113,355,074...113,367,408
Ensembl chr 6:113,355,076...113,367,409
G
Asap3
ArfGAP with SH3 domain, ankyrin repeat and PH domain 3
increases expression
ISO
Vitamin E results in increased expression of ASAP3 mRNA
CTD
PMID:19244175
NCBI chr 4:135,933,662...135,973,888
Ensembl chr 4:135,933,676...135,972,527
G
Asb1
ankyrin repeat and SOCS box-containing 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ASB1 mRNA Vitamin E results in increased expression of ASB1 mRNA
CTD
PMID:19244175
NCBI chr 1:91,467,725...91,487,312
Ensembl chr 1:91,468,266...91,487,311
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of ASXL1 mRNA
CTD
PMID:19244175
NCBI chr 2:153,187,750...153,245,927
Ensembl chr 2:153,187,749...153,245,927
G
Atf2
activating transcription factor 2
increases phosphorylation
ISO
Vitamin E results in increased phosphorylation of ATF2 protein
CTD
PMID:11522656
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Atf3
activating transcription factor 3
decreases expression
ISO
Vitamin E results in decreased expression of ATF3 mRNA
CTD
PMID:19244175
NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236
G
Atf5
activating transcription factor 5
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ATF5 mRNA Vitamin E results in increased expression of ATF5 mRNA
CTD
PMID:19244175
NCBI chr 7:44,461,680...44,466,082
Ensembl chr 7:44,461,680...44,466,082
G
Atg12
autophagy related 12
decreases expression
ISO
Vitamin E results in decreased expression of ATG12 mRNA
CTD
PMID:19244175
NCBI chr18:46,865,484...46,874,683
Ensembl chr18:46,863,211...46,874,647
G
Atmin
ATM interactor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ATMIN mRNA Vitamin E results in decreased expression of ATMIN mRNA
CTD
PMID:19244175
NCBI chr 8:117,670,132...117,687,184
Ensembl chr 8:117,670,132...117,687,184
G
Atox1
antioxidant 1 copper chaperone
increases expression
ISO
Vitamin E results in increased expression of ATOX1 mRNA
CTD
PMID:19244175
NCBI chr11:55,337,463...55,352,034
Ensembl chr11:55,337,467...55,352,065
G
Atp5f1b
ATP synthase F1 subunit beta
increases expression
ISO
Vitamin E results in increased expression of ATP5F1B mRNA
CTD
PMID:19244175
NCBI chr10:127,919,176...127,926,257
Ensembl chr10:127,919,142...127,926,260
G
Atp5f1c
ATP synthase F1 subunit gamma
decreases expression
ISO
Vitamin E results in decreased expression of ATP5F1C mRNA
CTD
PMID:19244175
NCBI chr 2:10,060,841...10,085,321
Ensembl chr 2:10,060,827...10,085,321
G
Atp5me
ATP synthase membrane subunit e
decreases expression
ISO
Vitamin E results in decreased expression of ATP5ME mRNA
CTD
PMID:19244175
NCBI chr 5:108,581,112...108,582,265
Ensembl chr 5:108,581,110...108,582,314
G
Atp6ap2
ATPase, H+ transporting, lysosomal accessory protein 2
decreases expression
ISO
Vitamin E results in decreased expression of ATP6AP2 mRNA
CTD
PMID:19244175
NCBI chr X:12,453,998...12,483,290
Ensembl chr X:12,454,040...12,483,288
G
Atp6v0d1
ATPase, H+ transporting, lysosomal V0 subunit D1
increases expression
ISO
Vitamin E results in increased expression of ATP6V0D1 mRNA
CTD
PMID:19244175
NCBI chr 8:106,251,093...106,292,696
Ensembl chr 8:106,251,097...106,292,679
G
Atp6v1c1
ATPase, H+ transporting, lysosomal V1 subunit C1
decreases expression
ISO
Vitamin E results in decreased expression of ATP6V1C1 mRNA
CTD
PMID:19244175
NCBI chr15:38,662,096...38,692,688
Ensembl chr15:38,662,177...38,692,690
G
Atp8b1
ATPase, class I, type 8B, member 1
decreases expression
ISO
Vitamin E results in decreased expression of ATP8B1 mRNA
CTD
PMID:19244175
NCBI chr18:64,662,050...64,794,342
Ensembl chr18:64,662,038...64,794,338
G
Atrx
ATRX, chromatin remodeler
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ATRX mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ATRX mRNA
CTD
PMID:19244175
NCBI chr X:104,841,221...104,972,978
Ensembl chr X:104,841,221...104,973,009
G
Atxn3
ataxin 3
decreases expression
ISO
Vitamin E results in decreased expression of ATXN3 mRNA
CTD
PMID:19244175
NCBI chr12:101,885,160...101,928,139
Ensembl chr12:101,885,160...101,924,505
G
Atxn7
ataxin 7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ATXN7 mRNA Vitamin E results in decreased expression of ATXN7 mRNA
CTD
PMID:19244175
NCBI chr14:8,358,358...8,508,324
Ensembl chr14:8,362,461...8,508,323
G
AU022252
expressed sequence AU022252
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of C1ORF50 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of C1ORF50 mRNA
CTD
PMID:19244175
NCBI chr 4:119,077,039...119,089,884
Ensembl chr 4:119,060,767...119,089,909
G
Auts2
autism susceptibility candidate 2
decreases expression
ISO
Vitamin E results in decreased expression of AUTS2 mRNA
CTD
PMID:19244175
NCBI chr 5:131,466,171...132,572,059
Ensembl chr 5:131,466,171...132,572,183
G
Axl
AXL receptor tyrosine kinase
decreases expression
ISO
Vitamin E results in decreased expression of AXL mRNA
CTD
PMID:19244175
NCBI chr 7:25,455,925...25,488,502
Ensembl chr 7:25,456,698...25,488,130
G
Baat
bile acid-Coenzyme A: amino acid N-acyltransferase
increases expression
ISO
Vitamin E results in increased expression of BAAT mRNA
CTD
PMID:28923436
NCBI chr 4:49,489,416...49,507,915
Ensembl chr 4:49,489,422...49,506,557
G
Babam1
BRISC and BRCA1 A complex member 1
increases expression
ISO
Vitamin E results in increased expression of BABAM1 mRNA
CTD
PMID:19244175
NCBI chr 8:71,848,809...71,857,416
Ensembl chr 8:71,849,505...71,857,263
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
Vitamin E results in increased expression of BABAM2 mRNA
CTD
PMID:19244175
NCBI chr 5:31,855,394...32,242,083
Ensembl chr 5:31,855,028...32,242,306
G
Bag5
BCL2-associated athanogene 5
decreases expression
ISO
Vitamin E results in decreased expression of BAG5 mRNA
CTD
PMID:19244175
NCBI chr12:111,675,922...111,679,690
Ensembl chr12:111,675,922...111,679,691
G
Bag6
BCL2-associated athanogene 6
increases expression
ISO
Vitamin E results in increased expression of BAG6 mRNA
CTD
PMID:19244175
NCBI chr17:35,354,132...35,366,297
Ensembl chr17:35,354,154...35,366,298
G
Banf1
BAF nuclear assembly factor 1
increases expression
ISO
Vitamin E results in increased expression of BANF1 mRNA
CTD
PMID:19244175
NCBI chr19:5,414,661...5,416,904
Ensembl chr19:5,414,666...5,417,196
G
Bap1
Brca1 associated protein 1
increases expression
ISO
Vitamin E results in increased expression of BAP1 mRNA
CTD
PMID:19244175
NCBI chr14:30,973,358...30,981,887
Ensembl chr14:30,973,407...30,981,901
G
Bard1
BRCA1 associated RING domain 1
decreases expression
ISO
Vitamin E results in decreased expression of BARD1 mRNA
CTD
PMID:19244175
NCBI chr 1:71,066,694...71,142,300
Ensembl chr 1:71,066,657...71,142,305
G
Batf
basic leucine zipper transcription factor, ATF-like
increases expression
ISO
Vitamin E results in increased expression of BATF mRNA
CTD
PMID:19244175
NCBI chr12:85,733,494...85,755,861
Ensembl chr12:85,733,443...85,755,861
G
Bax
BCL2-associated X protein
multiple interactions affects expression increases expression
ISO
Vitamin E inhibits the reaction [bioallethrin results in increased expression of BAX protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of BAX protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased expression of BAX protein] [Vitamin E co-treated with Folic Acid] affects the expression of BAX protein; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased expression of BAX protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased expression of BAX protein] Vitamin E affects the expression of BAX protein Vitamin E results in increased expression of BAX protein
CTD
PMID:11166918 PMID:15566391 PMID:16054126 PMID:16933212 PMID:22020378 PMID:23523949 PMID:27353299 PMID:30935902 PMID:35511042 More...
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Baz1a
bromodomain adjacent to zinc finger domain 1A
decreases expression
ISO
Vitamin E results in decreased expression of BAZ1A mRNA
CTD
PMID:19244175
NCBI chr12:54,939,774...55,061,155
Ensembl chr12:54,940,336...55,061,133
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
increases expression
ISO
Vitamin E results in increased expression of BAZ1B mRNA
CTD
PMID:19244175
NCBI chr 5:135,214,094...135,274,985
Ensembl chr 5:135,216,118...135,274,983
G
Bbx
bobby sox HMG box containing
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BBX mRNA Vitamin E results in decreased expression of BBX mRNA
CTD
PMID:19244175
NCBI chr16:50,012,207...50,252,829
Ensembl chr16:50,012,207...50,252,753
G
Bcap31
B cell receptor associated protein 31
increases expression
ISO
Vitamin E results in increased expression of BCAP31 mRNA
CTD
PMID:19244175
NCBI chr X:72,729,784...72,761,464
Ensembl chr X:72,729,784...72,759,781
G
Bche
butyrylcholinesterase
multiple interactions
EXP
[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein; Hexachlorocyclohexane inhibits the reaction [[Resveratrol co-treated with Ascorbic Acid co-treated with Thioctic Acid co-treated with Vitamin E] results in increased activity of BCHE protein]
CTD
PMID:20663516
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl11a
BCL11 transcription factor A
decreases expression
ISO
Vitamin E results in decreased expression of BCL11A mRNA
CTD
PMID:19244175
NCBI chr11:24,026,498...24,123,558
Ensembl chr11:24,028,056...24,124,123
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions increases expression
ISO
[Vitamin E co-treated with Curcumin] results in decreased expression of BCL2 protein; Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BCL2 protein] Vitamin E results in increased expression of BCL2 mRNA [Vitamin E co-treated with Folic Acid] affects the expression of BCL2 protein; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of BCL2 mRNA]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased expression of BCL2 protein]
CTD
PMID:15566391 PMID:16933212 PMID:22020378 PMID:27353299 PMID:30935902 PMID:32810592 More...
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
multiple interactions increases expression
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA Vitamin E results in increased expression of BCL2L1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bcl6
B cell leukemia/lymphoma 6
decreases expression
ISO
Vitamin E results in decreased expression of BCL6 mRNA
CTD
PMID:19244175
NCBI chr16:23,780,058...23,807,602
Ensembl chr16:23,783,802...23,807,602
G
Bclaf1
BCL2-associated transcription factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of BCLAF1 mRNA Vitamin E results in decreased expression of BCLAF1 mRNA
CTD
PMID:19244175
NCBI chr10:20,187,897...20,218,390
Ensembl chr10:20,188,215...20,220,359
G
Bco1
beta-carotene oxygenase 1
multiple interactions
ISO
Vitamin E inhibits the reaction [Oxidants inhibits the reaction [BCO1 protein results in increased oxidation of beta Carotene]]
CTD
PMID:9526112
NCBI chr 8:117,822,590...117,860,459
Ensembl chr 8:117,822,593...117,860,459
G
Becn1
beclin 1, autophagy related
multiple interactions decreases expression
ISO
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 mRNA]; Vitamin E inhibits the reaction [Pilocarpine results in increased expression of BECN1 protein] Vitamin E results in decreased expression of BECN1 protein
CTD
PMID:19138675
NCBI chr11:101,179,084...101,193,112
Ensembl chr11:101,176,778...101,193,112
G
Bglap
bone gamma carboxyglutamate protein
multiple interactions
ISO
Vitamin E inhibits the reaction [Doxorubicin results in increased expression of BGLAP protein]
CTD
PMID:32810592
NCBI chr 3:88,290,802...88,291,773
Ensembl chr 3:88,290,808...88,291,771
G
Bicd1
BICD cargo adaptor 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of BICD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of BICD1 mRNA
CTD
PMID:19244175
NCBI chr 6:149,310,322...149,464,827
Ensembl chr 6:149,310,384...149,464,827
G
Bicd2
BICD cargo adaptor 2
decreases expression
ISO
Vitamin E results in decreased expression of BICD2 mRNA
CTD
PMID:19244175
NCBI chr13:49,495,025...49,540,502
Ensembl chr13:49,495,061...49,540,502
G
Bin1
bridging integrator 1
increases expression
ISO
Vitamin E results in increased expression of BIN1 mRNA
CTD
PMID:19244175
NCBI chr18:32,509,671...32,568,793
Ensembl chr18:32,510,283...32,568,790
G
Birc2
baculoviral IAP repeat-containing 2
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BIRC2 mRNA Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC2 protein]
CTD
PMID:11444866 PMID:15566391
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
G
Birc3
baculoviral IAP repeat-containing 3
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of BIRC3 protein]
CTD
PMID:15566391
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
Birc5
baculoviral IAP repeat-containing 5
multiple interactions
ISO
Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein]
CTD
PMID:24664296
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Bltp2
bridge-like lipid transfer protein family member 2
increases expression
ISO
Vitamin E results in increased expression of BLTP2 mRNA
CTD
PMID:19244175
NCBI chr11:78,152,476...78,181,451
Ensembl chr11:78,152,578...78,181,449
G
Bltp3b
bridge-like lipid transfer protein family member 3B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BLTP3B mRNA Vitamin E results in decreased expression of BLTP3B mRNA
CTD
PMID:19244175
NCBI chr10:89,580,830...89,655,753
Ensembl chr10:89,580,853...89,655,733
G
Blvra
biliverdin reductase A
increases expression
ISO
Vitamin E results in increased expression of BLVRA mRNA
CTD
PMID:19244175
NCBI chr 2:126,912,549...126,939,004
Ensembl chr 2:126,912,585...126,939,004
G
Bmp2k
BMP2 inducible kinase
decreases expression
ISO
Vitamin E results in decreased expression of BMP2K mRNA
CTD
PMID:19244175
NCBI chr 5:97,143,588...97,239,809
Ensembl chr 5:97,145,548...97,239,726
G
Bmp4
bone morphogenetic protein 4
increases expression
ISO
Vitamin E results in increased expression of BMP4 mRNA
CTD
PMID:19244175
NCBI chr14:46,620,982...46,628,126
Ensembl chr14:46,620,977...46,628,126
G
Bptf
bromodomain PHD finger transcription factor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BPTF mRNA Vitamin E results in decreased expression of BPTF mRNA
CTD
PMID:19244175
NCBI chr11:106,923,907...107,022,982
Ensembl chr11:106,923,907...107,022,953
G
Brd2
bromodomain containing 2
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of BRD2 mRNA Vitamin E results in increased expression of BRD2 mRNA Vitamin E results in decreased expression of BRD2 mRNA
CTD
PMID:19244175
NCBI chr17:34,330,993...34,341,581
Ensembl chr17:34,330,997...34,341,608
G
Brf2
BRF2, RNA polymerase III transcription initiation factor 50kDa subunit
increases expression
ISO
Vitamin E results in increased expression of BRF2 mRNA
CTD
PMID:19244175
NCBI chr 8:27,613,367...27,618,743
Ensembl chr 8:27,613,392...27,618,708
G
Brms1
breast cancer metastasis-suppressor 1
increases expression
ISO
Vitamin E results in increased expression of BRMS1 mRNA
CTD
PMID:19244175
NCBI chr19:5,091,391...5,099,940
Ensembl chr19:5,091,382...5,099,945
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of BSCL2 mRNA Vitamin E results in increased expression of BSCL2 mRNA
CTD
PMID:19244175
NCBI chr19:8,814,831...8,826,047
Ensembl chr19:8,814,831...8,826,047
G
Bst2
bone marrow stromal cell antigen 2
increases expression
ISO
Vitamin E results in increased expression of BST2 mRNA
CTD
PMID:19244175
NCBI chr 8:71,986,899...71,990,116
Ensembl chr 8:71,986,899...71,990,100
G
C1s1
complement component 1, s subcomponent 1
increases expression
ISO
Vitamin E results in increased expression of C1S mRNA
CTD
PMID:19244175
NCBI chr 6:124,507,303...124,519,340
Ensembl chr 6:124,507,304...124,519,318
G
C87436
expressed sequence C87436
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of C2ORF42 mRNA Vitamin E results in decreased expression of C2ORF42 mRNA
CTD
PMID:19244175
NCBI chr 6:86,411,616...86,447,370
Ensembl chr 6:86,415,356...86,450,482
G
Caap1
caspase activity and apoptosis inhibitor 1
decreases expression
ISO
Vitamin E results in decreased expression of CAAP1 mRNA
CTD
PMID:19244175
NCBI chr 4:94,388,318...94,445,033
Ensembl chr 4:94,388,318...94,445,033
G
Cab39
calcium binding protein 39
increases expression
ISO
Vitamin E results in increased expression of MO25 mRNA
CTD
PMID:19244175
NCBI chr 1:85,707,796...85,779,298
Ensembl chr 1:85,721,162...85,779,297
G
Cald1
caldesmon 1
decreases expression
ISO
Vitamin E results in decreased expression of CALD1 mRNA
CTD
PMID:19244175
NCBI chr 6:34,575,433...34,752,404
Ensembl chr 6:34,575,435...34,752,408
G
Calm3
calmodulin 3
increases expression
ISO
Vitamin E results in increased expression of CALM3 mRNA
CTD
PMID:19244175
NCBI chr 7:16,649,304...16,657,957
Ensembl chr 7:16,649,304...16,658,039
G
Calr
calreticulin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CALR mRNA Vitamin E results in decreased expression of CALR mRNA
CTD
PMID:19244175
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Calu
calumenin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CALU mRNA Vitamin E results in increased expression of CALU mRNA
CTD
PMID:19244175
NCBI chr 6:29,348,105...29,376,674
Ensembl chr 6:29,348,068...29,377,109
G
Camk2b
calcium/calmodulin-dependent protein kinase II, beta
increases expression
ISO
Vitamin E results in increased expression of CAMK2B mRNA
CTD
PMID:19244175
NCBI chr11:5,919,642...6,016,401
Ensembl chr11:5,919,644...6,016,362
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
decreases expression
ISO
Vitamin E results in decreased expression of CAMK2G mRNA
CTD
PMID:19244175
NCBI chr14:20,784,943...20,844,225
Ensembl chr14:20,784,943...20,844,156
G
Cap1
cyclase associated actin cytoskeleton regulatory protein 1
increases expression
ISO
Vitamin E results in increased expression of CAP1 mRNA
CTD
PMID:19244175
NCBI chr 4:122,752,841...122,779,869
Ensembl chr 4:122,752,840...122,779,849
G
Capg
capping actin protein, gelsolin like
increases expression
ISO
Vitamin E results in increased expression of CAPG mRNA
CTD
PMID:19244175
NCBI chr 6:72,515,265...72,539,966
Ensembl chr 6:72,521,374...72,539,966
G
Capn7
calpain 7
decreases expression
ISO
Vitamin E results in decreased expression of CAPN7 mRNA
CTD
PMID:19244175
NCBI chr14:31,058,582...31,093,944
Ensembl chr14:31,058,595...31,093,943
G
Capns1
calpain, small subunit 1
increases expression
ISO
Vitamin E results in increased expression of CAPNS1 mRNA
CTD
PMID:19244175
NCBI chr 7:29,886,359...29,898,308
Ensembl chr 7:29,886,361...29,898,236
G
Caprin2
caprin family member 2
decreases expression
ISO
Vitamin E results in decreased expression of CAPRIN2 mRNA
CTD
PMID:19244175
NCBI chr 6:148,743,990...148,797,756
Ensembl chr 6:148,743,990...148,797,735
G
Capzb
capping actin protein of muscle Z-line subunit beta
increases expression
ISO
Vitamin E results in increased expression of CAPZB mRNA
CTD
PMID:19244175
NCBI chr 4:138,920,210...139,019,131
Ensembl chr 4:138,920,210...139,019,129
G
Car3
carbonic anhydrase 3
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CA3 mRNA
CTD
PMID:11444866
NCBI chr 3:14,928,598...14,937,441
Ensembl chr 3:14,928,572...14,937,583
G
Casc3
exon junction complex subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MLN51 mRNA Vitamin E results in increased expression of MLN51 mRNA
CTD
PMID:19244175
NCBI chr11:98,700,634...98,724,633
Ensembl chr11:98,695,731...98,724,640
G
Casp3
caspase 3
multiple interactions increases expression
ISO EXP
Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [cinnamaldehyde results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Curcumin results in decreased expression of CASP3 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in increased activity of CASP3 protein] Vitamin E results in increased expression of CASP3 mRNA Vitamin E inhibits the reaction [titanium dioxide results in increased activity of CASP3 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP3 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Acrylamide results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [APP protein results in increased activity of CASP3]; Vitamin E inhibits the reaction [Diazinon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP3 protein]; Vitamin E inhibits the reaction [Diazinon results in increased expression of CASP3 protein modified form]; Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CASP3 mRNA]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in increased activity of CASP3 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of CASP3 protein]
CTD
PMID:12117551 PMID:15566391 PMID:16054126 PMID:16973328 PMID:21628957 PMID:21873648 PMID:22020378 PMID:23523949 PMID:27353299 PMID:28237877 PMID:30626778 PMID:30935902 PMID:31618080 PMID:32810592 PMID:35511042 PMID:38043637 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
increases expression multiple interactions
ISO
Vitamin E results in increased expression of CASP9 mRNA Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dichlorvos results in increased activity of CASP9 protein]; [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of CASP9 mRNA]; Vitamin E inhibits the reaction [Diazinon results in increased cleavage of CASP9 protein]
CTD
PMID:16973328 PMID:19244175 PMID:21628957 PMID:27353299 PMID:35511042
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
multiple interactions increases expression decreases activity affects expression
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Air Pollutants, Occupational affects the expression of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Malathion results in increased activity of CAT protein]; [Ascorbic Acid co-treated with Vitamin E] results in increased expression of CAT mRNA; Vitamin E inhibits the reaction [Aluminum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Oleic Acid results in decreased activity of CAT protein] Vitamin E results in increased expression of CAT protein [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of CAT mRNA]; [Selenium co-treated with Vitamin E] inhibits the reaction [Malathion results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of CAT protein; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; [Vitamin E co-treated with Quercetin] inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; [Vitamin E co-treated with Sodium Selenite] inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; [Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]] which affects the abundance of Reactive Oxygen Species; [Zinc co-treated with Vitamin E co-treated with Ascorbic Acid co-treated with sodium arsenite] results in increased activity of CAT protein; Ginkgo biloba extract promotes the reaction [Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]]; Vitamin E inhibits the reaction [Atrazine results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Carbofuran results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cyclosporine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Dimethoate results in increased activity of CAT protein]; Vitamin E inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Food Additives affects the activity of CAT protein]; Vitamin E inhibits the reaction [Formaldehyde results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Malathion results in increased activity of CAT protein]; Vitamin E inhibits the reaction [Mercuric Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Nanotubes, Carbon results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Petroleum results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of CAT protein]; Vitamin E promotes the reaction [Ginkgo biloba extract inhibits the reaction [endotoxin, Escherichia coli results in decreased activity of CAT protein]] Vitamin E results in decreased activity of CAT protein [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of CAT protein]; Vitamin E inhibits the reaction [fipronil results in decreased activity of CAT protein] Vitamin E affects the expression of CAT protein
CTD
PMID:11597945 PMID:11834209 PMID:11955947 PMID:12355564 PMID:14535831 PMID:15669049 PMID:15820619 PMID:16144695 PMID:16298753 PMID:16758767 PMID:16937016 PMID:17262218 PMID:17383094 PMID:17709913 PMID:17927767 PMID:18655177 PMID:19914224 PMID:19958828 PMID:20077558 PMID:20079796 PMID:20136348 PMID:20535553 PMID:21086752 PMID:21628957 PMID:21736874 PMID:21787585 PMID:22020378 PMID:22207723 PMID:23348005 PMID:23369933 PMID:23619517 PMID:24865641 PMID:25046308 PMID:25721553 PMID:29948670 PMID:30064338 More...
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav1
caveolin 1, caveolae protein
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAV1 protein] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of CAV1 protein]
CTD
PMID:12134086 PMID:35349355
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Cavin1
caveolae associated 1
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased expression of CAVIN1 protein] Vitamin E results in increased expression of CAVIN1 mRNA
CTD
PMID:19244175 PMID:21705337
NCBI chr11:100,847,562...100,861,443
Ensembl chr11:100,847,559...100,861,713
G
Cavin3
caveolae associated 3
increases expression
ISO
Vitamin E results in increased expression of CAVIN3 mRNA
CTD
PMID:19244175
NCBI chr 7:105,129,823...105,131,404
Ensembl chr 7:105,129,290...105,131,507
G
Cblb
Casitas B-lineage lymphoma b
decreases expression
ISO
Vitamin E results in decreased expression of CBLB mRNA
CTD
PMID:19244175
NCBI chr16:51,851,593...52,028,410
Ensembl chr16:51,851,588...52,028,411
G
Cbx5
chromobox 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CBX5 mRNA Vitamin E results in decreased expression of CBX5 mRNA
CTD
PMID:19244175
NCBI chr15:103,099,973...103,148,337
Ensembl chr15:103,099,971...103,148,243
G
Cbx6
chromobox 6
increases expression
ISO
Vitamin E results in increased expression of CBX6 mRNA
CTD
PMID:19244175
NCBI chr15:79,708,099...79,718,534
Ensembl chr15:79,708,097...79,718,889
G
Cbx7
chromobox 7
increases expression
ISO
Vitamin E results in increased expression of CBX7 mRNA
CTD
PMID:19244175
NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
G
Cby1
chibby family member 1, beta catenin antagonist
increases expression
ISO
Vitamin E results in increased expression of CBY1 mRNA
CTD
PMID:19244175
NCBI chr15:79,543,437...79,551,861
Ensembl chr15:79,543,400...79,551,861
G
Ccdc85b
coiled-coil domain containing 85B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DIPA mRNA Vitamin E results in increased expression of DIPA mRNA
CTD
PMID:19244175
NCBI chr19:5,503,191...5,507,591
Ensembl chr19:5,503,208...5,507,922
G
Cchcr1
coiled-coil alpha-helical rod protein 1
increases expression
ISO
Vitamin E results in increased expression of CCHCR1 mRNA
CTD
PMID:19244175
NCBI chr17:35,827,914...35,841,912
Ensembl chr17:35,827,997...35,841,912
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions increases expression
EXP
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein]
CTD
PMID:19735175
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccl5
C-C motif chemokine ligand 5
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of CCL5 mRNA
CTD
PMID:16797527
NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344
G
Ccnd1
cyclin D1
increases expression multiple interactions affects expression
ISO
Vitamin E results in increased expression of CCND1 mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CCND1 protein] Vitamin E affects the expression of CCND1 mRNA; Vitamin E affects the expression of CCND1 protein [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of CCND1 mRNA
CTD
PMID:11444866 PMID:16298738 PMID:19244175 PMID:30935902
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd2
cyclin D2
increases expression
ISO
Vitamin E results in increased expression of CCND2 mRNA
CTD
PMID:19244175
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Ccnd3
cyclin D3
affects expression
ISO
Vitamin E affects the expression of CCND3 mRNA
CTD
PMID:15370891
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
G
Ccne1
cyclin E1
affects expression
ISO
Vitamin E affects the expression of CCNE1 mRNA
CTD
PMID:16298738
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
G
Ccnl1
cyclin L1
decreases expression
ISO
Vitamin E results in decreased expression of CCNL1 mRNA
CTD
PMID:19244175
NCBI chr 3:65,853,333...65,869,451
Ensembl chr 3:65,853,572...65,865,670
G
Ccpg1
cell cycle progression 1
decreases expression
ISO
Vitamin E results in decreased expression of CPR8 mRNA
CTD
PMID:19244175
NCBI chr 9:72,892,692...72,923,622
Ensembl chr 9:72,892,711...72,923,622
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
Vitamin E results in increased expression of CCS mRNA
CTD
PMID:19244175
NCBI chr19:4,875,394...4,889,326
Ensembl chr19:4,875,394...4,889,360
G
Cd2bp2
CD2 cytoplasmic tail binding protein 2
increases expression
ISO
Vitamin E results in increased expression of CD2BP2 mRNA
CTD
PMID:19244175
NCBI chr 7:126,790,832...126,795,249
Ensembl chr 7:126,790,832...126,795,222
G
Cd44
CD44 antigen
decreases expression
ISO
Vitamin E results in decreased expression of CD44 mRNA
CTD
PMID:19244175
NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010
G
Cd63
CD63 antigen
increases expression
ISO
Vitamin E results in increased expression of CD63 mRNA
CTD
PMID:19244175
NCBI chr10:128,731,577...128,748,691
Ensembl chr10:128,736,858...128,748,691
G
Cd86
CD86 antigen
multiple interactions
ISO
Vitamin E inhibits the reaction [Dinitrochlorobenzene results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Ethylmercuric Chloride results in increased expression of CD86 protein]; Vitamin E inhibits the reaction [Thimerosal results in increased expression of CD86 protein]
CTD
PMID:20457211
NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443
G
Cd99
CD99 antigen
increases expression
ISO
Vitamin E results in increased expression of CD99 mRNA
CTD
PMID:19244175
G
Cdc14b
CDC14 cell division cycle 14B
decreases expression
ISO
Vitamin E results in decreased expression of CDC14B mRNA
CTD
PMID:19244175
NCBI chr13:64,337,085...64,423,670
Ensembl chr13:64,337,082...64,423,104
G
Cdc16
CDC16 cell division cycle 16
decreases expression
ISO
Vitamin E results in decreased expression of CDC16 mRNA
CTD
PMID:19244175
NCBI chr 8:13,807,650...13,831,951
Ensembl chr 8:13,807,676...13,831,938
G
Cdc25b
cell division cycle 25B
increases expression
ISO
Vitamin E results in increased expression of CDC25B mRNA
CTD
PMID:19244175
NCBI chr 2:131,028,356...131,040,431
Ensembl chr 2:131,028,869...131,040,417
G
Cdc27
cell division cycle 27
decreases expression
ISO
Vitamin E results in decreased expression of CDC27 mRNA
CTD
PMID:19244175
NCBI chr11:104,393,350...104,441,371
Ensembl chr11:104,393,571...104,441,446
G
Cdc42bpa
CDC42 binding protein kinase alpha
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CDC42BPA mRNA Vitamin E results in increased expression of CDC42BPA mRNA Vitamin E results in decreased expression of CDC42BPA mRNA
CTD
PMID:19244175
NCBI chr 1:179,787,058...179,993,171
Ensembl chr 1:179,788,037...179,993,168
G
Cdh2
cadherin 2
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CDH2 protein]
CTD
PMID:29940330
NCBI chr18:16,721,934...16,942,303
Ensembl chr18:16,721,934...16,942,303
G
Cdh3
cadherin 3
increases expression
ISO
Vitamin E results in increased expression of CDH3 mRNA
CTD
PMID:19244175
NCBI chr 8:107,237,484...107,283,543
Ensembl chr 8:107,237,523...107,283,929
G
Cdk10
cyclin dependent kinase 10
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CDK10 mRNA
CTD
PMID:19244175
NCBI chr 8:123,951,580...123,958,995
Ensembl chr 8:123,951,581...123,958,989
G
Cdk13
cyclin dependent kinase 13
decreases expression
ISO
Vitamin E results in decreased expression of CDK13 mRNA
CTD
PMID:19244175
NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682
G
Cdk4
cyclin dependent kinase 4
increases expression
ISO
Vitamin E results in increased expression of CDK4 mRNA
CTD
PMID:19244175
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
affects expression multiple interactions
ISO
Vitamin E affects the expression of CDKN1A mRNA Vitamin E inhibits the reaction [Curcumin results in decreased expression of CDKN1A protein]
CTD
PMID:16298738 PMID:30935902
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
increases expression
ISO
Vitamin E results in increased expression of CDKN1B protein
CTD
PMID:12352461
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cds1
CDP-diacylglycerol synthase 1
decreases expression
ISO
Vitamin E results in decreased expression of CDS1 mRNA
CTD
PMID:19244175
NCBI chr 5:101,913,001...101,971,724
Ensembl chr 5:101,912,996...101,971,724
G
Cebpa
CCAAT/enhancer binding protein alpha
multiple interactions
EXP
Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein]; Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein]
CTD
PMID:16737972
NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353
G
Cebpb
CCAAT/enhancer binding protein beta
increases response to substance
ISO
CEBPB results in increased susceptibility to Vitamin E
CTD
PMID:9359698
NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338
G
Cep164
centrosomal protein 164
increases expression
ISO
Vitamin E results in increased expression of CEP164 mRNA
CTD
PMID:19244175
NCBI chr 9:45,678,244...45,739,984
Ensembl chr 9:45,678,244...45,739,989
G
Cep170
centrosomal protein 170
decreases expression
ISO
Vitamin E results in decreased expression of CEP170 mRNA
CTD
PMID:19244175
NCBI chr 1:176,556,638...176,641,545
Ensembl chr 1:176,561,219...176,641,633
G
Cep290
centrosomal protein 290
decreases expression
ISO
Vitamin E results in decreased expression of CEP290 mRNA
CTD
PMID:19244175
NCBI chr10:100,323,410...100,409,527
Ensembl chr10:100,323,420...100,410,702
G
Cep350
centrosomal protein 350
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CEP350 mRNA Vitamin E results in decreased expression of CEP350 mRNA
CTD
PMID:19244175
NCBI chr 1:155,720,710...155,848,976
Ensembl chr 1:155,720,710...155,849,001
G
Cep57
centrosomal protein 57
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CEP57 mRNA Vitamin E results in decreased expression of CEP57 mRNA
CTD
PMID:19244175
NCBI chr 9:13,717,979...13,738,698
Ensembl chr 9:13,719,088...13,738,403
G
Cep97
centrosomal protein 97
decreases expression
ISO
Vitamin E results in decreased expression of CEP97 mRNA
CTD
PMID:19244175
NCBI chr16:55,720,250...55,755,237
Ensembl chr16:55,720,251...55,755,218
G
Cerk
ceramide kinase
increases expression
ISO
Vitamin E results in increased expression of CERK mRNA
CTD
PMID:19244175
NCBI chr15:86,023,302...86,070,537
Ensembl chr15:86,023,329...86,070,342
G
Cert1
ceramide transporter 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CERT1 mRNA Vitamin E results in decreased expression of CERT1 mRNA
CTD
PMID:19244175
NCBI chr13:96,679,243...96,782,362
Ensembl chr13:96,679,243...96,776,675
G
Ces1d
carboxylesterase 1D
increases expression
ISO
Vitamin E results in increased expression of CES1 mRNA
CTD
PMID:19244175
NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466
G
Cflar
CASP8 and FADD-like apoptosis regulator
increases expression
ISO
Vitamin E results in increased expression of CFLAR mRNA
CTD
PMID:19244175
NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043
G
Chd1
chromodomain helicase DNA binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CHD1 mRNA Vitamin E results in decreased expression of CHD1 mRNA
CTD
PMID:19244175
NCBI chr17:15,925,229...15,992,874
Ensembl chr17:15,925,229...15,992,872
G
Chordc1
cysteine and histidine rich domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of CHORDC1 mRNA
CTD
PMID:19244175
NCBI chr 9:18,203,563...18,225,296
Ensembl chr 9:18,203,421...18,228,738
G
Chpf
chondroitin polymerizing factor
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CHPF mRNA
CTD
PMID:19244175
NCBI chr 1:75,451,213...75,456,115
Ensembl chr 1:75,451,213...75,455,951
G
Chst3
carbohydrate sulfotransferase 3
increases expression
ISO
Vitamin E results in increased expression of CHST3 mRNA
CTD
PMID:19244175
NCBI chr10:60,017,349...60,057,936
Ensembl chr10:60,017,354...60,055,082
G
Chst5
carbohydrate sulfotransferase 5
increases expression
ISO
Vitamin E results in increased expression of CHST6 mRNA
CTD
PMID:19244175
NCBI chr 8:112,615,767...112,636,831
Ensembl chr 8:112,615,768...112,637,079
G
Ciao2b
cytosolic iron-sulfur assembly component 2B
increases expression
ISO
Vitamin E results in increased expression of CIAO2B mRNA
CTD
PMID:19244175
NCBI chr 8:105,366,471...105,368,360
Ensembl chr 8:105,366,470...105,368,597
G
Cib2
calcium and integrin binding family member 2
increases expression
ISO
Vitamin E results in increased expression of CIB2 mRNA
CTD
PMID:19244175
NCBI chr 9:54,452,074...54,467,512
Ensembl chr 9:54,452,078...54,467,502
G
Cirbp
cold inducible RNA binding protein
increases expression
ISO
Vitamin E results in increased expression of CIRBP mRNA
CTD
PMID:19244175
NCBI chr10:80,001,824...80,008,620
Ensembl chr10:80,001,819...80,008,620
G
Ckap2
cytoskeleton associated protein 2
decreases expression
ISO
Vitamin E results in decreased expression of CKAP2 mRNA
CTD
PMID:19244175
NCBI chr 8:22,658,168...22,675,835
Ensembl chr 8:22,658,176...22,675,835
G
Ckb
creatine kinase, brain
increases expression
ISO
Vitamin E results in increased expression of CKB mRNA
CTD
PMID:19244175
NCBI chr12:111,635,789...111,638,772
Ensembl chr12:111,635,795...111,638,772
G
Ckm
creatine kinase, muscle
multiple interactions
ISO
Vitamin E inhibits the reaction [Diazinon results in increased activity of CKM protein]
CTD
PMID:23523949
NCBI chr 7:19,145,019...19,155,508
Ensembl chr 7:19,138,701...19,156,766
G
Clcc1
chloride channel CLIC-like 1
decreases expression
ISO
Vitamin E results in decreased expression of CLCC1 mRNA
CTD
PMID:19244175
NCBI chr 3:108,561,194...108,586,156
Ensembl chr 3:108,561,229...108,586,156
G
Clcn3
chloride channel, voltage-sensitive 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CLCN3 mRNA Vitamin E results in decreased expression of CLCN3 mRNA
CTD
PMID:19244175
NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
G
Cldn4
claudin 4
multiple interactions
ISO
Vitamin E inhibits the reaction [phoxim results in decreased expression of CLDN4 mRNA]
CTD
PMID:30003487
NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
G
Clec3b
C-type lectin domain family 3, member b
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TNA mRNA Vitamin E results in increased expression of TNA mRNA
CTD
PMID:19244175
NCBI chr 9:122,980,011...122,986,497
Ensembl chr 9:122,980,011...122,986,497
G
Clic1
chloride intracellular channel 1
increases expression
ISO
Vitamin E results in increased expression of CLIC1 mRNA
CTD
PMID:19244175
NCBI chr17:35,269,219...35,277,695
Ensembl chr17:35,268,942...35,277,725
G
Clip1
CAP-GLY domain containing linker protein 1
decreases expression
ISO
Vitamin E results in decreased expression of CLIP1 mRNA
CTD
PMID:19244175
NCBI chr 5:123,715,857...123,822,527
Ensembl chr 5:123,715,858...123,822,681
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CLN3 mRNA Vitamin E results in increased expression of CLN3 mRNA
CTD
PMID:19244175
NCBI chr 7:126,170,571...126,184,991
Ensembl chr 7:126,170,379...126,184,989
G
Cltb
clathrin light chain B
increases expression
ISO
Vitamin E results in increased expression of CLTB mRNA
CTD
PMID:19244175
NCBI chr13:54,740,199...54,759,186
Ensembl chr13:54,740,214...54,759,157
G
Clu
clusterin
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Estradiol results in increased expression of CLU protein] Vitamin E results in increased expression of CLU mRNA
CTD
PMID:9037392 PMID:19244175
NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996
G
Cmtr1
cap methyltransferase 1
increases expression
ISO
Vitamin E results in increased expression of CMTR1 mRNA
CTD
PMID:19244175
NCBI chr17:29,879,569...29,924,953
Ensembl chr17:29,879,569...29,924,953
G
Cngb1
cyclic nucleotide gated channel beta 1
decreases expression
ISO
Vitamin E results in decreased expression of CNGB1 mRNA
CTD
PMID:19244175
NCBI chr 8:95,965,671...96,033,213
Ensembl chr 8:95,965,673...96,033,213
G
Cnn1
calponin 1
increases expression
ISO
Vitamin E results in increased expression of CNN1 mRNA
CTD
PMID:19244175
NCBI chr 9:22,010,501...22,020,517
Ensembl chr 9:22,010,512...22,020,926
G
Cnpy2
canopy FGF signaling regulator 2
decreases expression
ISO
Vitamin E results in decreased expression of CNPY2 mRNA
CTD
PMID:19244175
NCBI chr10:128,157,972...128,163,056
Ensembl chr10:128,158,328...128,163,422
G
Cnpy3
canopy FGF signaling regulator 3
increases expression
ISO
Vitamin E results in increased expression of CNPY3 mRNA
CTD
PMID:19244175
NCBI chr17:47,046,637...47,063,639
Ensembl chr17:47,046,631...47,063,140
G
Cog4
component of oligomeric golgi complex 4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of COG4 mRNA
CTD
PMID:19244175
NCBI chr 8:111,573,232...111,608,866
Ensembl chr 8:111,573,232...111,608,859
G
Col18a1
collagen, type XVIII, alpha 1
increases expression
ISO
Vitamin E results in increased expression of COL18A1 mRNA
CTD
PMID:19244175
NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382
G
Col1a1
collagen, type I, alpha 1
multiple interactions
ISO
[silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA]
CTD
PMID:16169303
NCBI chr11:94,827,050...94,843,868
Ensembl chr11:94,827,050...94,843,868
G
Col1a2
collagen, type I, alpha 2
multiple interactions
ISO
Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA]
CTD
PMID:10498651
NCBI chr 6:4,505,618...4,541,543
Ensembl chr 6:4,504,814...4,541,544
G
Col4a1
collagen, type IV, alpha 1
increases expression
ISO
Vitamin E results in increased expression of COL4A1 mRNA
CTD
PMID:19244175
NCBI chr 8:11,248,423...11,362,889
Ensembl chr 8:11,248,423...11,362,826
G
Col4a3
collagen, type IV, alpha 3
decreases expression
ISO
Vitamin E results in decreased expression of COL4A3 mRNA
CTD
PMID:19244175
NCBI chr 1:82,564,647...82,699,778
Ensembl chr 1:82,564,642...82,699,780
G
Col6a2
collagen, type VI, alpha 2
increases expression
ISO
Vitamin E results in increased expression of COL6A2 mRNA
CTD
PMID:19244175
NCBI chr10:76,431,590...76,459,464
Ensembl chr10:76,431,596...76,459,464
G
Col6a3
collagen, type VI, alpha 3
increases expression
ISO
Vitamin E results in increased expression of COL6A3 mRNA
CTD
PMID:19244175
NCBI chr 1:90,694,582...90,771,710
Ensembl chr 1:90,693,645...90,771,693
G
Colgalt2
collagen beta(1-O)galactosyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of COLGALT2 mRNA
CTD
PMID:19244175
NCBI chr 1:152,275,485...152,386,942
Ensembl chr 1:152,275,581...152,386,446
G
Commd3
COMM domain containing 3
decreases expression
ISO
Vitamin E results in decreased expression of COMMD3 mRNA
CTD
PMID:19244175
NCBI chr 2:18,677,246...18,681,042
Ensembl chr 2:18,677,234...18,681,042
G
Cope
coatomer protein complex, subunit epsilon
increases expression
ISO
Vitamin E results in increased expression of COPE mRNA
CTD
PMID:19244175
NCBI chr 8:70,755,417...70,765,652
Ensembl chr 8:70,755,168...70,765,643
G
Cops6
COP9 signalosome subunit 6
increases expression
ISO
Vitamin E results in increased expression of COPS6 mRNA
CTD
PMID:19244175
NCBI chr 5:138,159,364...138,162,246
Ensembl chr 5:138,159,333...138,162,908
G
Copz2
coatomer protein complex, subunit zeta 2
increases expression
ISO
Vitamin E results in increased expression of COPZ2 mRNA
CTD
PMID:19244175
NCBI chr11:96,740,702...96,752,029
Ensembl chr11:96,740,696...96,752,029
G
Coq9
coenzyme Q9
increases expression
ISO
Vitamin E results in increased expression of COQ9 mRNA
CTD
PMID:19244175
NCBI chr 8:95,565,041...95,581,523
Ensembl chr 8:95,564,949...95,581,523
G
Cox6a1
cytochrome c oxidase subunit 6A1
decreases expression
ISO
Vitamin E results in decreased expression of COX6A1 mRNA
CTD
PMID:19244175
NCBI chr 5:115,483,711...115,487,017
Ensembl chr 5:115,483,701...115,487,040
G
Cpm
carboxypeptidase M
decreases expression
ISO
Vitamin E results in decreased expression of CPM mRNA
CTD
PMID:19244175
NCBI chr10:117,465,405...117,523,257
Ensembl chr10:117,465,405...117,523,257
G
Cpne1
copine I
increases expression
ISO
Vitamin E results in increased expression of CPNE1 mRNA
CTD
PMID:19244175
NCBI chr 2:155,913,765...155,953,847
Ensembl chr 2:155,913,762...155,953,885
G
Cpsf1
cleavage and polyadenylation specific factor 1
increases expression
ISO
Vitamin E results in increased expression of CPSF1 mRNA
CTD
PMID:19244175
NCBI chr15:76,480,008...76,491,861
Ensembl chr15:76,480,003...76,491,791
G
Cr1l
complement C3b/C4b receptor 1 like
multiple interactions
EXP
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR1L mRNA]
CTD
PMID:23208437
NCBI chr 1:194,781,019...194,813,878
Ensembl chr 1:194,779,690...194,813,894
G
Cr2
complement receptor 2
multiple interactions
EXP
Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 mRNA]; Vitamin E inhibits the reaction [Endosulfan results in decreased expression of CR2 protein]
CTD
PMID:23208437
NCBI chr 1:194,819,120...194,859,096
Ensembl chr 1:194,819,119...194,859,024
G
Creb1
cAMP responsive element binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CREB1 mRNA Vitamin E results in decreased expression of CREB1 mRNA
CTD
PMID:19244175
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Creb3
cAMP responsive element binding protein 3
increases expression
ISO
Vitamin E results in increased expression of CREB3 mRNA
CTD
PMID:19244175
NCBI chr 4:43,562,658...43,567,061
Ensembl chr 4:43,562,332...43,567,060
G
Crebbp
CREB binding protein
decreases expression
ISO
Vitamin E results in decreased expression of CREBBP mRNA
CTD
PMID:19244175
NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861
G
Crp
C-reactive protein, pentraxin-related
multiple interactions decreases expression
ISO EXP
[Eicosapentaenoic Acid co-treated with Docosahexaenoic Acids co-treated with Oleic Acid co-treated with Folic Acid co-treated with Vitamin B 6 co-treated with Vitamin E] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid co-treated with Folic Acid co-treated with Riboflavin co-treated with Vitamin B 6 co-treated with Vitamin B 12] results in decreased expression of CRP protein; [Vitamin E co-treated with Ascorbic Acid] results in decreased expression of CRP protein Vitamin E inhibits the reaction [titanium dioxide results in increased expression of CRP protein] Vitamin E results in decreased expression of CRP protein
CTD
PMID:16517955 PMID:17237316 PMID:20370442 PMID:30626778
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Crybg2
crystallin beta-gamma domain containing 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CRYBG2 mRNA Vitamin E results in increased expression of CRYBG2 mRNA
CTD
PMID:19244175
NCBI chr 4:133,788,042...133,819,815
Ensembl chr 4:133,788,126...133,819,815
G
Csnk1a1
casein kinase 1, alpha 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1A1 mRNA Vitamin E results in decreased expression of CSNK1A1 mRNA
CTD
PMID:19244175
NCBI chr18:61,687,307...61,723,391
Ensembl chr18:61,688,345...61,723,132
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1D mRNA
CTD
PMID:19244175
NCBI chr11:120,848,535...120,882,180
Ensembl chr11:120,849,816...120,882,156
G
Csnk1e
casein kinase 1, epsilon
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CSNK1E mRNA
CTD
PMID:19244175
NCBI chr15:79,302,054...79,339,779
Ensembl chr15:79,302,056...79,339,767
G
Csnk1g2
casein kinase 1, gamma 2
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1G2 mRNA
CTD
PMID:19244175
NCBI chr10:80,458,465...80,476,605
Ensembl chr10:80,458,672...80,476,583
G
Csnk1g3
casein kinase 1, gamma 3
decreases expression
ISO
Vitamin E results in decreased expression of CSNK1G3 mRNA
CTD
PMID:19244175
NCBI chr18:53,995,154...54,088,756
Ensembl chr18:53,995,194...54,088,620
G
Csnk2a1
casein kinase 2, alpha 1 polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of CSNK2A1 mRNA
CTD
PMID:19244175
NCBI chr 2:152,068,468...152,123,772
Ensembl chr 2:152,068,759...152,123,772
G
Csnk2b
casein kinase 2, beta polypeptide
increases expression
ISO
Vitamin E results in increased expression of CSNK2B mRNA
CTD
PMID:19244175
NCBI chr17:35,335,171...35,341,029
Ensembl chr17:35,335,172...35,341,029
G
Cspg4
chondroitin sulfate proteoglycan 4
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CSPG4 mRNA Vitamin E results in increased expression of CSPG4 mRNA
CTD
PMID:19244175
NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154
G
Cspp1
centrosome and spindle pole associated protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CSPP1 mRNA Vitamin E results in decreased expression of CSPP1 mRNA
CTD
PMID:19244175
NCBI chr 1:10,108,194...10,206,996
Ensembl chr 1:10,108,212...10,206,993
G
Csrp1
cysteine and glycine-rich protein 1
increases expression
ISO
Vitamin E results in increased expression of CSRP1 mRNA
CTD
PMID:19244175
NCBI chr 1:135,614,650...135,679,970
Ensembl chr 1:135,647,799...135,679,970
G
Cst3
cystatin C
increases expression
ISO
Vitamin E results in increased expression of CST3 mRNA
CTD
PMID:19244175
NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612
G
Ctbp1
C-terminal binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of CTBP1 mRNA
CTD
PMID:19244175
NCBI chr 5:33,405,067...33,432,348
Ensembl chr 5:33,405,067...33,432,338
G
Ctbp2
C-terminal binding protein 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CTBP2 mRNA Vitamin E results in decreased expression of CTBP2 mRNA
CTD
PMID:19244175
NCBI chr 7:132,588,727...132,726,048
Ensembl chr 7:132,589,292...132,726,083
G
Ctdnep1
CTD nuclear envelope phosphatase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CTDNEP1 mRNA Vitamin E results in increased expression of CTDNEP1 mRNA
CTD
PMID:19244175
NCBI chr11:69,871,994...69,881,427
Ensembl chr11:69,871,982...69,881,427
G
Ctdspl
CTD small phosphatase like
increases expression
ISO
Vitamin E results in increased expression of CTDSPL mRNA
CTD
PMID:19244175
NCBI chr 9:118,751,313...118,873,187
Ensembl chr 9:118,755,521...118,873,066
G
Ctf1
cardiotrophin 1
decreases expression
EXP
Vitamin E results in decreased expression of CTF1 protein
CTD
PMID:16507596
NCBI chr 7:127,311,872...127,317,360
Ensembl chr 7:127,311,908...127,317,364
G
Ctnnb1
catenin beta 1
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of and affects the localization of CTNNB1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of CTNNB1 protein] Vitamin E inhibits the reaction [Curcumin results in decreased expression of CTNNB1 protein]
CTD
PMID:29940330 PMID:30935902
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Ctnnbl1
catenin, beta like 1
increases expression
ISO
Vitamin E results in increased expression of CTNNBL1 mRNA
CTD
PMID:19244175
NCBI chr 2:157,579,321...157,733,823
Ensembl chr 2:157,579,321...157,733,534
G
Cttn
cortactin
decreases expression
ISO
Vitamin E results in decreased expression of CTTN mRNA
CTD
PMID:19244175
NCBI chr 7:143,989,468...144,024,743
Ensembl chr 7:143,989,470...144,024,746
G
Cuedc2
CUE domain containing 2
increases expression
ISO
Vitamin E results in increased expression of CUEDC2 mRNA
CTD
PMID:19244175
NCBI chr19:46,318,251...46,327,144
Ensembl chr19:46,318,251...46,327,141
G
Cul3
cullin 3
decreases expression
ISO
Vitamin E results in decreased expression of CUL3 mRNA
CTD
PMID:19244175
NCBI chr 1:80,242,640...80,318,426
Ensembl chr 1:80,242,640...80,318,197
G
Cul4a
cullin 4A
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of CUL4A mRNA Vitamin E results in increased expression of CUL4A mRNA
CTD
PMID:19244175
NCBI chr 8:13,155,623...13,197,940
Ensembl chr 8:13,155,621...13,197,940
G
Cutc
cutC copper transporter
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of CUTC mRNA Vitamin E results in decreased expression of CUTC mRNA
CTD
PMID:19244175
NCBI chr19:43,741,462...43,757,077
Ensembl chr19:43,741,435...43,757,077
G
Cux1
cut-like homeobox 1
decreases expression
ISO
Vitamin E results in decreased expression of CUX1 mRNA
CTD
PMID:19244175
NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344
G
Cwh43
cell wall biogenesis 43 C-terminal homolog
decreases expression
ISO
Vitamin E results in decreased expression of CWH43 mRNA
CTD
PMID:19244175
NCBI chr 5:73,563,394...73,610,778
Ensembl chr 5:73,563,418...73,610,778
G
Cxcl15
C-X-C motif chemokine ligand 15
multiple interactions
ISO EXP
Vitamin E affects the reaction [Homocysteine results in increased secretion of CXCL8 protein]; Vitamin E affects the reaction [homocysteine thiolactone results in increased secretion of CXCL8 protein]; Vitamin E inhibits the reaction [Anthralin results in increased expression of CXCL8 protein]; Vitamin E inhibits the reaction [Oleic Acid results in increased expression of CXCL8 protein]; Vitamin E inhibits the reaction [Particulate Matter results in increased expression of CXCL8 protein]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of CXCL8 protein] Vitamin E inhibits the reaction [titanium dioxide results in increased secretion of CXCL8 protein]
CTD
PMID:9628260 PMID:16076765 PMID:16715183 PMID:23348005 PMID:30626778
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcr1
C-X-C motif chemokine receptor 1
increases expression
ISO
Vitamin E results in increased expression of CXCR1 mRNA
CTD
PMID:19244175
NCBI chr 1:74,228,862...74,233,867
Ensembl chr 1:74,230,944...74,233,790
G
Cyba
cytochrome b-245, alpha polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of CYBA mRNA
CTD
PMID:15571180
NCBI chr 8:123,151,510...123,159,679
Ensembl chr 8:123,151,515...123,159,669
G
Cycs
cytochrome c, somatic
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of CYCS protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of CYCS protein] Vitamin E inhibits the reaction [Diazinon affects the localization of CYCS protein]
CTD
PMID:15566391 PMID:16054126 PMID:23523949
NCBI chr 6:50,539,543...50,543,549
Ensembl chr 6:50,539,543...50,543,518
G
Cyfip1
cytoplasmic FMR1 interacting protein 1
increases expression
ISO
Vitamin E results in increased expression of CYFIP1 mRNA
CTD
PMID:19244175
NCBI chr 7:55,491,556...55,582,381
Ensembl chr 7:55,491,493...55,582,350
G
Cyp11a1
cytochrome P450, family 11, subfamily a, polypeptide 1
multiple interactions
ISO
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of CYP11A protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CYP11A1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP11A1 mRNA]
CTD
PMID:16298753 PMID:17280759 PMID:28395332
NCBI chr 9:57,905,307...57,934,314
Ensembl chr 9:57,913,694...57,934,306
G
Cyp11b2
cytochrome P450, family 11, subfamily b, polypeptide 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of CYP11B2 mRNA Vitamin E inhibits the reaction [adrenocorticotropin zinc results in decreased expression of CYP11B2 mRNA]; Vitamin E promotes the reaction [adrenocorticotropin zinc results in decreased activity of CYP11B2 protein]
CTD
PMID:10822027 PMID:28923436
NCBI chr15:74,722,467...74,728,080
Ensembl chr15:74,722,467...74,728,167
G
Cyp19a1
cytochrome P450, family 19, subfamily a, polypeptide 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of CYP19A1 mRNA Vitamin E inhibits the reaction [Doxorubicin results in decreased expression of CYP19A1 mRNA]
CTD
PMID:15084515 PMID:32810592
NCBI chr 9:54,073,221...54,175,448
Ensembl chr 9:54,073,221...54,175,394
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Vitamin E results in increased expression of CYP1A1 mRNA
CTD
PMID:28923436
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
affects expression
ISO
Vitamin E inhibits the reaction [nitroglycerine decreases Cyp1a2 protein expression in rat heart]
RGD
PMID:16520233
RGD:401900296
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2a5
cytochrome P450, family 2, subfamily a, polypeptide 5
multiple interactions
EXP
Vitamin E inhibits the reaction [pyrazole results in increased expression of CYP2A5 mRNA]
CTD
PMID:12499123 PMID:14610226
NCBI chr 7:26,534,764...26,542,689
Ensembl chr 7:26,534,730...26,542,973
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
multiple interactions
ISO
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]; Vitamin E inhibits the reaction [CYP2E1 protein results in increased expression of COL1A2 mRNA] Vitamin E inhibits the reaction [decamethrin results in increased expression of CYP2E1 mRNA]
CTD
PMID:10498651 PMID:22486562 PMID:25439240
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
decreases expression
ISO
Vitamin E results in decreased expression of CYP3A4 mRNA
CTD
PMID:19244175
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
decreases expression
ISO
Vitamin E results in decreased expression of CYP3A5 mRNA
CTD
PMID:19244175
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
D6Wsu163e
DNA segment, Chr 6, Wayne State University 163, expressed
decreases expression
ISO
Vitamin E results in decreased expression of FERRY3 mRNA
CTD
PMID:19244175
NCBI chr 6:126,916,938...126,952,667
Ensembl chr 6:126,916,925...126,952,930
G
Daam1
dishevelled associated activator of morphogenesis 1
decreases expression
ISO
Vitamin E results in decreased expression of DAAM1 mRNA
CTD
PMID:19244175
NCBI chr12:71,877,834...72,039,150
Ensembl chr12:71,877,852...72,039,107
G
Daam2
dishevelled associated activator of morphogenesis 2
increases expression
ISO
Vitamin E results in increased expression of DAAM2 mRNA
CTD
PMID:19244175
NCBI chr17:49,763,050...49,871,517
Ensembl chr17:49,763,050...49,871,371
G
Dact1
dishevelled-binding antagonist of beta-catenin 1
decreases expression
ISO
Vitamin E results in decreased expression of DACT1 mRNA
CTD
PMID:19244175
NCBI chr12:71,356,658...71,366,881
Ensembl chr12:71,356,658...71,366,881
G
Dad1
defender against cell death 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of DAD1 mRNA
CTD
PMID:11444866
NCBI chr14:54,472,942...54,491,386
Ensembl chr14:54,472,936...54,491,561
G
Dapk3
death-associated protein kinase 3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DAPK3 mRNA Vitamin E results in increased expression of DAPK3 mRNA
CTD
PMID:19244175
NCBI chr10:81,018,821...81,029,031
Ensembl chr10:81,018,839...81,029,031
G
Dcaf8
DDB1 and CUL4 associated factor 8
increases expression
ISO
Vitamin E results in increased expression of DCAF8 mRNA
CTD
PMID:19244175
NCBI chr 1:171,975,574...172,023,959
Ensembl chr 1:171,975,651...172,024,572
G
Dcn
decorin
increases expression
ISO
Vitamin E results in increased expression of DCN mRNA
CTD
PMID:19244175
NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005
G
Dctn3
dynactin 3
increases expression
ISO
Vitamin E results in increased expression of DCTN3 mRNA
CTD
PMID:19244175
NCBI chr 4:41,714,798...41,723,213
Ensembl chr 4:41,714,798...41,723,170
G
Ddah2
DDAH family member 2, ADMA independent
increases expression
ISO
Vitamin E results in increased expression of DDAH2 mRNA
CTD
PMID:19244175
NCBI chr17:35,278,011...35,281,075
Ensembl chr17:35,278,011...35,281,071
G
Ddost
dolichyl-di-phosphooligosaccharide-protein glycotransferase
increases expression
ISO
Vitamin E results in increased expression of DDOST mRNA
CTD
PMID:19244175
NCBI chr 4:138,032,049...138,039,930
Ensembl chr 4:138,032,041...138,039,939
G
Ddx17
DEAD box helicase 17
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DDX17 mRNA Vitamin E results in decreased expression of DDX17 mRNA
CTD
PMID:19244175
NCBI chr15:79,411,897...79,430,976
Ensembl chr15:79,411,937...79,430,942
G
Ddx18
DEAD box helicase 18
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DDX18 mRNA Vitamin E results in decreased expression of DDX18 mRNA
CTD
PMID:19244175
NCBI chr 1:121,481,564...121,495,709
Ensembl chr 1:121,481,564...121,495,718
G
Ddx24
DEAD box helicase 24
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DDX24 mRNA Vitamin E results in decreased expression of DDX24 mRNA
CTD
PMID:19244175
NCBI chr12:103,374,235...103,392,106
Ensembl chr12:103,374,241...103,392,089
G
Ddx39b
DEAD box helicase 39b
increases expression decreases expression
ISO
Vitamin E results in increased expression of DDX39B mRNA Vitamin E results in decreased expression of DDX39B mRNA
CTD
PMID:19244175
NCBI chr17:35,460,722...35,472,683
Ensembl chr17:35,460,722...35,472,683
G
Ddx41
DEAD box helicase 41
increases expression multiple interactions
ISO
Vitamin E results in increased expression of DDX41 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DDX41 mRNA
CTD
PMID:19244175
NCBI chr13:55,678,223...55,684,471
Ensembl chr13:55,678,223...55,684,471
G
Dedd
death effector domain-containing
increases expression
ISO
Vitamin E results in increased expression of DEDD mRNA
CTD
PMID:19244175
NCBI chr 1:171,152,229...171,170,843
Ensembl chr 1:171,156,713...171,169,899
G
Dennd1b
DENN domain containing 1B
decreases expression
ISO
Vitamin E results in decreased expression of DENND1B mRNA
CTD
PMID:19244175
NCBI chr 1:138,891,447...139,103,781
Ensembl chr 1:138,891,173...139,106,698
G
Dennd2b
DENN domain containing 2B
increases expression
ISO
Vitamin E results in increased expression of DENND2B mRNA
CTD
PMID:19244175
NCBI chr 7:109,123,118...109,302,828
Ensembl chr 7:109,123,118...109,302,812
G
Dennd2d
DENN domain containing 2D
decreases expression
ISO
Vitamin E results in decreased expression of DENND2D mRNA
CTD
PMID:19244175
NCBI chr 3:106,389,745...106,410,346
Ensembl chr 3:106,389,721...106,410,346
G
Dennd4a
DENN domain containing 4A
decreases expression
ISO
Vitamin E results in decreased expression of DENND4A mRNA
CTD
PMID:19244175
NCBI chr 9:64,713,408...64,826,949
Ensembl chr 9:64,718,622...64,826,949
G
Dennd5a
DENN domain containing 5A
increases expression
ISO
Vitamin E results in increased expression of DENND5A mRNA
CTD
PMID:19244175
NCBI chr 7:109,492,987...109,559,677
Ensembl chr 7:109,492,987...109,559,677
G
Des
desmin
increases expression
ISO
Vitamin E results in increased expression of DES mRNA
CTD
PMID:19244175
NCBI chr 1:75,336,936...75,345,223
Ensembl chr 1:75,336,973...75,345,223
G
Dgcr8
DGCR8, microprocessor complex subunit
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DGCR8 mRNA
CTD
PMID:19244175
NCBI chr16:18,071,812...18,107,115
Ensembl chr16:18,071,812...18,107,110
G
Dhcr7
7-dehydrocholesterol reductase
affects expression
ISO
Vitamin E affects the expression of DHCR7 mRNA
CTD
PMID:15370891
NCBI chr 7:143,376,827...143,402,147
Ensembl chr 7:143,376,882...143,402,147
G
Dhodh
dihydroorotate dehydrogenase
decreases expression
ISO
Vitamin E results in decreased expression of DHODH mRNA
CTD
PMID:19244175
NCBI chr 8:110,319,876...110,335,330
Ensembl chr 8:110,317,975...110,335,305
G
Dhps
deoxyhypusine synthase
increases expression multiple interactions
ISO
Vitamin E results in increased expression of DHPS mRNA [Selenium co-treated with Vitamin E] results in increased expression of DHPS mRNA
CTD
PMID:19244175
NCBI chr 8:85,798,106...85,801,790
Ensembl chr 8:85,798,386...85,801,791
G
Dhrs1
dehydrogenase/reductase 1
increases expression
ISO
Vitamin E results in increased expression of DHRS1 mRNA
CTD
PMID:19244175
NCBI chr14:55,976,477...55,983,147
Ensembl chr14:55,976,477...55,983,147
G
Dhrs4
dehydrogenase/reductase 4
increases expression
ISO
Vitamin E results in increased expression of DHRS4 mRNA
CTD
PMID:19244175
NCBI chr14:55,715,880...55,727,797
Ensembl chr14:55,716,215...55,727,797
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
Vitamin E results in decreased expression of DHX9 mRNA
CTD
PMID:19244175
NCBI chr 1:153,331,506...153,363,464
Ensembl chr 1:153,331,504...153,363,406
G
Diablo
diablo, IAP-binding mitochondrial protein
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of DIABLO protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate affects the localization of DIABLO protein]
CTD
PMID:15566391 PMID:16054126
NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
G
Dicer1
dicer 1, ribonuclease type III
decreases expression
ISO
Vitamin E results in decreased expression of DICER1 mRNA
CTD
PMID:19244175
NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211
G
Dio2
deiodinase, iodothyronine, type II
increases expression
ISO
Vitamin E results in increased expression of DIO2 mRNA
CTD
PMID:19244175
NCBI chr12:90,691,326...90,705,812
Ensembl chr12:90,691,326...90,705,812
G
Dlst
dihydrolipoamide S-succinyltransferase
increases expression
ISO
Vitamin E results in increased expression of DLST mRNA
CTD
PMID:19244175
NCBI chr12:85,157,597...85,180,865
Ensembl chr12:85,157,607...85,181,619
G
Dmtf1
cyclin D binding myb like transcription factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DMTF1 mRNA Vitamin E results in decreased expression of DMTF1 mRNA
CTD
PMID:19244175
NCBI chr 5:9,168,868...9,211,782
Ensembl chr 5:9,168,801...9,211,776
G
Dnaja3
DnaJ heat shock protein family (Hsp40) member A3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJA3 mRNA Vitamin E results in decreased expression of DNAJA3 mRNA
CTD
PMID:19244175
NCBI chr16:4,501,934...4,525,559
Ensembl chr16:4,457,853...4,525,559
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
ISO
Vitamin E results in decreased expression of DNAJB4 mRNA
CTD
PMID:19244175
NCBI chr 3:151,887,217...151,915,720
Ensembl chr 3:151,884,148...151,915,939
G
Dnajc2
DnaJ heat shock protein family (Hsp40) member C2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of DNAJC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DNAJC2 mRNA
CTD
PMID:19244175
NCBI chr 5:21,962,279...21,990,183
Ensembl chr 5:21,962,265...21,990,249
G
Dnajc3
DnaJ heat shock protein family (Hsp40) member C3
decreases expression
ISO
Vitamin E results in decreased expression of DNAJC3 mRNA
CTD
PMID:19244175
NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109
G
Dnajc7
DnaJ heat shock protein family (Hsp40) member C7
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of DNAJC7 mRNA Vitamin E results in increased expression of DNAJC7 mRNA
CTD
PMID:19244175
NCBI chr11:100,473,644...100,511,030
Ensembl chr11:100,473,644...100,511,014
G
Dnmt1
DNA methyltransferase 1
increases expression
ISO
Vitamin E results in increased expression of DNMT1 mRNA
CTD
PMID:29854080
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dnmt3a
DNA methyltransferase 3A
decreases expression
ISO
Vitamin E results in decreased expression of DNMT3A mRNA
CTD
PMID:19244175
NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
increases expression
ISO
Vitamin E results in increased expression of DNPH1 mRNA
CTD
PMID:19244175
NCBI chr17:46,807,715...46,810,544
Ensembl chr17:46,807,637...46,810,550
G
Dock1
dedicator of cytokinesis 1
decreases expression
ISO
Vitamin E results in decreased expression of DOCK1 mRNA
CTD
PMID:19244175
NCBI chr 7:134,272,416...134,775,376
Ensembl chr 7:134,272,383...134,775,368
G
Dohh
deoxyhypusine hydroxylase/monooxygenase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of DOHH mRNA Vitamin E results in increased expression of DOHH mRNA
CTD
PMID:19244175
NCBI chr10:81,220,268...81,224,186
Ensembl chr10:81,220,262...81,224,186
G
Dok1
docking protein 1
increases expression
ISO
Vitamin E results in increased expression of DOK1 mRNA
CTD
PMID:19244175
NCBI chr 6:83,007,915...83,010,448
Ensembl chr 6:83,007,915...83,010,452
G
Dpt
dermatopontin
increases expression
ISO
Vitamin E results in increased expression of DPT mRNA
CTD
PMID:19244175
NCBI chr 1:164,624,232...164,651,843
Ensembl chr 1:164,624,213...164,651,835
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
Vitamin E results in increased expression of DPYSL3 mRNA
CTD
PMID:19244175
NCBI chr18:43,454,044...43,571,354
Ensembl chr18:43,454,049...43,571,351
G
Dr1
down-regulator of transcription 1
decreases expression
ISO
Vitamin E results in decreased expression of DR1 mRNA
CTD
PMID:19244175
NCBI chr 5:108,416,763...108,428,387
Ensembl chr 5:108,416,763...108,428,392
G
Drg2
developmentally regulated GTP binding protein 2
increases expression
ISO
Vitamin E results in increased expression of DRG2 mRNA
CTD
PMID:19244175
NCBI chr11:60,345,442...60,359,589
Ensembl chr11:60,345,417...60,359,580
G
Dsc2
desmocollin 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of DSC2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of DSC2 mRNA
CTD
PMID:19244175
NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611
G
Dxo
decapping exoribonuclease
increases expression
ISO
Vitamin E results in increased expression of DXO mRNA
CTD
PMID:19244175
NCBI chr17:35,055,998...35,058,162
Ensembl chr17:35,055,995...35,058,209
G
Dync1h1
dynein cytoplasmic 1 heavy chain 1
increases expression
ISO
Vitamin E results in increased expression of DYNC1H1 mRNA
CTD
PMID:19244175
NCBI chr12:110,567,829...110,633,378
Ensembl chr12:110,567,886...110,633,379
G
E2f6
E2F transcription factor 6
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of E2F6 mRNA Vitamin E results in decreased expression of E2F6 mRNA
CTD
PMID:19244175
NCBI chr12:16,860,932...16,876,753
Ensembl chr12:16,860,964...16,889,743
G
Echdc2
enoyl Coenzyme A hydratase domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of ECHDC2 mRNA
CTD
PMID:19244175
NCBI chr 4:108,022,630...108,036,505
Ensembl chr 4:108,022,634...108,036,505
G
Ecsit
ECSIT signalling integrator
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ECSIT mRNA [Selenium co-treated with Vitamin E] results in increased expression of ECSIT mRNA
CTD
PMID:19244175
NCBI chr 9:21,982,731...21,997,648
Ensembl chr 9:21,983,542...21,996,734
G
Eda
ectodysplasin-A
decreases expression
ISO
Vitamin E results in decreased expression of EDA mRNA
CTD
PMID:19244175
NCBI chr X:99,019,212...99,444,366
Ensembl chr X:99,019,212...99,444,368
G
Edem3
ER degradation enhancer, mannosidase alpha-like 3
decreases expression
ISO
Vitamin E results in decreased expression of EDEM3 mRNA
CTD
PMID:19244175
NCBI chr 1:151,631,099...151,698,079
Ensembl chr 1:151,631,122...151,697,802
G
Edf1
endothelial differentiation-related factor 1
increases expression
ISO
Vitamin E results in increased expression of EDF1 mRNA
CTD
PMID:19244175
NCBI chr 2:25,447,838...25,452,096
Ensembl chr 2:25,447,859...25,452,094
G
Ednra
endothelin receptor type A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EDNRA mRNA Vitamin E results in decreased expression of EDNRA mRNA
CTD
PMID:19244175
NCBI chr 8:78,389,658...78,451,081
Ensembl chr 8:78,389,660...78,451,093
G
Eef1a2
eukaryotic translation elongation factor 1 alpha 2
increases expression multiple interactions
ISO
Vitamin E results in increased expression of EEF1A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EEF1A2 mRNA
CTD
PMID:19244175
NCBI chr 2:180,783,551...180,798,808
Ensembl chr 2:180,789,446...180,798,807
G
Eef1d
eukaryotic translation elongation factor 1 delta
increases expression
ISO
Vitamin E results in increased expression of EEF1D mRNA
CTD
PMID:19244175
NCBI chr15:75,766,643...75,781,425
Ensembl chr15:75,766,054...75,781,405
G
Eef2
eukaryotic translation elongation factor 2
multiple interactions increases expression
ISO
Vitamin E analog inhibits the reaction [cumene hydroperoxide results in decreased expression of EEF2 protein] Vitamin E analog results in increased expression of EEF2 protein
CTD
PMID:17510559
NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332
G
Efcab14
EF-hand calcium binding domain 14
increases expression
ISO
Vitamin E results in increased expression of EFCAB14 mRNA
CTD
PMID:19244175
NCBI chr 4:115,594,914...115,634,590
Ensembl chr 4:115,594,941...115,634,524
G
Efemp2
epidermal growth factor-containing fibulin-like extracellular matrix protein 2
increases expression
ISO
Vitamin E results in increased expression of EFEMP2 mRNA
CTD
PMID:19244175
NCBI chr19:5,523,974...5,532,548
Ensembl chr19:5,523,982...5,532,545
G
Efhc1
EF-hand domain (C-terminal) containing 1
decreases expression
ISO
Vitamin E results in decreased expression of EFHC1 mRNA
CTD
PMID:19244175
NCBI chr 1:21,021,776...21,061,065
Ensembl chr 1:21,021,850...21,061,065
G
Efhd2
EF hand domain containing 2
increases expression
ISO
Vitamin E results in increased expression of EFHD2 mRNA
CTD
PMID:19244175
NCBI chr 4:141,585,453...141,602,231
Ensembl chr 4:141,585,453...141,602,231
G
Egfr
epidermal growth factor receptor
decreases expression
ISO
Vitamin E results in decreased expression of EGFR mRNA
CTD
PMID:19244175
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Egln2
egl-9 family hypoxia-inducible factor 2
increases expression
ISO
Vitamin E results in increased expression of EGLN2 mRNA
CTD
PMID:19244175
NCBI chr 7:26,858,083...26,866,227
Ensembl chr 7:26,858,083...26,866,227
G
Egr1
early growth response 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of EGR1 mRNA [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA
CTD
PMID:11444866 PMID:19244175
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Ehbp1
EH domain binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of EHBP1 mRNA
CTD
PMID:19244175
NCBI chr11:21,955,825...22,237,086
Ensembl chr11:21,955,828...22,292,292
G
Ehd2
EH-domain containing 2
increases expression
ISO
Vitamin E results in increased expression of EHD2 mRNA
CTD
PMID:19244175
NCBI chr 7:15,680,883...15,701,402
Ensembl chr 7:15,680,883...15,701,492
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
decreases expression
ISO
Vitamin E results in decreased expression of EIF2AK2 mRNA
CTD
PMID:19244175
NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002
G
Eif2b2
eukaryotic translation initiation factor 2B, subunit 2 beta
increases expression
ISO
Vitamin E results in increased expression of EIF2B2 mRNA
CTD
PMID:19244175
NCBI chr12:85,266,255...85,273,402
Ensembl chr12:85,266,255...85,273,402
G
Eif3a
eukaryotic translation initiation factor 3, subunit A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EIF3A mRNA Vitamin E results in decreased expression of EIF3A mRNA
CTD
PMID:19244175
NCBI chr19:60,749,554...60,779,131
Ensembl chr19:60,749,555...60,779,096
G
Eif3b
eukaryotic translation initiation factor 3, subunit B
increases expression
ISO
Vitamin E results in increased expression of EIF3B mRNA
CTD
PMID:19244175
NCBI chr 5:140,405,060...140,429,113
Ensembl chr 5:140,405,083...140,429,115
G
Eif3k
eukaryotic translation initiation factor 3, subunit K
increases expression
ISO
Vitamin E results in increased expression of EIF3K mRNA
CTD
PMID:19244175
NCBI chr 7:28,670,797...28,681,322
Ensembl chr 7:28,670,797...28,681,289
G
Eif4a1
eukaryotic translation initiation factor 4A1
increases expression
ISO
Vitamin E results in increased expression of EIF4A1 mRNA
CTD
PMID:19244175
NCBI chr11:69,557,762...69,563,249
Ensembl chr11:69,557,762...69,563,249
G
Eif4ebp2
eukaryotic translation initiation factor 4E binding protein 2
increases expression
ISO
Vitamin E results in increased expression of EIF4EBP2 mRNA
CTD
PMID:19244175
NCBI chr10:61,268,276...61,288,448
Ensembl chr10:61,264,270...61,288,440
G
Eif4g1
eukaryotic translation initiation factor 4, gamma 1
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EIF4G1 mRNA Vitamin E results in increased expression of EIF4G1 mRNA Vitamin E results in decreased expression of EIF4G1 mRNA
CTD
PMID:19244175
NCBI chr16:20,491,457...20,511,633
Ensembl chr16:20,487,063...20,511,634
G
Eif5
eukaryotic translation initiation factor 5
decreases expression
ISO
Vitamin E results in decreased expression of EIF5 mRNA
CTD
PMID:19244175
NCBI chr12:111,504,535...111,513,187
Ensembl chr12:111,504,450...111,513,186
G
Eif5a
eukaryotic translation initiation factor 5A
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EIF5A mRNA Vitamin E results in increased expression of EIF5A mRNA Vitamin E results in decreased expression of EIF5A mRNA
CTD
PMID:19244175
NCBI chr11:69,807,538...69,812,784
Ensembl chr11:69,807,540...69,812,784
G
Eif5b
eukaryotic translation initiation factor 5B
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IF2 mRNA Vitamin E results in decreased expression of IF2 mRNA
CTD
PMID:19244175
NCBI chr 1:38,037,091...38,094,660
Ensembl chr 1:38,037,091...38,094,660
G
Eif6
eukaryotic translation initiation factor 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EIF6 mRNA Vitamin E results in increased expression of EIF6 mRNA
CTD
PMID:19244175
NCBI chr 2:155,661,757...155,668,845
Ensembl chr 2:155,661,752...155,668,845
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
Vitamin E results in decreased expression of ELF1 mRNA
CTD
PMID:19244175
NCBI chr14:79,718,619...79,819,916
Ensembl chr14:79,718,634...79,819,934
G
Elk1
ELK1, member of ETS oncogene family
increases phosphorylation
ISO
Vitamin E results in increased phosphorylation of ELK1 protein
CTD
PMID:11522656
NCBI chr X:20,799,634...20,816,847
Ensembl chr X:20,799,634...20,816,847
G
Eloa
elongin A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ELOA mRNA Vitamin E results in decreased expression of ELOA mRNA
CTD
PMID:19244175
NCBI chr 4:135,730,681...135,748,960
Ensembl chr 4:135,730,679...135,749,074
G
Emc6
ER membrane protein complex subunit 6
increases expression
ISO
Vitamin E results in increased expression of EMC6 mRNA
CTD
PMID:19244175
NCBI chr11:73,066,329...73,067,868
Ensembl chr11:73,066,345...73,067,863
G
Emc9
ER membrane protein complex subunit 9
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EMC9 mRNA Vitamin E results in increased expression of EMC9 mRNA
CTD
PMID:19244175
NCBI chr14:55,818,976...55,822,832
Ensembl chr14:55,818,973...55,822,759
G
Emilin1
elastin microfibril interfacer 1
increases expression
ISO
Vitamin E results in increased expression of EMILIN1 mRNA
CTD
PMID:19244175
NCBI chr 5:31,070,729...31,078,623
Ensembl chr 5:31,070,746...31,078,621
G
Eml2
echinoderm microtubule associated protein like 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of EML2 mRNA Vitamin E results in increased expression of EML2 mRNA
CTD
PMID:19244175
NCBI chr 7:18,910,322...18,940,407
Ensembl chr 7:18,910,346...18,940,407
G
Emp3
epithelial membrane protein 3
increases expression
ISO
Vitamin E results in increased expression of EMP3 mRNA
CTD
PMID:19244175
NCBI chr 7:45,567,447...45,570,850
Ensembl chr 7:45,567,447...45,570,828
G
Emsy
EMSY, BRCA2-interacting transcriptional repressor
decreases expression
ISO
Vitamin E results in decreased expression of EMSY mRNA
CTD
PMID:19244175
NCBI chr 7:98,236,344...98,308,779
Ensembl chr 7:98,236,344...98,305,990
G
Endog
endonuclease G
increases expression
ISO
Vitamin E results in increased expression of ENDOG mRNA
CTD
PMID:19244175
NCBI chr 2:30,061,525...30,064,057
Ensembl chr 2:30,061,505...30,064,081
G
Eno1
enolase 1, alpha non-neuron
increases expression
ISO
Vitamin E results in increased expression of ENO1 mRNA
CTD
PMID:19244175
NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 Ensembl chr18:150,321,178...150,333,336
G
Eno2
enolase 2, gamma neuronal
increases expression
ISO
Vitamin E results in increased expression of ENO2 mRNA
CTD
PMID:19244175
NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636
G
Entpd1
ectonucleoside triphosphate diphosphohydrolase 1
increases expression
ISO
Vitamin E results in increased expression of ENTPD1 mRNA
CTD
PMID:19244175
NCBI chr19:40,600,810...40,730,046
Ensembl chr19:40,600,810...40,730,046
G
Entpd5
ectonucleoside triphosphate diphosphohydrolase 5
decreases expression
ISO
Vitamin E results in decreased expression of ENTPD5 mRNA
CTD
PMID:19244175
NCBI chr12:84,420,649...84,455,803
Ensembl chr12:84,420,631...84,455,803
G
Epb41l2
erythrocyte membrane protein band 4.1 like 2
increases expression
ISO
Vitamin E results in increased expression of EPB41L2 mRNA
CTD
PMID:19244175
NCBI chr10:25,235,680...25,399,413
Ensembl chr10:25,235,696...25,399,417
G
Epn2
epsin 2
increases expression
ISO
Vitamin E results in increased expression of EPN2 mRNA
CTD
PMID:19244175
NCBI chr11:61,406,709...61,470,560
Ensembl chr11:61,408,075...61,470,513
G
Erbb2
erb-b2 receptor tyrosine kinase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ERBB2 mRNA
CTD
PMID:19244175
NCBI chr11:98,303,310...98,328,542
Ensembl chr11:98,303,296...98,328,542
G
Ercc1
excision repair cross-complementing rodent repair deficiency, complementation group 1
increases expression
ISO
Vitamin E results in increased expression of ERCC1 mRNA
CTD
PMID:19244175
NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449
G
Ercc3
excision repair cross-complementing rodent repair deficiency, complementation group 3
increases expression
ISO
Vitamin E results in increased expression of ERCC3 mRNA
CTD
PMID:19244175
NCBI chr18:32,373,357...32,403,206
Ensembl chr18:32,373,353...32,403,204
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions affects expression
ISO
Vitamin E affects the reaction [Doxorubicin affects the expression of ESR1 mRNA] Vitamin E affects the expression of ESR1 mRNA
CTD
PMID:32810592
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esrp2
epithelial splicing regulatory protein 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ESRP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ESRP2 mRNA
CTD
PMID:19244175
NCBI chr 8:106,856,658...106,863,825
Ensembl chr 8:106,856,951...106,863,606
G
Ess2
ess-2 splicing factor
increases expression
ISO
Vitamin E results in increased expression of ESS2 mRNA
CTD
PMID:19244175
NCBI chr16:17,718,573...17,729,225
Ensembl chr16:17,718,573...17,729,212
G
Ets2
E26 avian leukemia oncogene 2, 3' domain
decreases expression
ISO
Vitamin E results in decreased expression of ETS2 mRNA
CTD
PMID:19244175
NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095
G
Evi5
ecotropic viral integration site 5
decreases expression
ISO
Vitamin E results in decreased expression of EVI5 mRNA
CTD
PMID:19244175
NCBI chr 5:107,892,661...108,022,973
Ensembl chr 5:107,892,661...108,022,973
G
Evl
Ena-vasodilator stimulated phosphoprotein
increases expression
ISO
Vitamin E results in increased expression of EVL mRNA
CTD
PMID:19244175
NCBI chr12:108,520,942...108,654,775
Ensembl chr12:108,520,979...108,654,775
G
Ewsr1
Ewing sarcoma breakpoint region 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EWSR1 mRNA Vitamin E results in increased expression of EWSR1 mRNA
CTD
PMID:19244175
NCBI chr11:5,019,687...5,049,314
Ensembl chr11:5,019,689...5,049,266
G
Exoc3
exocyst complex component 3
increases expression
ISO
Vitamin E results in increased expression of SEC6 mRNA
CTD
PMID:19244175
NCBI chr13:74,317,921...74,358,151
Ensembl chr13:74,317,607...74,356,851
G
Exosc4
exosome component 4
increases expression
ISO
Vitamin E results in increased expression of EXOSC4 mRNA
CTD
PMID:19244175
NCBI chr15:76,211,597...76,214,870
Ensembl chr15:76,211,597...76,214,877
G
Ext1
exostosin glycosyltransferase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of EXT1 mRNA Vitamin E results in increased expression of EXT1 mRNA
CTD
PMID:19244175
NCBI chr15:52,931,657...53,209,579
Ensembl chr15:52,927,434...53,209,555
G
Eya2
EYA transcriptional coactivator and phosphatase 2
increases expression
ISO
Vitamin E results in increased expression of EYA2 mRNA
CTD
PMID:19244175
NCBI chr 2:165,436,892...165,613,645
Ensembl chr 2:165,436,952...165,613,647
G
Ezh1
enhancer of zeste 1 polycomb repressive complex 2 subunit
increases expression
ISO
Vitamin E results in increased expression of EZH1 mRNA
CTD
PMID:19244175
NCBI chr11:101,081,941...101,117,268
Ensembl chr11:101,081,941...101,117,289
G
Ezr
ezrin
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of EZR mRNA [Selenium co-treated with Vitamin E] results in decreased expression of EZR mRNA
CTD
PMID:19244175
NCBI chr17:7,005,530...7,050,179
Ensembl chr17:7,005,440...7,050,183
G
F10
coagulation factor X
increases expression
ISO
Vitamin E results in increased expression of F10 mRNA
CTD
PMID:19244175
NCBI chr 8:13,087,308...13,106,676
Ensembl chr 8:13,087,308...13,106,676
G
F2
coagulation factor II
multiple interactions
ISO
Vitamin E results in decreased expression of and results in decreased activity of F2 protein
CTD
PMID:10216089
NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759
G
F2r
coagulation factor II thrombin receptor
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of F2R mRNA [Selenium co-treated with Vitamin E] results in increased expression of F2R mRNA
CTD
PMID:19244175
NCBI chr13:95,738,288...95,754,974
Ensembl chr13:95,738,311...95,754,995
G
F3
coagulation factor III
multiple interactions
ISO
Vitamin E inhibits the reaction [Copper results in increased activity of F3 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of F3 mRNA]; Vitamin E results in decreased expression of and results in decreased activity of F3 protein
CTD
PMID:7600656 PMID:10216089 PMID:23114885
NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697
G
Fabp3
fatty acid binding protein 3, muscle and heart
increases expression
ISO
Vitamin E results in increased expression of FABP3 mRNA
CTD
PMID:19244175
NCBI chr 4:130,202,531...130,209,256
Ensembl chr 4:130,202,388...130,209,256
G
Faim
Fas apoptotic inhibitory molecule
increases expression
ISO
Vitamin E results in increased expression of FAIM mRNA
CTD
PMID:19244175
NCBI chr 9:98,868,426...98,884,076
Ensembl chr 9:98,868,426...98,884,074
G
Fam107a
family with sequence similarity 107, member A
increases expression
ISO
Vitamin E results in increased expression of FAM107A mRNA
CTD
PMID:19244175
NCBI chr14:14,152,166...14,173,503
Ensembl chr14:14,151,750...14,173,499
G
Fam111a
family with sequence similarity 111, member A
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of FAM111A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of FAM111A mRNA
CTD
PMID:19244175
NCBI chr19:12,550,874...12,567,133
Ensembl chr19:12,523,104...12,567,132
G
Fam149a
family with sequence similarity 149, member A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FAM149A mRNA Vitamin E results in decreased expression of FAM149A mRNA
CTD
PMID:19244175
NCBI chr 8:45,789,752...45,835,328
Ensembl chr 8:45,789,754...45,835,328
G
Fam174c
family with sequence similarity 174, member C
decreases expression
ISO
Vitamin E results in decreased expression of FAM174C mRNA
CTD
PMID:19244175
NCBI chr10:80,008,778...80,010,953
Ensembl chr10:80,008,778...80,010,980
G
Fam222b
family with sequence similarity 222, member B
decreases expression
ISO
Vitamin E results in decreased expression of FAM222B mRNA
CTD
PMID:19244175
NCBI chr11:77,985,516...78,048,165
Ensembl chr11:77,985,486...78,047,526
G
Fam3a
FAM3 metabolism regulating signaling molecule A
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FAM3A mRNA
CTD
PMID:19244175
NCBI chr X:73,427,816...73,436,856
Ensembl chr X:73,428,325...73,436,878
G
Fam53b
family with sequence similarity 53, member B
increases expression
ISO
Vitamin E results in increased expression of FAM53B mRNA
CTD
PMID:19244175
NCBI chr 7:132,313,813...132,429,518
Ensembl chr 7:132,313,811...132,415,615
G
Fam89b
family with sequence similarity 89, member B
increases expression
ISO
Vitamin E results in increased expression of FAM89B mRNA
CTD
PMID:19244175
NCBI chr19:5,778,115...5,779,694
Ensembl chr19:5,778,115...5,779,681
G
Farsa
phenylalanyl-tRNA synthetase, alpha subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FARSA mRNA Vitamin E results in increased expression of FARSA mRNA
CTD
PMID:19244175
NCBI chr 8:85,583,597...85,595,886
Ensembl chr 8:85,583,618...85,595,886
G
Fastkd3
FAST kinase domains 3
decreases expression
ISO
Vitamin E results in decreased expression of FASTKD3 mRNA
CTD
PMID:19244175
NCBI chr13:68,730,281...68,740,457
Ensembl chr13:68,730,353...68,740,457
G
Fat4
FAT atypical cadherin 4
decreases expression
ISO
Vitamin E results in decreased expression of FAT4 mRNA
CTD
PMID:19244175
NCBI chr 3:38,939,867...39,066,134
Ensembl chr 3:38,941,089...39,066,134
G
Fbln1
fibulin 1
increases expression
ISO
Vitamin E results in increased expression of FBLN1 mRNA
CTD
PMID:19244175
NCBI chr15:85,090,150...85,170,495
Ensembl chr15:85,090,150...85,170,736
G
Fbxl7
F-box and leucine-rich repeat protein 7
increases expression
ISO
Vitamin E results in increased expression of FBXL7 mRNA
CTD
PMID:19244175
NCBI chr15:26,540,540...26,895,650
Ensembl chr15:26,540,545...26,895,666
G
Fbxo17
F-box protein 17
increases expression
ISO
Vitamin E results in increased expression of FBXO17 mRNA
CTD
PMID:19244175
NCBI chr 7:28,416,176...28,437,570
Ensembl chr 7:28,416,229...28,437,569
G
Fbxo28
F-box protein 28
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FBXO28 mRNA
CTD
PMID:19244175
NCBI chr 1:182,140,667...182,169,171
Ensembl chr 1:182,140,667...182,169,194
G
Fbxo31
F-box protein 31
increases expression
ISO
Vitamin E results in increased expression of FBXO31 mRNA
CTD
PMID:19244175
NCBI chr 8:122,276,182...122,305,607
Ensembl chr 8:122,276,179...122,305,545
G
Fbxw2
F-box and WD-40 domain protein 2
increases expression
ISO
Vitamin E results in increased expression of FBXW2 mRNA
CTD
PMID:19244175
NCBI chr 2:34,694,185...34,716,229
Ensembl chr 2:34,694,526...34,716,323
G
Fech
ferrochelatase
decreases expression
ISO
Vitamin E results in decreased expression of FECH mRNA
CTD
PMID:19244175
NCBI chr18:64,589,613...64,622,169
Ensembl chr18:64,585,985...64,623,322
G
Fermt1
fermitin family member 1
decreases expression
ISO
Vitamin E results in decreased expression of FERMT1 mRNA
CTD
PMID:19244175
NCBI chr 2:132,746,097...132,787,956
Ensembl chr 2:132,746,309...132,787,826
G
Fgg
fibrinogen gamma chain
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of FGG mRNA
CTD
PMID:11444866
NCBI chr 3:82,915,031...82,922,363
Ensembl chr 3:82,915,031...82,922,356
G
Fibp
fibroblast growth factor (acidic) intracellular binding protein
increases expression
ISO
Vitamin E results in increased expression of FIBP mRNA
CTD
PMID:19244175
NCBI chr19:5,510,626...5,515,080
Ensembl chr19:5,510,643...5,515,079
G
Fig4
FIG4 phosphoinositide 5-phosphatase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FIG4 mRNA Vitamin E results in decreased expression of FIG4 mRNA
CTD
PMID:19244175
NCBI chr10:41,064,168...41,179,237
Ensembl chr10:41,064,168...41,179,256
G
Fis1
fission, mitochondrial 1
increases expression
ISO
Vitamin E results in increased expression of FIS1 mRNA
CTD
PMID:19244175
NCBI chr 5:136,982,129...136,995,088
Ensembl chr 5:136,982,129...136,995,088
G
Fkbp1a
FK506 binding protein 1a
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FKBP1A mRNA Vitamin E results in increased expression of FKBP1A mRNA
CTD
PMID:19244175
NCBI chr 2:151,384,403...151,403,611
Ensembl chr 2:151,384,403...151,403,612
G
Flii
flightless I actin binding protein
increases expression
ISO
Vitamin E results in increased expression of FLII mRNA
CTD
PMID:19244175
NCBI chr11:60,604,969...60,618,089
Ensembl chr11:60,604,949...60,618,089
G
Flna
filamin, alpha
increases expression
ISO
Vitamin E results in increased expression of FLNA mRNA
CTD
PMID:19244175
NCBI chr X:73,267,067...73,293,787
Ensembl chr X:73,267,067...73,293,426
G
Flot1
flotillin 1
increases expression
ISO
Vitamin E results in increased expression of FLOT1 mRNA
CTD
PMID:19244175
NCBI chr17:36,134,243...36,143,674
Ensembl chr17:36,134,122...36,143,683
G
Flrt3
fibronectin leucine rich transmembrane protein 3
decreases expression
ISO
Vitamin E results in decreased expression of FLRT3 mRNA
CTD
PMID:19244175
NCBI chr 2:140,500,118...140,513,396
Ensembl chr 2:140,492,834...140,513,389
G
Fmo5
flavin containing monooxygenase 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of FMO5 mRNA Vitamin E results in decreased expression of FMO5 mRNA
CTD
PMID:19244175
NCBI chr 3:97,517,248...97,562,603
Ensembl chr 3:97,536,120...97,562,598
G
Fnbp1
formin binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of FNBP1 mRNA
CTD
PMID:19244175
NCBI chr 2:30,916,218...31,032,046
Ensembl chr 2:30,916,218...31,032,020
G
Fnbp4
formin binding protein 4
decreases expression
ISO
Vitamin E results in decreased expression of FNBP4 mRNA
CTD
PMID:19244175
NCBI chr 2:90,575,793...90,611,365
Ensembl chr 2:90,575,714...90,611,365
G
Folh1
folate hydrolase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of FOLH1 mRNA Vitamin E results in decreased expression of FOLH1 mRNA
CTD
PMID:19244175
NCBI chr 7:86,365,733...86,425,171
Ensembl chr 7:86,368,185...86,425,151
G
Fos
FBJ osteosarcoma oncogene
multiple interactions
EXP
Vitamin E promotes the reaction [Alcohols results in increased expression of FOS mRNA]
CTD
PMID:18814483
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Foxa2
forkhead box A2
multiple interactions
ISO
Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of FOXA2 mRNA]
CTD
PMID:16490937 PMID:16863852
NCBI chr 2:147,884,797...147,888,889
Ensembl chr 2:147,884,797...147,888,889
G
Foxe1
forkhead box E1
decreases expression
ISO
Vitamin E results in decreased expression of FOXE1 mRNA
CTD
PMID:19244175
NCBI chr 4:46,343,644...46,345,774
Ensembl chr 4:46,343,609...46,346,412
G
Foxf2
forkhead box F2
decreases expression
ISO
Vitamin E results in decreased expression of FOXF2 mRNA
CTD
PMID:19244175
NCBI chr13:31,809,686...31,815,390
Ensembl chr13:31,809,799...31,815,386
G
Foxm1
forkhead box M1
decreases expression
ISO
Vitamin E results in decreased expression of FOXM1 mRNA
CTD
PMID:19244175
NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
G
Foxo1
forkhead box O1
decreases expression
ISO
Vitamin E results in decreased expression of FOXO1 mRNA
CTD
PMID:19244175
NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642
G
Frat1
frequently rearranged in advanced T cell lymphomas
increases expression
ISO
Vitamin E results in increased expression of FRAT1 mRNA
CTD
PMID:19244175
NCBI chr19:41,818,409...41,821,022
Ensembl chr19:41,818,409...41,821,022
G
Fshb
follicle stimulating hormone beta
multiple interactions
ISO
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of FSHB protein]; Vitamin E inhibits the reaction [Petroleum results in increased expression of FSHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in increased expression of FSHB protein]
CTD
PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308
NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001
G
Fst
follistatin
increases expression
ISO
Vitamin E results in increased expression of FST mRNA
CTD
PMID:19244175
NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
G
Ftsj1
FtsJ RNA 2'-O-methyltransferase 1
decreases expression
ISO
Vitamin E results in decreased expression of FTSJ1 mRNA
CTD
PMID:19244175
NCBI chr X:8,104,907...8,118,609
Ensembl chr X:8,104,907...8,118,645
G
Fus
fused in sarcoma
increases expression
ISO
Vitamin E results in increased expression of FUS mRNA
CTD
PMID:19244175
NCBI chr 7:127,565,276...127,581,204
Ensembl chr 7:127,566,629...127,584,873
G
Fxr1
FMR1 autosomal homolog 1
decreases expression
ISO
Vitamin E results in decreased expression of FXR1 mRNA
CTD
PMID:19244175
NCBI chr 3:34,074,133...34,124,129
Ensembl chr 3:34,074,092...34,124,471
G
Fxr2
FMR1 autosomal homolog 2
increases expression
ISO
Vitamin E results in increased expression of FXR2 mRNA
CTD
PMID:19244175
NCBI chr11:69,523,788...69,544,123
Ensembl chr11:69,523,816...69,544,123
G
Fxyd6
FXYD domain-containing ion transport regulator 6
increases expression
ISO
Vitamin E results in increased expression of FXYD6 mRNA
CTD
PMID:19244175
NCBI chr 9:45,280,768...45,307,457
Ensembl chr 9:45,281,483...45,307,457
G
Fzr1
fizzy and cell division cycle 20 related 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of FZR1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of FZR1 mRNA
CTD
PMID:19244175
NCBI chr10:81,202,713...81,214,204
Ensembl chr10:81,202,056...81,214,350
G
G0s2
G0/G1 switch gene 2
increases expression
ISO
Vitamin E results in increased expression of G0S2 mRNA
CTD
PMID:19244175
NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
G
G6pdx
glucose-6-phosphate dehydrogenase X-linked
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [sodium arsenite results in decreased activity of G6PD protein] Vitamin E inhibits the reaction [Atrazine results in decreased activity of G6PD protein]
CTD
PMID:19635623 PMID:20136348
NCBI chr X:73,453,089...73,472,486
Ensembl chr X:73,453,089...73,472,800
G
Gab2
growth factor receptor bound protein 2-associated protein 2
increases expression
ISO
Vitamin E results in increased expression of GAB2 mRNA
CTD
PMID:19244175
NCBI chr 7:96,730,958...96,958,158
Ensembl chr 7:96,730,793...96,958,153
G
Gabpb2
GA repeat binding protein, beta 2
decreases expression
ISO
Vitamin E results in decreased expression of GABPB2 mRNA
CTD
PMID:19244175
NCBI chr 3:95,089,077...95,125,291
Ensembl chr 3:95,089,077...95,125,227
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GADD45A mRNA Vitamin E results in decreased expression of GADD45A mRNA
CTD
PMID:19244175
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Gak
cyclin G associated kinase
decreases expression
ISO
Vitamin E results in decreased expression of GAK mRNA
CTD
PMID:19244175
NCBI chr 5:108,716,973...108,777,643
Ensembl chr 5:108,717,277...108,777,621
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GALNT1 mRNA Vitamin E results in decreased expression of GALNT1 mRNA
CTD
PMID:19244175
NCBI chr18:24,338,401...24,419,873
Ensembl chr18:24,338,401...24,419,875
G
Galnt10
polypeptide N-acetylgalactosaminyltransferase 10
decreases expression
ISO
Vitamin E results in decreased expression of GALNT10 mRNA
CTD
PMID:19244175
NCBI chr11:57,536,268...57,678,327
Ensembl chr11:57,536,268...57,678,340
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
decreases expression
ISO
Vitamin E results in decreased expression of GALNT3 mRNA
CTD
PMID:19244175
NCBI chr 2:65,913,110...65,955,217
Ensembl chr 2:65,913,110...65,955,338
G
Galr3
galanin receptor 3
increases expression
ISO
Vitamin E results in increased expression of GALR3 mRNA
CTD
PMID:19244175
NCBI chr15:78,926,085...78,927,758
Ensembl chr15:78,926,085...78,927,758
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
Vitamin E results in increased expression of GAPDH mRNA
CTD
PMID:19244175
NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430
G
Gas8
growth arrest specific 8
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GAS8 mRNA Vitamin E results in increased expression of GAS8 mRNA
CTD
PMID:19244175
NCBI chr 8:124,245,630...124,263,394
Ensembl chr 8:124,245,573...124,263,389
G
Gata4
GATA binding protein 4
affects expression
ISO
Vitamin E affects the expression of GATA4 mRNA
CTD
PMID:15370891
NCBI chr14:63,436,363...63,509,161
Ensembl chr14:63,436,371...63,509,141
G
Gatad1
GATA zinc finger domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of GATAD1 mRNA
CTD
PMID:19244175
NCBI chr 5:3,689,961...3,697,936
Ensembl chr 5:3,682,932...3,707,185
G
Gatd3a
glutamine amidotransferase like class 1 domain containing 3A
increases expression
ISO
Vitamin E results in increased expression of GATD3 mRNA
CTD
PMID:19244175
NCBI chr10:77,997,900...78,005,589
Ensembl chr10:77,997,900...78,005,616
G
Gbp2b
guanylate binding protein 2b
decreases expression
ISO
Vitamin E results in decreased expression of GBP1 mRNA
CTD
PMID:19244175
NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940
G
Gcfc2
GC-rich sequence DNA binding factor 2
decreases expression
ISO
Vitamin E results in decreased expression of GCFC2 mRNA
CTD
PMID:19244175
NCBI chr 6:81,887,543...81,936,079
Ensembl chr 6:81,900,650...81,936,896
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions affects expression
EXP ISO
Vitamin E inhibits the reaction [Alcohols results in increased expression of GCLC mRNA] [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA; Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA] Vitamin E affects the expression of GCLC mRNA; Vitamin E affects the expression of GCLC protein
CTD
PMID:11444866 PMID:16298738 PMID:18814483
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
multiple interactions affects expression
ISO
Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] Vitamin E affects the expression of GCLM mRNA
CTD
PMID:16298738 PMID:20447326
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gdap1l1
ganglioside-induced differentiation-associated protein 1-like 1
decreases expression
ISO
Vitamin E results in decreased expression of GDAP1L1 mRNA
CTD
PMID:19244175
NCBI chr 2:163,280,387...163,297,264
Ensembl chr 2:163,280,396...163,297,244
G
Gdi1
GDP dissociation inhibitor 1
increases expression
ISO
Vitamin E results in increased expression of GDI1 mRNA
CTD
PMID:19244175
NCBI chr X:73,348,618...73,355,473
Ensembl chr X:73,348,604...73,355,468
G
Gfap
glial fibrillary acidic protein
multiple interactions
ISO
Vitamin E inhibits the reaction [Aluminum results in increased expression of GFAP protein]
CTD
PMID:16545059
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gfod1
glucose-fructose oxidoreductase domain containing 1
increases expression
ISO
Vitamin E results in increased expression of GFOD1 mRNA
CTD
PMID:19244175
NCBI chr13:43,348,716...43,457,648
Ensembl chr13:43,348,721...43,457,648
G
Gfus
GDP-L-fucose synthase
increases expression
ISO
Vitamin E results in increased expression of GFUS mRNA
CTD
PMID:19244175
NCBI chr15:75,796,532...75,801,613
Ensembl chr15:75,796,525...75,801,681
G
Ggps1
geranylgeranyl diphosphate synthase 1
decreases expression
ISO
Vitamin E results in decreased expression of GGPS1 mRNA
CTD
PMID:19244175
NCBI chr13:14,224,375...14,238,319
Ensembl chr13:14,225,244...14,238,073
G
Ggt1
gamma-glutamyltransferase 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GGT1 mRNA Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GGT1 protein]
CTD
PMID:16298753 PMID:19244175
NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034
G
Gigyf2
GRB10 interacting GYF protein 2
decreases expression
ISO
Vitamin E results in decreased expression of GIGYF2 mRNA
CTD
PMID:19244175
NCBI chr 1:87,254,653...87,378,532
Ensembl chr 1:87,254,720...87,378,518
G
Gimap5
GTPase, IMAP family member 5
increases expression
ISO
Vitamin E results in increased expression of GIMAP5 mRNA
CTD
PMID:19244175
NCBI chr 6:48,723,131...48,731,134
Ensembl chr 6:48,723,131...48,731,144
G
Gipc1
GIPC PDZ domain containing family, member 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of GIPC1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of GIPC1 mRNA
CTD
PMID:19244175
NCBI chr 8:84,376,037...84,391,418
Ensembl chr 8:84,379,306...84,391,323
G
Gja1
gap junction protein, alpha 1
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of GJA1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of GJA1 protein]
CTD
PMID:29940330
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Glg1
golgi apparatus protein 1
decreases expression increases expression
ISO
Vitamin E results in decreased expression of GLG1 mRNA Vitamin E results in increased expression of GLG1 mRNA
CTD
PMID:19244175
NCBI chr 8:111,879,916...111,985,842
Ensembl chr 8:111,881,053...111,985,848
G
Gli2
GLI-Kruppel family member GLI2
increases expression
ISO
Vitamin E results in increased expression of GLI2 mRNA
CTD
PMID:19244175
NCBI chr 1:118,761,791...118,987,578
Ensembl chr 1:118,761,862...118,981,349
G
Glmn
glomulin, FKBP associated protein
decreases expression
ISO
Vitamin E results in decreased expression of GLMN mRNA
CTD
PMID:19244175
NCBI chr 5:107,696,828...107,745,754
Ensembl chr 5:107,696,833...107,745,754
G
Gm38656
predicted gene, 38656
decreases expression
ISO
Vitamin E results in decreased expression of SCGB1D2 mRNA
CTD
PMID:15084515
NCBI chr19:9,162,589...9,164,383
G
Gmppa
GDP-mannose pyrophosphorylase A
increases expression
ISO
Vitamin E results in increased expression of GMPPA mRNA
CTD
PMID:19244175
NCBI chr 1:75,412,555...75,419,823
Ensembl chr 1:75,412,574...75,419,823
G
Gnas
GNAS complex locus
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GNAS mRNA
CTD
PMID:19244175
NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537
G
Gnaz
guanine nucleotide binding protein, alpha z subunit
increases expression
ISO
Vitamin E results in increased expression of GNAZ mRNA
CTD
PMID:19244175
NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739
G
Gng4
guanine nucleotide binding protein (G protein), gamma 4
decreases expression
ISO
Vitamin E results in decreased expression of GNG4 mRNA
CTD
PMID:19244175
NCBI chr13:13,958,644...14,002,480
Ensembl chr13:13,958,644...14,002,481
G
Golga3
golgin A3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GOLGA3 mRNA Vitamin E results in increased expression of GOLGA3 mRNA
CTD
PMID:19244175
NCBI chr 5:110,324,723...110,374,336
Ensembl chr 5:110,324,567...110,374,336
G
Gosr1
golgi SNAP receptor complex member 1
decreases expression
ISO
Vitamin E results in decreased expression of GOSR1 mRNA
CTD
PMID:19244175
NCBI chr11:76,617,428...76,654,404
Ensembl chr11:76,617,428...76,654,405
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
multiple interactions
ISO
Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GOT1 protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GOT1 protein]
CTD
PMID:30064338 PMID:31618080
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Gp6
glycoprotein 6 platelet
decreases expression
ISO
Vitamin E results in decreased expression of GP6 mRNA
CTD
PMID:19244175
NCBI chr 7:4,365,852...4,400,849
Ensembl chr 7:4,366,964...4,400,743
G
Gpatch8
G patch domain containing 8
decreases expression
ISO
Vitamin E results in decreased expression of GPATCH8 mRNA
CTD
PMID:19244175
NCBI chr11:102,366,737...102,447,217
Ensembl chr11:102,366,741...102,447,218
G
Gpi1
glucose-6-phosphate isomerase 1
increases expression
ISO
Vitamin E results in increased expression of GPI mRNA
CTD
PMID:19244175
NCBI chr 7:33,900,752...33,929,761
Ensembl chr 7:33,900,755...33,929,761
G
Gpkow
G patch domain and KOW motifs
increases expression
ISO
Vitamin E results in increased expression of GPKOW mRNA
CTD
PMID:19244175
NCBI chr X:7,563,373...7,576,500
Ensembl chr X:7,563,370...7,576,501
G
Gpn3
GPN-loop GTPase 3
decreases expression
ISO
Vitamin E results in decreased expression of GPN3 mRNA
CTD
PMID:19244175
NCBI chr 5:122,510,571...122,520,834
Ensembl chr 5:122,509,939...122,520,965
G
Gpr107
G protein-coupled receptor 107
increases expression
ISO
Vitamin E results in increased expression of GPR107 mRNA
CTD
PMID:19244175
NCBI chr 2:31,042,099...31,106,579
Ensembl chr 2:31,042,328...31,108,787
G
Gprin2
G protein regulated inducer of neurite outgrowth 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of GPRIN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GPRIN2 mRNA
CTD
PMID:19244175
NCBI chr14:33,907,645...33,923,649
Ensembl chr14:33,907,645...33,923,610
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions
ISO
[Quercetin co-treated with Vitamin E] inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Cyclophosphamide results in increased expression of GPT protein]; Vitamin E inhibits the reaction [Cyclosporine results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Food Additives results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPT protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of GPT protein]
CTD
PMID:16758767 PMID:17927767 PMID:25779342 PMID:30064338 PMID:31618080
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx1
glutathione peroxidase 1
multiple interactions decreases expression
ISO
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 mRNA; [Vitamin A co-treated with Ascorbic Acid co-treated with Vitamin E] results in increased expression of GPX1 protein; Vitamin E inhibits the reaction [Aluminum results in decreased activity of GPX1 protein] Vitamin E decreases expression of Gpx1 mRNA in distal colon [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of GPX1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased expression of GPX1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GPX1 mRNA; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GPX1 protein]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in increased activity of GPX1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GPX1 mRNA]
CTD RGD
PMID:11444866 PMID:15337585 PMID:16298753 PMID:17179735 PMID:17709913 PMID:19914224 PMID:22207723 PMID:28849685 PMID:29663635 PMID:30064338 PMID:16038882 More...
RGD:152998891
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx2
glutathione peroxidase 2
multiple interactions
ISO
Vitamin E inhibits the reaction [phoxim results in increased expression of GPX2 mRNA]
CTD
PMID:30003487
NCBI chr12:76,839,109...76,842,328
Ensembl chr12:76,839,107...76,842,273
G
Gpx3
glutathione peroxidase 3
increases expression
ISO
Vitamin E results in increased expression of GPX3 mRNA
CTD
PMID:19244175
NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203
G
Grhpr
glyoxylate reductase/hydroxypyruvate reductase
increases expression
ISO
Vitamin E results in increased expression of GRHPR mRNA
CTD
PMID:19244175
NCBI chr 4:44,981,394...44,990,734
Ensembl chr 4:44,981,395...44,990,734
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
decreases expression
ISO
Vitamin E results in decreased expression of GRIA2 mRNA
CTD
PMID:19244175
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Grina
glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of GRINA mRNA
CTD
PMID:19244175
NCBI chr15:76,130,917...76,134,109
Ensembl chr15:76,130,964...76,134,104
G
Grk3
G protein-coupled receptor kinase 3
decreases expression
ISO
Vitamin E results in decreased expression of GRK3 mRNA
CTD
PMID:19244175
NCBI chr 5:113,058,344...113,163,518
Ensembl chr 5:113,058,348...113,163,657
G
Grn
granulin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of GRN mRNA Vitamin E results in increased expression of GRN mRNA
CTD
PMID:19244175
NCBI chr11:102,321,333...102,327,635
Ensembl chr11:102,321,141...102,327,874
G
Gsk3a
glycogen synthase kinase 3 alpha
increases expression
ISO
Vitamin E results in increased expression of GSK3A mRNA
CTD
PMID:19244175
NCBI chr 7:24,927,683...24,937,276
Ensembl chr 7:24,927,683...24,937,276
G
Gsk3b
glycogen synthase kinase 3 beta
multiple interactions decreases expression
ISO EXP
[Selenium co-treated with Vitamin E] results in increased expression of GSK3B mRNA Vitamin E results in decreased expression of GSK3B mRNA Vitamin E inhibits the reaction [wortmannin results in decreased expression of GSK3B protein modified form]
CTD
PMID:15842767 PMID:19244175
NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446
G
Gsn
gelsolin
increases expression
ISO
Vitamin E results in increased expression of GSN mRNA
CTD
PMID:19244175
NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904
G
Gsr
glutathione reductase
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [Cadmium results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Ethanol results in decreased activity of GSR protein] [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]; [Vitamin E co-treated with coenzyme Q10] inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; [Vitamin E co-treated with coenzyme Q10] results in increased activity of GSR protein; [Vitamin E co-treated with Folic Acid] inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium Chloride results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of GSR protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Diethylnitrosamine results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Hydrogen Peroxide results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Methoxychlor results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of GSR protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of GSR mRNA]
CTD
PMID:11955947 PMID:12355564 PMID:14535831 PMID:16144695 PMID:16298753 PMID:17262218 PMID:19914224 PMID:19958828 PMID:21086752 PMID:28849685 More...
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstk1
glutathione S-transferase kappa 1
increases expression
ISO
Vitamin E results in increased expression of GSTK1 mRNA
CTD
PMID:19244175
NCBI chr 6:42,222,869...42,227,375
Ensembl chr 6:42,222,869...42,227,381
G
Gstp1
glutathione S-transferase, pi 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of GSTP1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GSTP1 mRNA
CTD
PMID:19244175
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Gtf2f1
general transcription factor IIF, polypeptide 1
decreases expression
ISO
Vitamin E results in decreased expression of GTF2F1 mRNA
CTD
PMID:19244175
NCBI chr17:57,310,402...57,318,398
Ensembl chr17:57,310,405...57,318,288
G
Gtf2ird1
general transcription factor II I repeat domain-containing 1
decreases expression
ISO
Vitamin E results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:19244175
NCBI chr 5:134,386,515...134,485,628
Ensembl chr 5:134,386,510...134,485,570
G
Gtpbp8
GTP-binding protein 8 (putative)
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of GTPBP8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of GTPBP8 mRNA
CTD
PMID:19244175
NCBI chr16:44,559,242...44,566,726
Ensembl chr16:44,557,131...44,566,726
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
increases expression
ISO
Vitamin E results in increased expression of HLA-DQB1 mRNA
CTD
PMID:19244175
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Ea
histocompatibility 2, class II antigen E alpha
increases expression
ISO
Vitamin E results in increased expression of HLA-DRA mRNA
CTD
PMID:19244175
NCBI chr17:34,560,926...34,563,619
Ensembl chr17:34,560,926...34,563,618
G
H2-M2
histocompatibility 2, M region locus 2
increases expression
ISO
Vitamin E results in increased expression of HLA-B mRNA
CTD
PMID:19244175
NCBI chr17:37,791,742...37,794,445
Ensembl chr17:37,791,742...37,794,443
G
H2-M3
histocompatibility 2, M region locus 3
increases expression
ISO
Vitamin E results in increased expression of HLA-G mRNA
CTD
PMID:19244175
NCBI chr17:37,581,094...37,585,380
Ensembl chr17:37,581,111...37,585,375
G
H2-Pa
histocompatibility 2, P region alpha locus
increases expression
ISO
Vitamin E results in increased expression of HLA-DPA1 mRNA
CTD
PMID:19244175
NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797
G
H2-T23
histocompatibility 2, T region locus 23
increases expression
ISO
Vitamin E results in increased expression of HLA-E mRNA
CTD
PMID:19244175
NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747
G
H3f3a
H3.3 histone A
decreases expression
ISO
Vitamin E results in decreased expression of H3-3A mRNA
CTD
PMID:19244175
NCBI chr 1:180,630,125...180,641,127
Ensembl chr 1:180,628,397...180,641,508
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
increases expression multiple interactions
ISO
Vitamin E results in increased expression of H6PD mRNA [Selenium co-treated with Vitamin E] results in decreased expression of H6PD mRNA
CTD
PMID:19244175
NCBI chr 4:150,063,931...150,093,480
Ensembl chr 4:150,063,932...150,093,480
G
Hadha
hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha
decreases expression
ISO
Vitamin E results in decreased expression of HADHA mRNA
CTD
PMID:19244175
NCBI chr 5:30,324,421...30,359,978
Ensembl chr 5:30,323,302...30,360,160
G
Hagh
hydroxyacyl glutathione hydrolase
increases expression
ISO
Vitamin E results in increased expression of HAGH mRNA
CTD
PMID:19244175
NCBI chr17:25,056,863...25,083,424
Ensembl chr17:25,059,117...25,083,424
G
Hamp
hepcidin antimicrobial peptide
multiple interactions
EXP
Vitamin E inhibits the reaction [Ethanol results in decreased expression of HAMP mRNA]
CTD
PMID:16737972
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hars1
histidyl-tRNA synthetase 1
increases expression
ISO
Vitamin E results in increased expression of HARS1 mRNA
CTD
PMID:19244175
NCBI chr18:36,899,581...36,916,258
Ensembl chr18:36,899,581...36,916,258
G
Haus3
HAUS augmin-like complex, subunit 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of HAUS3 mRNA Vitamin E results in decreased expression of HAUS3 mRNA
CTD
PMID:19244175
NCBI chr 5:34,311,240...34,326,768
Ensembl chr 5:34,311,224...34,326,871
G
Haus4
HAUS augmin-like complex, subunit 4
increases expression
ISO
Vitamin E results in increased expression of HAUS4 mRNA
CTD
PMID:19244175
NCBI chr14:54,779,242...54,792,446
Ensembl chr14:54,779,242...54,792,073
G
Hba-a1
hemoglobin alpha, adult chain 1
decreases expression
ISO
Vitamin E results in decreased expression of HBA1 protein
CTD
PMID:1991440
NCBI chr11:32,233,672...32,234,486
Ensembl chr11:32,233,511...32,234,465
G
Hba-a2
hemoglobin alpha, adult chain 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HBA2 mRNA
CTD
PMID:19244175
NCBI chr11:32,246,492...32,247,310
Ensembl chr11:32,246,489...32,247,298
G
Hcfc1
host cell factor C1
increases expression
ISO
Vitamin E results in increased expression of HCFC1 mRNA
CTD
PMID:19244175
NCBI chr X:72,986,400...73,011,430
Ensembl chr X:72,986,398...73,009,963
G
Hdac1
histone deacetylase 1
increases expression
ISO
Vitamin E results in increased expression of HDAC1 mRNA
CTD
PMID:19244175
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
G
Hdac5
histone deacetylase 5
increases expression
ISO
Vitamin E results in increased expression of HDAC5 mRNA
CTD
PMID:19244175
NCBI chr11:102,085,244...102,120,968
Ensembl chr11:102,085,258...102,120,992
G
Hemk1
HemK methyltransferase family member 1
increases expression
ISO
Vitamin E results in increased expression of HEMK1 mRNA
CTD
PMID:19244175
NCBI chr 9:107,204,281...107,217,640
Ensembl chr 9:107,204,283...107,215,549
G
Hes1
hes family bHLH transcription factor 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HES1 mRNA [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of HES1 protein] [Selenium co-treated with Vitamin E] results in increased expression of HES1 mRNA
CTD
PMID:19244175 PMID:29663635
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
G
Hif1a
hypoxia inducible factor 1, alpha subunit
decreases expression
EXP
Vitamin E results in decreased expression of HIF1A protein
CTD
PMID:16507596
NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304
G
Hif1an
hypoxia-inducible factor 1, alpha subunit inhibitor
increases expression
ISO
Vitamin E results in increased expression of HIF1AN mRNA
CTD
PMID:19244175
NCBI chr19:44,551,293...44,564,713
Ensembl chr19:44,551,289...44,564,713
G
Higd2a
HIG1 domain family, member 2A
increases expression
ISO
Vitamin E results in increased expression of HIGD2A mRNA
CTD
PMID:19244175
NCBI chr13:54,738,044...54,738,960
Ensembl chr13:54,738,020...54,738,971
G
Hipk2
homeodomain interacting protein kinase 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HIPK2 mRNA Vitamin E results in decreased expression of HIPK2 mRNA
CTD
PMID:19244175
NCBI chr 6:38,664,447...38,853,236
Ensembl chr 6:38,671,325...38,853,099
G
Hmces
5-hydroxymethylcytosine (hmC) binding, ES cell specific
increases expression
ISO
Vitamin E results in increased expression of HMCES mRNA
CTD
PMID:19244175
NCBI chr 6:87,890,889...87,913,603
Ensembl chr 6:87,890,917...87,913,611
G
Hmgb1
high mobility group box 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HMGB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HMGB1 mRNA
CTD
PMID:19244175
NCBI chr 5:148,983,512...148,989,867
Ensembl chr 5:148,983,512...149,121,299
G
Hmgxb4
HMG box domain containing 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HMGXB4 mRNA Vitamin E results in decreased expression of HMGXB4 mRNA
CTD
PMID:19244175
NCBI chr 8:75,720,305...75,758,606
Ensembl chr 8:75,719,984...75,758,606
G
Hmox1
heme oxygenase 1
multiple interactions increases expression
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of HMOX1 protein] [Vitamin E co-treated with bioallethrin] results in increased expression of HMOX1 protein; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of HMOX1 protein] Vitamin E results in increased expression of HMOX1 mRNA
CTD
PMID:15571180 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30513525 PMID:35511042 More...
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hnmt
histamine N-methyltransferase
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HNMT mRNA Vitamin E results in decreased expression of HNMT mRNA
CTD
PMID:19244175
NCBI chr 2:23,892,923...23,939,756
Ensembl chr 2:23,892,922...23,939,406
G
Hnrnpm
heterogeneous nuclear ribonucleoprotein M
increases expression
ISO
Vitamin E results in increased expression of HNRNPM mRNA
CTD
PMID:19244175
NCBI chr17:33,865,207...33,904,432
Ensembl chr17:33,865,207...33,905,834
G
Hnrnpr
heterogeneous nuclear ribonucleoprotein R
decreases expression
ISO
Vitamin E results in decreased expression of HNRNPR mRNA
CTD
PMID:19244175
NCBI chr 4:136,038,230...136,086,758
Ensembl chr 4:136,038,253...136,086,758
G
Homer1
homer scaffolding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HOMER1 mRNA Vitamin E results in decreased expression of HOMER1 mRNA
CTD
PMID:19244175
NCBI chr13:93,440,265...93,549,471
Ensembl chr13:93,436,143...93,541,637
G
Hook1
hook microtubule tethering protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HOOK1 mRNA Vitamin E results in decreased expression of HOOK1 mRNA
CTD
PMID:19244175
NCBI chr 4:95,855,418...95,913,649
Ensembl chr 4:95,855,477...95,913,650
G
Hoxa11
homeobox A11
increases expression
ISO
Vitamin E results in increased expression of HOXA11 mRNA
CTD
PMID:19244175
NCBI chr 6:52,219,086...52,222,784
Ensembl chr 6:52,219,086...52,222,790
G
Hoxa7
homeobox A7
decreases expression
ISO
Vitamin E results in decreased expression of HOXA7 mRNA
CTD
PMID:19244175
NCBI chr 6:52,191,471...52,198,757
Ensembl chr 6:52,191,471...52,198,834
G
Hpcal1
hippocalcin-like 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of HPCAL1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HPCAL1 mRNA
CTD
PMID:19244175
NCBI chr12:17,740,810...17,841,943
Ensembl chr12:17,740,857...17,841,934
G
Hprt1
hypoxanthine phosphoribosyltransferase 1
multiple interactions
ISO
Vitamin E inhibits the reaction [2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased mutagenesis of HPRT1 gene]
CTD
PMID:12467141
NCBI chr X:52,076,955...52,110,537
Ensembl chr X:52,077,014...52,110,536
G
Hras
Harvey rat sarcoma virus oncogene
multiple interactions increases expression
EXP ISO
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]] Vitamin E results in increased expression of HRAS mRNA [Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA
CTD
PMID:11062179 PMID:19244175
NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
increases expression
ISO
Vitamin E results in increased expression of HSD11B1 mRNA
CTD
PMID:19244175
NCBI chr 1:192,903,917...192,946,345
Ensembl chr 1:192,903,942...192,946,383
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of HSD11B2 mRNA
CTD
PMID:11444866
NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
multiple interactions
ISO
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD17B3 mRNA]
CTD
PMID:17280759
NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
G
Hsd17b8
hydroxysteroid 17-beta dehydrogenase 8
increases expression
ISO
Vitamin E results in increased expression of HSD17B8 mRNA
CTD
PMID:19244175
NCBI chr17:34,245,007...34,247,029
Ensembl chr17:34,245,007...34,247,034
G
Hsd3b1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
multiple interactions
ISO
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of HSD3B1 mRNA]
CTD
PMID:17280759
NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110
G
Hsp90aa1
heat shock protein 90, alpha (cytosolic), class A member 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HSP90AA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSP90AA1 mRNA
CTD
PMID:19244175
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
G
Hsp90ab1
heat shock protein 90 alpha (cytosolic), class B member 1
increases expression
ISO
Vitamin E results in increased expression of HSP90AB1 mRNA
CTD
PMID:19244175
NCBI chr17:45,878,704...45,884,187
Ensembl chr17:45,878,701...45,884,197
G
Hsp90b1
heat shock protein 90, beta (Grp94), member 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of HSP90B1 mRNA Vitamin E results in decreased expression of HSP90B1 mRNA
CTD
PMID:19244175
NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373
G
Hspa1a
heat shock protein 1A
increases expression
ISO
Vitamin E results in increased expression of HSPA1A mRNA
CTD
PMID:19244175
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa4
heat shock protein 4
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of HSPA4 mRNA Vitamin E results in increased expression of HSPA4 mRNA
CTD
PMID:19244175
NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284
G
Hspa5
heat shock protein 5
multiple interactions
EXP
Vitamin E inhibits the reaction [pyrazole results in increased expression of HSPA5 protein]
CTD
PMID:18068688
NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559
G
Hspa9
heat shock protein 9
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of HSPA9 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of HSPA9 mRNA
CTD
PMID:19244175
NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410
G
Hspb1
heat shock protein 1
increases expression
ISO
Vitamin E results in increased expression of HSPB1 mRNA
CTD
PMID:19244175
NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417
G
Htra1
HtrA serine peptidase 1
increases expression
ISO
Vitamin E results in increased expression of HTRA1 mRNA
CTD
PMID:19244175
NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390
G
Htra2
HtrA serine peptidase 2
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde affects the localization of HTRA2 protein]
CTD
PMID:15566391
NCBI chr 6:83,028,247...83,031,552
Ensembl chr 6:83,028,247...83,032,254
G
Iars1
isoleucyl-tRNA synthetase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IARS1 mRNA Vitamin E results in decreased expression of IARS1 mRNA
CTD
PMID:19244175
NCBI chr13:49,835,606...49,887,743
Ensembl chr13:49,835,576...49,887,743
G
Ica1
islet cell autoantigen 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ICA1 mRNA Vitamin E results in increased expression of ICA1 mRNA
CTD
PMID:19244175
NCBI chr 6:8,630,527...8,778,531
Ensembl chr 6:8,630,527...8,778,488
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of ICAM1 protein modified form; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of ICAM1 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of ICAM1 mRNA]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of ICAM1 protein modified form]
CTD
PMID:14602771 PMID:23114885 PMID:35349355
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Id2
inhibitor of DNA binding 2
decreases expression
ISO
Vitamin E results in decreased expression of ID2 mRNA
CTD
PMID:19244175
NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139
G
Idh3b
isocitrate dehydrogenase 3 (NAD+) beta
increases expression
ISO
Vitamin E results in increased expression of IDH3B mRNA
CTD
PMID:19244175
NCBI chr 2:130,121,229...130,126,371
Ensembl chr 2:130,121,229...130,126,467
G
Idh3g
isocitrate dehydrogenase 3 (NAD+), gamma
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of IDH3G mRNA Vitamin E results in increased expression of IDH3G mRNA
CTD
PMID:19244175
NCBI chr X:72,822,569...72,830,471
Ensembl chr X:72,822,569...72,830,503
G
Ids
iduronate 2-sulfatase
increases expression
ISO
Vitamin E results in increased expression of IDS mRNA
CTD
PMID:19244175
NCBI chr X:69,386,675...69,429,437
Ensembl chr X:69,386,675...69,408,690
G
Idua
iduronidase, alpha-L
increases expression multiple interactions
ISO
Vitamin E results in increased expression of IDUA mRNA [Selenium co-treated with Vitamin E] results in increased expression of IDUA mRNA
CTD
PMID:19244175
NCBI chr 5:108,808,197...108,833,312
Ensembl chr 5:108,808,197...108,832,423
G
Iffo1
intermediate filament family orphan 1
increases expression
ISO
Vitamin E results in increased expression of IFFO1 mRNA
CTD
PMID:19244175
NCBI chr 6:125,122,167...125,138,746
Ensembl chr 6:125,122,204...125,138,745
G
Ifi35
interferon-induced protein 35
increases expression
ISO
Vitamin E results in increased expression of IFI35 mRNA
CTD
PMID:19244175
NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524
G
Ifitm1
interferon induced transmembrane protein 1
increases expression
ISO
Vitamin E results in increased expression of IFITM1 mRNA
CTD
PMID:19244175
NCBI chr 7:140,547,342...140,549,740
Ensembl chr 7:140,547,134...140,549,738
G
Ifitm2
interferon induced transmembrane protein 2
increases expression
ISO
Vitamin E results in increased expression of IFITM2 mRNA
CTD
PMID:19244175
NCBI chr 7:140,534,750...140,539,602
Ensembl chr 7:140,534,750...140,535,900
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
Vitamin E results in increased expression of IFITM3 mRNA
CTD
PMID:19244175
NCBI chr 7:140,589,503...140,590,657
Ensembl chr 7:140,589,499...140,590,683
G
Ifng
interferon gamma
multiple interactions decreases expression
EXP ISO
Vitamin E inhibits the reaction [Ethanol results in increased activity of IFNG protein] Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]] Vitamin E results in decreased expression of IFNG protein
CTD
PMID:14624943 PMID:15223066 PMID:21086752
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ift74
intraflagellar transport 74
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IFT74 mRNA Vitamin E results in decreased expression of IFT74 mRNA
CTD
PMID:19244175
NCBI chr 4:94,491,503...94,581,470
Ensembl chr 4:94,502,728...94,581,466
G
Ift81
intraflagellar transport 81
decreases expression
ISO
Vitamin E results in decreased expression of IFT81 mRNA
CTD
PMID:19244175
NCBI chr 5:122,678,328...122,752,614
Ensembl chr 5:122,688,267...122,752,581
G
Igf1r
insulin-like growth factor I receptor
multiple interactions decreases expression
ISO
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IGF1R protein] Vitamin E inhibits the reaction [Thyroxine results in increased expression of IGF1R protein] Vitamin E results in decreased expression of IGF1R mRNA; Vitamin E results in decreased expression of IGF1R protein
CTD
PMID:17447016 PMID:19244175 PMID:20015448
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
decreases expression
ISO
Vitamin E results in decreased expression of IGF2BP2 mRNA
CTD
PMID:19244175
NCBI chr16:21,877,759...21,982,049
Ensembl chr16:21,877,759...21,982,049
G
Igf2r
insulin-like growth factor 2 receptor
decreases expression
ISO
Vitamin E results in decreased expression of IGF2R mRNA
CTD
PMID:19244175
NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551
G
Igfbp2
insulin-like growth factor binding protein 2
increases expression
ISO
Vitamin E results in increased expression of IGFBP2 mRNA
CTD
PMID:19244175
NCBI chr 1:72,863,650...72,891,633
Ensembl chr 1:72,863,662...72,891,633
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
Vitamin E results in increased expression of IGFBP4 mRNA
CTD
PMID:19244175
NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218
G
Igfbp6
insulin-like growth factor binding protein 6
increases expression
ISO
Vitamin E results in increased expression of IGFBP6 mRNA
CTD
PMID:19244175
NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946
G
Ighm
immunoglobulin heavy constant mu
increases expression
ISO
Vitamin E results in increased expression of IGHM mRNA
CTD
PMID:19244175
NCBI chr12:113,382,446...113,386,350
Ensembl chr12:113,382,178...113,386,350
G
Ik
IK cytokine
increases expression
ISO
Vitamin E results in increased expression of IK mRNA
CTD
PMID:19244175
NCBI chr18:36,877,709...36,890,692
Ensembl chr18:36,877,731...36,890,688
G
Il10
interleukin 10
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [Ethanol results in increased activity of IL10 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in decreased expression of IL10 protein]
CTD
PMID:15862027 PMID:21086752
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
multiple interactions
EXP
Vitamin E inhibits the reaction [Ozone results in increased expression of IL13 protein]
CTD
PMID:30090343
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il13ra1
interleukin 13 receptor, alpha 1
increases expression
ISO
Vitamin E results in increased expression of IL13RA1 mRNA
CTD
PMID:19244175
NCBI chr X:35,375,761...35,434,915
Ensembl chr X:35,375,763...35,434,912
G
Il1b
interleukin 1 beta
multiple interactions increases expression
EXP ISO
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL1B protein] Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of IL1B protein]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL1B mRNA]
CTD
PMID:15223066 PMID:16545059 PMID:18234736 PMID:19735175 PMID:35349355
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il2
interleukin 2
multiple interactions
ISO
Vitamin E inhibits the reaction [Formaldehyde results in increased expression of IL2 protein]
CTD
PMID:16937016
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il4
interleukin 4
decreases expression multiple interactions
EXP ISO
Vitamin E results in decreased expression of IL4 protein Vitamin E inhibits the reaction [Ozone results in increased expression of IL4 protein] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] results in increased expression of IL4 protein
CTD
PMID:14624943 PMID:15862027 PMID:30090343
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il4ra
interleukin 4 receptor, alpha
increases expression multiple interactions
ISO
Vitamin E results in increased expression of IL4R mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IL4R mRNA
CTD
PMID:19244175
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
Il5
interleukin 5
multiple interactions
ISO EXP
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL5 mRNA Vitamin E inhibits the reaction [Ozone results in increased expression of IL5 protein]
CTD
PMID:16797527 PMID:30090343
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il6
interleukin 6
multiple interactions decreases expression
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of IL6 mRNA; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of IL6 protein] Vitamin E inhibits the reaction [phoxim results in decreased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of IL6 protein] Vitamin E results in decreased expression of IL6 protein
CTD
PMID:16797527 PMID:18234736 PMID:20370442 PMID:30003487 PMID:35349355
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ilf3
interleukin enhancer binding factor 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ILF3 mRNA Vitamin E results in decreased expression of ILF3 mRNA
CTD
PMID:19244175
NCBI chr 9:21,278,964...21,316,659
Ensembl chr 9:21,279,167...21,316,657
G
Ilk
integrin linked kinase
increases expression
ISO
Vitamin E results in increased expression of ILK mRNA
CTD
PMID:19244175
NCBI chr 7:105,385,797...105,392,132
Ensembl chr 7:105,385,799...105,392,132
G
Inpp5k
inositol polyphosphate 5-phosphatase K
increases expression
ISO
Vitamin E results in increased expression of INPP5K mRNA
CTD
PMID:19244175
NCBI chr11:75,519,893...75,539,691
Ensembl chr11:75,521,814...75,539,697
G
Ins1
insulin I
multiple interactions
EXP ISO
[Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 mRNA; [Selenium co-treated with Vitamin E co-treated with Vanadium co-treated with Chromium] results in increased expression of INS1 protein [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of INS1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse inhibits the reaction [INS1 protein results in increased uptake of Glucose]]
CTD
PMID:17198541 PMID:20108212 PMID:21911000
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Insr
insulin receptor
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of INSR mRNA]
CTD
PMID:21911000
NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617
G
Ints15
integrator complex subunit 15
increases expression
ISO
Vitamin E results in increased expression of INTS15 mRNA
CTD
PMID:19244175
NCBI chr 5:143,286,827...143,301,147
Ensembl chr 5:143,286,950...143,301,115
G
Ints6
integrator complex subunit 6
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of INTS6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of INTS6 mRNA
CTD
PMID:19244175
NCBI chr14:62,913,774...62,998,617
Ensembl chr14:62,913,779...62,998,618
G
Ipp
IAP promoted placental gene
decreases expression
ISO
Vitamin E results in decreased expression of IPP mRNA
CTD
PMID:19244175
NCBI chr 4:116,364,710...116,400,607
Ensembl chr 4:116,364,746...116,395,440
G
Iqcb1
IQ calmodulin-binding motif containing 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IQCB1 mRNA
CTD
PMID:19244175
NCBI chr16:36,648,722...36,694,044
Ensembl chr16:36,648,747...36,693,083
G
Iqck
IQ motif containing K
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of IQCK mRNA [Selenium co-treated with Vitamin E] results in decreased expression of IQCK mRNA
CTD
PMID:19244175
NCBI chr 7:118,454,975...118,571,343
Ensembl chr 7:118,454,975...118,571,875
G
Iqgap1
IQ motif containing GTPase activating protein 1
decreases expression
ISO
Vitamin E results in decreased expression of IQGAP1 mRNA
CTD
PMID:19244175
NCBI chr 7:80,361,331...80,453,288
Ensembl chr 7:80,361,331...80,475,722
G
Iqsec1
IQ motif and Sec7 domain 1
increases expression
ISO
Vitamin E results in increased expression of IQSEC1 mRNA
CTD
PMID:19244175
NCBI chr 6:90,636,578...90,965,766
Ensembl chr 6:90,633,070...90,965,667
G
Irf9
interferon regulatory factor 9
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of IRF9 mRNA Vitamin E results in increased expression of IRF9 mRNA
CTD
PMID:19244175
NCBI chr14:55,841,442...55,847,487
Ensembl chr14:55,841,028...55,847,487
G
Irs1
insulin receptor substrate 1
multiple interactions decreases expression
ISO
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of IRS1 protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of IRS1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of IRS1 protein]; [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in decreased phosphorylation of IRS1 protein]
CTD
PMID:20015448 PMID:21911000
NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137
G
Isca1
iron-sulfur cluster assembly 1
decreases expression
ISO
Vitamin E results in decreased expression of ISCA1 mRNA
CTD
PMID:19244175
NCBI chr13:59,903,229...59,917,603
Ensembl chr13:59,903,223...59,917,624
G
Islr
immunoglobulin superfamily containing leucine-rich repeat
increases expression
ISO
Vitamin E results in increased expression of ISLR mRNA
CTD
PMID:19244175
NCBI chr 9:58,063,547...58,066,563
Ensembl chr 9:58,063,551...58,111,589
G
Isyna1
myo-inositol 1-phosphate synthase A1
increases expression
ISO
Vitamin E results in increased expression of ISYNA1 mRNA
CTD
PMID:19244175
NCBI chr 8:71,047,131...71,049,940
Ensembl chr 8:71,047,023...71,049,940
G
Itga3
integrin alpha 3
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ITGA3 mRNA Vitamin E results in increased expression of ITGA3 mRNA
CTD
PMID:19244175
NCBI chr11:94,935,301...94,967,637
Ensembl chr11:94,935,300...94,967,627
G
Itgb3bp
integrin beta 3 binding protein (beta3-endonexin)
decreases expression
ISO
Vitamin E results in decreased expression of ITGB3BP mRNA
CTD
PMID:19244175
NCBI chr 4:99,655,643...99,717,403
Ensembl chr 4:99,653,639...99,787,010
G
Itm2c
integral membrane protein 2C
increases expression
ISO
Vitamin E results in increased expression of ITM2C mRNA
CTD
PMID:19244175
NCBI chr 1:85,822,231...85,836,419
Ensembl chr 1:85,822,002...85,836,396
G
Itpkb
inositol 1,4,5-trisphosphate 3-kinase B
increases expression
ISO
Vitamin E results in increased expression of ITPKB mRNA
CTD
PMID:19244175
NCBI chr 1:180,156,655...180,252,367
Ensembl chr 1:180,158,050...180,252,367
G
Jun
jun proto-oncogene
multiple interactions increases phosphorylation decreases expression
ISO EXP
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of JUN protein]; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of JUN protein] Vitamin E promotes the reaction [Alcohols results in increased expression of JUN mRNA] Vitamin E results in increased phosphorylation of JUN protein Vitamin E results in decreased expression of JUN mRNA; Vitamin E results in decreased expression of JUN protein
CTD
PMID:11522656 PMID:18814483 PMID:19244175 PMID:20015448
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kat5
K(lysine) acetyltransferase 5
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KAT5 mRNA
CTD
PMID:19244175
NCBI chr19:5,653,042...5,661,584
Ensembl chr19:5,653,042...5,660,265
G
Kbtbd2
kelch repeat and BTB (POZ) domain containing 2
increases expression
ISO
Vitamin E results in increased expression of KBTBD2 mRNA
CTD
PMID:19244175
NCBI chr 6:56,754,510...56,774,798
Ensembl chr 6:56,754,509...56,774,798
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein] Vitamin E results in increased expression of KCNH2 mRNA
CTD
PMID:14973143 PMID:19244175
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
decreases expression
ISO
Vitamin E results in decreased expression of KCNJ5 mRNA
CTD
PMID:19244175
NCBI chr 9:32,226,002...32,255,640
Ensembl chr 9:32,226,003...32,255,646
G
Kcnj8
potassium inwardly-rectifying channel, subfamily J, member 8
increases expression
ISO
Vitamin E results in increased expression of KCNJ8 mRNA
CTD
PMID:19244175
NCBI chr 6:142,510,563...142,517,340
Ensembl chr 6:142,510,563...142,517,340
G
Kctd17
potassium channel tetramerisation domain containing 17
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KCTD17 mRNA
CTD
PMID:19244175
NCBI chr15:78,312,578...78,323,503
Ensembl chr15:78,312,764...78,323,503
G
Kctd2
potassium channel tetramerisation domain containing 2
increases expression
ISO
Vitamin E results in increased expression of KCTD2 mRNA
CTD
PMID:19244175
NCBI chr11:115,310,915...115,322,100
Ensembl chr11:115,310,954...115,322,100
G
Kdm6b
KDM1 lysine (K)-specific demethylase 6B
increases expression
ISO
Vitamin E results in increased expression of KDM6B mRNA
CTD
PMID:19244175
NCBI chr11:69,289,334...69,311,188
Ensembl chr11:69,289,334...69,304,501
G
Khdrbs1
KH domain containing, RNA binding, signal transduction associated 1
decreases expression
ISO
Vitamin E results in decreased expression of KHDRBS1 mRNA
CTD
PMID:19244175
NCBI chr 4:129,596,143...129,637,402
Ensembl chr 4:129,596,957...129,636,096
G
Kif16b
kinesin family member 16B
decreases expression
ISO
Vitamin E results in decreased expression of KIF16B mRNA
CTD
PMID:19244175
NCBI chr 2:142,459,399...142,743,535
Ensembl chr 2:142,459,394...142,743,451
G
Kif1b
kinesin family member 1B
decreases expression
ISO
Vitamin E results in decreased expression of KIF1B mRNA
CTD
PMID:19244175
NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150
G
Kif5b
kinesin family member 5B
decreases expression
ISO
Vitamin E results in decreased expression of KIF5B mRNA
CTD
PMID:19244175
NCBI chr18:6,201,005...6,241,524
Ensembl chr18:6,201,002...6,242,174
G
Kif5c
kinesin family member 5C
decreases expression
ISO
Vitamin E results in decreased expression of KIF5C mRNA
CTD
PMID:19244175
NCBI chr 2:49,509,298...49,664,790
Ensembl chr 2:49,509,310...49,664,790
G
Kl
klotho
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KL mRNA
CTD
PMID:19244175
NCBI chr 5:150,876,072...150,917,282
Ensembl chr 5:150,876,072...150,917,282
G
Klc1
kinesin light chain 1
increases expression
ISO
Vitamin E results in increased expression of KLC1 mRNA
CTD
PMID:19244175
NCBI chr12:111,724,869...111,774,278
Ensembl chr12:111,725,283...111,774,278
G
Klf6
Kruppel-like transcription factor 6
multiple interactions
ISO
Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Paraquat] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [[CYP2E1 protein co-treated with Vitamin K 3] results in increased expression of KLF6 protein]; Vitamin E inhibits the reaction [Arachidonic Acid promotes the reaction [CYP2E1 protein results in increased expression of KLF6 mRNA]]; Vitamin E inhibits the reaction [CYP2E1 protein promotes the reaction [Arachidonic Acid results in increased expression of KLF6 mRNA alternative form]]
CTD
PMID:22486562
NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393
G
Klf9
Kruppel-like transcription factor 9
decreases expression
ISO
Vitamin E results in decreased expression of KLF9 mRNA
CTD
PMID:19244175
NCBI chr19:23,118,590...23,145,493
Ensembl chr19:23,118,590...23,145,498
G
Klhdc10
kelch domain containing 10
decreases expression
ISO
Vitamin E results in decreased expression of KLHDC10 mRNA
CTD
PMID:19244175
NCBI chr 6:30,401,516...30,455,178
Ensembl chr 6:30,401,867...30,455,178
G
Klhl20
kelch-like 20
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KLHL20 mRNA Vitamin E results in decreased expression of KLHL20 mRNA
CTD
PMID:19244175
NCBI chr 1:160,915,945...160,959,078
Ensembl chr 1:160,915,945...160,959,081
G
Klhl24
kelch-like 24
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KLHL24 mRNA
CTD
PMID:19244175
NCBI chr16:19,916,286...19,947,976
Ensembl chr16:19,916,292...19,947,971
G
Klhl4
kelch-like 4
decreases expression
ISO
Vitamin E results in decreased expression of KLHL4 mRNA
CTD
PMID:19244175
NCBI chr X:113,384,030...113,470,826
Ensembl chr X:113,384,030...113,470,526
G
Klhl9
kelch-like 9
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KLHL9 mRNA
CTD
PMID:19244175
NCBI chr 4:88,636,529...88,640,745
Ensembl chr 4:88,636,529...88,640,702
G
Kmt2b
lysine (K)-specific methyltransferase 2B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of KMT2B mRNA Vitamin E results in increased expression of KMT2B mRNA
CTD
PMID:19244175
NCBI chr 7:30,268,280...30,288,371
Ensembl chr 7:30,268,283...30,288,151
G
Kpna1
karyopherin subunit alpha 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KPNA1 mRNA Vitamin E results in decreased expression of KPNA1 mRNA
CTD
PMID:19244175
NCBI chr16:35,803,693...35,859,479
Ensembl chr16:35,799,120...35,857,501
G
Kpna3
karyopherin subunit alpha 3
decreases expression
ISO
Vitamin E results in decreased expression of KPNA3 mRNA
CTD
PMID:19244175
NCBI chr14:61,602,635...61,677,396
Ensembl chr14:61,602,660...61,677,323
G
Kpnb1
karyopherin subunit beta 1
decreases expression increases expression multiple interactions
ISO
Vitamin E results in decreased expression of KPNB1 mRNA Vitamin E results in increased expression of KPNB1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of KPNB1 mRNA
CTD
PMID:19244175
NCBI chr11:97,050,536...97,078,718
Ensembl chr11:97,050,540...97,078,707
G
Ktn1
kinectin 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of KTN1 mRNA Vitamin E results in decreased expression of KTN1 mRNA
CTD
PMID:19244175
NCBI chr14:47,886,551...47,974,021
Ensembl chr14:47,885,905...47,977,351
G
Lad1
ladinin
decreases expression
ISO
Vitamin E results in decreased expression of LAD1 mRNA
CTD
PMID:19244175
NCBI chr 1:135,746,336...135,761,079
Ensembl chr 1:135,746,336...135,761,080
G
Lamb2
laminin, beta 2
increases expression
ISO
Vitamin E results in increased expression of LAMB2 mRNA
CTD
PMID:19244175
NCBI chr 9:108,357,080...108,367,729
Ensembl chr 9:108,356,935...108,367,729
G
Lamp1
lysosomal-associated membrane protein 1
increases expression
ISO
Vitamin E results in increased expression of LAMP1 mRNA
CTD
PMID:19244175
NCBI chr 8:13,209,161...13,225,338
Ensembl chr 8:13,209,161...13,225,338
G
Lamp2
lysosomal-associated membrane protein 2
multiple interactions
ISO
Vitamin E inhibits the reaction [Pilocarpine results in increased expression of LAMP2 protein]
CTD
PMID:19272430
NCBI chr X:37,488,524...37,545,337
Ensembl chr X:37,490,234...37,545,331
G
Larp4b
La ribonucleoprotein 4B
decreases expression
ISO
Vitamin E results in decreased expression of LARP4B mRNA
CTD
PMID:19244175
NCBI chr13:9,143,643...9,224,487
Ensembl chr13:9,143,917...9,224,487
G
Lbhd1
LBH domain containing 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of LBHD1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of LBHD1 mRNA
CTD
PMID:19244175
NCBI chr19:8,861,242...8,868,123
Ensembl chr19:8,861,096...8,869,991
G
Lcmt2
leucine carboxyl methyltransferase 2
increases expression
ISO
Vitamin E results in increased expression of LCMT2 mRNA; Vitamin E results in increased expression of LCMT2 protein
CTD
PMID:9359698
NCBI chr 2:120,967,773...120,971,179
Ensembl chr 2:120,958,788...120,971,134
G
Ldb2
LIM domain binding 2
increases expression
ISO
Vitamin E results in increased expression of LDB2 mRNA
CTD
PMID:19244175
NCBI chr 5:44,593,292...44,957,466
Ensembl chr 5:44,629,474...44,957,022
G
Ldha
lactate dehydrogenase A
multiple interactions
ISO
Vitamin E inhibits the reaction [Hexachlorobenzene affects the expression of LDHA protein]
CTD
PMID:30064338
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
G
Lep
leptin
multiple interactions
ISO
Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP mRNA]; Vitamin E inhibits the reaction [Dietary Fats results in decreased expression of LEP protein]
CTD
PMID:20404018
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lhb
luteinizing hormone beta
multiple interactions
ISO
[Vitamin E co-treated with LHB protein] results in increased chemical synthesis of Testosterone; Vitamin E inhibits the reaction [acetamiprid results in increased expression of LHB protein]; Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [chromium hexavalent ion results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [cypermethrin results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Petroleum results in decreased expression of LHB protein]; Vitamin E inhibits the reaction [Potassium Dichromate results in decreased expression of LHB protein]
CTD
PMID:16054318 PMID:16298753 PMID:17280759 PMID:20079796 PMID:24759048 PMID:25046308 PMID:28395332 More...
NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321
G
Limch1
LIM and calponin homology domains 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LIMCH1 mRNA
CTD
PMID:19244175
NCBI chr 5:66,903,232...67,214,502
Ensembl chr 5:66,903,170...67,214,501
G
Lipt1
lipoyltransferase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LIPT1 mRNA Vitamin E results in decreased expression of LIPT1 mRNA
CTD
PMID:19244175
NCBI chr 1:37,910,819...37,915,309
Ensembl chr 1:37,910,819...37,915,309
G
Lman2
lectin, mannose-binding 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of LMAN2 mRNA Vitamin E results in increased expression of LMAN2 mRNA
CTD
PMID:19244175
NCBI chr13:55,491,646...55,510,596
Ensembl chr13:55,491,646...55,510,596
G
Lmna
lamin A
increases expression
ISO
Vitamin E results in increased expression of LMNA mRNA
CTD
PMID:19244175
NCBI chr 3:88,388,455...88,413,842
Ensembl chr 3:88,387,454...88,417,263
G
Lmo3
LIM domain only 3
increases expression
ISO
Vitamin E results in increased expression of LMO3 mRNA
CTD
PMID:19244175
NCBI chr 6:138,339,916...138,559,204
Ensembl chr 6:138,339,916...138,558,966
G
Lmod1
leiomodin 1 (smooth muscle)
increases expression
ISO
Vitamin E results in increased expression of LMOD1 mRNA
CTD
PMID:19244175
NCBI chr 1:135,252,551...135,295,803
Ensembl chr 1:135,252,545...135,295,803
G
Lpar1
lysophosphatidic acid receptor 1
increases expression
ISO
Vitamin E results in increased expression of LPAR1 mRNA
CTD
PMID:19244175
NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898
G
Lpar2
lysophosphatidic acid receptor 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of LPAR2 mRNA
CTD
PMID:19244175
NCBI chr 8:70,275,215...70,283,752
Ensembl chr 8:70,275,079...70,283,752
G
Lpin1
lipin 1
decreases expression
ISO
Vitamin E results in decreased expression of LPIN1 mRNA
CTD
PMID:19244175
NCBI chr12:16,585,670...16,697,020
Ensembl chr12:16,585,670...16,696,967
G
Lrrc41
leucine rich repeat containing 41
increases expression
ISO
Vitamin E results in increased expression of LRRC41 mRNA
CTD
PMID:19244175
NCBI chr 4:115,932,466...115,954,306
Ensembl chr 4:115,932,466...115,954,240
G
Lrrc47
leucine rich repeat containing 47
increases expression multiple interactions
ISO
Vitamin E results in increased expression of LRRC47 mRNA [Selenium co-treated with Vitamin E] results in increased expression of LRRC47 mRNA
CTD
PMID:19244175
NCBI chr 4:154,096,260...154,105,969
Ensembl chr 4:154,096,188...154,105,970
G
Lrrfip1
leucine rich repeat (in FLII) interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of LRRFIP1 mRNA
CTD
PMID:19244175
NCBI chr 1:90,924,652...91,056,666
Ensembl chr 1:90,926,459...91,056,666
G
Lsm7
LSM7 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
Vitamin E results in decreased expression of LSM7 mRNA
CTD
PMID:19244175
NCBI chr10:80,688,659...80,691,043
Ensembl chr10:80,688,655...80,691,043
G
Lsr
lipolysis stimulated lipoprotein receptor
increases expression
ISO
Vitamin E results in increased expression of LSR mRNA
CTD
PMID:19244175
NCBI chr 7:30,657,195...30,672,894
Ensembl chr 7:30,657,195...30,672,889
G
Ltb
lymphotoxin B
increases expression
ISO
Vitamin E results in increased expression of LTB mRNA
CTD
PMID:19244175
NCBI chr17:35,413,483...35,415,281
Ensembl chr17:35,413,415...35,415,296
G
Ltbp4
latent transforming growth factor beta binding protein 4
increases expression
ISO
Vitamin E results in increased expression of LTBP4 mRNA
CTD
PMID:19244175
NCBI chr 7:27,004,566...27,039,142
Ensembl chr 7:27,004,561...27,037,117
G
Luc7l2
LUC7-like 2 (S. cerevisiae)
decreases expression
ISO
Vitamin E results in decreased expression of LUC7L2 mRNA
CTD
PMID:19244175
NCBI chr 6:38,522,996...38,586,888
Ensembl chr 6:38,528,269...38,586,405
G
Luc7l3
LUC7-like 3 (S. cerevisiae)
decreases expression
ISO
Vitamin E results in decreased expression of LUC7L3 mRNA
CTD
PMID:19244175
NCBI chr11:94,181,899...94,213,196
Ensembl chr11:94,178,716...94,212,814
G
Ly6e
lymphocyte antigen 6 family member E
increases expression
ISO
Vitamin E results in increased expression of LY6E mRNA
CTD
PMID:19244175
NCBI chr15:74,826,874...74,831,753
Ensembl chr15:74,826,900...74,831,752
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
Vitamin E results in decreased expression of LYN mRNA
CTD
PMID:19244175
NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122
G
Lypla2
lysophospholipase 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of LYPLA2 mRNA
CTD
PMID:19244175
NCBI chr 4:135,695,541...135,700,954
Ensembl chr 4:135,695,535...135,699,937
G
Lyrm4
LYR motif containing 4
increases expression
ISO
Vitamin E results in increased expression of LYRM4 mRNA
CTD
PMID:19244175
NCBI chr13:36,162,778...36,301,543
Ensembl chr13:36,162,378...36,301,509
G
Macf1
microtubule-actin crosslinking factor 1
decreases expression
ISO
Vitamin E results in decreased expression of MACF1 mRNA
CTD
PMID:19244175
NCBI chr 4:123,243,386...123,581,594
Ensembl chr 4:123,243,426...123,581,331
G
Macroh2a2
macroH2A.2 histone
increases expression
ISO
Vitamin E results in increased expression of MACROH2A2 mRNA
CTD
PMID:19244175
NCBI chr10:61,574,419...61,620,383
Ensembl chr10:61,574,444...61,619,926
G
Maged2
MAGE family member D2
increases expression
ISO
Vitamin E results in increased expression of MAGED2 mRNA
CTD
PMID:19244175
NCBI chr X:149,589,417...149,597,358
Ensembl chr X:149,589,366...149,597,341
G
Man1b1
mannosidase, alpha, class 1B, member 1
increases expression
ISO
Vitamin E results in increased expression of MAN1B1 mRNA
CTD
PMID:19244175
NCBI chr 2:25,222,742...25,242,225
Ensembl chr 2:25,222,350...25,242,224
G
Map2k7
mitogen-activated protein kinase kinase 7
decreases expression
ISO
Vitamin E results in decreased expression of MAP2K7 mRNA
CTD
PMID:19244175
NCBI chr 8:4,288,740...4,297,897
Ensembl chr 8:4,288,740...4,297,897 Ensembl chr 8:4,288,740...4,297,897
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAP3K1 protein]
CTD
PMID:11062179
NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
decreases expression
ISO
Vitamin E results in decreased expression of MAP3K5 mRNA
CTD
PMID:19244175
NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499
G
Map3k8
mitogen-activated protein kinase kinase kinase 8
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of MAP3K8 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MAP3K8 mRNA
CTD
PMID:19244175
NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015
G
Map4
microtubule-associated protein 4
increases expression
ISO
Vitamin E results in increased expression of MAP4 mRNA
CTD
PMID:19244175
NCBI chr 9:109,758,909...109,913,018
Ensembl chr 9:109,760,528...109,913,023
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MAP4K5 mRNA
CTD
PMID:11444866
NCBI chr12:69,850,531...69,939,937
Ensembl chr12:69,850,524...69,939,974
G
Map6d1
MAP6 domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of MAP6D1 mRNA
CTD
PMID:19244175
NCBI chr16:20,052,059...20,060,108
Ensembl chr16:20,052,053...20,060,108
G
Mapk1
mitogen-activated protein kinase 1
increases activity multiple interactions
ISO EXP
Vitamin E results in increased activity of MAPK1 protein Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK1 protein]
CTD
PMID:11062179 PMID:11522656
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk11
mitogen-activated protein kinase 11
increases expression
ISO
Vitamin E results in increased expression of MAPK11 mRNA
CTD
PMID:19244175
NCBI chr15:89,026,685...89,033,809
Ensembl chr15:89,026,689...89,033,831
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions increases activity
EXP ISO
Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAPK3 protein] Vitamin E results in increased activity of MAPK3 protein
CTD
PMID:11062179 PMID:11522656
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
increases activity decreases expression
ISO
Vitamin E results in increased activity of MAPK8 protein Vitamin E results in decreased expression of MAPK8 mRNA
CTD
PMID:11522656 PMID:19244175
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mapt
microtubule-associated protein tau
multiple interactions
EXP
Vitamin E inhibits the reaction [wortmannin results in increased phosphorylation of MAPT protein]
CTD
PMID:15842767
NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916
G
Marchf6
membrane associated ring-CH-type finger 6
decreases expression
ISO
Vitamin E results in decreased expression of MARCHF6 mRNA
CTD
PMID:19244175
NCBI chr15:31,456,045...31,531,172
Ensembl chr15:31,456,037...31,531,199
G
Mast4
microtubule associated serine/threonine kinase family member 4
decreases expression
ISO
Vitamin E results in decreased expression of MAST4 mRNA
CTD
PMID:19244175
NCBI chr13:102,868,996...103,471,607
Ensembl chr13:102,868,994...103,471,005
G
Mau2
MAU2 sister chromatid cohesion factor
decreases expression
ISO
Vitamin E results in decreased expression of MAU2 mRNA
CTD
PMID:19244175
NCBI chr 8:70,465,896...70,495,384
Ensembl chr 8:70,468,773...70,495,384
G
Mb
myoglobin
increases expression
ISO
Vitamin E results in increased expression of MB mRNA
CTD
PMID:19244175
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
G
Mbd1
methyl-CpG binding domain protein 1
decreases expression
ISO
Vitamin E results in decreased expression of MBD1 mRNA
CTD
PMID:19244175
NCBI chr18:74,400,676...74,415,808
Ensembl chr18:74,400,676...74,415,803
G
Mbd4
methyl-CpG binding domain protein 4
decreases expression
ISO
Vitamin E results in decreased expression of MBD4 mRNA
CTD
PMID:19244175
NCBI chr 6:115,817,658...115,830,361
Ensembl chr 6:115,817,658...115,830,332
G
Mbnl1
muscleblind like splicing regulator 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MBNL1 mRNA Vitamin E results in decreased expression of MBNL1 mRNA
CTD
PMID:19244175
NCBI chr 3:60,380,209...60,537,171
Ensembl chr 3:60,380,251...60,537,171
G
Mboat7
membrane bound O-acyltransferase domain containing 7
decreases expression
ISO
Vitamin E results in decreased expression of MBOAT7 mRNA
CTD
PMID:19244175
NCBI chr 7:3,680,788...3,696,188
Ensembl chr 7:3,680,788...3,696,522
G
Mcam
melanoma cell adhesion molecule
increases expression
ISO
Vitamin E results in increased expression of MCAM mRNA
CTD
PMID:19244175
NCBI chr 9:44,045,958...44,054,024
Ensembl chr 9:44,045,766...44,054,024
G
Mcm3ap
minichromosome maintenance complex component 3 associated protein
decreases expression
ISO
Vitamin E results in decreased expression of MCM3AP mRNA
CTD
PMID:19244175
NCBI chr10:76,304,736...76,351,693
Ensembl chr10:76,304,761...76,351,691
G
Mcrs1
microspherule protein 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MCRS1 mRNA Vitamin E results in increased expression of MCRS1 mRNA
CTD
PMID:19244175
NCBI chr15:99,140,698...99,149,838
Ensembl chr15:99,140,698...99,149,842
G
Mdh2
malate dehydrogenase 2, NAD (mitochondrial)
increases expression
ISO
Vitamin E results in increased expression of MDH2 mRNA
CTD
PMID:19244175
NCBI chr 5:135,807,503...135,819,240
Ensembl chr 5:135,807,334...135,819,252
G
Mdk
midkine
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MDK mRNA Vitamin E results in increased expression of MDK mRNA
CTD
PMID:19244175
NCBI chr 2:91,760,149...91,762,348
Ensembl chr 2:91,760,150...91,762,642
G
Mdm1
MDM1 nuclear protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MDM1 mRNA Vitamin E results in decreased expression of MDM1 mRNA
CTD
PMID:19244175
NCBI chr10:117,977,446...118,004,904
Ensembl chr10:117,977,716...118,004,902
G
Mea1
male enhanced antigen 1
increases expression
ISO
Vitamin E results in increased expression of MEA mRNA
CTD
PMID:19244175
NCBI chr17:46,989,699...46,994,052
Ensembl chr17:46,989,719...46,994,037
G
Med1
mediator complex subunit 1
decreases expression
ISO
Vitamin E results in decreased expression of MED1 mRNA
CTD
PMID:19244175
NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119
G
Med15
mediator complex subunit 15
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MED15 mRNA Vitamin E results in increased expression of MED15 mRNA
CTD
PMID:19244175
NCBI chr16:17,469,072...17,540,811
Ensembl chr16:17,469,072...17,550,755
G
Med27
mediator complex subunit 27
increases expression
ISO
Vitamin E results in increased expression of MED27 mRNA
CTD
PMID:19244175
NCBI chr 2:29,236,822...29,414,802
Ensembl chr 2:29,236,831...29,414,805
G
Metap2
methionine aminopeptidase 2
decreases expression
ISO
Vitamin E results in decreased expression of METAP2 mRNA
CTD
PMID:19244175
NCBI chr10:93,694,351...93,732,952
Ensembl chr10:93,694,351...93,732,955
G
Mfap2
microfibrillar-associated protein 2
increases expression
ISO
Vitamin E results in increased expression of MFAP2 mRNA
CTD
PMID:19244175
NCBI chr 4:140,737,735...140,743,284
Ensembl chr 4:140,737,729...140,743,295
G
Mfge8
milk fat globule EGF and factor V/VIII domain containing
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MFGE8 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MFGE8 mRNA
CTD
PMID:19244175
NCBI chr 7:78,783,516...78,798,808
Ensembl chr 7:78,783,516...78,798,808
G
Mfsd14b
major facilitator superfamily domain containing 14B
decreases expression
ISO
Vitamin E results in decreased expression of MFSD14B mRNA
CTD
PMID:19244175
NCBI chr13:65,212,843...65,260,813
Ensembl chr13:65,212,477...65,260,789
G
Mgp
matrix Gla protein
increases expression
ISO
Vitamin E results in increased expression of MGP mRNA
CTD
PMID:19244175
NCBI chr 6:136,849,433...136,852,821
Ensembl chr 6:136,849,433...136,852,821
G
Mia
MIA SH3 domain containing
increases expression
ISO
Vitamin E results in increased expression of MIA mRNA
CTD
PMID:19244175
NCBI chr 7:26,879,166...26,880,574
Ensembl chr 7:26,879,167...26,880,582
G
Mis12
MIS12 kinetochore complex component
decreases expression
ISO
Vitamin E results in decreased expression of MIS12 mRNA
CTD
PMID:19244175
NCBI chr11:70,910,394...70,918,197
Ensembl chr11:70,910,437...70,918,197
G
Mlec
malectin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MLEC mRNA Vitamin E results in decreased expression of MLEC mRNA
CTD
PMID:19244175
NCBI chr 5:115,281,040...115,296,235
Ensembl chr 5:115,281,040...115,296,238
G
Mlf2
myeloid leukemia factor 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MLF2 mRNA Vitamin E results in increased expression of MLF2 mRNA
CTD
PMID:19244175
NCBI chr 6:124,908,351...124,913,112
Ensembl chr 6:124,908,349...124,914,201
G
Mlh1
mutL homolog 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MLH1 mRNA [Vitamin E co-treated with Hydrogen Peroxide] results in increased methylation of MLH1 promoter
CTD
PMID:29854080
NCBI chr 9:111,057,296...111,100,854
Ensembl chr 9:111,057,296...111,100,859
G
Mmp2
matrix metallopeptidase 2
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MMP2 mRNA [silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of MMP2 mRNA]
CTD
PMID:16169303 PMID:19244175
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp24
matrix metallopeptidase 24
increases expression
ISO
Vitamin E results in increased expression of MMP24 mRNA
CTD
PMID:19244175
NCBI chr 2:155,617,262...155,660,286
Ensembl chr 2:155,617,262...155,660,286
G
Mms19
MMS19 cytosolic iron-sulfur assembly component
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MMS19 mRNA Vitamin E results in increased expression of MMS19 mRNA
CTD
PMID:19244175
NCBI chr19:41,932,146...41,969,603
Ensembl chr19:41,929,525...41,969,596
G
Mnt
max binding protein
decreases expression
ISO
Vitamin E results in decreased expression of MNT mRNA
CTD
PMID:19244175
NCBI chr11:74,721,651...74,736,551
Ensembl chr11:74,721,746...74,736,551
G
Mog
myelin oligodendrocyte glycoprotein
decreases expression
ISO
Vitamin E results in decreased expression of MOG mRNA
CTD
PMID:19244175
NCBI chr17:37,321,632...37,334,290
Ensembl chr17:37,321,635...37,334,290
G
Mon2
MON2 homolog, regulator of endosome to Golgi trafficking
decreases expression
ISO
Vitamin E results in decreased expression of MON2 mRNA
CTD
PMID:19244175
NCBI chr10:122,827,965...122,913,684
Ensembl chr10:122,827,965...122,912,410
G
Moxd1
monooxygenase, DBH-like 1
increases expression
ISO
Vitamin E results in increased expression of MOXD1 mRNA
CTD
PMID:19244175
NCBI chr10:24,099,415...24,178,681
Ensembl chr10:24,099,415...24,178,688
G
Mphosph10
M-phase phosphoprotein 10 (U3 small nucleolar ribonucleoprotein)
decreases expression
ISO
Vitamin E results in decreased expression of MPHOSPH10 mRNA
CTD
PMID:19244175
NCBI chr 7:64,026,289...64,041,984
Ensembl chr 7:64,026,275...64,042,016
G
Mpo
myeloperoxidase
multiple interactions
ISO
Vitamin E inhibits the reaction [Nicotine results in increased activity of MPO protein]
CTD
PMID:17216608
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Mprip
myosin phosphatase Rho interacting protein
increases expression
ISO
Vitamin E results in increased expression of MPRIP mRNA
CTD
PMID:19244175
NCBI chr11:59,552,973...59,671,686
Ensembl chr11:59,552,131...59,671,686
G
Mpst
mercaptopyruvate sulfurtransferase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MPST mRNA Vitamin E results in increased expression of MPST mRNA
CTD
PMID:19244175
NCBI chr15:78,290,918...78,298,213
Ensembl chr15:78,290,616...78,298,213
G
Mpzl1
myelin protein zero-like 1
increases expression
ISO
Vitamin E results in increased expression of MPZL1 mRNA
CTD
PMID:19244175
NCBI chr 1:165,419,745...165,462,144
Ensembl chr 1:165,419,809...165,462,107
G
Mr1
major histocompatibility complex, class I-related
decreases expression
ISO
Vitamin E results in decreased expression of MR1 mRNA
CTD
PMID:19244175
NCBI chr 1:155,003,620...155,022,560
Ensembl chr 1:155,003,023...155,022,560
G
Mrm3
mitochondrial rRNA methyltransferase 3
increases expression
ISO
Vitamin E results in increased expression of MRM3 mRNA
CTD
PMID:19244175
NCBI chr11:76,134,562...76,141,451
Ensembl chr11:76,134,541...76,141,445
G
Mrpl11
mitochondrial ribosomal protein L11
increases expression
ISO
Vitamin E results in increased expression of MRPL11 mRNA
CTD
PMID:19244175
NCBI chr19:5,012,180...5,017,023
Ensembl chr19:5,012,175...5,017,027
G
Mrpl12
mitochondrial ribosomal protein L12
increases expression
ISO
Vitamin E results in increased expression of MRPL12 mRNA
CTD
PMID:19244175
NCBI chr11:120,375,463...120,379,580
Ensembl chr11:120,375,439...120,379,891
G
Mrpl2
mitochondrial ribosomal protein L2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MRPL2 mRNA Vitamin E results in increased expression of MRPL2 mRNA
CTD
PMID:19244175
NCBI chr17:46,957,094...46,961,058
Ensembl chr17:46,957,155...46,961,065
G
Mrpl24
mitochondrial ribosomal protein L24
increases expression
ISO
Vitamin E results in increased expression of MRPL24 mRNA
CTD
PMID:19244175
NCBI chr 3:87,825,438...87,830,757
Ensembl chr 3:87,826,813...87,830,979
G
Mrpl34
mitochondrial ribosomal protein L34
increases expression
ISO
Vitamin E results in increased expression of MRPL34 mRNA
CTD
PMID:19244175
NCBI chr 8:71,917,570...71,918,397
Ensembl chr 8:71,917,603...71,918,391
G
Mrpl35
mitochondrial ribosomal protein L35
decreases expression
ISO
Vitamin E results in decreased expression of MRPL35 mRNA
CTD
PMID:19244175
NCBI chr 6:71,789,981...71,800,768
Ensembl chr 6:71,789,981...71,803,953
G
Mrpl4
mitochondrial ribosomal protein L4
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MRPL4 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MRPL4 mRNA
CTD
PMID:19244175
NCBI chr 9:20,907,040...20,920,135
Ensembl chr 9:20,914,034...20,920,135
G
Mrpl44
mitochondrial ribosomal protein L44
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of MRPL44 mRNA Vitamin E results in decreased expression of MRPL44 mRNA
CTD
PMID:19244175
NCBI chr 1:79,753,735...79,759,162
Ensembl chr 1:79,753,735...79,759,162
G
Mrpl49
mitochondrial ribosomal protein L49
increases expression
ISO
Vitamin E results in increased expression of MRPL49 mRNA
CTD
PMID:19244175
NCBI chr19:6,103,660...6,107,785
Ensembl chr19:6,103,652...6,107,815
G
Mrpl9
mitochondrial ribosomal protein L9
increases expression
ISO
Vitamin E results in increased expression of MRPL9 mRNA
CTD
PMID:19244175
NCBI chr 3:94,350,631...94,355,831
Ensembl chr 3:94,350,625...94,358,437
G
Mrps6
mitochondrial ribosomal protein S6
decreases expression
ISO
Vitamin E results in decreased expression of MRPS6 mRNA
CTD
PMID:19244175
NCBI chr16:91,855,224...91,909,115
Ensembl chr16:91,855,158...91,909,115
G
Msh5
mutS homolog 5
decreases expression
ISO
Vitamin E results in decreased expression of MSH5 mRNA
CTD
PMID:19244175
NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721
G
Msn
moesin
increases expression
ISO
Vitamin E results in increased expression of MSN mRNA
CTD
PMID:19244175
NCBI chr X:95,139,651...95,212,159
Ensembl chr X:95,139,648...95,212,158
G
Msra
methionine sulfoxide reductase A
increases expression
ISO
Vitamin E results in increased expression of MSRA mRNA
CTD
PMID:19244175
NCBI chr14:64,360,070...64,693,352
Ensembl chr14:64,360,074...64,693,352
G
Mt1
metallothionein 1
multiple interactions increases expression
EXP ISO
Vitamin E inhibits the reaction [Copper results in increased activity of MT1 promoter] Vitamin E results in increased expression of MT1A mRNA Vitamin E promotes the reaction [Mercuric Chloride results in increased expression of MT1A mRNA]
CTD
PMID:14576086 PMID:21787585
NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955
G
Mt3
metallothionein 3
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of MT3 mRNA
CTD
PMID:11444866
NCBI chr 8:94,879,235...94,880,776
Ensembl chr 8:94,879,235...94,880,774
G
Mtch2
mitochondrial carrier 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MTCH2 mRNA Vitamin E results in increased expression of MTCH2 mRNA
CTD
PMID:19244175
NCBI chr 2:90,677,434...90,697,154
Ensembl chr 2:90,677,499...90,697,154
G
Mtcl2
microtubule crosslinking factor 2
decreases expression
ISO
Vitamin E results in decreased expression of MTCL2 mRNA
CTD
PMID:19244175
NCBI chr 2:156,852,361...156,921,185
Ensembl chr 2:156,857,719...156,921,174
G
Mterf3
mitochondrial transcription termination factor 3
decreases expression
ISO
Vitamin E results in decreased expression of MTERF3 mRNA
CTD
PMID:19244175
NCBI chr13:67,053,520...67,081,148
Ensembl chr13:67,055,032...67,081,152
G
Mtf1
metal response element binding transcription factor 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MTF1 mRNA
CTD
PMID:19244175
NCBI chr 4:124,696,342...124,743,593
Ensembl chr 4:124,695,897...124,743,593
G
Mtf2
metal response element binding transcription factor 2
decreases expression
ISO
Vitamin E results in decreased expression of MTF2 mRNA
CTD
PMID:19244175
NCBI chr 5:108,213,518...108,257,085
Ensembl chr 5:108,213,540...108,256,870
G
Mtfr1
mitochondrial fission regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of MTFR1 mRNA
CTD
PMID:19244175
NCBI chr 3:19,241,481...19,274,981
Ensembl chr 3:19,241,491...19,274,981
G
Mtm1
X-linked myotubular myopathy gene 1
decreases expression
ISO
Vitamin E results in decreased expression of MTM1 mRNA
CTD
PMID:19244175
NCBI chr X:70,254,373...70,359,019
Ensembl chr X:70,254,373...70,359,297
G
Mtmr9
myotubularin related protein 9
decreases expression
ISO
Vitamin E results in decreased expression of MTMR9 mRNA
CTD
PMID:19244175
NCBI chr14:63,757,100...63,781,402
Ensembl chr14:63,757,100...63,781,431
G
Mul1
mitochondrial ubiquitin ligase activator of NFKB 1
increases expression
ISO
Vitamin E results in increased expression of MUL1 mRNA
CTD
PMID:19244175
NCBI chr 4:138,160,239...138,169,576
Ensembl chr 4:138,161,982...138,169,576
G
Mx1
MX dynamin-like GTPase 1
increases expression
ISO
Vitamin E results in increased expression of MX1 mRNA
CTD
PMID:19244175
NCBI chr16:97,248,235...97,264,106
Ensembl chr16:97,248,235...97,264,107
G
Myl6
myosin, light polypeptide 6, alkali, smooth muscle and non-muscle
increases expression multiple interactions
ISO
Vitamin E results in increased expression of MYL6 mRNA [Selenium co-treated with Vitamin E] results in increased expression of MYL6 mRNA
CTD
PMID:19244175
NCBI chr10:128,326,728...128,329,755
Ensembl chr10:128,326,729...128,330,014
G
Myl9
myosin, light polypeptide 9, regulatory
increases expression
ISO
Vitamin E results in increased expression of MYL9 mRNA
CTD
PMID:19244175
NCBI chr 2:156,617,373...156,623,578
Ensembl chr 2:156,617,340...156,623,578
G
Myo18a
myosin XVIIIA
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of MYO18A mRNA Vitamin E results in increased expression of MYO18A mRNA
CTD
PMID:19244175
NCBI chr11:77,654,066...77,756,806
Ensembl chr11:77,654,072...77,756,806
G
Myo6
myosin VI
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of MYO6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA
CTD
PMID:19244175
NCBI chr 9:80,072,262...80,219,011
Ensembl chr 9:80,072,313...80,219,011
G
Myof
myoferlin
decreases expression
ISO
Vitamin E results in decreased expression of MYOF mRNA
CTD
PMID:19244175
NCBI chr19:37,887,484...38,032,025
Ensembl chr19:37,887,484...38,032,025
G
N4bp1
NEDD4 binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of N4BP1 mRNA
CTD
PMID:19244175
NCBI chr 8:87,567,764...87,612,489
Ensembl chr 8:87,534,788...87,611,886
G
N4bp2l2
NEDD4 binding protein 2-like 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of N4BP2L2 mRNA
CTD
PMID:19244175
NCBI chr 5:150,515,310...150,589,213
Ensembl chr 5:150,531,472...150,589,648
G
Naa10
N(alpha)-acetyltransferase 10, NatA catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of NAA10 mRNA
CTD
PMID:19244175
NCBI chr X:72,960,476...72,965,550
Ensembl chr X:72,960,479...72,965,550
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
decreases expression
ISO
Vitamin E results in decreased expression of NAA15 mRNA
CTD
PMID:19244175
NCBI chr 3:51,323,437...51,383,406
Ensembl chr 3:51,322,569...51,383,928
G
Naa60
N(alpha)-acetyltransferase 60, NatF catalytic subunit
decreases expression
ISO
Vitamin E results in decreased expression of NAA60 mRNA
CTD
PMID:19244175
NCBI chr16:3,690,365...3,722,645
Ensembl chr16:3,690,239...3,722,634
G
Nacad
NAC alpha domain containing
increases expression
ISO
Vitamin E results in increased expression of NACAD mRNA
CTD
PMID:19244175
NCBI chr11:6,547,814...6,556,059
Ensembl chr11:6,547,823...6,556,053
G
Nacc2
nucleus accumbens associated 2, BEN and BTB (POZ) domain containing
increases expression
ISO
Vitamin E results in increased expression of NACC2 mRNA
CTD
PMID:19244175
NCBI chr 2:25,945,547...26,012,823
Ensembl chr 2:25,945,547...26,013,232
G
Nadk
NAD kinase
decreases expression
ISO
Vitamin E results in decreased expression of NADK mRNA
CTD
PMID:19244175
NCBI chr 4:155,646,838...155,675,458
Ensembl chr 4:155,646,835...155,675,458
G
Nagk
N-acetylglucosamine kinase
increases expression
ISO
Vitamin E results in increased expression of NAGK mRNA
CTD
PMID:19244175
NCBI chr 6:83,770,810...83,779,538
Ensembl chr 6:83,771,964...83,781,000
G
Nav3
neuron navigator 3
decreases expression
ISO
Vitamin E results in decreased expression of NAV3 mRNA
CTD
PMID:19244175
NCBI chr10:109,517,121...110,292,148
Ensembl chr10:109,517,120...110,292,065
G
Nbas
neuroblastoma amplified sequence
increases expression
ISO
Vitamin E results in increased expression of NBAS mRNA
CTD
PMID:19244175
NCBI chr12:13,319,102...13,687,381
Ensembl chr12:13,319,134...13,633,812
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
Vitamin E results in decreased expression of NCAPG2 mRNA
CTD
PMID:19244175
NCBI chr12:116,368,969...116,427,152
Ensembl chr12:116,369,022...116,427,351
G
Ncdn
neurochondrin
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NCDN mRNA Vitamin E results in increased expression of NCDN mRNA
CTD
PMID:19244175
NCBI chr 4:126,637,548...126,647,203
Ensembl chr 4:126,637,543...126,647,231
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NCOA2 mRNA Vitamin E results in decreased expression of NCOA2 mRNA
CTD
PMID:19244175
NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307
G
Ncor1
nuclear receptor co-repressor 1
decreases expression
ISO
Vitamin E results in decreased expression of NCOR1 mRNA
CTD
PMID:19244175
NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367
G
Ndrg2
N-myc downstream regulated gene 2
increases expression
ISO
Vitamin E results in increased expression of NDRG2 mRNA
CTD
PMID:19244175
NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
decreases expression
ISO
Vitamin E results in decreased expression of NDUFA3 mRNA
CTD
PMID:19244175
NCBI chr 7:3,620,372...3,623,162
Ensembl chr 7:3,620,372...3,623,326
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NDUFA7 mRNA Vitamin E results in decreased expression of NDUFA7 mRNA
CTD
PMID:19244175
NCBI chr17:34,043,546...34,057,290
Ensembl chr17:34,043,546...34,057,291
G
Ndufb8
NADH:ubiquinone oxidoreductase subunit B8
increases expression
ISO
Vitamin E results in increased expression of NDUFB8 mRNA
CTD
PMID:19244175
NCBI chr19:44,537,010...44,543,881
Ensembl chr19:44,537,011...44,543,879
G
Ndufs3
NADH:ubiquinone oxidoreductase core subunit S3
increases expression
ISO
Vitamin E results in increased expression of NDUFS3 mRNA
CTD
PMID:19244175
NCBI chr 2:90,724,971...90,735,065
Ensembl chr 2:90,724,978...90,735,171
G
Ndufv1
NADH:ubiquinone oxidoreductase core subunit V1
increases expression
ISO
Vitamin E results in increased expression of NDUFV1 mRNA
CTD
PMID:19244175
NCBI chr19:4,057,499...4,062,755
Ensembl chr19:4,057,384...4,062,806
G
Nedd8
neural precursor cell expressed, developmentally down-regulated gene 8
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NEDD8 mRNA Vitamin E results in increased expression of NEDD8 mRNA
CTD
PMID:19244175
NCBI chr14:55,899,720...55,909,337
Ensembl chr14:55,899,720...55,909,581
G
Nek1
NIMA (never in mitosis gene a)-related expressed kinase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NEK1 mRNA Vitamin E results in decreased expression of NEK1 mRNA
CTD
PMID:19244175
NCBI chr 8:61,446,184...61,584,383
Ensembl chr 8:61,446,229...61,584,380
G
Nek2
NIMA (never in mitosis gene a)-related expressed kinase 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of NEK2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NEK2 mRNA
CTD
PMID:19244175
NCBI chr 1:191,553,622...191,565,161
Ensembl chr 1:191,553,556...191,565,162
G
Nelfa
negative elongation factor complex member A, Whsc2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NELFA mRNA
CTD
PMID:19244175
NCBI chr 5:34,055,263...34,093,615
Ensembl chr 5:34,055,260...34,093,757
G
Nenf
neuron derived neurotrophic factor
increases expression
ISO
Vitamin E results in increased expression of NENF mRNA
CTD
PMID:19244175
NCBI chr 1:191,038,984...191,050,328
Ensembl chr 1:191,038,986...191,050,391
G
Nf2
neurofibromin 2
increases expression multiple interactions
ISO
Vitamin E results in increased expression of NF2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of NF2 mRNA
CTD
PMID:19244175
NCBI chr11:4,715,845...4,799,544
Ensembl chr11:4,715,845...4,799,536
G
Nfat5
nuclear factor of activated T cells 5
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NFAT5 mRNA Vitamin E results in decreased expression of NFAT5 mRNA
CTD
PMID:19244175
NCBI chr 8:108,020,072...108,106,149
Ensembl chr 8:108,020,102...108,106,149
G
Nfatc3
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3
decreases expression
ISO
Vitamin E results in decreased expression of NFATC3 mRNA
CTD
PMID:19244175
NCBI chr 8:106,785,450...106,857,169
Ensembl chr 8:106,785,472...106,857,169
G
Nfe2l1
nuclear factor, erythroid derived 2,-like 1
increases expression
ISO
Vitamin E results in increased expression of NFE2L1 mRNA
CTD
PMID:19244175
NCBI chr11:96,708,239...96,720,810
Ensembl chr11:96,708,240...96,720,794
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions increases expression decreases expression
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NFE2L2 protein] Vitamin E inhibits the reaction [Ozone results in decreased expression of NFE2L2 protein] Vitamin E results in increased expression of NFE2L2 mRNA Vitamin E results in decreased expression of NFE2L2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NFE2L2 mRNA; Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein]; Vitamin E inhibits the reaction [Polychlorinated Biphenyls analog results in increased expression of NFE2L2 protein]
CTD
PMID:19244175 PMID:24361488 PMID:29663635 PMID:29940330 PMID:30090343 PMID:30513525 PMID:35511042 More...
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
multiple interactions
ISO
Vitamin E inhibits the reaction [Norepinephrine affects the localization of NFKB1 protein]
CTD
PMID:23114885
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions decreases expression
ISO EXP
Vitamin E inhibits the reaction [Hydrogen Peroxide results in decreased expression of NFKBIA protein]; Vitamin E inhibits the reaction [Hydrogen Peroxide results in increased degradation of NFKBIA protein] Vitamin E inhibits the reaction [Alcohols results in increased expression of NFKBIA mRNA]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased degradation of NFKBIA protein] Vitamin E results in decreased expression of NFKBIA mRNA
CTD
PMID:10921504 PMID:15081873 PMID:18814483 PMID:19244175
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nfkbib
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta
increases expression
ISO
Vitamin E results in increased expression of NFKBIB mRNA
CTD
PMID:19244175
NCBI chr 7:28,457,676...28,466,069
Ensembl chr 7:28,457,676...28,466,937
G
Nfyc
nuclear transcription factor-Y gamma
increases expression
ISO
Vitamin E results in increased expression of NFYC mRNA
CTD
PMID:19244175
NCBI chr 4:120,614,632...120,688,776
Ensembl chr 4:120,614,635...120,688,769
G
Nhp2
NHP2 ribonucleoprotein
increases expression
ISO
Vitamin E results in increased expression of NOLA2 mRNA
CTD
PMID:19244175
NCBI chr11:51,510,600...51,514,545
Ensembl chr11:51,510,562...51,514,541
G
Nhsl3
NHS like 3
decreases expression
ISO
Vitamin E results in decreased expression of NHSL3 mRNA
CTD
PMID:19244175
NCBI chr 4:129,113,371...129,155,194
Ensembl chr 4:129,113,371...129,155,197
G
Niban1
niban apoptosis regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of NIBAN1 mRNA
CTD
PMID:19244175
NCBI chr 1:151,447,215...151,597,690
Ensembl chr 1:151,446,937...151,597,690
G
Ninl
ninein-like
decreases expression
ISO
Vitamin E results in decreased expression of NINL mRNA
CTD
PMID:19244175
NCBI chr 2:150,776,439...150,851,330
Ensembl chr 2:150,776,439...150,881,302
G
Nipbl
NIPBL cohesin loading factor
decreases expression
ISO
Vitamin E results in decreased expression of NIPBL mRNA
CTD
PMID:19244175
NCBI chr15:8,319,308...8,494,799
Ensembl chr15:8,320,101...8,473,947
G
Nktr
natural killer tumor recognition sequence
decreases expression
ISO
Vitamin E results in decreased expression of NKTR mRNA
CTD
PMID:19244175
NCBI chr 9:121,542,244...121,585,908
Ensembl chr 9:121,548,235...121,585,909
G
Nkx2-1
NK2 homeobox 1
multiple interactions
ISO
Vitamin E inhibits the reaction [nitrofen results in decreased expression of NKX2-1 protein] Vitamin E inhibits the reaction [nitrofen results in decreased expression of NKX2-1 mRNA]
CTD
PMID:16490937 PMID:16863852
NCBI chr12:56,578,741...56,583,570
Ensembl chr12:56,578,743...56,583,693
G
Noc3l
NOC3 like DNA replication regulator
decreases expression
ISO
Vitamin E results in decreased expression of NOC3L mRNA
CTD
PMID:19244175
NCBI chr19:38,776,565...38,808,754
Ensembl chr19:38,776,572...38,807,681
G
Nol3
nucleolar protein 3 (apoptosis repressor with CARD domain)
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOL3 mRNA
CTD
PMID:19244175
NCBI chr 8:106,002,777...106,008,571
Ensembl chr 8:106,002,772...106,008,571
G
Nol8
nucleolar protein 8
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOL8 mRNA Vitamin E results in decreased expression of NOL8 mRNA
CTD
PMID:19244175
NCBI chr13:49,806,554...49,832,492
Ensembl chr13:49,806,554...49,832,492
G
Nolc1
nucleolar and coiled-body phosphoprotein 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of NOLC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of NOLC1 mRNA
CTD
PMID:19244175
NCBI chr19:46,064,286...46,073,982
Ensembl chr19:46,064,302...46,073,969
G
Nop56
NOP56 ribonucleoprotein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of NOP56 mRNA Vitamin E results in decreased expression of NOP56 mRNA
CTD
PMID:19244175
NCBI chr 2:130,112,904...130,121,233
Ensembl chr 2:130,116,350...130,121,233
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in increased expression of NOS2 mRNA]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [APP protein modified form promotes the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of NOS2 protein]]; Vitamin E inhibits the reaction [Lead results in increased expression of NOS2 protein]
CTD
PMID:10523326 PMID:15223066 PMID:18779489
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
multiple interactions decreases expression
ISO EXP
[Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein]; Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] Vitamin E results in decreased expression of NOS3 protein
CTD
PMID:10523326 PMID:11597945 PMID:20068362
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nosip
nitric oxide synthase interacting protein
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NOSIP mRNA Vitamin E results in increased expression of NOSIP mRNA
CTD
PMID:19244175
NCBI chr 7:44,711,840...44,727,927
Ensembl chr 7:44,711,853...44,727,634
G
Notch4
notch 4
multiple interactions
ISO
Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of NOTCH4 protein]
CTD
PMID:20722969
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
G
Nova1
NOVA alternative splicing regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of NOVA1 mRNA
CTD
PMID:19244175
NCBI chr12:46,744,678...46,866,143
Ensembl chr12:46,741,300...46,865,712
G
Npepl1
aminopeptidase-like 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of NPEPL1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of NPEPL1 mRNA
CTD
PMID:19244175
NCBI chr 2:173,951,904...173,964,495
Ensembl chr 2:173,952,142...173,964,863
G
Npepps
aminopeptidase puromycin sensitive
increases expression
ISO
Vitamin E results in increased expression of NPEPPS mRNA
CTD
PMID:19244175
NCBI chr11:97,096,668...97,171,503
Ensembl chr11:97,096,668...97,171,464
G
Npm1
nucleophosmin 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of NPM1 mRNA
CTD
PMID:11444866
NCBI chr11:33,102,498...33,114,143
Ensembl chr11:33,102,287...33,113,206
G
Nppb
natriuretic peptide type B
multiple interactions
ISO
Vitamin E affects the reaction [Triiodothyronine, Reverse results in increased expression of NPPB mRNA]
CTD
PMID:17198541
NCBI chr 4:148,070,264...148,071,662
Ensembl chr 4:148,070,245...148,071,662
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions increases expression
ISO EXP
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of NQO1 protein]; [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of NQO1 mRNA Vitamin E inhibits the reaction [Ozone results in decreased expression of NQO1 protein] [Vitamin E co-treated with bioallethrin] results in increased expression of NQO1 protein Vitamin E results in increased expression of NQO1 mRNA
CTD
PMID:11444866 PMID:29663635 PMID:30090343 PMID:30513525 PMID:35511042
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr2c1
nuclear receptor subfamily 2, group C, member 1
decreases expression
ISO
Vitamin E results in decreased expression of NR2C1 mRNA
CTD
PMID:19244175
NCBI chr10:93,983,491...94,033,078
Ensembl chr10:93,983,885...94,033,073
G
Nr2f1
nuclear receptor subfamily 2, group F, member 1
increases expression
ISO
Vitamin E results in increased expression of NR2F1 mRNA
CTD
PMID:19244175
NCBI chr13:78,337,090...78,346,954
Ensembl chr13:78,337,092...78,347,876
G
Nr2f2
nuclear receptor subfamily 2, group F, member 2
increases expression
ISO
Vitamin E results in increased expression of NR2F2 mRNA
CTD
PMID:19244175
NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
multiple interactions increases expression
ISO
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of NR4A2 protein Vitamin E results in increased expression of NR4A2 protein
CTD
PMID:18772553
NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015
G
Nras
neuroblastoma ras oncogene
decreases expression
ISO
Vitamin E results in decreased expression of NRAS mRNA
CTD
PMID:19244175
NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230
G
Nsfl1c
NSFL1 (p97) cofactor (p47)
increases expression
ISO
Vitamin E results in increased expression of NSFL1C mRNA
CTD
PMID:19244175
NCBI chr 2:151,336,102...151,353,230
Ensembl chr 2:151,336,102...151,353,334
G
Nsun5
NOL1/NOP2/Sun domain family, member 5
decreases expression
ISO
Vitamin E results in decreased expression of NSUN5 mRNA
CTD
PMID:19244175
NCBI chr 5:135,398,784...135,405,661
Ensembl chr 5:135,398,807...135,405,659
G
Nt5dc2
5'-nucleotidase domain containing 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of NT5DC2 mRNA Vitamin E results in increased expression of NT5DC2 mRNA
CTD
PMID:19244175
NCBI chr14:30,853,046...30,861,081
Ensembl chr14:30,853,010...30,861,081
G
Nudc
nudC nuclear distribution protein
increases expression
ISO
Vitamin E results in increased expression of NUDC mRNA
CTD
PMID:19244175
NCBI chr 4:133,259,853...133,273,338
Ensembl chr 4:133,259,853...133,273,307
G
Nudt18
nudix hydrolase 18
increases expression
ISO
Vitamin E results in increased expression of NUDT18 mRNA
CTD
PMID:19244175
NCBI chr14:70,815,264...70,820,128
Ensembl chr14:70,815,077...70,820,128
G
Numa1
nuclear mitotic apparatus protein 1
decreases expression
ISO
Vitamin E results in decreased expression of NUMA1 mRNA
CTD
PMID:19244175
NCBI chr 7:101,583,169...101,664,166
Ensembl chr 7:101,583,318...101,664,171
G
Nup160
nucleoporin 160
decreases expression
ISO
Vitamin E results in decreased expression of NUP160 mRNA
CTD
PMID:19244175
NCBI chr 2:90,504,405...90,570,217
Ensembl chr 2:90,507,559...90,566,672
G
Nup93
nucleoporin 93
increases expression
ISO
Vitamin E results in increased expression of NUP93 mRNA
CTD
PMID:19244175
NCBI chr 8:94,941,203...95,043,858
Ensembl chr 8:94,941,192...95,043,855
G
Nutf2
nuclear transport factor 2
increases expression
ISO
Vitamin E results in increased expression of NUTF2 mRNA
CTD
PMID:19244175
NCBI chr 8:106,587,165...106,607,034
Ensembl chr 8:106,587,212...106,605,962
G
Oaz2
ornithine decarboxylase antizyme 2
increases expression
ISO
Vitamin E results in increased expression of OAZ2 mRNA
CTD
PMID:19244175
NCBI chr 9:65,583,830...65,597,582
Ensembl chr 9:65,575,283...65,597,582
G
Ocln
occludin
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate affects the localization of OCLN protein]; Vitamin E inhibits the reaction [phoxim results in decreased expression of OCLN mRNA]
CTD
PMID:29940330 PMID:30003487
NCBI chr13:100,633,012...100,689,226
Ensembl chr13:100,633,015...100,689,226
G
Odc1
ornithine decarboxylase, structural 1
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [mezerein results in increased activity of ODC1 protein]; Vitamin E inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of ODC1 protein]; Vitamin E inhibits the reaction [Urethane results in increased activity of ODC1 protein] Vitamin E inhibits the reaction [ferric nitrilotriacetate results in increased activity of ODC1 protein]
CTD
PMID:3098411 PMID:11062179 PMID:15949125
NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506
G
Ogfod1
2-oxoglutarate and iron-dependent oxygenase domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of OGFOD1 mRNA
CTD
PMID:19244175
NCBI chr 8:94,763,782...94,794,550
Ensembl chr 8:94,763,826...94,794,549
G
Ogfr
opioid growth factor receptor
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of OGFR mRNA Vitamin E results in increased expression of OGFR mRNA
CTD
PMID:19244175
NCBI chr 2:180,231,200...180,237,630
Ensembl chr 2:180,231,038...180,237,629
G
Olah
oleoyl-ACP hydrolase
decreases expression
ISO
Vitamin E results in decreased expression of OLAH mRNA
CTD
PMID:19244175
NCBI chr 2:3,343,019...3,367,964
Ensembl chr 2:3,343,019...3,398,247
G
Olfml3
olfactomedin-like 3
increases expression
ISO
Vitamin E results in increased expression of OLFML3 mRNA
CTD
PMID:19244175
NCBI chr 3:103,642,710...103,645,317
Ensembl chr 3:103,629,538...103,645,317
G
Or5v1b
olfactory receptor family 5 subfamily V member 1B
decreases expression
ISO
Vitamin E results in decreased expression of OR5V1 mRNA
CTD
PMID:19244175
NCBI chr17:37,815,851...37,844,816
Ensembl chr17:37,818,921...37,843,340
G
Orc6
origin recognition complex, subunit 6
decreases expression
ISO
Vitamin E results in decreased expression of ORC6 mRNA
CTD
PMID:19244175
NCBI chr 8:86,026,261...86,034,908
Ensembl chr 8:86,026,261...86,034,907
G
Orm1
orosomucoid 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of ORM1 mRNA
CTD
PMID:11444866
NCBI chr 4:63,262,793...63,266,400
Ensembl chr 4:63,262,797...63,266,400
G
Os9
amplified in osteosarcoma
increases expression
ISO
Vitamin E results in increased expression of OS9 mRNA
CTD
PMID:19244175
NCBI chr10:126,928,880...126,957,029
Ensembl chr10:126,931,519...126,957,000
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of OSBPL1A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of OSBPL1A mRNA
CTD
PMID:19244175
NCBI chr18:12,886,955...13,074,933
Ensembl chr18:12,888,371...13,074,898
G
Osr2
odd-skipped related 2
increases expression
ISO
Vitamin E results in increased expression of OSR2 mRNA
CTD
PMID:19244175
NCBI chr15:35,296,244...35,303,451
Ensembl chr15:35,296,244...35,303,451
G
Ovgp1
oviductal glycoprotein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of OVGP1 mRNA Vitamin E results in decreased expression of OVGP1 mRNA
CTD
PMID:19244175
NCBI chr 3:105,881,118...105,894,739
Ensembl chr 3:105,881,027...105,894,739
G
Pa2g4
proliferation-associated 2G4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PA2G4 mRNA
CTD
PMID:19244175
NCBI chr10:128,393,635...128,401,803
Ensembl chr10:128,393,635...128,401,856
G
Pabpc1
poly(A) binding protein, cytoplasmic 1
decreases expression
ISO
Vitamin E results in decreased expression of PABPC1 mRNA
CTD
PMID:19244175
NCBI chr15:36,595,902...36,609,825
Ensembl chr15:36,595,905...36,609,912
G
Pabpc6
poly(A) binding protein, cytoplasmic 6
decreases expression
ISO
Vitamin E results in decreased expression of PABPC3 mRNA
CTD
PMID:19244175
NCBI chr17:9,885,426...9,888,633
Ensembl chr17:9,885,424...9,888,646
G
Pafah1b1
platelet-activating factor acetylhydrolase, isoform 1b, subunit 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PAFAH1B1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PAFAH1B1 mRNA
CTD
PMID:19244175
NCBI chr11:74,564,775...74,615,210
Ensembl chr11:74,564,775...74,615,496
G
Pafah1b3
platelet-activating factor acetylhydrolase, isoform 1b, subunit 3
increases expression
ISO
Vitamin E results in increased expression of PAFAH1B3 mRNA
CTD
PMID:19244175
NCBI chr 7:24,994,473...24,997,377
Ensembl chr 7:24,994,474...24,997,411
G
Pak2
p21 (RAC1) activated kinase 2
increases expression
ISO
Vitamin E results in increased expression of PAK2 mRNA
CTD
PMID:19244175
NCBI chr16:31,835,108...31,898,160
Ensembl chr16:31,835,108...31,898,160
G
Pakap
paralemmin A kinase anchor protein
increases expression decreases expression
ISO
Vitamin E results in increased expression of PALM2AKAP2 mRNA Vitamin E results in decreased expression of PALM2AKAP2 mRNA
CTD
PMID:19244175
NCBI chr 4:57,434,475...57,896,984
Ensembl chr 4:57,717,657...57,896,984 Ensembl chr 4:57,717,657...57,896,984 Ensembl chr 4:57,717,657...57,896,984
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
ISO
Vitamin E results in decreased expression of PAM mRNA
CTD
PMID:19244175
NCBI chr 1:97,748,816...98,023,578
Ensembl chr 1:97,722,839...98,023,371
G
Paox
polyamine oxidase (exo-N4-amino)
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PAOX mRNA Vitamin E results in increased expression of PAOX mRNA
CTD
PMID:19244175 PMID:28923436
NCBI chr 7:139,693,182...139,714,249
Ensembl chr 7:139,695,712...139,717,137
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
Vitamin E results in decreased expression of PARD3 mRNA
CTD
PMID:19244175
NCBI chr 8:127,790,131...128,338,767
Ensembl chr 8:127,790,643...128,338,767
G
Parl
presenilin associated, rhomboid-like
increases expression
ISO
Vitamin E results in increased expression of PARL mRNA
CTD
PMID:19244175
NCBI chr16:20,098,570...20,121,090
Ensembl chr16:20,098,568...20,121,137
G
Parn
poly(A)-specific ribonuclease (deadenylation nuclease)
increases expression
ISO
Vitamin E results in increased expression of PARN mRNA
CTD
PMID:19244175
NCBI chr16:13,355,828...13,486,035
Ensembl chr16:13,355,824...13,486,034
G
Parp1
poly (ADP-ribose) polymerase family, member 1
multiple interactions increases expression
ISO
Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased expression of PARP1 protein]; Vitamin E inhibits the reaction [osimertinib results in increased expression of PARP1 protein modified form] Vitamin E results in increased expression of PARP1 mRNA
CTD
PMID:19244175 PMID:24664296 PMID:28237877
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Parva
parvin, alpha
decreases expression
ISO
Vitamin E results in decreased expression of PARVA mRNA
CTD
PMID:19244175
NCBI chr 7:112,027,102...112,190,899
Ensembl chr 7:112,026,712...112,190,899
G
Pawr
PRKC, apoptosis, WT1, regulator
decreases expression
ISO
Vitamin E results in decreased expression of PAWR mRNA
CTD
PMID:19244175
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pax4
paired box 4
decreases expression
ISO
Vitamin E results in decreased expression of PAX4 mRNA
CTD
PMID:19244175
NCBI chr 6:28,442,333...28,449,339
Ensembl chr 6:28,442,333...28,449,352
G
Paxbp1
PAX3 and PAX7 binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of PAXBP1 mRNA
CTD
PMID:19244175
NCBI chr16:90,810,925...90,841,267
Ensembl chr16:90,810,925...90,841,431
G
Pbxip1
pre B cell leukemia transcription factor interacting protein 1
increases expression
ISO
Vitamin E results in increased expression of PBXIP1 mRNA
CTD
PMID:19244175
NCBI chr 3:89,343,982...89,358,259
Ensembl chr 3:89,344,013...89,358,259
G
Pcdhgc3
protocadherin gamma subfamily C, 3
increases expression
ISO
Vitamin E results in increased expression of PCDHGC3 mRNA
CTD
PMID:19244175
NCBI chr18:37,939,463...37,974,926
Ensembl chr18:37,939,417...37,974,926
G
Pcgf1
polycomb group ring finger 1
increases expression
ISO
Vitamin E results in increased expression of PCGF1 mRNA
CTD
PMID:19244175
NCBI chr 6:83,047,573...83,057,836
Ensembl chr 6:83,054,850...83,057,836
G
Pclaf
PCNA clamp associated factor
decreases expression
ISO
Vitamin E results in decreased expression of PCLAF mRNA
CTD
PMID:19244175
NCBI chr 9:65,797,605...65,810,833
Ensembl chr 9:65,797,519...65,810,548
G
Pcm1
pericentriolar material 1
decreases expression
ISO
Vitamin E results in decreased expression of PCM1 mRNA
CTD
PMID:19244175
NCBI chr 8:41,692,521...41,787,125
Ensembl chr 8:41,692,789...41,785,381
G
Pcna
proliferating cell nuclear antigen
multiple interactions
EXP
Vitamin E inhibits the reaction [Urethane results in increased expression of PCNA protein]
CTD
PMID:11062179
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pcolce
procollagen C-endopeptidase enhancer protein
increases expression
ISO
Vitamin E results in increased expression of PCOLCE mRNA
CTD
PMID:19244175
NCBI chr 5:137,603,369...137,609,666
Ensembl chr 5:137,603,365...137,612,046
G
Pcsk7
proprotein convertase subtilisin/kexin type 7
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PCSK7 mRNA Vitamin E results in increased expression of PCSK7 mRNA
CTD
PMID:19244175
NCBI chr 9:45,817,745...45,843,405
Ensembl chr 9:45,817,795...45,841,024
G
Pcyox1l
prenylcysteine oxidase 1 like
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PCYOX1L mRNA Vitamin E results in decreased expression of PCYOX1L mRNA
CTD
PMID:19244175
NCBI chr18:61,829,907...61,840,712
Ensembl chr18:61,829,908...61,840,706
G
Pde8a
phosphodiesterase 8A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PDE8A mRNA Vitamin E results in decreased expression of PDE8A mRNA
CTD
PMID:19244175
NCBI chr 7:80,863,013...80,984,283
Ensembl chr 7:80,863,344...80,984,281
G
Pdgfa
platelet derived growth factor, alpha
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PDGFA mRNA
CTD
PMID:19244175
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfra
platelet derived growth factor receptor, alpha polypeptide
increases expression
ISO
Vitamin E results in increased expression of PDGFRA mRNA
CTD
PMID:19244175
NCBI chr 5:75,311,988...75,358,867
Ensembl chr 5:75,312,953...75,358,876
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
increases expression
ISO
Vitamin E results in increased expression of PDGFRB mRNA
CTD
PMID:19244175
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pdlim2
PDZ and LIM domain 2
increases expression
ISO
Vitamin E results in increased expression of PDLIM2 mRNA
CTD
PMID:19244175
NCBI chr14:70,401,667...70,415,140
Ensembl chr14:70,401,667...70,415,130
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
Vitamin E results in decreased expression of PDLIM3 mRNA
CTD
PMID:19244175
NCBI chr 8:46,338,524...46,372,672
Ensembl chr 8:46,338,498...46,372,585
G
Pdlim4
PDZ and LIM domain 4
increases expression
ISO
Vitamin E results in increased expression of PDLIM4 mRNA
CTD
PMID:19244175
NCBI chr11:53,945,754...53,959,814
Ensembl chr11:53,945,754...53,959,840
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
Vitamin E results in increased expression of PDLIM7 mRNA
CTD
PMID:19244175
NCBI chr13:55,645,300...55,661,281
Ensembl chr13:55,643,608...55,661,489
G
Pdpk1
3-phosphoinositide dependent protein kinase 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PDPK1 mRNA Vitamin E results in decreased expression of PDPK1 mRNA
CTD
PMID:19244175
NCBI chr17:24,292,654...24,370,957
Ensembl chr17:24,292,654...24,369,898
G
Pds5b
PDS5 cohesin associated factor B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of APRIN mRNA
CTD
PMID:19244175
NCBI chr 5:150,597,178...150,734,174
Ensembl chr 5:150,597,204...150,734,155
G
Pea15a
proliferation and apoptosis adaptor protein 15A
increases expression
ISO
Vitamin E results in increased expression of PEA15 mRNA
CTD
PMID:19244175
NCBI chr 1:172,024,295...172,034,298
Ensembl chr 1:172,024,295...172,034,371
G
Pebp1
phosphatidylethanolamine binding protein 1
increases expression
ISO
Vitamin E results in increased expression of PEBP1 mRNA
CTD
PMID:19244175
NCBI chr 5:117,420,716...117,425,629
Ensembl chr 5:117,420,719...117,425,690
G
Pecam1
platelet/endothelial cell adhesion molecule 1
increases expression
ISO
Vitamin E results in increased expression of PECAM1 mRNA
CTD
PMID:19244175
NCBI chr11:106,545,039...106,606,107
Ensembl chr11:106,545,043...106,641,454
G
Pef1
penta-EF hand domain containing 1
increases expression
ISO
Vitamin E results in increased expression of PEF1 mRNA
CTD
PMID:19244175
NCBI chr 4:130,001,349...130,021,927
Ensembl chr 4:129,996,351...130,021,928
G
Peli1
pellino 1
decreases expression
ISO
Vitamin E results in decreased expression of PELI1 mRNA
CTD
PMID:19244175
NCBI chr11:21,041,283...21,100,327
Ensembl chr11:21,041,291...21,100,323
G
Pemt
phosphatidylethanolamine N-methyltransferase
increases expression
ISO
Vitamin E results in increased expression of PEMT mRNA
CTD
PMID:19244175
NCBI chr11:59,861,440...59,937,394
Ensembl chr11:59,861,440...59,937,315
G
Per3
period circadian clock 3
decreases expression
ISO
Vitamin E results in decreased expression of PER3 mRNA
CTD
PMID:19244175
NCBI chr 4:151,081,475...151,129,167
Ensembl chr 4:151,088,109...151,129,122
G
Pes1
pescadillo ribosomal biogenesis factor 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PES1 mRNA Vitamin E results in increased expression of PES1 mRNA
CTD
PMID:19244175
NCBI chr11:3,913,975...3,930,004
Ensembl chr11:3,913,975...3,930,004
G
Pex1
peroxisomal biogenesis factor 1
decreases expression
ISO
Vitamin E results in decreased expression of PEX1 mRNA
CTD
PMID:19244175
NCBI chr 5:3,646,066...3,687,230
Ensembl chr 5:3,646,066...3,687,232
G
Pex16
peroxisomal biogenesis factor 16
decreases expression
ISO
Vitamin E results in decreased expression of PEX16 mRNA
CTD
PMID:19244175
NCBI chr 2:92,205,043...92,211,563
Ensembl chr 2:92,205,021...92,211,562
G
Pex3
peroxisomal biogenesis factor 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PEX3 mRNA Vitamin E results in decreased expression of PEX3 mRNA
CTD
PMID:19244175
NCBI chr10:13,399,586...13,428,886
Ensembl chr10:13,399,586...13,428,886
G
Pex5
peroxisomal biogenesis factor 5
increases expression
ISO
Vitamin E results in increased expression of PEX5 mRNA
CTD
PMID:19244175
NCBI chr 6:124,373,774...124,392,878
Ensembl chr 6:124,373,775...124,392,026
G
Pex7
peroxisomal biogenesis factor 7
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PEX7 mRNA
CTD
PMID:19244175
NCBI chr10:19,735,836...19,783,420
Ensembl chr10:19,729,646...19,783,435
G
Pfdn2
prefoldin 2
increases expression
ISO
Vitamin E results in increased expression of PFDN2 mRNA
CTD
PMID:19244175
NCBI chr 1:171,172,522...171,186,822
Ensembl chr 1:171,173,238...171,186,822
G
Pfdn5
prefoldin 5
increases expression
ISO
Vitamin E results in increased expression of PFDN5 mRNA
CTD
PMID:19244175
NCBI chr15:102,234,551...102,239,925
Ensembl chr15:102,234,551...102,240,308
G
Pfkl
phosphofructokinase, liver, B-type
increases expression
ISO
Vitamin E results in increased expression of PFKL mRNA
CTD
PMID:19244175
NCBI chr10:77,822,781...77,845,641
Ensembl chr10:77,822,781...77,845,917
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
Vitamin E results in increased expression of PFKP mRNA
CTD
PMID:19244175
NCBI chr13:6,629,910...6,699,096
Ensembl chr13:6,629,804...6,698,813
G
Pfn1
profilin 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PFN1 mRNA Vitamin E results in increased expression of PFN1 mRNA
CTD
PMID:19244175
NCBI chr11:70,542,670...70,547,625
Ensembl chr11:70,542,676...70,545,470
G
Pgap2
post-GPI attachment to proteins 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PGAP2 mRNA
CTD
PMID:19244175
NCBI chr 7:101,859,153...101,887,771
Ensembl chr 7:101,859,415...101,887,774
G
Pgm3
phosphoglucomutase 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PGM3 mRNA
CTD
PMID:19244175
NCBI chr 9:86,423,997...86,453,927
Ensembl chr 9:86,436,430...86,453,895
G
Phactr2
phosphatase and actin regulator 2
decreases expression
ISO
Vitamin E results in decreased expression of PHACTR2 mRNA
CTD
PMID:19244175
NCBI chr10:13,083,461...13,350,266
Ensembl chr10:13,083,461...13,350,156
G
Phb1
prohibitin 1
increases expression
ISO
Vitamin E results in increased expression of PHB1 mRNA
CTD
PMID:19244175
NCBI chr11:95,557,783...95,571,599
Ensembl chr11:95,557,783...95,571,599
G
Phc2
polyhomeotic 2
increases expression
ISO
Vitamin E results in increased expression of PHC2 mRNA
CTD
PMID:19244175
NCBI chr 4:128,548,448...128,646,674
Ensembl chr 4:128,548,495...128,646,674
G
Phf20
PHD finger protein 20
decreases expression
ISO
Vitamin E results in decreased expression of PHF20 mRNA
CTD
PMID:19244175
NCBI chr 2:156,038,567...156,151,873
Ensembl chr 2:156,038,386...156,151,872
G
Phf3
PHD finger protein 3
decreases expression
ISO
Vitamin E results in decreased expression of PHF3 mRNA
CTD
PMID:19244175
NCBI chr 1:30,841,417...30,912,989
Ensembl chr 1:30,841,420...30,913,002
G
Phlda1
pleckstrin homology like domain, family A, member 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PHLDA1 mRNA
CTD
PMID:19244175
NCBI chr10:111,342,147...111,344,510
Ensembl chr10:111,342,147...111,344,506
G
Pi4kb
phosphatidylinositol 4-kinase beta
increases expression
ISO
Vitamin E results in increased expression of PI4KB mRNA
CTD
PMID:19244175
NCBI chr 3:94,882,042...94,914,248
Ensembl chr 3:94,882,042...94,914,154
G
Pias1
protein inhibitor of activated STAT 1
decreases expression
ISO
Vitamin E results in decreased expression of PIAS1 mRNA
CTD
PMID:19244175
NCBI chr 9:62,785,648...62,888,161
Ensembl chr 9:62,785,650...62,895,206
G
Pias4
protein inhibitor of activated STAT 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PIAS4 mRNA Vitamin E results in decreased expression of PIAS4 mRNA
CTD
PMID:19244175
NCBI chr10:80,989,795...81,003,554
Ensembl chr10:80,989,100...81,003,757
G
Pigg
phosphatidylinositol glycan anchor biosynthesis, class G
decreases expression
ISO
Vitamin E results in decreased expression of PIGG mRNA
CTD
PMID:19244175
NCBI chr 5:108,460,679...108,497,225
Ensembl chr 5:108,460,475...108,497,221
G
Pigh
phosphatidylinositol glycan anchor biosynthesis, class H
decreases expression
ISO
Vitamin E results in decreased expression of PIGH mRNA
CTD
PMID:19244175
NCBI chr12:79,127,443...79,136,478
Ensembl chr12:79,127,438...79,136,425
G
Pih1d1
PIH1 domain containing 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of PIH1D1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PIH1D1 mRNA
CTD
PMID:19244175
NCBI chr 7:44,800,036...44,809,489
Ensembl chr 7:44,803,727...44,809,489
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PIK3CD mRNA Vitamin E results in increased expression of PIK3CD mRNA
CTD
PMID:19244175
NCBI chr 4:149,733,625...149,787,023
Ensembl chr 4:149,733,625...149,787,028
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression
ISO
Vitamin E results in decreased expression of PIK3R1 mRNA
CTD
PMID:19244175
NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725
G
Pim1
proviral integration site 1
increases expression
ISO
Vitamin E results in increased expression of PIM1 mRNA
CTD
PMID:19244175
NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086
G
Pink1
PTEN induced putative kinase 1
increases expression
ISO
Vitamin E results in increased expression of PINK1 mRNA
CTD
PMID:19244175
NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618
G
Pip4k2c
phosphatidylinositol-5-phosphate 4-kinase, type II, gamma
increases expression
ISO
Vitamin E results in increased expression of PIP4K2C mRNA
CTD
PMID:19244175
NCBI chr10:127,032,936...127,047,508
Ensembl chr10:127,032,936...127,047,454
G
Pitpna
phosphatidylinositol transfer protein, alpha
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PITPNA mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PITPNA mRNA
CTD
PMID:19244175
NCBI chr11:75,478,889...75,519,630
Ensembl chr11:75,478,923...75,519,630
G
Pitx1
paired-like homeodomain transcription factor 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PITX1 mRNA
CTD
PMID:19244175
NCBI chr13:55,972,857...55,984,002
Ensembl chr13:55,972,864...55,984,005
G
Pja1
praja ring finger ubiquitin ligase 1
increases expression
ISO
Vitamin E results in increased expression of PJA1 mRNA
CTD
PMID:19244175
NCBI chr X:98,509,344...98,514,874
Ensembl chr X:98,509,340...98,514,879
G
Pkd1
polycystin 1, transient receptor potential channel interacting
increases expression
ISO
Vitamin E results in increased expression of PKD1 mRNA
CTD
PMID:19244175
NCBI chr17:24,767,657...24,815,457
Ensembl chr17:24,768,808...24,815,482
G
Pkm
pyruvate kinase, muscle
increases expression
ISO
Vitamin E results in increased expression of PKM mRNA
CTD
PMID:19244175
NCBI chr 9:59,563,859...59,586,655
Ensembl chr 9:59,563,651...59,586,658
G
Pkn2
protein kinase N2
decreases expression
ISO
Vitamin E results in decreased expression of PKN2 mRNA
CTD
PMID:19244175
NCBI chr 3:142,496,663...142,587,765
Ensembl chr 3:142,496,663...142,587,765
G
Pla2g12a
phospholipase A2, group XIIA
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PLA2G12A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PLA2G12A mRNA
CTD
PMID:19244175
NCBI chr 3:129,672,255...129,689,474
Ensembl chr 3:129,672,255...129,689,474
G
Plaat3
phospholipase A and acyltransferase 3
increases expression
ISO
Vitamin E results in increased expression of PLAAT3 mRNA
CTD
PMID:19244175
NCBI chr19:7,534,824...7,565,914
Ensembl chr19:7,534,824...7,565,910
G
Plagl1
pleiomorphic adenoma gene-like 1
decreases expression
ISO
Vitamin E results in decreased expression of PLAGL1 mRNA
CTD
PMID:19244175
NCBI chr10:12,966,576...13,007,438
Ensembl chr10:12,936,248...13,007,438
G
Plat
plasminogen activator, tissue
multiple interactions increases activity
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Endosulfan results in increased activity of PLAT protein]; Ascorbic Acid promotes the reaction [Vitamin E results in increased activity of PLAT protein]
CTD
PMID:21804306
NCBI chr 8:23,247,655...23,272,864
Ensembl chr 8:23,247,743...23,272,860
G
Plcb4
phospholipase C, beta 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PLCB4 mRNA Vitamin E results in decreased expression of PLCB4 mRNA
CTD
PMID:19244175
NCBI chr 2:135,500,523...135,856,522
Ensembl chr 2:135,500,931...135,856,513
G
Plekha1
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
decreases expression
ISO
Vitamin E results in decreased expression of PLEKHA1 mRNA
CTD
PMID:19244175
NCBI chr 7:130,462,281...130,515,224
Ensembl chr 7:130,467,486...130,515,042
G
Plekhf2
pleckstrin homology domain containing, family F (with FYVE domain) member 2
decreases expression
ISO
Vitamin E results in decreased expression of PLEKHF2 mRNA
CTD
PMID:19244175
NCBI chr 4:10,988,662...11,007,619
Ensembl chr 4:10,988,662...11,007,927
G
Plekhj1
pleckstrin homology domain containing, family J member 1
increases expression
ISO
Vitamin E results in increased expression of PLEKHJ1 mRNA
CTD
PMID:19244175
NCBI chr10:80,631,933...80,634,404
Ensembl chr10:80,631,933...80,634,460
G
Plekho1
pleckstrin homology domain containing, family O member 1
increases expression
ISO
Vitamin E results in increased expression of PLEKHO1 mRNA
CTD
PMID:19244175
NCBI chr 3:95,896,110...95,903,258
Ensembl chr 3:95,895,741...95,903,313
G
Plekho2
pleckstrin homology domain containing, family O member 2
increases expression
ISO
Vitamin E results in increased expression of PLEKHO2 mRNA
CTD
PMID:19244175
NCBI chr 9:65,459,859...65,487,369
Ensembl chr 9:65,459,980...65,487,322
G
Pllp
plasma membrane proteolipid
increases expression
ISO
Vitamin E results in increased expression of PLLP mRNA
CTD
PMID:19244175
NCBI chr 8:95,401,523...95,422,870
Ensembl chr 8:95,401,522...95,422,906
G
Plod2
procollagen lysine, 2-oxoglutarate 5-dioxygenase 2
decreases expression
ISO
Vitamin E results in decreased expression of PLOD2 mRNA
CTD
PMID:19244175
NCBI chr 9:92,421,828...92,490,481
Ensembl chr 9:92,424,276...92,490,481
G
Plpp3
phospholipid phosphatase 3
increases expression
ISO
Vitamin E results in increased expression of PLPP3 mRNA
CTD
PMID:19244175
NCBI chr 4:105,014,544...105,089,964
Ensembl chr 4:105,014,544...105,089,961
G
Pml
promyelocytic leukemia
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PML mRNA Vitamin E results in increased expression of PML mRNA
CTD
PMID:19244175
NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069
G
Pmpcb
peptidase (mitochondrial processing) beta
decreases expression
ISO
Vitamin E results in decreased expression of PMPCB mRNA
CTD
PMID:19244175
NCBI chr 5:21,942,158...21,962,150
Ensembl chr 5:21,942,139...21,962,150
G
Pms1
PMS1 homolog 1, mismatch repair system component
decreases expression
ISO
Vitamin E results in decreased expression of PMS1 mRNA
CTD
PMID:19244175
NCBI chr 1:53,225,794...53,336,190
Ensembl chr 1:53,228,346...53,336,177
G
Pmvk
phosphomevalonate kinase
increases expression decreases expression
ISO
Vitamin E results in increased expression of PMVK mRNA Vitamin E results in decreased expression of PMVK mRNA
CTD
PMID:19244175 PMID:28923436
NCBI chr 3:89,361,848...89,376,321
Ensembl chr 3:89,361,848...89,376,320
G
Pnisr
PNN interacting serine/arginine-rich
decreases expression
ISO
Vitamin E results in decreased expression of PNISR mRNA
CTD
PMID:19244175
NCBI chr 4:21,846,621...21,876,475
Ensembl chr 4:21,847,583...21,876,475
G
Pnkp
polynucleotide kinase 3'- phosphatase
decreases expression
ISO
Vitamin E results in decreased expression of PNKP mRNA
CTD
PMID:19244175
NCBI chr 7:44,505,903...44,514,761
Ensembl chr 7:44,506,563...44,512,416
G
Pnliprp1
pancreatic lipase related protein 1
decreases expression
ISO
Vitamin E results in decreased expression of PNLIPRP1 mRNA
CTD
PMID:19244175
NCBI chr19:58,717,319...58,732,601
Ensembl chr19:58,717,319...58,732,601
G
Pnp2
purine-nucleoside phosphorylase 2
decreases expression
ISO
Vitamin E results in decreased expression of PNP mRNA
CTD
PMID:19244175
NCBI chr14:51,193,598...51,202,206
Ensembl chr14:51,193,449...51,202,206
G
Poli
polymerase (DNA directed), iota
decreases expression
ISO
Vitamin E results in decreased expression of POLI mRNA
CTD
PMID:19244175
NCBI chr18:70,641,754...70,668,021
Ensembl chr18:70,641,751...70,663,691
G
Poll
polymerase (DNA directed), lambda
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of POLL mRNA
CTD
PMID:19244175
NCBI chr19:45,540,714...45,549,025
Ensembl chr19:45,540,714...45,548,970
G
Polr2c
polymerase (RNA) II (DNA directed) polypeptide C
increases expression
ISO
Vitamin E results in increased expression of POLR2C mRNA
CTD
PMID:19244175
NCBI chr 8:95,584,078...95,590,870
Ensembl chr 8:95,584,078...95,600,163
G
Pon1
paraoxonase 1
multiple interactions increases activity
ISO
Vitamin E inhibits the reaction [Propylthiouracil results in decreased activity of PON1 protein] Vitamin E results in increased activity of PON1 protein
CTD
PMID:15386442
NCBI chr 6:5,168,101...5,193,824
Ensembl chr 6:5,168,090...5,193,946
G
Pon2
paraoxonase 2
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of PON2 mRNA Vitamin E results in decreased expression of and results in decreased activity of PON2 protein
CTD
PMID:15544923 PMID:19244175
NCBI chr 6:5,264,620...5,298,408
Ensembl chr 6:5,264,147...5,298,455
G
Pon3
paraoxonase 3
increases activity
EXP
Vitamin E results in increased activity of PON3 protein
CTD
PMID:12615656
NCBI chr 6:5,216,253...5,256,236
Ensembl chr 6:5,220,852...5,256,286
G
Por
cytochrome p450 oxidoreductase
increases expression
ISO
Vitamin E results in increased expression of POR mRNA
CTD
PMID:19244175
NCBI chr 5:135,698,894...135,764,180
Ensembl chr 5:135,698,887...135,764,180
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
Vitamin E inhibits the reaction [Diethylhexyl Phthalate results in increased expression of PPARG mRNA]
CTD
PMID:28532275
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppat
phosphoribosyl pyrophosphate amidotransferase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of PPAT mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PPAT mRNA
CTD
PMID:19244175
NCBI chr 5:77,061,096...77,099,425
Ensembl chr 5:77,061,096...77,099,425
G
Ppdpf
pancreatic progenitor cell differentiation and proliferation factor
decreases expression
ISO
Vitamin E results in decreased expression of PPDPF mRNA
CTD
PMID:19244175
NCBI chr 2:180,828,615...180,830,297
Ensembl chr 2:180,829,040...180,830,564
G
Ppib
peptidylprolyl isomerase B
increases expression
ISO
Vitamin E results in increased expression of PPIB mRNA
CTD
PMID:19244175
NCBI chr 9:65,967,451...65,973,911
Ensembl chr 9:65,967,504...65,973,905
G
Ppic
peptidylprolyl isomerase C
increases expression
ISO
Vitamin E results in increased expression of PPIC mRNA
CTD
PMID:19244175
NCBI chr18:53,539,413...53,551,079
Ensembl chr18:53,539,404...53,551,187
G
Ppig
peptidyl-prolyl isomerase G (cyclophilin G)
decreases expression
ISO
Vitamin E results in decreased expression of PPIG mRNA
CTD
PMID:19244175
NCBI chr 2:69,553,152...69,584,356
Ensembl chr 2:69,552,889...69,584,356
G
Ppl
periplakin
decreases expression
ISO
Vitamin E results in decreased expression of PPL mRNA
CTD
PMID:19244175
NCBI chr16:4,904,155...4,950,345
Ensembl chr16:4,904,155...4,950,285
G
Ppm1j
protein phosphatase 1J
increases expression
ISO
Vitamin E results in increased expression of PPM1J mRNA
CTD
PMID:19244175
NCBI chr 3:104,688,322...104,693,334
Ensembl chr 3:104,688,372...104,693,334
G
Ppme1
protein phosphatase methylesterase 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of PPME1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PPME1 mRNA
CTD
PMID:19244175
NCBI chr 7:99,975,944...100,021,103
Ensembl chr 7:99,975,944...100,021,514
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
increases expression
ISO
Vitamin E results in increased expression of PPP1CA mRNA
CTD
PMID:19244175
NCBI chr19:4,242,173...4,245,418
Ensembl chr19:4,242,064...4,245,419
G
Ppp1r10
protein phosphatase 1, regulatory subunit 10
increases expression decreases expression multiple interactions
ISO
Vitamin E results in increased expression of PPP1R10 mRNA Vitamin E results in decreased expression of PPP1R10 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of PPP1R10 mRNA
CTD
PMID:19244175
NCBI chr17:36,227,404...36,243,175
Ensembl chr17:36,227,326...36,243,175
G
Ppp1r12b
protein phosphatase 1, regulatory subunit 12B
increases expression
ISO
Vitamin E results in increased expression of PPP1R12B mRNA
CTD
PMID:19244175
NCBI chr 1:134,682,396...134,883,699
Ensembl chr 1:134,682,396...134,883,680
G
Ppp1r9a
protein phosphatase 1, regulatory subunit 9A
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA Vitamin E results in decreased expression of PPP1R9A mRNA
CTD
PMID:19244175
NCBI chr 6:4,902,702...5,165,661
Ensembl chr 6:4,902,917...5,165,661
G
Ppp2r1a
protein phosphatase 2, regulatory subunit A, alpha
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PPP2R1A mRNA Vitamin E results in increased expression of PPP2R1A mRNA
CTD
PMID:19244175
NCBI chr17:21,165,716...21,186,167
Ensembl chr17:21,165,573...21,186,178
G
Ppp2r1b
protein phosphatase 2, regulatory subunit A, beta
decreases expression
ISO
Vitamin E results in decreased expression of PPP2R1B mRNA
CTD
PMID:19244175
NCBI chr 9:50,767,946...50,810,625
Ensembl chr 9:50,756,601...50,805,529
G
Ppp2r3a
protein phosphatase 2, regulatory subunit B'', alpha
decreases expression
ISO
Vitamin E results in decreased expression of PPP2R3A mRNA
CTD
PMID:19244175
NCBI chr 9:100,982,188...101,129,031
Ensembl chr 9:100,982,283...101,128,994
G
Ppp4c
protein phosphatase 4, catalytic subunit
increases expression
ISO
Vitamin E results in increased expression of PPP4C mRNA
CTD
PMID:19244175
NCBI chr 7:126,385,038...126,391,729
Ensembl chr 7:126,385,038...126,391,668
G
Ppp6r2
protein phosphatase 6, regulatory subunit 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PPP6R2 mRNA
CTD
PMID:19244175
NCBI chr15:89,095,654...89,171,218
Ensembl chr15:89,095,756...89,171,213
G
Prdm2
PR domain containing 2, with ZNF domain
decreases expression increases expression
ISO
Vitamin E results in decreased expression of PRDM2 mRNA Vitamin E results in increased expression of PRDM2 mRNA
CTD
PMID:19244175
NCBI chr 4:142,833,961...142,939,560
Ensembl chr 4:142,833,961...142,939,565
G
Prdx2
peroxiredoxin 2
increases expression
ISO
Vitamin E results in increased expression of PRDX2 mRNA
CTD
PMID:19244175
NCBI chr 8:85,696,251...85,701,440
Ensembl chr 8:85,696,216...85,701,463
G
Prdx4
peroxiredoxin 4
decreases expression
ISO
Vitamin E results in decreased expression of PRDX4 mRNA
CTD
PMID:19244175
NCBI chr X:154,106,914...154,125,268
Ensembl chr X:154,106,914...154,123,750
G
Prelp
proline arginine-rich end leucine-rich repeat
increases expression
ISO
Vitamin E results in increased expression of PRELP mRNA
CTD
PMID:19244175
NCBI chr 1:133,838,042...133,857,820
Ensembl chr 1:133,838,042...133,849,152
G
Prkci
protein kinase C, iota
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PRKCI mRNA Vitamin E results in decreased expression of PRKCI mRNA
CTD
PMID:19244175
NCBI chr 3:31,049,893...31,106,889
Ensembl chr 3:31,049,896...31,107,108
G
Prl
prolactin
multiple interactions
ISO
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of PRL protein]
CTD
PMID:16298753
NCBI chr13:27,241,553...27,249,187
Ensembl chr13:27,241,553...27,249,188
G
Prmt1
protein arginine N-methyltransferase 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRMT1 mRNA Vitamin E results in increased expression of PRMT1 mRNA
CTD
PMID:19244175
NCBI chr 7:44,626,179...44,635,844
Ensembl chr 7:44,625,413...44,635,992
G
Prmt2
protein arginine N-methyltransferase 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRMT2 mRNA Vitamin E results in increased expression of PRMT2 mRNA
CTD
PMID:19244175
NCBI chr10:76,043,060...76,073,699
Ensembl chr10:76,043,056...76,073,699
G
Prmt3
protein arginine N-methyltransferase 3
decreases expression
ISO
Vitamin E results in decreased expression of PRMT3 mRNA
CTD
PMID:19244175
NCBI chr 7:49,428,067...49,508,016
Ensembl chr 7:49,428,094...49,508,013
G
Prpf18
pre-mRNA processing factor 18
decreases expression
ISO
Vitamin E results in decreased expression of PRPF18 mRNA
CTD
PMID:19244175
NCBI chr 2:4,626,869...4,656,946
Ensembl chr 2:4,626,869...4,656,924
G
Prpf3
pre-mRNA processing factor 3
increases expression
ISO
Vitamin E results in increased expression of PRPF3 mRNA
CTD
PMID:19244175
NCBI chr 3:95,737,436...95,763,197
Ensembl chr 3:95,737,436...95,763,197
G
Prpf40a
pre-mRNA processing factor 40A
decreases expression
ISO
Vitamin E results in decreased expression of PRPF40A mRNA
CTD
PMID:19244175
NCBI chr 2:53,024,714...53,081,450
Ensembl chr 2:53,024,716...53,081,714
G
Prpf6
pre-mRNA splicing factor 6
decreases expression increases expression multiple interactions
ISO
Vitamin E results in decreased expression of PRPF6 mRNA Vitamin E results in increased expression of PRPF6 mRNA [Selenium co-treated with Vitamin E] results in increased expression of PRPF6 mRNA
CTD
PMID:19244175
NCBI chr 2:181,243,112...181,297,454
Ensembl chr 2:181,233,661...181,297,453
G
Prr13
proline rich 13
decreases expression
ISO
Vitamin E results in decreased expression of PRR13 mRNA
CTD
PMID:19244175
NCBI chr15:102,367,605...102,371,241
Ensembl chr15:102,367,463...102,371,241
G
Prr14
proline rich 14
increases expression
ISO
Vitamin E results in increased expression of PRR14 mRNA
CTD
PMID:19244175
NCBI chr 7:127,070,189...127,075,932
Ensembl chr 7:127,058,783...127,075,931
G
Prrc2c
proline-rich coiled-coil 2C
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PRRC2C mRNA Vitamin E results in decreased expression of PRRC2C mRNA
CTD
PMID:19244175
NCBI chr 1:162,499,354...162,568,125
Ensembl chr 1:162,498,294...162,568,125
G
Prrg4
proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)
decreases expression
ISO
Vitamin E results in decreased expression of PRRG4 mRNA
CTD
PMID:19244175
NCBI chr 2:104,657,374...104,680,216
Ensembl chr 2:104,661,086...104,680,221
G
Prune1
prune exopolyphosphatase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PRUNE1 mRNA Vitamin E results in increased expression of PRUNE1 mRNA
CTD
PMID:19244175
NCBI chr 3:95,160,985...95,190,817
Ensembl chr 3:95,160,985...95,189,387
G
Psap
prosaposin
increases expression
ISO
Vitamin E results in increased expression of PSAP mRNA
CTD
PMID:19244175
NCBI chr10:60,113,436...60,138,379
Ensembl chr10:60,113,449...60,138,376
G
Psmb2
proteasome (prosome, macropain) subunit, beta type 2
increases expression
ISO
Vitamin E results in increased expression of PSMB2 mRNA
CTD
PMID:19244175
NCBI chr 4:126,571,460...126,603,503
Ensembl chr 4:126,571,423...126,603,507
G
Psmb3
proteasome (prosome, macropain) subunit, beta type 3
increases expression
ISO
Vitamin E results in increased expression of PSMB3 mRNA
CTD
PMID:19244175
NCBI chr11:97,594,260...97,604,326
Ensembl chr11:97,594,225...97,604,326
G
Psmb4
proteasome (prosome, macropain) subunit, beta type 4
increases expression
ISO
Vitamin E results in increased expression of PSMB4 mRNA
CTD
PMID:19244175
NCBI chr 3:94,791,635...94,794,269
Ensembl chr 3:94,791,404...94,794,272
G
Psmb5
proteasome (prosome, macropain) subunit, beta type 5
increases expression
ISO
Vitamin E results in increased expression of PSMB5 mRNA
CTD
PMID:19244175
NCBI chr14:54,851,577...54,855,452
Ensembl chr14:54,851,576...54,855,479
G
Psmb6
proteasome (prosome, macropain) subunit, beta type 6
increases expression
ISO
Vitamin E results in increased expression of PSMB6 mRNA
CTD
PMID:19244175
NCBI chr11:70,416,116...70,418,684
Ensembl chr11:70,416,193...70,418,684
G
Psmb9
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2)
increases expression
ISO
Vitamin E results in increased expression of PSMB9 mRNA
CTD
PMID:19244175
NCBI chr17:34,401,006...34,406,347
Ensembl chr17:34,400,961...34,406,738
G
Psmc1
protease (prosome, macropain) 26S subunit, ATPase 1
increases expression
ISO
Vitamin E results in increased expression of PSMC1 mRNA
CTD
PMID:19244175
NCBI chr12:100,076,461...100,089,623
Ensembl chr12:100,076,413...100,089,664
G
Psmc4
proteasome (prosome, macropain) 26S subunit, ATPase, 4
increases expression
ISO
Vitamin E results in increased expression of PSMC4 mRNA
CTD
PMID:19244175
NCBI chr 7:27,741,127...27,749,517
Ensembl chr 7:27,741,132...27,749,526
G
Psmd2
proteasome (prosome, macropain) 26S subunit, non-ATPase, 2
increases expression
ISO
Vitamin E results in increased expression of PSMD2 mRNA
CTD
PMID:19244175
NCBI chr16:20,469,872...20,482,164
Ensembl chr16:20,470,402...20,482,164
G
Psmd4
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4
increases expression
ISO
Vitamin E results in increased expression of PSMD4 mRNA
CTD
PMID:19244175
NCBI chr 3:94,939,999...94,949,880
Ensembl chr 3:94,940,005...94,949,925
G
Ptgds
prostaglandin D2 synthase (brain)
increases expression
ISO
Vitamin E results in increased expression of PTGDS mRNA
CTD
PMID:19244175
NCBI chr 2:25,356,723...25,360,080
Ensembl chr 2:25,356,721...25,360,058
G
Ptges
prostaglandin E synthase
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTGES mRNA Vitamin E results in increased expression of PTGES mRNA
CTD
PMID:19244175
NCBI chr 2:30,779,483...30,793,309
Ensembl chr 2:30,779,483...30,819,875
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP ISO
Vitamin E inhibits the reaction [Excitatory Amino Acid Agents results in increased expression of PTGS2 mRNA]; Vitamin E inhibits the reaction [Excitatory Amino Acid Agents results in increased expression of PTGS2 protein]; Vitamin E inhibits the reaction [JP8 aviation fuel results in increased expression of PTGS2 mRNA] Vitamin E inhibits the reaction [erastin analog results in increased expression of PTGS2 mRNA] [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 mRNA; [Vitamin E co-treated with Selenium] results in decreased expression of PTGS2 protein; Vitamin E inhibits the reaction [[sodium bisulfite co-treated with sodium sulfite] results in increased expression of PTGS2 protein]; Vitamin E inhibits the reaction [decamethrin results in increased expression of PTGS2 mRNA]; Vitamin E inhibits the reaction [Vehicle Emissions results in increased expression of PTGS2 mRNA]
CTD
PMID:16012341 PMID:18234736 PMID:19095747 PMID:21873648 PMID:22223226 PMID:24439385 PMID:25439240 More...
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptms
parathymosin
increases expression
ISO
Vitamin E results in increased expression of PTMS mRNA
CTD
PMID:19244175
NCBI chr 6:124,890,638...124,894,909
Ensembl chr 6:124,890,644...124,897,066
G
Ptp4a1
protein tyrosine phosphatase 4a1
decreases expression
ISO
Vitamin E results in decreased expression of PTP4A1 mRNA
CTD
PMID:19244175
NCBI chr 1:30,979,384...30,988,838
Ensembl chr 1:30,979,383...30,988,390 Ensembl chr 1:30,979,383...30,988,390
G
Ptpa
protein phosphatase 2 protein activator
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTPA mRNA Vitamin E results in increased expression of PTPA mRNA
CTD
PMID:19244175
NCBI chr 2:30,306,062...30,337,819
Ensembl chr 2:30,306,051...30,337,818
G
Ptpn6
protein tyrosine phosphatase, non-receptor type 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of PTPN6 mRNA Vitamin E results in increased expression of PTPN6 mRNA
CTD
PMID:19244175
NCBI chr 6:124,697,670...124,715,672
Ensembl chr 6:124,697,670...124,715,677
G
Ptprd
protein tyrosine phosphatase receptor type D
decreases expression
ISO
Vitamin E results in decreased expression of PTPRD mRNA
CTD
PMID:19244175
NCBI chr 4:75,859,474...78,132,282
Ensembl chr 4:75,859,475...78,130,198
G
Ptpro
protein tyrosine phosphatase receptor type O
decreases expression
ISO
Vitamin E results in decreased expression of PTPRO mRNA
CTD
PMID:19244175
NCBI chr 6:137,229,189...137,440,251
Ensembl chr 6:137,229,317...137,440,231
G
Puf60
poly-U binding splicing factor 60
increases expression
ISO
Vitamin E results in increased expression of PUF60 mRNA
CTD
PMID:19244175
NCBI chr15:75,942,031...75,954,386
Ensembl chr15:75,942,031...75,952,773
G
Pwp1
PWP1 homolog, endonuclein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PWP1 mRNA Vitamin E results in decreased expression of PWP1 mRNA
CTD
PMID:19244175
NCBI chr10:85,707,695...85,724,967
Ensembl chr10:85,665,358...85,724,960
G
Pxdn
peroxidasin
decreases expression
ISO
Vitamin E results in decreased expression of PXDN mRNA
CTD
PMID:19244175
NCBI chr12:29,986,641...30,067,657
Ensembl chr12:29,987,607...30,067,657
G
Pxmp4
peroxisomal membrane protein 4
increases expression
ISO
Vitamin E results in increased expression of PXMP4 mRNA
CTD
PMID:28923436
NCBI chr 2:154,427,678...154,445,592
Ensembl chr 2:154,427,678...154,445,628
G
Pycr3
pyrroline-5-carboxylate reductase 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of PYCR3 mRNA Vitamin E results in decreased expression of PYCR3 mRNA
CTD
PMID:19244175
NCBI chr15:75,788,319...75,793,369
Ensembl chr15:75,788,326...75,793,409
G
Pygb
brain glycogen phosphorylase
increases expression
ISO
Vitamin E results in increased expression of PYGB mRNA
CTD
PMID:19244175
NCBI chr 2:150,628,716...150,673,668
Ensembl chr 2:150,628,655...150,673,678
G
Pygo2
pygopus 2
increases expression
ISO
Vitamin E results in increased expression of PYGO2 mRNA
CTD
PMID:19244175
NCBI chr 3:89,337,521...89,342,438
Ensembl chr 3:89,337,521...89,342,435
G
Qsox1
quiescin Q6 sulfhydryl oxidase 1
increases expression
ISO
Vitamin E results in increased expression of QSOX1 mRNA
CTD
PMID:19244175
NCBI chr 1:155,653,901...155,688,645
Ensembl chr 1:155,651,775...155,688,635
G
Qtrt1
queuine tRNA-ribosyltransferase catalytic subunit 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of QTRT1 mRNA Vitamin E results in increased expression of QTRT1 mRNA
CTD
PMID:19244175
NCBI chr 9:21,323,096...21,331,575
Ensembl chr 9:21,323,133...21,331,570
G
R3hdm1
R3H domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of R3HDM1 mRNA
CTD
PMID:19244175
NCBI chr 1:128,031,016...128,165,475
Ensembl chr 1:128,031,038...128,165,473
G
Rab14
RAB14, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB14 mRNA
CTD
PMID:19244175
NCBI chr 2:35,070,217...35,091,132
Ensembl chr 2:35,070,217...35,091,132
G
Rab26
RAB26, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB26 mRNA
CTD
PMID:19244175
NCBI chr17:24,748,038...24,752,696
Ensembl chr17:24,746,215...24,753,184
G
Rab2a
RAB2A, member RAS oncogene family
multiple interactions decreases expression increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RAB2 mRNA Vitamin E results in decreased expression of RAB2 mRNA Vitamin E results in increased expression of RAB2 mRNA
CTD
PMID:19244175
NCBI chr 4:8,535,661...8,607,708
Ensembl chr 4:8,535,644...8,607,778
G
Rab31
RAB31, member RAS oncogene family
increases expression
ISO
Vitamin E results in increased expression of RAB31 mRNA
CTD
PMID:19244175
NCBI chr17:65,958,721...66,079,747
Ensembl chr17:65,958,724...66,079,747
G
Rab33b
RAB33B, member RAS oncogene family
decreases expression
ISO
Vitamin E results in decreased expression of RAB33B mRNA
CTD
PMID:19244175
NCBI chr 3:51,391,387...51,403,649
Ensembl chr 3:51,391,341...51,403,653
G
Rab3gap2
RAB3 GTPase activating protein subunit 2
decreases expression
ISO
Vitamin E results in decreased expression of RAB3GAP2 mRNA
CTD
PMID:19244175
NCBI chr 1:184,936,287...185,018,953
Ensembl chr 1:184,936,314...185,018,956
G
Rabac1
Rab acceptor 1 (prenylated)
increases expression
ISO
Vitamin E results in increased expression of RABAC1 mRNA
CTD
PMID:19244175
NCBI chr 7:24,669,175...24,672,153
Ensembl chr 7:24,669,177...24,672,179
G
Rabgap1
RAB GTPase activating protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RABGAP1 mRNA
CTD
PMID:19244175
NCBI chr 2:37,333,274...37,463,653
Ensembl chr 2:37,333,291...37,456,466
G
Rad23b
RAD23 homolog B, nucleotide excision repair protein
decreases expression
ISO
Vitamin E results in decreased expression of RAD23B mRNA
CTD
PMID:19244175
NCBI chr 4:55,350,042...55,392,237
Ensembl chr 4:55,350,043...55,392,237
G
Raf1
v-raf-leukemia viral oncogene 1
multiple interactions
EXP
Vitamin E inhibits the reaction [Urethane promotes the reaction [RAF1 protein binds to HRAS protein]]
CTD
PMID:11062179
NCBI chr 6:115,595,530...115,653,596
Ensembl chr 6:115,595,028...115,653,596
G
Rai14
retinoic acid induced 14
increases expression
ISO
Vitamin E results in increased expression of RAI14 mRNA
CTD
PMID:19244175
NCBI chr15:10,569,057...10,719,353
Ensembl chr15:10,569,055...10,714,710
G
Ralbp1
ralA binding protein 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RALBP1 mRNA Vitamin E results in decreased expression of RALBP1 mRNA
CTD
PMID:19244175
NCBI chr17:66,155,410...66,192,750
Ensembl chr17:66,155,413...66,192,793
G
Ralgps1
Ral GEF with PH domain and SH3 binding motif 1
decreases expression
ISO
Vitamin E results in decreased expression of RALGPS1 mRNA
CTD
PMID:19244175
NCBI chr 2:33,023,431...33,261,569
Ensembl chr 2:33,023,429...33,261,498
G
Raly
hnRNP-associated with lethal yellow
increases expression
ISO
Vitamin E results in increased expression of RALY mRNA
CTD
PMID:19244175
NCBI chr 2:154,632,989...154,712,930
Ensembl chr 2:154,633,016...154,709,181
G
Ranbp2
RAN binding protein 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RANBP2 mRNA Vitamin E results in decreased expression of RANBP2 mRNA
CTD
PMID:19244175
NCBI chr10:58,282,674...58,329,977
Ensembl chr10:58,282,742...58,330,178
G
Ranbp3
RAN binding protein 3
increases expression
ISO
Vitamin E results in increased expression of RANBP3 mRNA
CTD
PMID:19244175
NCBI chr17:56,980,225...57,018,769
Ensembl chr17:56,980,294...57,018,764
G
Ranbp9
RAN binding protein 9
decreases expression
ISO
Vitamin E results in decreased expression of RANBP9 mRNA
CTD
PMID:19244175
NCBI chr13:43,556,151...43,634,949
Ensembl chr13:43,556,151...43,634,758
G
Rangap1
RAN GTPase activating protein 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RANGAP1 mRNA Vitamin E results in increased expression of RANGAP1 mRNA
CTD
PMID:19244175
NCBI chr15:81,588,449...81,614,120
Ensembl chr15:81,588,449...81,629,731
G
Rapgef2
Rap guanine nucleotide exchange factor (GEF) 2
decreases expression
ISO
Vitamin E results in decreased expression of RAPGEF2 mRNA
CTD
PMID:19244175
NCBI chr 3:78,969,818...79,194,681
Ensembl chr 3:78,969,823...79,193,824
G
Rapgef6
Rap guanine nucleotide exchange factor (GEF) 6
decreases expression
ISO
Vitamin E results in decreased expression of RAPGEF6 mRNA
CTD
PMID:19244175
NCBI chr11:54,413,630...54,590,112
Ensembl chr11:54,413,673...54,590,111
G
Rarres2
retinoic acid receptor responder (tazarotene induced) 2
increases expression
ISO
Vitamin E results in increased expression of RARRES2 mRNA
CTD
PMID:19244175
NCBI chr 6:48,546,630...48,549,778
Ensembl chr 6:48,546,630...48,549,723
G
Rasgrp2
RAS, guanyl releasing protein 2
increases expression
ISO
Vitamin E results in increased expression of RASGRP2 mRNA
CTD
PMID:19244175
NCBI chr19:6,449,038...6,465,243
Ensembl chr19:6,449,370...6,465,246
G
Rassf1
Ras association (RalGDS/AF-6) domain family member 1
increases expression
ISO
Vitamin E results in increased expression of RASSF1 mRNA
CTD
PMID:19244175
NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466
G
Rassf7
Ras association (RalGDS/AF-6) domain family (N-terminal) member 7
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RASSF7 mRNA
CTD
PMID:19244175
NCBI chr 7:140,795,338...140,798,571
Ensembl chr 7:140,795,773...140,798,571
G
Rbbp4
retinoblastoma binding protein 4, chromatin remodeling factor
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RBBP4 mRNA
CTD
PMID:19244175
NCBI chr 4:129,200,893...129,229,163
Ensembl chr 4:129,200,893...129,229,163
G
Rbbp6
retinoblastoma binding protein 6, ubiquitin ligase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RBBP6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RBBP6 mRNA
CTD
PMID:19244175
NCBI chr 7:122,568,980...122,601,780
Ensembl chr 7:122,564,909...122,601,780
G
Rbfox2
RNA binding protein, fox-1 homolog (C. elegans) 2
decreases expression increases expression
ISO
Vitamin E results in decreased expression of RBFOX2 mRNA Vitamin E results in increased expression of RBFOX2 mRNA
CTD
PMID:19244175
NCBI chr15:76,963,190...77,193,058
Ensembl chr15:76,963,190...77,191,204
G
Rbm14
RNA binding motif protein 14
increases expression
ISO
Vitamin E results in increased expression of RBM14 mRNA
CTD
PMID:19244175
NCBI chr19:4,850,594...4,861,662
Ensembl chr19:4,850,597...4,861,662
G
Rbm25
RNA binding motif protein 25
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RBM25 mRNA Vitamin E results in decreased expression of RBM25 mRNA
CTD
PMID:19244175
NCBI chr12:83,678,990...83,729,901
Ensembl chr12:83,678,010...83,729,897
G
Rbm4
RNA binding motif protein 4
decreases expression
ISO
Vitamin E results in decreased expression of RBM4 mRNA
CTD
PMID:19244175
NCBI chr19:4,834,321...4,844,037
Ensembl chr19:4,834,321...4,843,929
G
Rbm42
RNA binding motif protein 42
increases expression
ISO
Vitamin E results in increased expression of RBM42 mRNA
CTD
PMID:19244175
NCBI chr 7:30,340,420...30,349,653
Ensembl chr 7:30,340,424...30,349,742
G
Rbm5
RNA binding motif protein 5
decreases expression
ISO
Vitamin E results in decreased expression of RBM5 mRNA
CTD
PMID:19244175
NCBI chr 9:107,617,694...107,648,228
Ensembl chr 9:107,617,570...107,648,195
G
Rbms1
RNA binding motif, single stranded interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RBMS1 mRNA
CTD
PMID:19244175
NCBI chr 2:60,580,537...60,794,224
Ensembl chr 2:60,580,537...60,793,536
G
Rbp1
retinol binding protein 1, cellular
increases expression
ISO
Vitamin E results in increased expression of RBP1 mRNA
CTD
PMID:19244175
NCBI chr 9:98,305,014...98,328,604
Ensembl chr 9:98,305,014...98,328,628
G
Rbpms
RNA binding protein gene with multiple splicing
increases expression
ISO
Vitamin E results in increased expression of RBPMS mRNA
CTD
PMID:19244175
NCBI chr 8:34,272,671...34,419,925
Ensembl chr 8:34,272,671...34,419,891
G
Rchy1
ring finger and CHY zinc finger domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of RCHY1 mRNA
CTD
PMID:19244175
NCBI chr 5:92,096,701...92,110,988
Ensembl chr 5:92,096,763...92,110,927
G
Rcn2
reticulocalbin 2
decreases expression
ISO
Vitamin E results in decreased expression of RCN2 mRNA
CTD
PMID:19244175
NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166
G
Recql
RecQ protein-like
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RECQL mRNA Vitamin E results in decreased expression of RECQL mRNA
CTD
PMID:19244175
NCBI chr 6:142,296,068...142,332,802
Ensembl chr 6:142,296,068...142,332,813
G
Reep1
receptor accessory protein 1
decreases expression
ISO
Vitamin E results in decreased expression of REEP1 mRNA
CTD
PMID:19244175
NCBI chr 6:71,684,413...71,787,694
Ensembl chr 6:71,684,545...71,787,694
G
Rel
reticuloendotheliosis oncogene
multiple interactions
ISO
Vitamin E affects the reaction [[REL binds to GCLC promoter] which affects the expression of GCLC mRNA]; Vitamin E affects the reaction [[REL binds to GCLM promoter] which affects the expression of GCLM mRNA] Vitamin E inhibits the reaction [Norepinephrine affects the localization of REL protein]
CTD
PMID:16298738 PMID:23114885
NCBI chr11:23,686,847...23,720,969
Ensembl chr11:23,686,847...23,720,970
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
multiple interactions
ISO EXP
Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased phosphorylation of RELA protein]; Vitamin E inhibits the reaction [Norepinephrine affects the localization of RELA protein] [Vitamin E co-treated with Selenium] results in decreased activity of RELA protein Vitamin E inhibits the reaction [Alcohols results in increased expression of RELA mRNA]; Vitamin E inhibits the reaction [Ethanol results in increased expression of RELA mRNA]
CTD
PMID:18814483 PMID:20067348 PMID:22223226 PMID:23114885 PMID:35349355
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Retreg1
reticulophagy regulator 1
decreases expression
ISO
Vitamin E results in decreased expression of RETREG1 mRNA
CTD
PMID:19244175
NCBI chr15:25,840,795...25,973,782
Ensembl chr15:25,843,266...25,973,773
G
Rfng
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase
increases expression
ISO
Vitamin E results in increased expression of RFNG mRNA
CTD
PMID:19244175
NCBI chr11:120,671,571...120,675,077
Ensembl chr11:120,671,572...120,675,033
G
Rftn1
raftlin lipid raft linker 1
increases expression
ISO
Vitamin E results in increased expression of RFTN1 mRNA
CTD
PMID:19244175
NCBI chr17:50,300,287...50,497,525
Ensembl chr17:50,299,285...50,497,702
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
Vitamin E results in increased expression of RGS2 mRNA
CTD
PMID:19244175
NCBI chr 1:143,875,076...143,879,887
Ensembl chr 1:143,875,076...143,879,899
G
Rhobtb1
Rho-related BTB domain containing 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB1 mRNA
CTD
PMID:19244175
NCBI chr10:68,987,106...69,127,621
Ensembl chr10:68,987,264...69,127,621
G
Rhobtb3
Rho-related BTB domain containing 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RHOBTB3 mRNA Vitamin E results in decreased expression of RHOBTB3 mRNA
CTD
PMID:19244175
NCBI chr13:76,017,656...76,092,054
Ensembl chr13:76,017,656...76,092,044
G
Rhog
ras homolog family member G
increases expression
ISO
Vitamin E results in increased expression of RHOG mRNA
CTD
PMID:19244175
NCBI chr 7:101,888,330...101,899,325
Ensembl chr 7:101,888,330...101,905,261
G
Rhoq
ras homolog family member Q
decreases expression
ISO
Vitamin E results in decreased expression of RHOQ mRNA
CTD
PMID:19244175
NCBI chr17:87,270,539...87,307,497
Ensembl chr17:87,270,510...87,307,497
G
Riok3
RIO kinase 3
decreases expression
ISO
Vitamin E results in decreased expression of RIOK3 mRNA
CTD
PMID:19244175
NCBI chr18:12,259,114...12,290,424
Ensembl chr18:12,261,798...12,290,444
G
Rlim
ring finger protein, LIM domain interacting
decreases expression
ISO
Vitamin E results in decreased expression of RLIM mRNA
CTD
PMID:19244175
NCBI chr X:103,000,770...103,024,886
Ensembl chr X:103,000,769...103,024,890
G
Rnaseh1
ribonuclease H1
decreases expression
ISO
Vitamin E results in decreased expression of RNASEH1 mRNA
CTD
PMID:19244175
NCBI chr12:28,699,600...28,709,591
Ensembl chr12:28,699,601...28,709,588
G
Rnaset2a
ribonuclease T2A
increases expression
ISO
Vitamin E results in increased expression of RNASET2 mRNA
CTD
PMID:19244175
NCBI chr17:8,347,412...8,367,078
Ensembl chr17:8,334,277...8,366,929
G
Rnd3
Rho family GTPase 3
decreases expression
ISO
Vitamin E results in decreased expression of RND3 mRNA
CTD
PMID:19244175
NCBI chr 2:51,020,451...51,039,123
Ensembl chr 2:51,020,450...51,039,123
G
Rnf111
ring finger 111
decreases expression
ISO
Vitamin E results in decreased expression of RNF111 mRNA
CTD
PMID:19244175
NCBI chr 9:70,332,706...70,411,122
Ensembl chr 9:70,332,706...70,411,007
G
Rnf113a1
ring finger protein 113A1
increases expression
ISO
Vitamin E results in increased expression of RNF113A mRNA
CTD
PMID:19244175
NCBI chr X:36,454,875...36,456,120
Ensembl chr X:36,454,898...36,456,120
G
Rnf5
ring finger protein 5
increases expression
ISO
Vitamin E results in increased expression of RNF5 mRNA
CTD
PMID:19244175
NCBI chr17:34,820,073...34,822,535
Ensembl chr17:34,820,065...34,822,664
G
Rnps1
RNA binding protein with serine rich domain 1
increases expression
ISO
Vitamin E results in increased expression of RNPS1 mRNA
CTD
PMID:19244175
NCBI chr17:24,633,620...24,644,872
Ensembl chr17:24,633,539...24,644,875
G
Ro60
Ro60, Y RNA binding protein
decreases expression
ISO
Vitamin E results in decreased expression of RO60 mRNA
CTD
PMID:19244175
NCBI chr 1:143,626,528...143,652,794
Ensembl chr 1:143,626,528...143,652,806
G
Rora
RAR-related orphan receptor alpha
decreases expression
ISO
Vitamin E results in decreased expression of RORA mRNA
CTD
PMID:19244175
NCBI chr 9:68,560,627...69,295,528
Ensembl chr 9:68,561,068...69,295,528
G
Rpa3
replication protein A3
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in increased expression of RPA3 mRNA
CTD
PMID:16797527
NCBI chr 6:8,255,936...8,259,141
Ensembl chr 6:8,255,936...8,259,173
G
Rpl10
ribosomal protein L10
increases expression
ISO
Vitamin E results in increased expression of RPL10 mRNA
CTD
PMID:19244175
NCBI chr X:73,314,463...73,316,741
Ensembl chr X:73,314,418...73,316,741
G
Rpl10a
ribosomal protein L10A
decreases expression
ISO
Vitamin E results in decreased expression of RPL10A mRNA
CTD
PMID:19244175
NCBI chr17:28,547,557...28,550,007
Ensembl chr17:28,547,445...28,550,007
G
Rpl14
ribosomal protein L14
decreases expression
ISO
Vitamin E results in decreased expression of RPL14 mRNA
CTD
PMID:19244175
NCBI chr 9:120,400,579...120,403,724
Ensembl chr 9:120,400,510...120,403,720
G
Rpl23
ribosomal protein L23
decreases expression
ISO
Vitamin E results in decreased expression of RPL23 mRNA
CTD
PMID:19244175
NCBI chr11:97,668,352...97,673,265
Ensembl chr11:97,668,353...97,673,263
G
Rpl27
ribosomal protein L27
decreases expression
ISO
Vitamin E results in decreased expression of RPL27 mRNA
CTD
PMID:19244175
NCBI chr11:101,333,071...101,336,422
Ensembl chr11:101,333,124...101,336,355
G
Rpl28
ribosomal protein L28
decreases expression
ISO
Vitamin E results in decreased expression of RPL28 mRNA
CTD
PMID:19244175
NCBI chr 7:4,795,964...4,797,546
Ensembl chr 7:4,795,873...4,798,065
G
Rpl38
ribosomal protein L38
decreases expression
ISO
Vitamin E results in decreased expression of RPL38 mRNA
CTD
PMID:19244175
NCBI chr11:114,558,644...114,563,159
Ensembl chr11:114,559,350...114,563,157
G
Rpl7
ribosomal protein L7
decreases expression
ISO
Vitamin E results in decreased expression of RPL7 mRNA
CTD
PMID:19244175
NCBI chr 1:16,171,519...16,174,657
Ensembl chr 1:16,171,519...16,174,886
G
Rprd2
regulation of nuclear pre-mRNA domain containing 2
increases expression
ISO
Vitamin E results in increased expression of RPRD2 mRNA
CTD
PMID:19244175
NCBI chr 3:95,667,183...95,727,034
Ensembl chr 3:95,667,653...95,726,175
G
Rprm
reprimo, TP53 dependent G2 arrest mediator candidate
increases expression
ISO
Vitamin E results in increased expression of RPRM mRNA
CTD
PMID:19244175
NCBI chr 2:53,974,105...53,975,564
Ensembl chr 2:53,974,105...53,975,564
G
Rps19
ribosomal protein S19
decreases expression
ISO
Vitamin E results in decreased expression of RPS19 mRNA
CTD
PMID:19244175
NCBI chr 7:24,584,013...24,589,236
Ensembl chr 7:24,583,796...24,589,231
G
Rps27
ribosomal protein S27
decreases expression
ISO
Vitamin E results in decreased expression of RPS27 mRNA
CTD
PMID:19244175
NCBI chr 3:90,119,974...90,120,955
Ensembl chr 3:90,119,829...90,120,958
G
Rps6ka1
ribosomal protein S6 kinase polypeptide 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA1 mRNA
CTD
PMID:19244175
NCBI chr 4:133,574,601...133,615,466
Ensembl chr 4:133,574,601...133,615,108
G
Rps6ka2
ribosomal protein S6 kinase, polypeptide 2
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RPS6KA2 mRNA
CTD
PMID:19244175
NCBI chr17:7,356,384...7,570,714
Ensembl chr17:7,292,942...7,570,726
G
Rps7
ribosomal protein S7
decreases expression
ISO
Vitamin E results in decreased expression of RPS7 mRNA
CTD
PMID:19244175
NCBI chr12:28,680,846...28,685,952
Ensembl chr12:28,680,853...28,685,952
G
Rraga
Ras-related GTP binding A
increases expression
ISO
Vitamin E results in increased expression of RRAGA mRNA
CTD
PMID:19244175
NCBI chr 4:86,493,910...86,495,522
Ensembl chr 4:86,493,905...86,495,522
G
Rrbp1
ribosome binding protein 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RRBP1 mRNA
CTD
PMID:19244175
NCBI chr 2:143,789,315...143,853,216
Ensembl chr 2:143,789,315...143,853,183
G
Rrp1
ribosomal RNA processing 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of RRP1 mRNA
CTD
PMID:19244175
NCBI chr10:78,236,196...78,248,877
Ensembl chr10:78,236,218...78,248,877
G
Rrp7a
ribosomal RNA processing 7 homolog A
increases expression
ISO
Vitamin E results in increased expression of RRP7A mRNA
CTD
PMID:19244175
NCBI chr15:83,000,047...83,007,002
Ensembl chr15:82,997,634...83,007,002
G
Rrs1
ribosome biogenesis regulator 1
increases expression
ISO
Vitamin E results in increased expression of RRS1 mRNA
CTD
PMID:19244175
NCBI chr 1:9,615,633...9,617,680
Ensembl chr 1:9,615,633...9,617,680
G
Rsad1
radical S-adenosyl methionine domain containing 1
increases expression
ISO
Vitamin E results in increased expression of RSAD1 mRNA
CTD
PMID:19244175
NCBI chr11:94,430,624...94,447,690
Ensembl chr11:94,430,624...94,440,081
G
Rsrc2
arginine/serine-rich coiled-coil 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of RSRC2 mRNA Vitamin E results in decreased expression of RSRC2 mRNA
CTD
PMID:19244175
NCBI chr 5:123,866,489...123,887,522
Ensembl chr 5:123,866,489...123,887,477
G
Rsrp1
arginine/serine rich protein 1
decreases expression
ISO
Vitamin E results in decreased expression of RSRP1 mRNA
CTD
PMID:19244175
NCBI chr 4:134,650,936...134,654,681
Ensembl chr 4:134,650,903...134,654,982
G
Rtl8a
retrotransposon Gag like 8A
increases expression multiple interactions
ISO
Vitamin E results in increased expression of RTL8A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RTL8A mRNA
CTD
PMID:19244175
NCBI chr X:52,644,455...52,645,730
Ensembl chr X:52,644,455...52,645,649
G
Rufy1
RUN and FYVE domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of RUFY1 mRNA
CTD
PMID:19244175
NCBI chr11:50,280,113...50,322,101
Ensembl chr11:50,280,113...50,321,952
G
Rufy2
RUN and FYVE domain-containing 2
decreases expression
ISO
Vitamin E results in decreased expression of RUFY2 mRNA
CTD
PMID:19244175
NCBI chr10:62,815,947...62,852,988
Ensembl chr10:62,816,002...62,852,989
G
Rufy3
RUN and FYVE domain containing 3
decreases expression
ISO
Vitamin E results in decreased expression of RUFY3 mRNA
CTD
PMID:19244175
NCBI chr 5:88,711,305...88,799,276
Ensembl chr 5:88,712,899...88,799,251
G
Rundc3b
RUN domain containing 3B
decreases expression
ISO
Vitamin E results in decreased expression of RUNDC3B mRNA
CTD
PMID:19244175
NCBI chr 5:8,540,336...8,673,079
Ensembl chr 5:8,540,334...8,672,952
G
Runx1t1
RUNX1 translocation partner 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RUNX1T1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RUNX1T1 mRNA
CTD
PMID:19244175
NCBI chr 4:13,742,628...13,895,056
Ensembl chr 4:13,743,436...13,893,649
G
Rybp
RING1 and YY1 binding protein
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of RYBP mRNA [Selenium co-treated with Vitamin E] results in decreased expression of RYBP mRNA
CTD
PMID:19244175
NCBI chr 6:100,205,526...100,264,319
Ensembl chr 6:100,205,526...100,264,446
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
Vitamin E results in increased expression of S100A11 mRNA
CTD
PMID:19244175
NCBI chr 3:93,427,803...93,433,595
Ensembl chr 3:93,427,795...93,433,594
G
S100a6
S100 calcium binding protein A6 (calcyclin)
increases expression
ISO
Vitamin E results in increased expression of S100A6 mRNA
CTD
PMID:19244175
NCBI chr 3:90,520,491...90,531,797
Ensembl chr 3:90,520,189...90,531,488
G
S100b
S100 protein, beta polypeptide, neural
multiple interactions
ISO
Vitamin E inhibits the reaction [Aluminum results in increased expression of S100B protein]
CTD
PMID:16545059
NCBI chr10:76,089,670...76,097,153
Ensembl chr10:76,089,687...76,096,993
G
Sacs
sacsin
decreases expression
ISO
Vitamin E results in decreased expression of SACS mRNA
CTD
PMID:19244175
NCBI chr14:61,375,870...61,478,142
Ensembl chr14:61,375,906...61,478,144
G
Samm50
SAMM50 sorting and assembly machinery component
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SAMM50 mRNA
CTD
PMID:19244175
NCBI chr15:84,076,441...84,100,284
Ensembl chr15:84,076,442...84,101,468
G
Sart3
squamous cell carcinoma antigen recognized by T cells 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SART3 mRNA Vitamin E results in decreased expression of SART3 mRNA
CTD
PMID:19244175
NCBI chr 5:113,880,505...113,910,461
Ensembl chr 5:113,880,507...113,910,571
G
Sash1
SAM and SH3 domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of SASH1 mRNA
CTD
PMID:19244175
NCBI chr10:8,597,981...8,821,290
Ensembl chr10:8,597,983...8,761,814
G
Sat1
spermidine/spermine N1-acetyl transferase 1
decreases expression
ISO
Vitamin E results in decreased expression of SAT1 mRNA
CTD
PMID:19244175
NCBI chr X:153,996,128...153,999,345
Ensembl chr X:153,996,128...153,999,445
G
Satb1
special AT-rich sequence binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of SATB1 mRNA
CTD
PMID:19244175
NCBI chr17:52,043,215...52,140,318
Ensembl chr17:52,043,215...52,140,318
G
Sbp
spermine binding protein
decreases expression
ISO
Vitamin E results in decreased expression of SBP mRNA
CTD
PMID:15084515
NCBI chr17:24,141,525...24,164,577
Ensembl chr17:24,160,646...24,164,581
G
Scaf11
SR-related CTD-associated factor 11
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SCAF11 mRNA Vitamin E results in decreased expression of SCAF11 mRNA
CTD
PMID:19244175
NCBI chr15:96,309,580...96,358,695
Ensembl chr15:96,309,580...96,358,724
G
Scaf4
SR-related CTD-associated factor 4
decreases expression
ISO
Vitamin E results in decreased expression of SCAF4 mRNA
CTD
PMID:19244175
NCBI chr16:90,021,504...90,082,074
Ensembl chr16:90,022,568...90,081,391
G
Scamp3
secretory carrier membrane protein 3
increases expression multiple interactions
ISO
Vitamin E results in increased expression of SCAMP3 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SCAMP3 mRNA
CTD
PMID:19244175
NCBI chr 3:89,084,698...89,090,077
Ensembl chr 3:89,084,780...89,090,072
G
Scaper
S phase cyclin A-associated protein in the ER
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SCAPER mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SCAPER mRNA
CTD
PMID:19244175
NCBI chr 9:55,457,163...55,845,505
Ensembl chr 9:55,457,163...55,845,403
G
Scd2
stearoyl-Coenzyme A desaturase 2
decreases expression
ISO
Vitamin E results in decreased expression of SCD4 mRNA
CTD
PMID:19244175
NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303
G
Scmh1
sex comb on midleg homolog 1
decreases expression
ISO
Vitamin E results in decreased expression of SCMH1 mRNA
CTD
PMID:19244175
NCBI chr 4:120,262,347...120,387,397
Ensembl chr 4:120,262,478...120,387,383
G
Scml1
Scm polycomb group protein like 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SCML1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SCML1 mRNA
CTD
PMID:19244175
NCBI chr X:160,597,689...160,615,118
Ensembl chr X:160,598,170...160,608,319
G
Scp2
sterol carrier protein 2, liver
increases expression
ISO
Vitamin E results in increased expression of SCP2 mRNA
CTD
PMID:28923436
NCBI chr 4:107,901,027...108,002,168
Ensembl chr 4:107,901,036...108,002,195
G
Sdc2
syndecan 2
increases expression
ISO
Vitamin E results in increased expression of SDC2 mRNA
CTD
PMID:19244175
NCBI chr15:32,920,869...33,034,867
Ensembl chr15:32,920,869...33,035,081
G
Sdc3
syndecan 3
increases expression
ISO
Vitamin E results in increased expression of SDC3 mRNA
CTD
PMID:19244175
NCBI chr 4:130,519,855...130,553,629
Ensembl chr 4:130,519,848...130,553,630
G
Sdccag8
serologically defined colon cancer antigen 8
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SDCCAG8 mRNA Vitamin E results in decreased expression of SDCCAG8 mRNA
CTD
PMID:19244175
NCBI chr 1:176,642,226...176,848,004
Ensembl chr 1:176,642,226...176,848,003
G
Sdf2l1
stromal cell-derived factor 2-like 1
increases expression
ISO
Vitamin E results in increased expression of SDF2L1 mRNA
CTD
PMID:19244175
NCBI chr16:16,948,002...16,950,247
Ensembl chr16:16,948,002...16,950,247
G
Sdhc
succinate dehydrogenase complex, subunit C, integral membrane protein
increases expression
ISO
Vitamin E results in increased expression of SDHC mRNA
CTD
PMID:19244175
NCBI chr 1:170,956,726...170,978,209
Ensembl chr 1:170,954,734...170,978,172
G
Sdr39u1
short chain dehydrogenase/reductase family 39U, member 1
decreases expression
ISO
Vitamin E results in decreased expression of SDR39U1 mRNA
CTD
PMID:19244175
NCBI chr14:56,134,742...56,137,802
Ensembl chr14:56,134,740...56,137,750
G
Sec13
SEC13 homolog, nuclear pore and COPII coat complex component
increases expression
ISO
Vitamin E results in increased expression of SEC13 mRNA
CTD
PMID:19244175
NCBI chr 6:113,705,013...113,717,642
Ensembl chr 6:113,705,023...113,717,704
G
Sec16a
SEC16 homolog A, endoplasmic reticulum export factor
decreases expression
ISO
Vitamin E results in decreased expression of SEC16A mRNA
CTD
PMID:19244175
NCBI chr 2:26,299,443...26,336,138
Ensembl chr 2:26,299,443...26,335,228
G
Sec31a
SEC31 homolog A, COPII coat complex component
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SEC31A mRNA Vitamin E results in decreased expression of SEC31A mRNA
CTD
PMID:19244175
NCBI chr 5:100,509,508...100,564,132
Ensembl chr 5:100,509,508...100,564,093
G
Sec62
SEC62 homolog, preprotein translocation
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SEC62 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SEC62 mRNA
CTD
PMID:19244175
NCBI chr 3:30,847,025...30,875,412
Ensembl chr 3:30,847,024...30,875,412
G
Sec63
SEC63 homolog, protein translocation regulator
decreases expression
ISO
Vitamin E results in decreased expression of SEC63 mRNA
CTD
PMID:19244175
NCBI chr10:42,637,492...42,708,510
Ensembl chr10:42,637,492...42,708,510
G
Secisbp2
SECIS binding protein 2
decreases expression
ISO
Vitamin E results in decreased expression of SBP2 mRNA
CTD
PMID:19244175
NCBI chr13:51,805,721...51,838,080
Ensembl chr13:51,805,733...51,838,080
G
Secisbp2l
SECIS binding protein 2-like
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SECISBP2L mRNA
CTD
PMID:19244175
NCBI chr 2:125,578,906...125,624,790
Ensembl chr 2:125,578,906...125,624,790
G
Sele
selectin, endothelial cell
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of SELE protein modified form; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of SELE protein modified form]
CTD
PMID:14602771
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
Selenow
selenoprotein W
increases expression
ISO
Vitamin E results in increased expression of SELENOW mRNA
CTD
PMID:19244175
NCBI chr 7:15,651,133...15,656,296
Ensembl chr 7:15,651,133...15,656,327
G
Sephs1
selenophosphate synthetase 1
increases expression
ISO
Vitamin E results in increased expression of SEPHS1 mRNA
CTD
PMID:19244175
NCBI chr 2:4,886,375...4,915,368
Ensembl chr 2:4,886,375...4,915,368
G
Septin6
septin 6
increases expression
ISO
Vitamin E results in increased expression of SEPTIN6 mRNA
CTD
PMID:19244175
NCBI chr X:36,174,925...36,253,711
Ensembl chr X:36,174,979...36,255,447
G
Septin8
septin 8
increases expression
ISO
Vitamin E results in increased expression of SEPTIN8 mRNA
CTD
PMID:19244175
NCBI chr11:53,410,224...53,440,432
Ensembl chr11:53,410,084...53,440,392
G
Serbp1
serpine1 mRNA binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of SERBP1 mRNA
CTD
PMID:19244175
NCBI chr 6:67,243,963...67,266,286
Ensembl chr 6:67,215,160...67,274,720
G
Serinc3
serine incorporator 3
increases expression
ISO
Vitamin E results in increased expression of SERINC3 mRNA
CTD
PMID:19244175
NCBI chr 2:163,466,577...163,487,767
Ensembl chr 2:163,465,192...163,487,051
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of SERPINA3N mRNA
CTD
PMID:11444866
NCBI chr12:104,372,967...104,380,588
Ensembl chr12:104,372,988...104,380,588
G
Serpine1
serine (or cysteine) peptidase inhibitor, clade E, member 1
multiple interactions
ISO
Ascorbic Acid promotes the reaction [Vitamin E inhibits the reaction [Endosulfan results in increased activity of SERPINE1 protein]]; Vitamin E inhibits the reaction [Endosulfan results in increased activity of SERPINE1 protein]
CTD
PMID:21804306
NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122
G
Serpinf1
serine (or cysteine) peptidase inhibitor, clade F, member 1
increases expression
ISO
Vitamin E results in increased expression of SERPINF1 mRNA
CTD
PMID:19244175
NCBI chr11:75,300,855...75,313,449
Ensembl chr11:75,300,595...75,313,527
G
Serping1
serine (or cysteine) peptidase inhibitor, clade G, member 1
increases expression
ISO
Vitamin E results in increased expression of SERPING1 mRNA
CTD
PMID:19244175
NCBI chr 2:84,595,704...84,605,748
Ensembl chr 2:84,595,731...84,605,788
G
Sertad2
SERTA domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of SERTAD2 mRNA
CTD
PMID:19244175
NCBI chr11:20,493,166...20,603,023
Ensembl chr11:20,493,253...20,603,021
G
Set
SET nuclear oncogene
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SET mRNA Vitamin E results in decreased expression of SET mRNA
CTD
PMID:19244175
NCBI chr 2:29,952,074...29,962,589
Ensembl chr 2:29,947,390...29,962,589
G
Setbp1
SET binding protein 1
decreases expression
ISO
Vitamin E results in decreased expression of SETBP1 mRNA
CTD
PMID:19244175
NCBI chr18:78,793,593...79,153,659
Ensembl chr18:78,793,595...79,152,606
G
Setd2
SET domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of SETD2 mRNA
CTD
PMID:19244175
NCBI chr 9:110,361,368...110,447,703
Ensembl chr 9:110,358,262...110,447,701
G
Setd6
SET domain containing 6
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SETD6 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SETD6 mRNA
CTD
PMID:19244175
NCBI chr 8:96,442,211...96,448,135
Ensembl chr 8:96,442,509...96,445,638
G
Sf1
splicing factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SF1 mRNA Vitamin E results in decreased expression of SF1 mRNA
CTD
PMID:19244175
NCBI chr19:6,413,952...6,428,060
Ensembl chr19:6,413,720...6,428,060
G
Sf3a2
splicing factor 3a, subunit 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SF3A2 mRNA Vitamin E results in increased expression of SF3A2 mRNA
CTD
PMID:19244175
NCBI chr10:80,634,569...80,640,756
Ensembl chr10:80,634,032...80,640,758
G
Sf3b1
splicing factor 3b, subunit 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SF3B1 mRNA Vitamin E results in decreased expression of SF3B1 mRNA
CTD
PMID:19244175
NCBI chr 1:55,024,328...55,066,660
Ensembl chr 1:55,024,328...55,066,640
G
Sf3b5
splicing factor 3b, subunit 5
increases expression
ISO
Vitamin E results in increased expression of SF3B5 mRNA
CTD
PMID:19244175
NCBI chr10:12,884,194...12,884,927
Ensembl chr10:12,881,087...12,884,927
G
Sfswap
splicing factor SWAP
decreases expression
ISO
Vitamin E results in decreased expression of SFSWAP mRNA
CTD
PMID:19244175
NCBI chr 5:129,578,286...129,648,448
Ensembl chr 5:129,578,285...129,648,448
G
Sftpb
surfactant associated protein B
multiple interactions
ISO
Vitamin E inhibits the reaction [nitrofen results in decreased expression of SFTPB mRNA] Vitamin E inhibits the reaction [nitrofen results in decreased expression of SFTPB protein]
CTD
PMID:16490937 PMID:16863852
NCBI chr 6:72,281,594...72,291,354
Ensembl chr 6:72,281,594...72,291,354
G
Sgsm2
small G protein signaling modulator 2
decreases expression
ISO
Vitamin E results in decreased expression of SGSM2 mRNA
CTD
PMID:19244175
NCBI chr11:74,740,088...74,787,929
Ensembl chr11:74,740,087...74,787,886
G
Sgsm3
small G protein signaling modulator 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SGSM3 mRNA
CTD
PMID:19244175
NCBI chr15:80,861,966...80,896,491
Ensembl chr15:80,861,966...80,896,491
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Vitamin E results in decreased expression of SHANK2 mRNA
CTD
PMID:19244175
NCBI chr 7:143,531,819...143,979,780
Ensembl chr 7:143,555,665...143,978,231
G
Siah1a
siah E3 ubiquitin protein ligase 1A
decreases expression
ISO
Vitamin E results in decreased expression of SIAH1 mRNA
CTD
PMID:19244175
NCBI chr 8:87,442,450...87,472,634
Ensembl chr 8:87,450,635...87,472,562
G
Sipa1l3
signal-induced proliferation-associated 1 like 3
increases expression
ISO
Vitamin E results in increased expression of SIPA1L3 mRNA
CTD
PMID:19244175
NCBI chr 7:29,016,687...29,218,694
Ensembl chr 7:29,019,797...29,218,066
G
Sirt1
sirtuin 1
decreases expression
ISO
Vitamin E results in decreased expression of SIRT1 mRNA
CTD
PMID:19244175
NCBI chr10:63,154,784...63,174,814
Ensembl chr10:63,154,784...63,217,483
G
Skap2
src family associated phosphoprotein 2
decreases expression
ISO
Vitamin E results in decreased expression of SKAP2 mRNA
CTD
PMID:19244175
NCBI chr 6:51,836,145...51,989,529
Ensembl chr 6:51,834,402...51,989,529
G
Ski
ski sarcoma viral oncogene homolog (avian)
increases expression
ISO
Vitamin E results in increased expression of SKI mRNA
CTD
PMID:19244175
NCBI chr 4:155,238,532...155,307,536
Ensembl chr 4:155,238,532...155,307,049
G
Skic3
SKI3 subunit of superkiller complex
decreases expression
ISO
Vitamin E results in decreased expression of SKIC3 mRNA
CTD
PMID:19244175
NCBI chr13:76,246,837...76,338,437
Ensembl chr13:76,246,853...76,338,435
G
Skp1
S-phase kinase-associated protein 1
increases expression
ISO
Vitamin E results in increased expression of SKP1 mRNA
CTD
PMID:19244175
NCBI chr11:52,121,349...52,137,685
Ensembl chr11:52,122,822...52,137,685
G
Slc11a2
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2
decreases expression multiple interactions
ISO EXP
Vitamin E results in decreased expression of SLC11A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SLC11A2 mRNA Vitamin E inhibits the reaction [Ethanol results in increased expression of SLC11A2 protein]
CTD
PMID:16737972 PMID:19244175
NCBI chr15:100,285,779...100,322,090
Ensembl chr15:100,285,779...100,322,953
G
Slc12a2
solute carrier family 12, member 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SLC12A2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SLC12A2 mRNA Vitamin E inhibits the reaction [Manganese results in increased expression of SLC12A2 protein]; Vitamin E inhibits the reaction [Manganese results in increased phosphorylation of and results in increased activity of SLC12A2 protein]
CTD
PMID:19244175 PMID:25817889
NCBI chr18:58,011,505...58,079,893
Ensembl chr18:58,011,750...58,079,893
G
Slc19a1
solute carrier family 19 (folate transporter), member 1
decreases expression
ISO
Vitamin E results in decreased expression of SLC19A1 mRNA
CTD
PMID:19244175
NCBI chr10:76,868,103...76,886,266
Ensembl chr10:76,868,075...76,896,836
G
Slc25a1
solute carrier family 25 (mitochondrial carrier, citrate transporter), member 1
increases expression
ISO
Vitamin E results in increased expression of SLC25A1 mRNA
CTD
PMID:19244175
NCBI chr16:17,743,075...17,746,083
Ensembl chr16:17,743,087...17,746,083
G
Slc25a12
solute carrier family 25 (mitochondrial carrier, Aralar), member 12
decreases expression
ISO
Vitamin E results in decreased expression of SLC25A12 mRNA
CTD
PMID:19244175
NCBI chr 2:71,104,614...71,198,125
Ensembl chr 2:71,101,407...71,198,093
G
Slc25a16
solute carrier family 25 (mitochondrial carrier, Graves disease autoantigen), member 16
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SLC25A16 mRNA Vitamin E results in decreased expression of SLC25A16 mRNA
CTD
PMID:19244175
NCBI chr10:62,756,454...62,782,278
Ensembl chr10:62,756,412...62,782,277
G
Slc25a36
solute carrier family 25, member 36
decreases expression
ISO
Vitamin E results in decreased expression of SLC25A36 mRNA
CTD
PMID:19244175
NCBI chr 9:96,957,014...96,993,094
Ensembl chr 9:96,957,014...96,993,210
G
Slc25a4
solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 4
increases expression
ISO
Vitamin E results in increased expression of SLC25A4 mRNA
CTD
PMID:19244175
NCBI chr 8:46,660,205...46,664,099
Ensembl chr 8:46,659,834...46,664,321
G
Slc29a1
solute carrier family 29 (nucleoside transporters), member 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SLC29A1 mRNA Vitamin E results in increased expression of SLC29A1 mRNA
CTD
PMID:19244175
NCBI chr17:45,896,126...45,910,544
Ensembl chr17:45,896,126...45,910,532
G
Slc2a4
solute carrier family 2 (facilitated glucose transporter), member 4
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate affects the localization of SLC2A4 protein]; Vitamin E affects the reaction [Triiodothyronine, Reverse results in decreased expression of SLC2A4 mRNA]
CTD
PMID:17198541 PMID:21911000
NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014
G
Slc30a5
solute carrier family 30 (zinc transporter), member 5
decreases expression
ISO
Vitamin E results in decreased expression of SLC30A5 mRNA
CTD
PMID:19244175
NCBI chr13:100,939,153...100,969,988
Ensembl chr13:100,939,156...100,969,935
G
Slc35d1
solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SLC35D1 mRNA Vitamin E results in decreased expression of SLC35D1 mRNA
CTD
PMID:19244175
NCBI chr 4:103,027,846...103,078,208
Ensembl chr 4:103,027,846...103,072,361
G
Slc39a1
solute carrier family 39 (zinc transporter), member 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of SLC39A1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of SLC39A1 mRNA
CTD
PMID:19244175
NCBI chr 3:90,155,512...90,160,923
Ensembl chr 3:90,155,479...90,160,919
G
Slc39a2
solute carrier family 39 (zinc transporter), member 2
increases expression
ISO
Vitamin E results in increased expression of SLC39A2 mRNA
CTD
PMID:19244175
NCBI chr14:52,130,539...52,134,202
Ensembl chr14:52,130,346...52,134,202
G
Slc47a1
solute carrier family 47, member 1
increases expression
ISO
Vitamin E results in increased expression of SLC47A1 mRNA
CTD
PMID:19244175
NCBI chr11:61,234,226...61,269,668
Ensembl chr11:61,234,227...61,269,171
G
Slc4a4
solute carrier family 4 (anion exchanger), member 4
decreases expression
ISO
Vitamin E results in decreased expression of SLC4A4 mRNA
CTD
PMID:19244175
NCBI chr 5:88,941,717...89,387,515
Ensembl chr 5:89,034,345...89,387,512
G
Slc4a7
solute carrier family 4, sodium bicarbonate cotransporter, member 7
decreases expression
ISO
Vitamin E results in decreased expression of SLC4A7 mRNA
CTD
PMID:19244175
NCBI chr14:7,669,819...7,766,808
Ensembl chr14:7,669,823...7,767,484
G
Slc6a2
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2
decreases expression
ISO
Vitamin E results in decreased expression of SLC6A2 mRNA
CTD
PMID:19244175
NCBI chr 8:93,687,100...93,728,295
Ensembl chr 8:93,686,707...93,728,295
G
Slc6a8
solute carrier family 6 (neurotransmitter transporter, creatine), member 8
increases expression
ISO
Vitamin E results in increased expression of SLC6A8 mRNA
CTD
PMID:19244175
NCBI chr X:72,716,739...72,726,108
Ensembl chr X:72,716,756...72,726,108
G
Slf2
SMC5-SMC6 complex localization factor 2
increases expression
ISO
Vitamin E results in increased expression of SLF2 mRNA
CTD
PMID:19244175
NCBI chr19:44,906,948...44,972,225
Ensembl chr19:44,919,558...44,972,225
G
Smad3
SMAD family member 3
increases expression
ISO
Vitamin E results in increased expression of SMAD3 mRNA
CTD
PMID:19244175
NCBI chr 9:63,554,048...63,665,276
Ensembl chr 9:63,554,049...63,665,276
G
Smad5
SMAD family member 5
decreases expression
ISO
Vitamin E results in decreased expression of SMAD5 mRNA
CTD
PMID:19244175
NCBI chr13:56,850,804...56,890,191
Ensembl chr13:56,850,823...56,890,190
G
Smap1
small ArfGAP 1
increases expression
ISO
Vitamin E results in increased expression of SMAP1 mRNA
CTD
PMID:19244175
NCBI chr 1:23,883,925...23,961,462
Ensembl chr 1:23,883,927...23,961,398
G
Smarca5
SNF2 related chromatin remodeling ATPase 5
decreases expression
ISO
Vitamin E results in decreased expression of SMARCA5 mRNA
CTD
PMID:19244175
NCBI chr 8:81,426,572...81,466,088
Ensembl chr 8:81,425,136...81,466,126
G
Smarcc1
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SMARCC1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SMARCC1 mRNA
CTD
PMID:19244175
NCBI chr 9:109,961,129...110,069,773
Ensembl chr 9:109,946,776...110,069,246
G
Smarcd2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SMARCD2 mRNA Vitamin E results in increased expression of SMARCD2 mRNA
CTD
PMID:19244175
NCBI chr11:106,153,997...106,163,810
Ensembl chr11:106,154,005...106,163,798
G
Smc5
structural maintenance of chromosomes 5
decreases expression
ISO
Vitamin E results in decreased expression of SMC5 mRNA
CTD
PMID:19244175
NCBI chr19:23,183,817...23,251,286
Ensembl chr19:23,183,815...23,251,261
G
Smc6
structural maintenance of chromosomes 6
decreases expression
ISO
Vitamin E results in decreased expression of SMC6 mRNA
CTD
PMID:19244175
NCBI chr12:11,315,887...11,369,786
Ensembl chr12:11,315,887...11,369,786
G
Smchd1
SMC hinge domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of SMCHD1 mRNA
CTD
PMID:19244175
NCBI chr17:71,651,484...71,782,361
Ensembl chr17:71,651,484...71,782,338
G
Smg5
SMG5 nonsense mediated mRNA decay factor
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SMG5 mRNA Vitamin E results in increased expression of SMG5 mRNA
CTD
PMID:19244175
NCBI chr 3:88,242,050...88,269,645
Ensembl chr 3:88,243,567...88,269,645
G
Smg6
SMG6 nonsense mediated mRNA decay factor
increases expression
ISO
Vitamin E results in increased expression of SMG6 mRNA
CTD
PMID:19244175
NCBI chr11:74,816,665...75,055,274
Ensembl chr11:74,816,649...75,055,274
G
Smox
spermine oxidase
increases expression
ISO
Vitamin E results in increased expression of SMOX mRNA
CTD
PMID:19244175
NCBI chr 2:131,333,624...131,367,103
Ensembl chr 2:131,333,416...131,367,842
G
Smpd4
sphingomyelin phosphodiesterase 4
increases expression
ISO
Vitamin E results in increased expression of SMPD4 mRNA
CTD
PMID:19244175
NCBI chr16:17,437,218...17,462,694
Ensembl chr16:17,437,218...17,462,692
G
Smtn
smoothelin
increases expression
ISO
Vitamin E results in increased expression of SMTN mRNA
CTD
PMID:19244175
NCBI chr11:3,467,522...3,489,337
Ensembl chr11:3,467,521...3,490,612
G
Smurf2
SMAD specific E3 ubiquitin protein ligase 2
decreases expression
ISO
Vitamin E results in decreased expression of SMURF2 mRNA
CTD
PMID:19244175
NCBI chr11:106,710,887...106,811,544
Ensembl chr11:106,710,892...106,811,541
G
Smyd2
SET and MYND domain containing 2
decreases expression
ISO
Vitamin E results in decreased expression of SMYD2 mRNA
CTD
PMID:19244175
NCBI chr 1:189,612,689...189,654,758
Ensembl chr 1:189,612,689...189,654,560
G
Snap25
synaptosomal-associated protein 25
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SNAP25 mRNA
CTD
PMID:19244175
NCBI chr 2:136,555,359...136,624,348
Ensembl chr 2:136,555,373...136,624,348
G
Snf8
SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)
increases expression
ISO
Vitamin E results in increased expression of SNF8 mRNA
CTD
PMID:19244175
NCBI chr11:95,925,711...95,938,256
Ensembl chr11:95,925,711...95,938,256
G
Snrnp27
small nuclear ribonucleoprotein 27 (U4/U6.U5)
decreases expression
ISO
Vitamin E results in decreased expression of SNRNP27 mRNA
CTD
PMID:19244175
NCBI chr 6:86,652,151...86,661,473
Ensembl chr 6:86,652,133...86,661,504
G
Snrnp35
small nuclear ribonucleoprotein 35 (U11/U12)
increases expression
ISO
Vitamin E results in increased expression of SNRNP35 mRNA
CTD
PMID:19244175
NCBI chr 5:124,621,099...124,631,649
Ensembl chr 5:124,621,197...124,629,187
G
Snrpb
small nuclear ribonucleoprotein B
increases expression
ISO
Vitamin E results in increased expression of SNRPB mRNA
CTD
PMID:19244175
NCBI chr 2:130,013,560...130,031,184
Ensembl chr 2:130,013,555...130,021,323
G
Snrpd3
small nuclear ribonucleoprotein D3
increases expression
ISO
Vitamin E results in increased expression of SNRPD3 mRNA
CTD
PMID:19244175
NCBI chr10:75,353,852...75,371,300
Ensembl chr10:75,353,385...75,373,215
G
Sntb2
syntrophin, basic 2
decreases expression
ISO
Vitamin E results in decreased expression of SNTB2 mRNA
CTD
PMID:19244175
NCBI chr 8:107,662,372...107,740,864
Ensembl chr 8:107,662,382...107,746,346
G
Snu13
SNU13 homolog, small nuclear ribonucleoprotein (U4/U6.U5)
increases expression
ISO
Vitamin E results in increased expression of SNU13 mRNA
CTD
PMID:19244175
NCBI chr15:81,925,546...81,931,799
Ensembl chr15:81,924,726...81,931,799
G
Snx13
sorting nexin 13
decreases expression
ISO
Vitamin E results in decreased expression of SNX13 mRNA
CTD
PMID:19244175
NCBI chr12:35,097,191...35,197,479
Ensembl chr12:35,097,185...35,197,478
G
Snx17
sorting nexin 17
increases expression
ISO
Vitamin E results in increased expression of SNX17 mRNA
CTD
PMID:19244175
NCBI chr 5:31,350,634...31,356,244
Ensembl chr 5:31,350,571...31,356,487
G
Snx6
sorting nexin 6
increases expression
ISO
Vitamin E results in increased expression of SNX6 mRNA
CTD
PMID:19244175
NCBI chr12:54,793,124...54,842,464
Ensembl chr12:54,793,134...54,842,488
G
Sobp
sine oculis binding protein
decreases expression
ISO
Vitamin E results in decreased expression of SOBP mRNA
CTD
PMID:19244175
NCBI chr10:42,878,484...43,059,144
Ensembl chr10:42,878,496...43,050,526
G
Sod1
superoxide dismutase 1, soluble
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of SOD1 mRNA; Vitamin E inhibits the reaction [Epinephrine results in increased activity of SOD1 protein] [Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of SOD1 protein]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in decreased expression of SOD1 mRNA]; [Curcumin co-treated with Vitamin E] inhibits the reaction [Thyroxine results in increased activity of SOD1 protein]; [Curcumin co-treated with Vitamin E] promotes the reaction [Thyroxine results in decreased activity of SOD1 protein]; Vitamin E inhibits the reaction [Cadmium results in increased activity of SOD1 protein]; Vitamin E inhibits the reaction [Hexachlorobenzene results in decreased activity of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD1 mRNA]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in increased activity of SOD1 protein]; Vitamin E inhibits the reaction [Thyroxine results in increased expression of SOD1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse results in decreased activity of and results in decreased expression of SOD1 protein]; Vitamin E inhibits the reaction [Triiodothyronine, Reverse results in decreased expression of SOD1 mRNA]; Vitamin E promotes the reaction [Thyroxine results in decreased activity of SOD1 protein]
CTD
PMID:11163531 PMID:14535831 PMID:17198541 PMID:17447016 PMID:19914224 PMID:22207723 PMID:29663635 PMID:30064338 More...
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 mRNA]; [Ascorbic Acid co-treated with Vitamin E co-treated with beta Carotene co-treated with Copper] inhibits the reaction [Streptozocin results in decreased expression of SOD2 protein]; [Vitamin E co-treated with Curcumin] inhibits the reaction [Thyroxine results in decreased expression of SOD2 mRNA]; Vitamin E affects the reaction [Ethanol affects the activity of SOD2 protein]; Vitamin E inhibits the reaction [Thyroxine results in decreased expression of SOD2 mRNA]; Vitamin E promotes the reaction [Thyroxine results in increased expression of SOD2 protein] Vitamin E inhibits the reaction [Epinephrine results in increased activity of SOD2 protein]; Vitamin E inhibits the reaction [Norepinephrine results in increased expression of SOD2 mRNA]
CTD
PMID:10787391 PMID:11163531 PMID:18779489 PMID:19914224 PMID:23114885
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Son
Son DNA binding protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SON mRNA Vitamin E results in decreased expression of SON mRNA
CTD
PMID:19244175
NCBI chr16:91,444,712...91,476,080
Ensembl chr16:91,444,394...91,476,109
G
Sort1
sortilin 1
decreases expression
ISO
Vitamin E results in decreased expression of SORT1 mRNA
CTD
PMID:19244175
NCBI chr 3:108,191,272...108,268,835
Ensembl chr 3:108,191,398...108,268,827
G
Sos1
SOS Ras/Rac guanine nucleotide exchange factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOS1 mRNA Vitamin E results in decreased expression of SOS1 mRNA
CTD
PMID:19244175
NCBI chr17:80,701,181...80,787,882
Ensembl chr17:80,701,180...80,787,882
G
Sox4
SRY (sex determining region Y)-box 4
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOX4 mRNA Vitamin E results in decreased expression of SOX4 mRNA
CTD
PMID:19244175
NCBI chr13:29,132,902...29,137,682
Ensembl chr13:29,132,902...29,137,696
G
Sox9
SRY (sex determining region Y)-box 9
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SOX9 mRNA Vitamin E results in decreased expression of SOX9 mRNA
CTD
PMID:19244175
NCBI chr11:112,673,036...112,678,583
Ensembl chr11:112,673,050...112,678,586
G
Sp100
nuclear antigen Sp100
decreases expression
ISO
Vitamin E results in decreased expression of SP100 mRNA
CTD
PMID:19244175
NCBI chr 1:85,577,683...85,637,719
Ensembl chr 1:85,577,709...85,637,719
G
Spag7
sperm associated antigen 7
increases expression
ISO
Vitamin E results in increased expression of SPAG7 mRNA
CTD
PMID:19244175
NCBI chr11:70,554,595...70,560,242
Ensembl chr11:70,554,597...70,560,242
G
Spata20
spermatogenesis associated 20
increases expression
ISO
Vitamin E results in increased expression of SPATA20 mRNA
CTD
PMID:19244175
NCBI chr11:94,369,730...94,376,136
Ensembl chr11:94,369,730...94,377,005
G
Spcs2
signal peptidase complex subunit 2 homolog (S. cerevisiae)
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SPCS2 mRNA Vitamin E results in decreased expression of SPCS2 mRNA
CTD
PMID:19244175
NCBI chr 7:99,486,775...99,512,576
Ensembl chr 7:99,486,776...99,512,669
G
Speg
SPEG complex locus
increases expression
ISO
Vitamin E results in increased expression of SPEG mRNA
CTD
PMID:19244175
NCBI chr 1:75,351,931...75,408,964
Ensembl chr 1:75,351,941...75,408,964
G
Spen
spen family transcription repressor
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SPEN mRNA Vitamin E results in decreased expression of SPEN mRNA
CTD
PMID:19244175
NCBI chr 4:141,195,199...141,265,955
Ensembl chr 4:141,195,201...141,265,908
G
Spidr
scaffolding protein involved in DNA repair
decreases expression
ISO
Vitamin E results in decreased expression of SPIDR mRNA
CTD
PMID:19244175
NCBI chr16:15,707,088...15,964,715
Ensembl chr16:15,707,088...15,964,715
G
Sppl2b
signal peptide peptidase like 2B
increases expression
ISO
Vitamin E results in increased expression of SPPL2B mRNA
CTD
PMID:19244175
NCBI chr10:80,691,067...80,704,542
Ensembl chr10:80,691,109...80,704,542
G
Spsb3
splA/ryanodine receptor domain and SOCS box containing 3
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SPSB3 mRNA
CTD
PMID:19244175
NCBI chr17:25,104,956...25,111,124
Ensembl chr17:25,105,617...25,111,126
G
Sptan1
spectrin alpha, non-erythrocytic 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SPTAN1 mRNA Vitamin E results in increased expression of SPTAN1 mRNA
CTD
PMID:19244175
NCBI chr 2:29,855,572...29,921,463
Ensembl chr 2:29,855,572...29,921,463
G
Sptb
spectrin beta, erythrocytic
decreases expression
ISO
Vitamin E results in decreased expression of SPTB mRNA
CTD
PMID:19244175
NCBI chr12:76,627,262...76,757,321
Ensembl chr12:76,627,262...76,757,321
G
Sptbn5
spectrin beta, non-erythrocytic 5
decreases expression
ISO
Vitamin E results in decreased expression of SPTBN5 mRNA
CTD
PMID:19244175
NCBI chr 2:119,871,974...119,919,394
Ensembl chr 2:119,871,974...119,916,159
G
Sptlc3
serine palmitoyltransferase, long chain base subunit 3
decreases expression
ISO
Vitamin E results in decreased expression of SPTLC3 mRNA
CTD
PMID:19244175
NCBI chr 2:139,335,833...139,478,981
Ensembl chr 2:139,335,833...139,479,594
G
Srd5a1
steroid 5 alpha-reductase 1
affects expression
ISO
Vitamin E affects the expression of SRD5A1 mRNA
CTD
PMID:20447326
NCBI chr13:69,721,568...69,759,611
Ensembl chr13:69,721,568...69,759,561
G
Srpk1
serine/arginine-rich protein specific kinase 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SRPK1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SRPK1 mRNA
CTD
PMID:19244175
NCBI chr17:28,806,622...28,841,795
Ensembl chr17:28,806,622...28,841,683
G
Srpk2
serine/arginine-rich protein specific kinase 2
decreases expression
ISO
Vitamin E results in decreased expression of SRPK2 mRNA
CTD
PMID:19244175
NCBI chr 5:23,708,262...23,889,639
Ensembl chr 5:23,708,262...23,889,615
G
Srrm2
serine/arginine repetitive matrix 2
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of SRRM2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of SRRM2 mRNA
CTD
PMID:19244175
NCBI chr17:24,009,501...24,043,715
Ensembl chr17:24,009,506...24,043,715
G
Srsf11
serine and arginine-rich splicing factor 11
decreases expression
ISO
Vitamin E results in decreased expression of SRSF11 mRNA
CTD
PMID:19244175
NCBI chr 3:157,716,552...157,742,304
Ensembl chr 3:157,716,110...157,742,276
G
Srsf7
serine and arginine-rich splicing factor 7
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of SRSF7 mRNA Vitamin E results in decreased expression of SRSF7 mRNA
CTD
PMID:19244175
NCBI chr17:80,507,509...80,514,734
Ensembl chr17:80,507,509...80,514,736
G
Srsf9
serine and arginine-rich splicing factor 9
increases expression
ISO
Vitamin E results in increased expression of SRSF9 mRNA
CTD
PMID:19244175
NCBI chr 5:115,465,236...115,471,139
Ensembl chr 5:115,465,236...115,471,139
G
Ssr4
signal sequence receptor, delta
decreases expression
ISO
Vitamin E results in decreased expression of SSR4 mRNA
CTD
PMID:19244175
NCBI chr X:72,830,778...72,834,432
Ensembl chr X:72,830,634...72,834,436
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
ISO
Vitamin E results in decreased expression of SSX2IP mRNA
CTD
PMID:19244175
NCBI chr 3:146,110,397...146,145,899
Ensembl chr 3:146,110,397...146,145,899
G
St13
suppression of tumorigenicity 13
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of ST13 mRNA
CTD
PMID:11444866
NCBI chr15:81,247,869...81,284,278
Ensembl chr15:81,247,870...81,284,278
G
Stab1
stabilin 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of STAB1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of STAB1 mRNA
CTD
PMID:19244175
NCBI chr14:30,860,974...30,890,616
Ensembl chr14:30,860,970...30,890,598
G
Stag2
STAG2 cohesin complex component
decreases expression
ISO
Vitamin E results in decreased expression of STAG2 mRNA
CTD
PMID:19244175
NCBI chr X:41,238,172...41,366,063
Ensembl chr X:41,238,194...41,366,062
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO
Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR mRNA]; Vitamin E inhibits the reaction [acetamiprid results in decreased expression of STAR protein]; Vitamin E inhibits the reaction [Cadmium results in decreased expression of STAR mRNA]
CTD
PMID:15055539 PMID:28395332
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
G
Stard5
StAR related lipid transfer domain containing 5
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of STARD5 mRNA
CTD
PMID:19244175
NCBI chr 7:83,281,225...83,291,536
Ensembl chr 7:83,281,167...83,302,335
G
Stat1
signal transducer and activator of transcription 1
decreases expression
ISO
Vitamin E results in decreased expression of STAT1 mRNA
CTD
PMID:19244175
NCBI chr 1:52,158,588...52,201,024
Ensembl chr 1:52,158,599...52,201,024
G
Stat2
signal transducer and activator of transcription 2
multiple interactions
ISO
[Vitamin E co-treated with Quercetin co-treated with kaempferol co-treated with 3,4-dihydroxyphenylethanol] results in decreased expression of STAT2 mRNA
CTD
PMID:16797527
NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718
G
Stat5a
signal transducer and activator of transcription 5A
increases expression
ISO
Vitamin E results in increased expression of STAT5A mRNA
CTD
PMID:19244175
NCBI chr11:100,750,177...100,775,995
Ensembl chr11:100,750,177...100,775,995
G
Stat5b
signal transducer and activator of transcription 5B
increases expression
ISO
Vitamin E results in increased expression of STAT5B mRNA
CTD
PMID:19244175
NCBI chr11:100,671,557...100,741,407
Ensembl chr11:100,671,557...100,741,550
G
Stc1
stanniocalcin 1
decreases expression
ISO
Vitamin E results in decreased expression of STC1 mRNA
CTD
PMID:19244175
NCBI chr14:69,266,738...69,278,850
Ensembl chr14:69,266,687...69,279,253
G
Stk38
serine/threonine kinase 38
increases expression
ISO
Vitamin E results in increased expression of STK38 mRNA
CTD
PMID:19244175
NCBI chr17:29,189,854...29,226,979
Ensembl chr17:29,189,854...29,226,969
G
Stk38l
serine/threonine kinase 38 like
decreases expression
ISO
Vitamin E results in decreased expression of STK38L mRNA
CTD
PMID:19244175
NCBI chr 6:146,626,428...146,680,312
Ensembl chr 6:146,626,493...146,680,310
G
Stk4
serine/threonine kinase 4
decreases expression
ISO
Vitamin E results in decreased expression of STK4 mRNA
CTD
PMID:19244175
NCBI chr 2:163,916,033...163,997,444
Ensembl chr 2:163,912,242...163,997,444
G
Stom
stomatin
increases expression
ISO
Vitamin E results in increased expression of STOM mRNA
CTD
PMID:19244175
NCBI chr 2:35,204,002...35,227,021
Ensembl chr 2:35,203,998...35,226,988
G
Stoml1
stomatin-like 1
increases expression
ISO
Vitamin E results in increased expression of STOML1 mRNA
CTD
PMID:19244175
NCBI chr 9:58,160,443...58,169,807
Ensembl chr 9:58,160,447...58,169,803
G
Stoml2
stomatin (Epb7.2)-like 2
increases expression
ISO
Vitamin E results in increased expression of STOML2 mRNA
CTD
PMID:19244175
NCBI chr 4:43,027,690...43,031,402
Ensembl chr 4:43,027,690...43,031,710
G
Strn
striatin, calmodulin binding protein
decreases expression
ISO
Vitamin E results in decreased expression of STRN mRNA
CTD
PMID:19244175
NCBI chr17:78,957,327...79,043,990
Ensembl chr17:78,957,342...79,044,625
G
Stt3a
STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)
increases expression multiple interactions
ISO
Vitamin E results in increased expression of STT3A mRNA [Selenium co-treated with Vitamin E] results in increased expression of STT3A mRNA
CTD
PMID:19244175
NCBI chr 9:36,640,640...36,678,918
Ensembl chr 9:36,640,640...36,678,975
G
Stub1
STIP1 homology and U-Box containing protein 1
increases expression
ISO
Vitamin E results in increased expression of STUB1 mRNA
CTD
PMID:19244175
NCBI chr17:26,049,608...26,051,893
Ensembl chr17:26,049,479...26,052,378
G
Stx17
syntaxin 17
decreases expression
ISO
Vitamin E results in decreased expression of STX17 mRNA
CTD
PMID:19244175
NCBI chr 4:48,124,912...48,186,507
Ensembl chr 4:48,124,915...48,186,507
G
Styxl1
serine/threonine/tyrosine interacting-like 1
increases expression
ISO
Vitamin E results in increased expression of STYXL1 mRNA
CTD
PMID:19244175
NCBI chr 5:135,776,074...135,807,277
Ensembl chr 5:135,776,074...135,807,239
G
Sult1e1
sulfotransferase family 1E, member 1
increases expression
ISO
Vitamin E results in increased expression of SULT1E1 mRNA
CTD
PMID:28923436
NCBI chr 5:87,723,827...87,739,470
Ensembl chr 5:87,723,828...87,739,453
G
Sult2a1
sulfotransferase family 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
decreases expression
ISO
Vitamin E results in decreased expression of SULT2A1 mRNA
CTD
PMID:28923436
NCBI chr 7:13,530,171...13,571,335
Ensembl chr 7:13,530,171...13,571,334
G
Sumo2
small ubiquitin-like modifier 2
increases expression
ISO
Vitamin E results in increased expression of SUMO2 mRNA
CTD
PMID:19244175
NCBI chr11:115,413,935...115,427,056
Ensembl chr11:115,413,928...115,427,102
G
Sun2
Sad1 and UNC84 domain containing 2
increases expression
ISO
Vitamin E results in increased expression of SUN2 mRNA
CTD
PMID:19244175
NCBI chr15:79,608,269...79,626,757
Ensembl chr15:79,608,271...79,626,737
G
Supt4a
SPT4A, DSIF elongation factor subunit
increases expression
ISO
Vitamin E results in increased expression of SUPT4H1 mRNA
CTD
PMID:19244175
NCBI chr11:87,628,377...87,634,449
Ensembl chr11:87,628,378...87,634,449
G
Supt5
suppressor of Ty 5, DSIF elongation factor subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of SUPT5H mRNA Vitamin E results in increased expression of SUPT5H mRNA
CTD
PMID:19244175
NCBI chr 7:28,014,316...28,038,341
Ensembl chr 7:28,014,316...28,038,171
G
Surf2
surfeit gene 2
increases expression
ISO
Vitamin E results in increased expression of SURF2 mRNA
CTD
PMID:19244175
NCBI chr 2:26,806,420...26,810,199
Ensembl chr 2:26,806,379...26,810,195
G
Suz12
SUZ12 polycomb repressive complex 2 subunit
decreases expression
ISO
Vitamin E results in decreased expression of SUZ12 mRNA
CTD
PMID:19244175
NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949
G
Swap70
SWA-70 protein
increases expression
ISO
Vitamin E results in increased expression of SWAP70 mRNA
CTD
PMID:19244175
NCBI chr 7:109,820,890...109,882,720
Ensembl chr 7:109,820,918...109,882,713
G
Syde1
synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
increases expression
ISO
Vitamin E results in increased expression of SYDE1 mRNA
CTD
PMID:19244175
NCBI chr10:78,420,336...78,427,798
Ensembl chr10:78,420,337...78,427,798
G
Syncrip
synaptotagmin binding, cytoplasmic RNA interacting protein
decreases expression
ISO
Vitamin E results in decreased expression of SYNCRIP mRNA
CTD
PMID:19244175
NCBI chr 9:88,331,417...88,364,645
Ensembl chr 9:88,329,062...88,364,627
G
Syndig1
synapse differentiation inducing 1
increases expression
ISO
Vitamin E results in increased expression of SYNDIG1 mRNA
CTD
PMID:19244175
NCBI chr 2:149,672,703...149,846,312
Ensembl chr 2:149,671,131...149,846,312
G
Syngr1
synaptogyrin 1
increases expression
ISO
Vitamin E results in increased expression of SYNGR1 mRNA
CTD
PMID:19244175
NCBI chr15:79,975,537...80,003,702
Ensembl chr15:79,975,535...80,003,702
G
Synj2
synaptojanin 2
increases expression
ISO
Vitamin E results in increased expression of SYNJ2 mRNA
CTD
PMID:19244175
NCBI chr17:5,991,555...6,106,041
Ensembl chr17:5,991,555...6,094,565
G
Synpo
synaptopodin
increases expression
ISO
Vitamin E results in increased expression of SYNPO mRNA
CTD
PMID:19244175
NCBI chr18:60,727,053...60,793,241
Ensembl chr18:60,727,045...60,793,214
G
Tada3
transcriptional adaptor 3
increases expression
ISO
Vitamin E results in increased expression of TADA3 mRNA
CTD
PMID:19244175
NCBI chr 6:113,343,594...113,354,799
Ensembl chr 6:113,342,986...113,354,844
G
Taf1d
TATA-box binding protein associated factor, RNA polymerase I, D
decreases expression
ISO
Vitamin E results in decreased expression of TAF1D mRNA
CTD
PMID:19244175
NCBI chr 9:15,217,485...15,228,293
Ensembl chr 9:15,217,510...15,228,287
G
Taf5l
TATA-box binding protein associated factor 5 like
decreases expression
ISO
Vitamin E results in decreased expression of TAF5L mRNA
CTD
PMID:19244175
NCBI chr 8:124,723,049...124,748,136
Ensembl chr 8:124,723,057...124,748,136
G
Taf6
TATA-box binding protein associated factor 6
increases expression
ISO
Vitamin E results in increased expression of TAF6 mRNA
CTD
PMID:19244175
NCBI chr 5:138,176,879...138,185,713
Ensembl chr 5:138,176,879...138,185,713
G
Taf9b
TATA-box binding protein associated factor 9B
decreases expression
ISO
Vitamin E results in decreased expression of TAF9B mRNA
CTD
PMID:19244175
NCBI chr X:105,250,480...105,264,764
Ensembl chr X:105,250,489...105,264,764
G
Tagln
transgelin
increases expression
ISO
Vitamin E results in increased expression of TAGLN mRNA
CTD
PMID:19244175
NCBI chr 9:45,840,926...45,847,356
Ensembl chr 9:45,840,917...45,847,356
G
Tarbp2
TARBP2, RISC loading complex RNA binding subunit
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TARBP2 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TARBP2 mRNA
CTD
PMID:19244175
NCBI chr15:102,423,327...102,432,112
Ensembl chr15:102,426,627...102,432,111
G
Tas2r140
taste receptor, type 2, member 140
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TAS2R14 mRNA
CTD
PMID:19244175
NCBI chr 6:133,031,818...133,032,756
Ensembl chr 6:133,031,780...133,032,779
G
Tasor
transcription activation suppressor
decreases expression
ISO
Vitamin E results in decreased expression of TASOR mRNA
CTD
PMID:19244175
NCBI chr14:27,150,759...27,205,512
Ensembl chr14:27,150,791...27,205,512
G
Tax1bp3
Tax1 (human T cell leukemia virus type I) binding protein 3
increases expression
ISO
Vitamin E results in increased expression of TAX1BP3 mRNA
CTD
PMID:19244175
NCBI chr11:73,067,909...73,072,872
Ensembl chr11:73,067,909...73,073,988
G
Tbc1d4
TBC1 domain family, member 4
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [Diethylhexyl Phthalate results in increased expression of TBC1D4 protein]
CTD
PMID:21911000
NCBI chr14:101,679,800...101,846,717
Ensembl chr14:101,679,796...101,846,627
G
Tbc1d8b
TBC1 domain family, member 8B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TBC1D8B mRNA
CTD
PMID:19244175
NCBI chr X:138,585,730...138,654,970
Ensembl chr X:138,585,745...138,654,154
G
Tbc1d9b
TBC1 domain family, member 9B
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TBC1D9B mRNA
CTD
PMID:19244175
NCBI chr11:50,021,891...50,063,612
Ensembl chr11:50,022,223...50,063,612
G
Tbcb
tubulin folding cofactor B
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TBCB mRNA Vitamin E results in increased expression of TBCB mRNA
CTD
PMID:19244175
NCBI chr 7:29,923,554...29,931,622
Ensembl chr 7:29,923,556...29,931,697
G
Tbl1x
transducin (beta)-like 1 X-linked
decreases expression
ISO
Vitamin E results in decreased expression of TBL1X mRNA
CTD
PMID:19244175
NCBI chr X:76,553,053...76,706,591
Ensembl chr X:76,554,619...76,706,589
G
Tcaf1
TRPM8 channel-associated factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCAF1 mRNA Vitamin E results in decreased expression of TCAF1 mRNA
CTD
PMID:19244175
NCBI chr 6:42,644,933...42,687,065
Ensembl chr 6:42,644,936...42,687,022
G
Tcea2
transcription elongation factor A (SII), 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TCEA2 mRNA Vitamin E results in increased expression of TCEA2 mRNA
CTD
PMID:19244175
NCBI chr 2:181,322,090...181,329,860
Ensembl chr 2:181,322,103...181,329,864
G
Tcerg1
transcription elongation regulator 1 (CA150)
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCERG1 mRNA Vitamin E results in decreased expression of TCERG1 mRNA
CTD
PMID:19244175
NCBI chr18:42,644,369...42,708,850
Ensembl chr18:42,644,552...42,708,858
G
Tcf21
transcription factor 21
increases expression
ISO
Vitamin E results in increased expression of TCF21 mRNA
CTD
PMID:19244175
NCBI chr10:22,693,162...22,696,042
Ensembl chr10:22,693,180...22,696,073
G
Tcf7l1
transcription factor 7 like 1 (T cell specific, HMG box)
increases expression
ISO
Vitamin E results in increased expression of TCF7L1 mRNA
CTD
PMID:19244175
NCBI chr 6:72,603,354...72,766,028
Ensembl chr 6:72,603,361...72,766,237
G
Tcf7l2
transcription factor 7 like 2, T cell specific, HMG box
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TCF7L2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TCF7L2 mRNA
CTD
PMID:19244175
NCBI chr19:55,730,227...55,922,091
Ensembl chr19:55,730,252...55,922,086
G
Tcp1
t-complex protein 1
multiple interactions
ISO
[Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of TCP1 mRNA
CTD
PMID:11444866
NCBI chr17:13,135,216...13,143,954
Ensembl chr17:13,134,588...13,143,954
G
Tctn1
tectonic family member 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TCTN1 mRNA Vitamin E results in decreased expression of TCTN1 mRNA
CTD
PMID:19244175
NCBI chr 5:122,377,558...122,402,557
Ensembl chr 5:122,375,911...122,402,523
G
Tdg
thymine DNA glycosylase
decreases expression
ISO
Vitamin E results in decreased expression of TDG mRNA
CTD
PMID:19244175
NCBI chr10:82,465,649...82,486,633
Ensembl chr10:82,465,662...82,486,633
G
Tent4a
terminal nucleotidyltransferase 4A
decreases expression
ISO
Vitamin E results in decreased expression of TENT4A mRNA
CTD
PMID:19244175
NCBI chr13:69,646,071...69,682,710
Ensembl chr13:69,646,078...69,682,736
G
Terf1
telomeric repeat binding factor 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TERF1 mRNA Vitamin E results in decreased expression of TERF1 mRNA
CTD
PMID:19244175
NCBI chr 1:15,875,634...15,914,283
Ensembl chr 1:15,875,870...15,914,276
G
Tfb2m
transcription factor B2, mitochondrial
decreases expression
ISO
Vitamin E results in decreased expression of TFB2M mRNA
CTD
PMID:19244175
NCBI chr 1:179,355,617...179,373,870
Ensembl chr 1:179,355,620...179,373,832
G
Tfeb
transcription factor EB
increases expression
ISO
Vitamin E results in increased expression of TFEB mRNA
CTD
PMID:19244175
NCBI chr17:48,047,962...48,103,341
Ensembl chr17:48,047,955...48,103,344
G
Tgfb1
transforming growth factor, beta 1
multiple interactions affects expression
EXP ISO
Vitamin E inhibits the reaction [Ethanol results in increased activity of TGFB1 protein] [Silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; Vitamin E inhibits the reaction [Cyclosporine results in increased secretion of TGFB1 protein]; Vitamin E inhibits the reaction [Streptozocin results in increased expression of TGFB1 mRNA] Vitamin E affects the expression of TGFB1 protein
CTD
PMID:10353404 PMID:15001429 PMID:15309289 PMID:16169303 PMID:21086752
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbi
transforming growth factor, beta induced
increases expression
ISO
Vitamin E results in increased expression of TGFBI mRNA
CTD
PMID:19244175
NCBI chr13:56,757,399...56,787,172
Ensembl chr13:56,757,336...56,787,375
G
Tgoln1
trans-golgi network protein
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TGOLN2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TGOLN2 mRNA
CTD
PMID:19244175
NCBI chr 6:72,585,403...72,593,983
Ensembl chr 6:72,585,415...72,593,983
G
Th
tyrosine hydroxylase
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] results in increased expression of TH protein
CTD
PMID:18772553
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Thada
thyroid adenoma associated
increases expression
ISO
Vitamin E results in increased expression of THADA mRNA
CTD
PMID:19244175
NCBI chr17:84,497,484...84,773,674
Ensembl chr17:84,497,504...84,773,633
G
Thap4
THAP domain containing 4
increases expression
ISO
Vitamin E results in increased expression of THAP4 mRNA
CTD
PMID:19244175
NCBI chr 1:93,633,113...93,682,560
Ensembl chr 1:93,629,657...93,682,586
G
Thbd
thrombomodulin
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of THBD mRNA Vitamin E results in decreased expression of THBD mRNA
CTD
PMID:19244175
NCBI chr 2:148,246,391...148,250,108
Ensembl chr 2:148,246,386...148,250,108
G
Thoc2
THO complex 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of THOC2 mRNA Vitamin E results in decreased expression of THOC2 mRNA
CTD
PMID:19244175
NCBI chr X:40,883,869...41,000,878
Ensembl chr X:40,883,868...41,009,551
G
Thsd7a
thrombospondin, type I, domain containing 7A
decreases expression
ISO
Vitamin E results in decreased expression of THSD7A mRNA
CTD
PMID:19244175
NCBI chr 6:12,311,607...12,749,252
Ensembl chr 6:12,311,609...12,749,409
G
Thy1
thymus cell antigen 1, theta
increases expression
ISO
Vitamin E results in increased expression of THY1 mRNA
CTD
PMID:19244175
NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876
G
Thyn1
thymocyte nuclear protein 1
increases expression
ISO
Vitamin E results in increased expression of THYN1 mRNA
CTD
PMID:19244175
NCBI chr 9:26,910,950...26,918,632
Ensembl chr 9:26,911,006...26,918,632
G
Tia1
cytotoxic granule-associated RNA binding protein 1
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TIA1 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TIA1 mRNA
CTD
PMID:19244175
NCBI chr 6:86,381,001...86,410,387
Ensembl chr 6:86,381,201...86,410,387
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
decreases expression
ISO
Vitamin E results in decreased expression of TIAL1 mRNA
CTD
PMID:19244175
NCBI chr 7:128,041,496...128,063,450
Ensembl chr 7:128,041,501...128,063,441
G
Timm13
translocase of inner mitochondrial membrane 13
decreases expression
ISO
Vitamin E results in decreased expression of TIMM13 mRNA
CTD
PMID:19244175
NCBI chr10:80,735,284...80,736,803
Ensembl chr10:80,735,284...80,736,803
G
Timm8a1
translocase of inner mitochondrial membrane 8A1
decreases expression
ISO
Vitamin E results in decreased expression of TIMM8A mRNA
CTD
PMID:19244175
NCBI chr X:133,438,005...133,442,419
Ensembl chr X:133,438,005...133,442,614
G
Timp1
tissue inhibitor of metalloproteinase 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TIMP1 mRNA [silybin co-treated with Phosphatidylcholines co-treated with Vitamin E] inhibits the reaction [Dimethylnitrosamine results in increased expression of TIMP1 mRNA]
CTD
PMID:16169303 PMID:19244175
NCBI chr X:20,736,524...20,740,972
Ensembl chr X:20,736,405...20,740,974
G
Timp3
tissue inhibitor of metalloproteinase 3
increases expression
ISO
Vitamin E results in increased expression of TIMP3 mRNA
CTD
PMID:19244175
NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370
G
Tjp1
tight junction protein 1
multiple interactions
ISO
[Ascorbic Acid co-treated with Vitamin E] inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Ritonavir co-treated with Saquinavir] results in decreased expression of TJP1 protein]; Vitamin E inhibits the reaction [[Nicotine co-treated with Saquinavir] results in decreased expression of TJP1 protein]
CTD
PMID:20722969 PMID:29940330
NCBI chr 7:64,945,913...65,177,629
Ensembl chr 7:64,945,913...65,177,529
G
Tkt
transketolase
increases expression
ISO
Vitamin E results in increased expression of TKT mRNA
CTD
PMID:19244175
NCBI chr14:30,271,088...30,296,681
Ensembl chr14:30,270,316...30,296,677
G
Tln1
talin 1
increases expression
ISO
Vitamin E results in increased expression of TLN1 mRNA
CTD
PMID:19244175
NCBI chr 4:43,531,513...43,562,583
Ensembl chr 4:43,531,519...43,562,691
G
Tm6sf1
transmembrane 6 superfamily member 1
decreases expression
ISO
Vitamin E results in decreased expression of TM6SF1 mRNA
CTD
PMID:19244175
NCBI chr 7:81,507,810...81,533,827
Ensembl chr 7:81,508,749...81,534,182
G
Tm9sf1
transmembrane 9 superfamily member 1
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TM9SF1 mRNA
CTD
PMID:19244175
NCBI chr14:55,873,422...55,881,263
Ensembl chr14:55,873,422...55,881,263
G
Tma16
translation machinery associated 16
decreases expression
ISO
Vitamin E results in decreased expression of TMA16 mRNA
CTD
PMID:19244175
NCBI chr 8:66,928,995...66,939,182
Ensembl chr 8:66,925,770...66,939,182
G
Tmbim1
transmembrane BAX inhibitor motif containing 1
increases expression
ISO
Vitamin E results in increased expression of TMBIM1 mRNA
CTD
PMID:19244175
NCBI chr 1:74,327,406...74,343,495
Ensembl chr 1:74,327,406...74,344,781
G
Tmc5
transmembrane channel-like gene family 5
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of TMC5 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of TMC5 mRNA
CTD
PMID:19244175
NCBI chr 7:118,196,520...118,274,308
Ensembl chr 7:118,196,520...118,274,309
G
Tmem11
transmembrane protein 11
increases expression
ISO
Vitamin E results in increased expression of TMEM11 mRNA
CTD
PMID:19244175
NCBI chr11:60,755,278...60,769,864
Ensembl chr11:60,755,278...60,770,098
G
Tmem161b
transmembrane protein 161B
decreases expression
ISO
Vitamin E results in decreased expression of TMEM161B mRNA
CTD
PMID:19244175
NCBI chr13:84,370,415...84,444,085
Ensembl chr13:84,370,415...84,444,260
G
Tmem176a
transmembrane protein 176A
increases expression
ISO
Vitamin E results in increased expression of TMEM176A mRNA
CTD
PMID:19244175
NCBI chr 6:48,818,417...48,822,298
Ensembl chr 6:48,817,853...48,824,005
G
Tmem186
transmembrane protein 186
increases expression
ISO
Vitamin E results in increased expression of TMEM186 mRNA
CTD
PMID:19244175
NCBI chr16:8,451,595...8,455,575
Ensembl chr16:8,451,093...8,455,576
G
Tmem208
transmembrane protein 208
increases expression
ISO
Vitamin E results in increased expression of TMEM208 mRNA
CTD
PMID:19244175
NCBI chr 8:106,052,980...106,062,117
Ensembl chr 8:106,052,986...106,061,851
G
Tmem222
transmembrane protein 222
increases expression
ISO
Vitamin E results in increased expression of TMEM222 mRNA
CTD
PMID:19244175
NCBI chr 4:132,993,356...133,005,101
Ensembl chr 4:132,993,356...133,005,103
G
Tmem260
transmembrane protein 260
decreases expression
ISO
Vitamin E results in decreased expression of TMEM260 mRNA
CTD
PMID:19244175
NCBI chr14:48,683,580...48,797,640
Ensembl chr14:48,683,581...48,761,703
G
Tmem63a
transmembrane protein 63a
increases expression
ISO
Vitamin E results in increased expression of TMEM63A mRNA
CTD
PMID:19244175
NCBI chr 1:180,769,899...180,802,671
Ensembl chr 1:180,769,909...180,802,677
G
Tmf1
TATA element modulatory factor 1
decreases expression
ISO
Vitamin E results in decreased expression of TMF1 mRNA
CTD
PMID:19244175
NCBI chr 6:97,128,911...97,156,107
Ensembl chr 6:97,129,958...97,156,083
G
Tmprss6
transmembrane serine protease 6
increases expression
ISO
Vitamin E results in increased expression of TMPRSS6 mRNA
CTD
PMID:19244175
NCBI chr15:78,323,867...78,352,848
Ensembl chr15:78,323,867...78,352,834
G
Tnf
tumor necrosis factor
multiple interactions increases expression
ISO EXP
Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Ethanol results in increased secretion of TNF protein]; Vitamin E inhibits the reaction [Oleic Acid results in increased expression of TNF mRNA]; Vitamin E inhibits the reaction [Oleic Acid results in increased expression of TNF protein]; Vitamin E inhibits the reaction [TNF protein results in decreased activity of KCNH2 protein]; Vitamin E inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species] [Vanadium co-treated with Selenium co-treated with Vitamin E co-treated with Chromium] inhibits the reaction [Streptozocin results in increased expression of TNF protein]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]; Vitamin E inhibits the reaction [[IL1B protein co-treated with TNF protein] results in increased expression of NOS2 protein]; Vitamin E inhibits the reaction [Aluminum results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Nicotine results in increased expression of TNF protein]; Vitamin E inhibits the reaction [phoxim results in increased expression of TNF protein]; Vitamin E inhibits the reaction [Tramadol results in increased expression of TNF protein] Vitamin E deficiency results in increased expression of TNF mRNA alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA]; Quercetin inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA]; Vitamin E inhibits the reaction [Ethanol results in increased activity of TNF protein]; Vitamin E inhibits the reaction [Platelet Activating Factor results in increased expression of TNF mRNA]
CTD
PMID:10921504 PMID:14973143 PMID:15223066 PMID:15862027 PMID:16545059 PMID:17216608 PMID:19735175 PMID:21086752 PMID:22841563 PMID:23348005 PMID:30003487 PMID:31618080 PMID:35349355 More...
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfsf10
tumor necrosis factor (ligand) superfamily, member 10
decreases expression
ISO
Vitamin E results in decreased expression of TNFSF10 mRNA
CTD
PMID:19244175
NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576
G
Tnik
TRAF2 and NCK interacting kinase
decreases expression
ISO
Vitamin E results in decreased expression of TNIK mRNA
CTD
PMID:19244175
NCBI chr 3:28,317,362...28,724,734
Ensembl chr 3:28,317,363...28,730,007
G
Tnpo1
transportin 1
decreases expression
ISO
Vitamin E results in decreased expression of TNPO1 mRNA
CTD
PMID:19244175
NCBI chr13:98,975,527...99,062,851
Ensembl chr13:98,975,527...99,062,892
G
Tnpo2
transportin 2 (importin 3, karyopherin beta 2b)
decreases expression
ISO
Vitamin E results in decreased expression of TNPO2 mRNA
CTD
PMID:19244175
NCBI chr 8:85,763,502...85,784,214
Ensembl chr 8:85,763,544...85,784,212
G
Tns1
tensin 1
increases expression
ISO
Vitamin E results in increased expression of TNS1 mRNA
CTD
PMID:19244175
NCBI chr 1:73,949,391...74,163,707
Ensembl chr 1:73,949,390...74,163,608
G
Tns2
tensin 2
increases expression
ISO
Vitamin E results in increased expression of TNS2 mRNA
CTD
PMID:19244175
NCBI chr15:102,006,910...102,024,836
Ensembl chr15:102,008,848...102,024,836
G
Tob2
transducer of ERBB2, 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TOB2 mRNA Vitamin E results in decreased expression of TOB2 mRNA
CTD
PMID:19244175
NCBI chr15:81,732,471...81,744,742
Ensembl chr15:81,732,473...81,742,997
G
Top1
topoisomerase (DNA) I
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TOP1 mRNA Vitamin E results in decreased expression of TOP1 mRNA
CTD
PMID:19244175
NCBI chr 2:160,487,901...160,564,684
Ensembl chr 2:160,487,808...160,564,684
G
Tor1a
torsin family 1, member A (torsin A)
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TOR1A mRNA
CTD
PMID:19244175
NCBI chr 2:30,850,573...30,857,930
Ensembl chr 2:30,850,639...30,857,945
G
Tor3a
torsin family 3, member A
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TOR3A mRNA [Selenium co-treated with Vitamin E] results in increased expression of TOR3A mRNA
CTD
PMID:19244175
NCBI chr 1:156,481,187...156,501,909
Ensembl chr 1:156,481,187...156,501,926
G
Tox4
TOX high mobility group box family member 4
increases expression
ISO
Vitamin E results in increased expression of TOX4 mRNA
CTD
PMID:19244175
NCBI chr14:52,516,603...52,532,966
Ensembl chr14:52,516,603...52,533,858
G
Tpi1
triosephosphate isomerase 1
increases expression
ISO
Vitamin E results in increased expression of TPI1 mRNA
CTD
PMID:19244175
NCBI chr 6:124,787,549...124,791,121
Ensembl chr 6:124,787,549...124,791,259
G
Tpm2
tropomyosin 2, beta
increases expression
ISO
Vitamin E results in increased expression of TPM2 mRNA
CTD
PMID:19244175
NCBI chr 4:43,513,726...43,523,583
Ensembl chr 4:43,514,711...43,523,765
G
Tpp1
tripeptidyl peptidase I
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TPP1 mRNA Vitamin E results in increased expression of TPP1 mRNA
CTD
PMID:19244175
NCBI chr 7:105,394,018...105,401,489
Ensembl chr 7:105,394,018...105,401,442
G
Tpr
translocated promoter region, nuclear basket protein
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TPR mRNA Vitamin E results in decreased expression of TPR mRNA
CTD
PMID:19244175
NCBI chr 1:150,268,544...150,325,686
Ensembl chr 1:150,268,589...150,325,686
G
Tra2a
transformer 2 alpha
decreases expression increases expression
ISO
Vitamin E results in decreased expression of TRA2A mRNA Vitamin E results in increased expression of TRA2A mRNA
CTD
PMID:19244175
NCBI chr 6:49,220,855...49,241,182
Ensembl chr 6:49,220,858...49,240,967
G
Traf3ip1
TRAF3 interacting protein 1
decreases expression
ISO
Vitamin E results in decreased expression of TRAF3IP1 mRNA
CTD
PMID:19244175
NCBI chr 1:91,422,311...91,457,029
Ensembl chr 1:91,422,369...91,457,029
G
Traf4
TNF receptor associated factor 4
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRAF4 mRNA
CTD
PMID:19244175
NCBI chr11:78,049,249...78,056,405
Ensembl chr11:78,049,325...78,056,415
G
Trafd1
TRAF type zinc finger domain containing 1
increases expression
ISO
Vitamin E results in increased expression of TRAFD1 mRNA
CTD
PMID:19244175
NCBI chr 5:121,509,788...121,524,543
Ensembl chr 5:121,509,788...121,523,695
G
Traj42
T cell receptor alpha joining 42
decreases expression
ISO
Vitamin E results in decreased expression of ZNF10 mRNA
CTD
PMID:19244175
NCBI chr14:54,413,230...54,413,293
Ensembl chr14:54,413,230...54,413,293
G
Traj48
T cell receptor alpha joining 48
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF26 mRNA Vitamin E results in decreased expression of ZNF26 mRNA
CTD
PMID:19244175
NCBI chr14:54,407,265...54,407,325
Ensembl chr14:54,407,265...54,407,325
G
Tram2
translocating chain-associating membrane protein 2
increases expression
ISO
Vitamin E results in increased expression of TRAM2 mRNA
CTD
PMID:19244175
NCBI chr 1:21,071,621...21,149,449
Ensembl chr 1:21,066,523...21,149,453
G
Trappc10
trafficking protein particle complex 10
decreases expression
ISO
Vitamin E results in decreased expression of TRAPPC10 mRNA
CTD
PMID:19244175
NCBI chr10:78,021,256...78,080,479
Ensembl chr10:78,022,559...78,080,475
G
Trappc3
trafficking protein particle complex 3
increases expression
ISO
Vitamin E results in increased expression of TRAPPC3 mRNA
CTD
PMID:19244175
NCBI chr 4:126,156,198...126,169,676
Ensembl chr 4:126,156,118...126,169,676
G
Trappc8
trafficking protein particle complex 8
decreases expression
ISO
Vitamin E results in decreased expression of TRAPPC8 mRNA
CTD
PMID:19244175
NCBI chr18:20,950,268...21,033,851
Ensembl chr18:20,950,280...21,029,150
G
Trex1
three prime repair exonuclease 1
decreases expression
ISO
Vitamin E results in decreased expression of TREX1 mRNA
CTD
PMID:19244175
NCBI chr 9:108,887,000...108,888,791
Ensembl chr 9:108,887,001...108,888,802
G
Trib3
tribbles pseudokinase 3
decreases expression
ISO
Vitamin E results in decreased expression of TRIB3 mRNA
CTD
PMID:19244175
NCBI chr 2:152,179,345...152,185,980
Ensembl chr 2:152,179,342...152,185,952
G
Trim14
tripartite motif-containing 14
decreases expression
ISO
Vitamin E results in decreased expression of TRIM14 mRNA
CTD
PMID:19244175
NCBI chr 4:46,505,072...46,536,148
Ensembl chr 4:46,493,781...46,536,141
G
Trim24
tripartite motif-containing 24
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TRIM24 mRNA Vitamin E results in decreased expression of TRIM24 mRNA
CTD
PMID:19244175
NCBI chr 6:37,846,816...37,945,380
Ensembl chr 6:37,847,746...37,943,231
G
Trim27
tripartite motif-containing 27
decreases expression
ISO
Vitamin E results in decreased expression of TRIM27 mRNA
CTD
PMID:19244175
NCBI chr13:21,363,570...21,378,893
Ensembl chr13:21,363,615...21,378,894
G
Trim29
tripartite motif-containing 29
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRIM29 mRNA
CTD
PMID:19244175
NCBI chr 9:43,222,012...43,247,422
Ensembl chr 9:43,222,145...43,247,412
G
Trim38
tripartite motif-containing 38
decreases expression
ISO
Vitamin E results in decreased expression of TRIM38 mRNA
CTD
PMID:19244175
NCBI chr13:23,962,483...23,975,721
Ensembl chr13:23,953,896...23,975,511
G
Trim44
tripartite motif-containing 44
increases expression
ISO
Vitamin E results in increased expression of TRIM44 mRNA
CTD
PMID:19244175
NCBI chr 2:102,130,464...102,231,541
Ensembl chr 2:102,130,464...102,238,173
G
Trip6
thyroid hormone receptor interactor 6
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TRIP6 mRNA Vitamin E results in increased expression of TRIP6 mRNA
CTD
PMID:19244175
NCBI chr 5:137,308,160...137,312,469
Ensembl chr 5:137,307,916...137,312,666
G
Trit1
tRNA isopentenyltransferase 1
decreases expression
ISO
Vitamin E results in decreased expression of TRIT1 mRNA
CTD
PMID:19244175
NCBI chr 4:122,910,342...122,948,742
Ensembl chr 4:122,910,390...122,948,742
G
Trmt11
tRNA methyltransferase 11
decreases expression
ISO
Vitamin E results in decreased expression of TRMT11 mRNA
CTD
PMID:19244175
NCBI chr10:30,410,218...30,477,598
Ensembl chr10:30,410,221...30,476,745
G
Trmt112
tRNA methyltransferase 11-2
increases expression
ISO
Vitamin E results in increased expression of TRMT112 mRNA
CTD
PMID:19244175
NCBI chr19:6,887,066...6,888,396
Ensembl chr19:6,887,066...6,888,417
G
Trmt12
tRNA methyltransferase 12
increases expression
ISO
Vitamin E results in increased expression of TRMT12 mRNA
CTD
PMID:19244175
NCBI chr15:58,744,498...58,748,630
Ensembl chr15:58,744,523...58,748,976
G
Tro
trophinin
increases expression
ISO
Vitamin E results in increased expression of TRO mRNA
CTD
PMID:19244175
NCBI chr X:149,427,706...149,440,579
Ensembl chr X:149,428,300...149,440,579
G
Trp53
transformation related protein 53
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TP53 mRNA; [Vitamin E co-treated with Curcumin] results in decreased expression of TP53 protein; Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of and results in increased activity of TP53 protein]; Vitamin E inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of TP53 protein] [Vitamin E co-treated with Selenium] inhibits the reaction [Malathion results in increased expression of TP53 mRNA]; Vitamin E inhibits the reaction [cypermethrin results in increased expression of TP53 mRNA]; Vitamin E inhibits the reaction [decamethrin results in increased expression of TP53 mRNA] Vitamin E results in increased expression of TP53 mRNA
CTD
PMID:15837074 PMID:19244175 PMID:21628957 PMID:24664296 PMID:24759048 PMID:25439240 PMID:30935902 More...
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Trpm6
transient receptor potential cation channel, subfamily M, member 6
decreases expression
ISO
Vitamin E results in decreased expression of TRPM6 mRNA
CTD
PMID:19244175
NCBI chr19:18,707,566...18,869,885
Ensembl chr19:18,727,347...18,869,875
G
Tsc2
TSC complex subunit 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TSC2 mRNA Vitamin E results in increased expression of TSC2 mRNA
CTD
PMID:19244175
NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
G
Tsc22d2
TSC22 domain family, member 2
decreases expression
ISO
Vitamin E results in decreased expression of TSC22D2 mRNA
CTD
PMID:19244175
NCBI chr 3:58,322,123...58,374,208
Ensembl chr 3:58,322,136...58,374,204
G
Tshb
thyroid stimulating hormone, beta subunit
multiple interactions
ISO
Vitamin E inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased expression of TSHB protein]
CTD
PMID:16298753
NCBI chr 3:102,684,621...102,718,175
Ensembl chr 3:102,682,781...102,690,034
G
Tslp
thymic stromal lymphopoietin
multiple interactions
EXP
Vitamin E inhibits the reaction [Ozone results in increased expression of TSLP protein]
CTD
PMID:30090343
NCBI chr18:32,948,436...32,952,852
Ensembl chr18:32,948,436...32,952,850
G
Tspan14
tetraspanin 14
increases expression multiple interactions
ISO
Vitamin E results in increased expression of TSPAN14 mRNA [Selenium co-treated with Vitamin E] results in increased expression of TSPAN14 mRNA
CTD
PMID:19244175
NCBI chr14:40,628,384...40,688,835
Ensembl chr14:40,628,402...40,688,764
G
Tsr3
TSR3 20S rRNA accumulation
increases expression
ISO
Vitamin E results in increased expression of TSR3 mRNA
CTD
PMID:19244175
NCBI chr17:25,459,120...25,461,773
Ensembl chr17:25,459,141...25,461,773
G
Ttc17
tetratricopeptide repeat domain 17
decreases expression
ISO
Vitamin E results in decreased expression of TTC17 mRNA
CTD
PMID:19244175
NCBI chr 2:94,131,111...94,237,034
Ensembl chr 2:94,131,112...94,237,034
G
Ttc24
tetratricopeptide repeat domain 24
decreases expression
ISO
Vitamin E results in decreased expression of TTC24 mRNA
CTD
PMID:19244175
NCBI chr 3:87,976,717...87,985,611
Ensembl chr 3:87,977,334...87,982,824 Ensembl chr 3:87,977,334...87,982,824
G
Ttc3
tetratricopeptide repeat domain 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TTC3 mRNA Vitamin E results in decreased expression of TTC3 mRNA
CTD
PMID:19244175
NCBI chr16:94,171,479...94,270,081
Ensembl chr16:94,171,477...94,270,202
G
Ttf1
transcription termination factor, RNA polymerase I
decreases expression
ISO
Vitamin E results in decreased expression of TTF1 mRNA
CTD
PMID:19244175
NCBI chr 2:28,950,211...28,977,668
Ensembl chr 2:28,950,274...28,977,668
G
Ttpa
tocopherol (alpha) transfer protein
decreases abundance affects abundance increases response to substance
ISO EXP
TTPA gene mutant form results in decreased abundance of Vitamin E; TTPA protein mutant form results in decreased abundance of Vitamin E TTPA affects the abundance of Vitamin E TTPA results in increased susceptibility to Vitamin E
CTD
PMID:10896705 PMID:11095717 PMID:15300460 PMID:19566498 PMID:20826775
NCBI chr 4:20,007,889...20,030,823
Ensembl chr 4:20,007,938...20,030,785
G
Tuba1b
tubulin, alpha 1B
increases expression
ISO
Vitamin E results in increased expression of TUBA1B mRNA
CTD
PMID:19244175
NCBI chr15:98,829,310...98,832,271
Ensembl chr15:98,829,306...98,832,446
G
Tuba1c
tubulin, alpha 1C
increases expression
ISO
Vitamin E results in increased expression of TUBA1C mRNA
CTD
PMID:19244175
NCBI chr15:98,927,772...98,935,986
Ensembl chr15:98,927,772...98,935,991
G
Tuba4a
tubulin, alpha 4A
increases expression
ISO
Vitamin E results in increased expression of TUBA4A mRNA
CTD
PMID:19244175
NCBI chr 1:75,190,867...75,197,905
Ensembl chr 1:75,190,872...75,196,509
G
Tubb2b
tubulin, beta 2B class IIB
increases expression
ISO
Vitamin E results in increased expression of TUBB2B mRNA
CTD
PMID:19244175
NCBI chr13:34,310,991...34,314,337
Ensembl chr13:34,310,731...34,314,449
G
Tubb3
tubulin, beta 3 class III
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of TUBB3 mRNA Vitamin E results in increased expression of TUBB3 mRNA
CTD
PMID:19244175
NCBI chr 8:124,138,292...124,148,754
Ensembl chr 8:124,138,163...124,148,754
G
Tubb4b
tubulin, beta 4B class IVB
increases expression
ISO
Vitamin E results in increased expression of TUBB4B mRNA
CTD
PMID:19244175
NCBI chr 2:25,112,170...25,114,714
Ensembl chr 2:25,112,172...25,114,714
G
Tubb5
tubulin, beta 5 class I
increases expression
ISO
Vitamin E results in increased expression of TUBB mRNA
CTD
PMID:19244175
NCBI chr17:36,144,812...36,149,193
Ensembl chr17:36,144,813...36,149,198
G
Tug1
taurine upregulated gene 1
decreases expression
ISO
Vitamin E results in decreased expression of TUG1 mRNA
CTD
PMID:19244175
NCBI chr11:3,589,313...3,599,021
Ensembl chr11:3,589,785...3,599,673
G
Tulp3
TUB like protein 3
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of TULP3 mRNA Vitamin E results in decreased expression of TULP3 mRNA
CTD
PMID:19244175
NCBI chr 6:128,298,103...128,332,833
Ensembl chr 6:128,298,124...128,332,814
G
Txlna
taxilin alpha
increases expression
ISO
Vitamin E results in increased expression of TXLNA mRNA
CTD
PMID:19244175
NCBI chr 4:129,519,870...129,534,867
Ensembl chr 4:129,519,871...129,534,858
G
Tymp
thymidine phosphorylase
increases expression
ISO
Vitamin E results in increased expression of TYMP mRNA
CTD
PMID:19244175
NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
G
U2af1
U2 small nuclear ribonucleoprotein auxiliary factor (U2AF) 1
increases expression
ISO
Vitamin E results in increased expression of U2AF1 mRNA
CTD
PMID:19244175
NCBI chr17:31,866,055...31,878,122
Ensembl chr17:31,866,055...31,877,866
G
Uba1
ubiquitin-like modifier activating enzyme 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of UBA1 mRNA Vitamin E results in increased expression of UBA1 mRNA
CTD
PMID:19244175
NCBI chr X:20,524,660...20,549,420
Ensembl chr X:20,524,565...20,549,418
G
Uba52
ubiquitin A-52 residue ribosomal protein fusion product 1
decreases expression
ISO
Vitamin E results in decreased expression of UBA52 mRNA
CTD
PMID:19244175
NCBI chr 8:70,960,913...70,963,067
Ensembl chr 8:70,960,913...70,963,451
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
Vitamin E results in decreased expression of UBAP2 mRNA
CTD
PMID:19244175
NCBI chr 4:41,194,313...41,276,016
Ensembl chr 4:41,194,313...41,275,144
G
Ubap2l
ubiquitin-associated protein 2-like
increases expression
ISO
Vitamin E results in increased expression of UBAP2L mRNA
CTD
PMID:19244175
NCBI chr 3:89,906,896...89,959,867
Ensembl chr 3:89,907,447...89,959,935
G
Ube2d1
ubiquitin-conjugating enzyme E2D 1
decreases expression
ISO
Vitamin E results in decreased expression of UBE2D1 mRNA
CTD
PMID:19244175
NCBI chr10:71,090,810...71,121,048
Ensembl chr10:71,090,810...71,121,092
G
Ube2l3
ubiquitin-conjugating enzyme E2L 3
increases expression
ISO
Vitamin E results in increased expression of UBE2L3 mRNA
CTD
PMID:19244175
NCBI chr16:16,969,879...17,019,363
Ensembl chr16:16,969,877...17,020,513
G
Ube2v1
ubiquitin-conjugating enzyme E2 variant 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of UBE2V1 mRNA Vitamin E results in decreased expression of UBE2V1 mRNA
CTD
PMID:19244175
NCBI chr 2:167,449,559...167,473,933
Ensembl chr 2:167,449,558...167,474,015
G
Ube2z
ubiquitin-conjugating enzyme E2Z
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of UBE2Z mRNA Vitamin E results in increased expression of UBE2Z mRNA
CTD
PMID:19244175
NCBI chr11:95,938,257...95,956,190
Ensembl chr11:95,938,258...95,956,214
G
Ube3a
ubiquitin protein ligase E3A
decreases expression
ISO
Vitamin E results in decreased expression of UBE3A mRNA
CTD
PMID:19244175
NCBI chr 7:58,871,891...58,960,585
Ensembl chr 7:58,878,498...58,961,284
G
Ube4b
ubiquitination factor E4B
increases expression
ISO
Vitamin E results in increased expression of UBE4B mRNA
CTD
PMID:19244175
NCBI chr 4:149,412,873...149,512,618
Ensembl chr 4:149,412,873...149,511,206
G
Ubl3
ubiquitin-like 3
decreases expression
ISO
Vitamin E results in decreased expression of UBL3 mRNA
CTD
PMID:19244175
NCBI chr 5:148,441,441...148,489,689
Ensembl chr 5:148,441,445...148,489,599
G
Ubl4a
ubiquitin-like 4A
increases expression
ISO
Vitamin E results in increased expression of UBL4A mRNA
CTD
PMID:19244175
NCBI chr X:73,409,324...73,412,154
Ensembl chr X:73,409,324...73,416,824
G
Ubn1
ubinuclein 1
multiple interactions increases expression decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of UBN1 mRNA; [Selenium co-treated with Vitamin E] results in increased expression of UBN1 mRNA Vitamin E results in increased expression of UBN1 mRNA Vitamin E results in decreased expression of UBN1 mRNA
CTD
PMID:19244175
NCBI chr16:4,867,921...4,904,153
Ensembl chr16:4,867,921...4,904,153
G
Ubxn4
UBX domain protein 4
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UBXD2 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UBXD2 mRNA
CTD
PMID:19244175
NCBI chr 1:128,171,635...128,207,115
Ensembl chr 1:128,171,701...128,207,115
G
Uchl1
ubiquitin carboxy-terminal hydrolase L1
increases expression
ISO
Vitamin E results in increased expression of UCHL1 mRNA
CTD
PMID:19244175
NCBI chr 5:66,833,464...66,844,577
Ensembl chr 5:66,833,434...66,844,577
G
Ucp2
uncoupling protein 2 (mitochondrial, proton carrier)
multiple interactions
ISO
Vitamin E inhibits the reaction [Carbon Tetrachloride results in increased expression of UCP2 mRNA]
CTD
PMID:18314881
NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227
G
Ugcg
UDP-glucose ceramide glucosyltransferase
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UGCG mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UGCG mRNA
CTD
PMID:19244175
NCBI chr 4:59,189,452...59,222,833
Ensembl chr 4:59,189,257...59,222,833
G
Uggt2
UDP-glucose glycoprotein glucosyltransferase 2
decreases expression
ISO
Vitamin E results in decreased expression of UGGT2 mRNA
CTD
PMID:19244175
NCBI chr14:119,219,177...119,337,208
Ensembl chr14:119,222,451...119,336,842
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
decreases expression
ISO
Vitamin E results in decreased expression of UGT1A2 mRNA
CTD
PMID:28923436
NCBI chr 1:88,128,333...88,147,724
Ensembl chr 1:88,128,323...88,146,719
G
Ugt1a9
UDP glucuronosyltransferase 1 family, polypeptide A9
decreases expression
ISO
Vitamin E results in decreased expression of UGT1A9 mRNA
CTD
PMID:28923436
NCBI chr 1:87,998,501...88,147,724
Ensembl chr 1:87,998,522...88,146,719
G
Ugt2b1
UDP glucuronosyltransferase 2 family, polypeptide B1
decreases expression
ISO
Vitamin E results in decreased expression of UGT2B4 mRNA
CTD
PMID:28923436
NCBI chr 5:87,064,498...87,074,362
Ensembl chr 5:87,064,497...87,074,389
G
Ugt8a
UDP galactosyltransferase 8A
decreases expression
ISO
Vitamin E results in decreased expression of UGT8 mRNA
CTD
PMID:19244175
NCBI chr 3:125,655,071...125,732,301
Ensembl chr 3:125,658,920...125,732,268
G
Upf3a
UPF3 regulator of nonsense transcripts homolog A (yeast)
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of UPF3A mRNA [Selenium co-treated with Vitamin E] results in decreased expression of UPF3A mRNA
CTD
PMID:19244175
NCBI chr 8:13,834,636...13,848,723
Ensembl chr 8:13,835,615...13,849,193
G
Upf3b
UPF3 regulator of nonsense transcripts homolog B (yeast)
decreases expression
ISO
Vitamin E results in decreased expression of UPF3B mRNA
CTD
PMID:19244175
NCBI chr X:36,355,331...36,374,124
Ensembl chr X:36,355,331...36,373,975
G
Uqcrc1
ubiquinol-cytochrome c reductase core protein 1
increases expression
ISO
Vitamin E results in increased expression of UQCRC1 mRNA
CTD
PMID:19244175
NCBI chr 9:108,765,716...108,778,709
Ensembl chr 9:108,765,701...108,778,691
G
Urod
uroporphyrinogen decarboxylase
increases activity
ISO
Vitamin E results in increased activity of UROD protein
CTD
PMID:12030801
NCBI chr 4:116,847,161...116,851,561
Ensembl chr 4:116,847,162...116,851,610
G
Usf2
upstream transcription factor 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of USF2 mRNA Vitamin E results in increased expression of USF2 mRNA
CTD
PMID:19244175
NCBI chr 7:30,645,421...30,656,288
Ensembl chr 7:30,644,673...30,656,228
G
Usp3
ubiquitin specific peptidase 3
decreases expression
ISO
Vitamin E results in decreased expression of USP3 mRNA
CTD
PMID:19244175
NCBI chr 9:66,421,573...66,501,996
Ensembl chr 9:66,421,919...66,500,424
G
Usp33
ubiquitin specific peptidase 33
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of USP33 mRNA Vitamin E results in decreased expression of USP33 mRNA
CTD
PMID:19244175
NCBI chr 3:152,051,797...152,099,254
Ensembl chr 3:152,052,115...152,099,254
G
Usp4
ubiquitin specific peptidase 4 (proto-oncogene)
decreases expression
ISO
Vitamin E results in decreased expression of USP4 mRNA
CTD
PMID:19244175
NCBI chr 9:108,223,763...108,269,744
Ensembl chr 9:108,225,052...108,269,744
G
Usp47
ubiquitin specific peptidase 47
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of USP47 mRNA Vitamin E results in decreased expression of USP47 mRNA
CTD
PMID:19244175
NCBI chr 7:111,622,692...111,710,591
Ensembl chr 7:111,622,711...111,710,868
G
Usp9x
ubiquitin specific peptidase 9, X chromosome
decreases expression
ISO
Vitamin E results in decreased expression of USP9X mRNA
CTD
PMID:19244175
NCBI chr X:12,937,221...13,039,567
Ensembl chr X:12,937,737...13,039,567
G
Uspl1
ubiquitin specific peptidase like 1
decreases expression
ISO
Vitamin E results in decreased expression of USPL1 mRNA
CTD
PMID:19244175
NCBI chr 5:149,121,338...149,152,246
Ensembl chr 5:149,121,160...149,152,244
G
Utp11
UTP11 small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP11 mRNA
CTD
PMID:19244175
NCBI chr 4:124,571,173...124,587,395
Ensembl chr 4:124,571,953...124,587,393
G
Utp20
UTP20 small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP20 mRNA
CTD
PMID:19244175
NCBI chr10:88,582,469...88,662,676
Ensembl chr10:88,582,469...88,662,666
G
Utp25
UTP25 small subunit processome component
decreases expression
ISO
Vitamin E results in decreased expression of UTP25 mRNA
CTD
PMID:19244175
NCBI chr 1:192,786,707...192,812,603
Ensembl chr 1:192,773,412...192,812,580
G
Vars2
valyl-tRNA synthetase 2, mitochondrial
increases expression
ISO
Vitamin E results in increased expression of VARS2 mRNA
CTD
PMID:19244175
NCBI chr17:35,966,526...35,978,531
Ensembl chr17:35,966,526...35,978,484
G
Vat1
vesicle amine transport 1
increases expression
ISO
Vitamin E results in increased expression of VAT1 mRNA
CTD
PMID:19244175
NCBI chr11:101,349,574...101,357,025
Ensembl chr11:101,349,571...101,357,056
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
[Vitamin E co-treated with Bezafibrate] results in decreased expression of VCAM1 protein modified form; Vitamin E inhibits the reaction [2,3,5-trichloro-6-phenyl-(1,4)benzoquinone results in increased expression of VCAM1 protein]; Vitamin E inhibits the reaction [Simvastatin results in decreased expression of VCAM1 protein modified form]
CTD
PMID:14602771 PMID:35349355
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Vegfa
vascular endothelial growth factor A
multiple interactions decreases expression
ISO EXP
Rutin results in increased susceptibility to [Vitamin E results in decreased expression of VEGFA mRNA]; Rutin results in increased susceptibility to [Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein]; Vitamin E results in decreased secretion of and results in decreased expression of VEGFA protein; Vitamin E results in increased susceptibility to [Rutin results in decreased expression of VEGFA mRNA]; Vitamin E results in increased susceptibility to [Rutin results in decreased secretion of and results in decreased expression of VEGFA protein] Vitamin E inhibits the reaction [Ethanol results in increased activity of VEGFA protein]
CTD
PMID:20015448 PMID:21086752
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vezf1
vascular endothelial zinc finger 1
decreases expression
ISO
Vitamin E results in decreased expression of VEZF1 mRNA
CTD
PMID:19244175
NCBI chr11:87,959,084...87,975,555
Ensembl chr11:87,959,105...87,975,555
G
Vezt
vezatin, adherens junctions transmembrane protein
decreases expression
ISO
Vitamin E results in decreased expression of VEZT mRNA
CTD
PMID:19244175
NCBI chr10:93,797,384...93,871,661
Ensembl chr10:93,775,027...93,871,679
G
Vgf
VGF nerve growth factor inducible
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VGF mRNA
CTD
PMID:19244175
NCBI chr 5:137,054,156...137,062,205
Ensembl chr 5:137,055,246...137,062,205
G
Vgll4
vestigial like family member 4
decreases expression
ISO
Vitamin E results in decreased expression of VGLL4 mRNA
CTD
PMID:19244175
NCBI chr 6:114,836,850...114,946,932
Ensembl chr 6:114,837,589...114,946,955
G
Vipas39
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog
increases expression
ISO
Vitamin E results in increased expression of VIPAS39 mRNA
CTD
PMID:19244175
NCBI chr12:87,285,647...87,313,426
Ensembl chr12:87,285,642...87,313,030
G
Vkorc1
vitamin K epoxide reductase complex, subunit 1
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VKORC1 mRNA Vitamin E results in increased expression of VKORC1 mRNA
CTD
PMID:19244175
NCBI chr 7:127,492,235...127,494,833
Ensembl chr 7:127,485,399...127,494,626 Ensembl chr 7:127,485,399...127,494,626
G
Vps13d
vacuolar protein sorting 13D
increases expression
ISO
Vitamin E results in increased expression of VPS13D mRNA
CTD
PMID:19244175
NCBI chr 4:144,597,619...144,921,598
Ensembl chr 4:144,699,192...144,921,575
G
Vps39
VPS39 HOPS complex subunit
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of VPS39 mRNA Vitamin E results in increased expression of VPS39 mRNA
CTD
PMID:19244175
NCBI chr 2:120,146,942...120,183,618
Ensembl chr 2:120,146,942...120,183,618
G
Vps4a
vacuolar protein sorting 4A
increases expression
ISO
Vitamin E results in increased expression of VPS4A mRNA
CTD
PMID:19244175
NCBI chr 8:107,757,901...107,772,392
Ensembl chr 8:107,757,854...107,772,387
G
Vps72
vacuolar protein sorting 72
increases expression
ISO
Vitamin E results in increased expression of TCFL1 mRNA
CTD
PMID:19244175
NCBI chr 3:95,018,353...95,030,362
Ensembl chr 3:95,018,333...95,030,362
G
Vstm4
V-set and transmembrane domain containing 4
increases expression
ISO
Vitamin E results in increased expression of VSTM4 mRNA
CTD
PMID:19244175
NCBI chr14:32,578,713...32,661,448
Ensembl chr14:32,578,713...32,661,448
G
Vti1b
vesicle transport through interaction with t-SNAREs 1B
increases expression
ISO
Vitamin E results in increased expression of VTI1B mRNA
CTD
PMID:19244175
NCBI chr12:79,202,791...79,219,428
Ensembl chr12:79,202,791...79,219,441
G
Vwf
Von Willebrand factor
increases expression
ISO
Vitamin E results in increased expression of VWF mRNA
CTD
PMID:19244175
NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642
G
Wapl
WAPL cohesin release factor
decreases expression
ISO
Vitamin E results in decreased expression of WAPL mRNA
CTD
PMID:19244175
NCBI chr14:34,394,086...34,469,940
Ensembl chr14:34,395,885...34,469,940
G
Wasf2
WASP family, member 2
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of WASF2 mRNA Vitamin E results in increased expression of WASF2 mRNA
CTD
PMID:19244175
NCBI chr 4:132,857,843...132,927,067
Ensembl chr 4:132,857,816...132,927,067
G
Washc2
WASH complex subunit 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of WASHC2C mRNA Vitamin E results in decreased expression of WASHC2C mRNA
CTD
PMID:19244175
NCBI chr 6:116,184,988...116,239,632
Ensembl chr 6:116,184,999...116,239,647
G
Wbp2
WW domain binding protein 2
increases expression
ISO
Vitamin E results in increased expression of WBP2 mRNA
CTD
PMID:19244175
NCBI chr11:115,969,397...115,977,821
Ensembl chr11:115,969,399...115,977,821
G
Wdr1
WD repeat domain 1
increases expression
ISO
Vitamin E results in increased expression of WDR1 mRNA
CTD
PMID:19244175
NCBI chr 5:38,684,149...38,720,265
Ensembl chr 5:38,684,156...38,720,564
G
Wdr19
WD repeat domain 19
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of WDR19 mRNA Vitamin E results in decreased expression of WDR19 mRNA
CTD
PMID:19244175
NCBI chr 5:65,357,039...65,417,758
Ensembl chr 5:65,357,039...65,417,758
G
Wdr4
WD repeat domain 4
increases expression
ISO
Vitamin E results in increased expression of WDR4 mRNA
CTD
PMID:19244175
NCBI chr17:31,713,296...31,738,946
Ensembl chr17:31,713,296...31,738,954
G
Wdr83os
WD repeat domain 83 opposite strand
increases expression
ISO
Vitamin E results in increased expression of WDR83OS mRNA
CTD
PMID:19244175
NCBI chr 8:85,807,592...85,808,968
Ensembl chr 8:85,807,369...85,808,968
G
Wfdc2
WAP four-disulfide core domain 2
increases expression
ISO
Vitamin E results in increased expression of WFDC2 mRNA
CTD
PMID:19244175
NCBI chr 2:164,404,635...164,410,430
Ensembl chr 2:164,404,333...164,410,430
G
Wipi2
WD repeat domain, phosphoinositide interacting 2
decreases expression
ISO
Vitamin E results in decreased expression of WIPI2 mRNA
CTD
PMID:19244175
NCBI chr 5:142,615,269...142,655,427
Ensembl chr 5:142,613,453...142,656,343
G
Wls
wntless WNT ligand secretion mediator
increases expression
ISO
Vitamin E results in increased expression of WLS mRNA
CTD
PMID:19244175
NCBI chr 3:159,545,287...159,644,302
Ensembl chr 3:159,545,309...159,644,300
G
Wrap53
WD repeat containing, antisense to Trp53
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of WRAP53 mRNA Vitamin E results in increased expression of WRAP53 mRNA
CTD
PMID:19244175
NCBI chr11:69,452,580...69,471,076
Ensembl chr11:69,452,584...69,471,081
G
Wscd1
WSC domain containing 1
decreases expression
ISO
Vitamin E results in decreased expression of WSCD1 mRNA
CTD
PMID:19244175
NCBI chr11:71,640,719...71,680,475
Ensembl chr11:71,640,746...71,680,473
G
Wt1
WT1 transcription factor
affects expression
ISO
Vitamin E affects the expression of WT1 mRNA
CTD
PMID:15370891
NCBI chr 2:104,956,874...105,003,959
Ensembl chr 2:104,956,874...105,003,961
G
Wwp1
WW domain containing E3 ubiquitin protein ligase 1
decreases expression
ISO
Vitamin E results in decreased expression of WWP1 mRNA
CTD
PMID:19244175
NCBI chr 4:19,608,296...19,709,004
Ensembl chr 4:19,608,303...19,708,993
G
Xdh
xanthine dehydrogenase
multiple interactions
ISO
Vitamin E inhibits the reaction [Petroleum results in increased activity of XDH protein]
CTD
PMID:25046308
NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191
G
Xiap
X-linked inhibitor of apoptosis
multiple interactions
ISO
Vitamin E inhibits the reaction [cinnamaldehyde results in decreased expression of XIAP protein]; Vitamin E inhibits the reaction [phenethyl isothiocyanate results in decreased expression of XIAP protein]
CTD
PMID:15566391 PMID:16054126
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
Xkr8
X-linked Kx blood group related 8
increases expression
ISO
Vitamin E results in increased expression of XKR8 mRNA
CTD
PMID:19244175
NCBI chr 4:132,452,212...132,459,916
Ensembl chr 4:132,452,208...132,459,857
G
Xpo6
exportin 6
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of XPO6 mRNA Vitamin E results in decreased expression of XPO6 mRNA
CTD
PMID:19244175
NCBI chr 7:125,700,890...125,799,715
Ensembl chr 7:125,700,887...125,799,673
G
Xrcc2
X-ray repair complementing defective repair in Chinese hamster cells 2
decreases expression
ISO
Vitamin E results in decreased expression of XRCC2 mRNA
CTD
PMID:19244175
NCBI chr 5:25,894,812...25,910,795
Ensembl chr 5:25,894,810...25,910,823
G
Xrcc6
X-ray repair complementing defective repair in Chinese hamster cells 6
increases expression
ISO
Vitamin E results in increased expression of XRCC6 mRNA
CTD
PMID:19244175
NCBI chr15:81,868,805...81,924,286
Ensembl chr15:81,872,036...81,924,286
G
Ybx3
Y box protein 3
decreases expression
ISO
Vitamin E results in decreased expression of YBX3 mRNA
CTD
PMID:19244175
NCBI chr 6:131,341,821...131,365,413
Ensembl chr 6:131,341,818...131,365,439
G
Yipf3
Yip1 domain family, member 3
increases expression
ISO
Vitamin E results in increased expression of YIPF3 mRNA
CTD
PMID:19244175
NCBI chr17:46,559,019...46,563,474
Ensembl chr17:46,559,006...46,563,463
G
Ylpm1
YLP motif containing 1
decreases expression
ISO
Vitamin E results in decreased expression of YLPM1 mRNA
CTD
PMID:19244175
NCBI chr12:85,042,977...85,130,501
Ensembl chr12:85,043,095...85,117,289
G
Ywhae
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide
decreases expression
ISO
Vitamin E results in decreased expression of YWHAE mRNA
CTD
PMID:19244175
NCBI chr11:75,620,121...75,656,667
Ensembl chr11:75,623,695...75,656,671
G
Ywhaz
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of YWHAZ mRNA
CTD
PMID:19244175
NCBI chr15:36,770,505...36,803,228
Ensembl chr15:36,771,014...36,797,173
G
Yy1
YY1 transcription factor
decreases expression
ISO
Vitamin E results in decreased expression of YY1 mRNA
CTD
PMID:19244175
NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074
G
Zbtb11
zinc finger and BTB domain containing 11
decreases expression
ISO
Vitamin E results in decreased expression of ZBTB11 mRNA
CTD
PMID:19244175
NCBI chr16:55,791,820...55,829,276
Ensembl chr16:55,794,246...55,829,276
G
Zbtb18
zinc finger and BTB domain containing 18
increases expression
ISO
Vitamin E results in increased expression of ZBTB18 mRNA
CTD
PMID:19244175
NCBI chr 1:177,269,892...177,278,330
Ensembl chr 1:177,269,917...177,278,330
G
Zbtb20
zinc finger and BTB domain containing 20
decreases expression
ISO
Vitamin E results in decreased expression of ZBTB20 mRNA
CTD
PMID:19244175
NCBI chr16:42,728,008...43,462,981
Ensembl chr16:42,696,244...43,462,965
G
Zc2hc1a
zinc finger, C2HC-type containing 1A
decreases expression
ISO
Vitamin E results in decreased expression of ZC2HC1A mRNA
CTD
PMID:19244175
NCBI chr 3:7,568,475...7,618,908
Ensembl chr 3:7,568,543...7,618,896
G
Zc3h15
zinc finger CCCH-type containing 15
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZC3H15 mRNA Vitamin E results in decreased expression of ZC3H15 mRNA
CTD
PMID:19244175
NCBI chr 2:83,474,922...83,494,961
Ensembl chr 2:83,474,779...83,494,966
G
Zcchc2
zinc finger, CCHC domain containing 2
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZCCHC2 mRNA Vitamin E results in decreased expression of ZCCHC2 mRNA
CTD
PMID:19244175
NCBI chr 1:105,916,929...105,961,807
Ensembl chr 1:105,918,136...105,961,804
G
Zcchc24
zinc finger, CCHC domain containing 24
decreases expression
ISO
Vitamin E results in decreased expression of ZCCHC24 mRNA
CTD
PMID:19244175
NCBI chr14:25,712,068...25,769,496
Ensembl chr14:25,712,066...25,769,463
G
Zcchc8
zinc finger, CCHC domain containing 8
decreases expression
ISO
Vitamin E results in decreased expression of ZCCHC8 mRNA
CTD
PMID:19244175
NCBI chr 5:123,836,365...123,859,107
Ensembl chr 5:123,836,357...123,859,163
G
Zcwpw1
zinc finger, CW type with PWWP domain 1
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ZCWPW1 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZCWPW1 mRNA
CTD
PMID:19244175
NCBI chr 5:137,785,593...137,820,883
Ensembl chr 5:137,786,060...137,820,883
G
Zeb1
zinc finger E-box binding homeobox 1
decreases expression
ISO
Vitamin E results in decreased expression of ZEB1 mRNA
CTD
PMID:19244175
NCBI chr18:5,591,330...5,775,468
Ensembl chr18:5,591,860...5,775,467
G
Zer1
zyg-11 related, cell cycle regulator
increases expression
ISO
Vitamin E results in increased expression of ZER1 mRNA
CTD
PMID:19244175
NCBI chr 2:29,987,295...30,016,299
Ensembl chr 2:29,987,295...30,014,597
G
Zfand5
zinc finger, AN1-type domain 5
decreases expression
ISO
Vitamin E results in decreased expression of ZFAND5 mRNA
CTD
PMID:19244175
NCBI chr19:21,249,150...21,264,204
Ensembl chr19:21,249,642...21,264,204
G
Zfp110
zinc finger protein 110
decreases expression multiple interactions
ISO
Vitamin E results in decreased expression of ZNF274 mRNA [Selenium co-treated with Vitamin E] results in decreased expression of ZNF274 mRNA
CTD
PMID:19244175
NCBI chr 7:12,565,225...12,584,513
Ensembl chr 7:12,568,688...12,584,504
G
Zfp12
zinc finger protein 12
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF12 mRNA Vitamin E results in decreased expression of ZNF12 mRNA
CTD
PMID:19244175
NCBI chr 5:143,220,910...143,233,712
Ensembl chr 5:143,220,918...143,234,589
G
Zfp131
zinc finger protein 131
decreases expression
ISO
Vitamin E results in decreased expression of ZNF131 mRNA
CTD
PMID:19244175
NCBI chr13:120,226,722...120,253,070
Ensembl chr13:120,226,723...120,252,425
G
Zfp148
zinc finger protein 148
decreases expression
ISO
Vitamin E results in decreased expression of ZNF148 mRNA
CTD
PMID:19244175
NCBI chr16:33,201,145...33,324,273
Ensembl chr16:33,201,206...33,324,733
G
Zfp160
zinc finger protein 160
decreases expression
ISO
Vitamin E results in decreased expression of ZNF665 mRNA
CTD
PMID:19244175
NCBI chr17:21,229,203...21,249,119
Ensembl chr17:21,229,165...21,263,332
G
Zfp180
zinc finger protein 180
decreases expression
ISO
Vitamin E results in decreased expression of ZNF180 mRNA
CTD
PMID:19244175
NCBI chr 7:23,781,303...23,807,134
Ensembl chr 7:23,781,349...23,807,138
G
Zfp212
Zinc finger protein 212
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ZNF212 mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZNF212 mRNA
CTD
PMID:19244175
NCBI chr 6:47,897,502...47,909,573
Ensembl chr 6:47,897,410...47,909,573
G
Zfp219
zinc finger protein 219
multiple interactions increases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF219 mRNA Vitamin E results in increased expression of ZNF219 mRNA
CTD
PMID:19244175
NCBI chr14:52,243,532...52,258,597
Ensembl chr14:52,243,534...52,258,190
G
Zfp239
zinc finger protein 239
decreases expression
ISO
Vitamin E results in decreased expression of ZNF239 mRNA
CTD
PMID:19244175
NCBI chr 6:117,838,907...117,849,727
Ensembl chr 6:117,839,061...117,850,252
G
Zfp266
zinc finger protein 266
decreases expression
ISO
Vitamin E results in decreased expression of ZNF562 mRNA
CTD
PMID:19244175
NCBI chr 9:20,406,364...20,432,715
Ensembl chr 9:20,406,364...20,432,713
G
Zfp324
zinc finger protein 324
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF324 mRNA
CTD
PMID:19244175
NCBI chr 7:12,699,765...12,707,749
Ensembl chr 7:12,699,765...12,708,163
G
Zfp358
zinc finger protein 358
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF358 mRNA
CTD
PMID:19244175
NCBI chr 8:3,543,138...3,547,208
Ensembl chr 8:3,543,138...3,547,208
G
Zfp36
zinc finger protein 36
decreases expression
ISO
Vitamin E results in decreased expression of ZFP36 mRNA
CTD
PMID:19244175
NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678
G
Zfp580
zinc finger protein 580
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZNF580 mRNA
CTD
PMID:19244175
NCBI chr 7:5,041,682...5,056,722
Ensembl chr 7:5,054,537...5,056,722
G
Zfp593
zinc finger protein 593
decreases expression
ISO
Vitamin E results in decreased expression of ZNF593 mRNA
CTD
PMID:19244175
NCBI chr 4:133,970,617...133,972,902
Ensembl chr 4:133,970,600...133,972,903
G
Zfp692
zinc finger protein 692
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF692 mRNA Vitamin E results in decreased expression of ZNF692 mRNA
CTD
PMID:19244175
NCBI chr11:58,197,883...58,205,971
Ensembl chr11:58,197,895...58,205,453
G
Zfp709
zinc finger protein 709
decreases expression
ISO
Vitamin E results in decreased expression of ZNF443 mRNA
CTD
PMID:19244175
NCBI chr 8:72,635,912...72,646,409
Ensembl chr 8:72,635,863...72,649,571
G
Zfp768
zinc finger protein 768
increases expression
ISO
Vitamin E results in increased expression of ZNF768 mRNA
CTD
PMID:19244175
NCBI chr 7:126,941,967...126,944,486
Ensembl chr 7:126,941,967...126,944,761
G
Zfp839
zinc finger protein 839
multiple interactions
ISO
[Selenium co-treated with Vitamin E] results in decreased expression of ZNF839 mRNA
CTD
PMID:19244175
NCBI chr12:110,816,686...110,838,346
Ensembl chr12:110,816,687...110,836,430
G
Zkscan1
zinc finger with KRAB and SCAN domains 1
decreases expression
ISO
Vitamin E results in decreased expression of ZKSCAN1 mRNA
CTD
PMID:19244175
NCBI chr 5:138,083,312...138,106,084
Ensembl chr 5:138,083,346...138,106,084
G
Zmym2
zinc finger, MYM-type 2
decreases expression
ISO
Vitamin E results in decreased expression of ZMYM2 mRNA
CTD
PMID:19244175
NCBI chr14:57,123,986...57,199,815
Ensembl chr14:57,124,110...57,200,158
G
Zyx
zyxin
increases expression multiple interactions
ISO
Vitamin E results in increased expression of ZYX mRNA [Selenium co-treated with Vitamin E] results in increased expression of ZYX mRNA
CTD
PMID:19244175
NCBI chr 6:42,326,507...42,337,158
Ensembl chr 6:42,326,564...42,337,147
G
Zzef1
zinc finger, ZZ-type with EF hand domain 1
multiple interactions decreases expression
ISO
[Selenium co-treated with Vitamin E] results in increased expression of ZZEF1 mRNA Vitamin E results in decreased expression of ZZEF1 mRNA
CTD
PMID:19244175
NCBI chr11:72,686,976...72,817,946
Ensembl chr11:72,687,052...72,817,946
G
A930009A15Rik
RIKEN cDNA A930009A15 gene
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [DCD protein results in increased phosphorylation of NFKBIA protein]
CTD
PMID:17532611
NCBI chr10:115,399,555...115,418,359
Ensembl chr10:115,405,891...115,418,353
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [nickel chloride results in increased expression of ABCB1 protein]
CTD
PMID:24448832
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcd1
ATP-binding cassette, sub-family D member 1
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD1 mRNA]
CTD
PMID:29065513
NCBI chr X:72,760,203...72,782,140
Ensembl chr X:72,760,203...72,782,140
G
Abcd3
ATP-binding cassette, sub-family D member 3
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of ABCD3 mRNA]
CTD
PMID:29065513
NCBI chr 3:121,552,553...121,609,851
Ensembl chr 3:121,552,423...121,608,951
G
Acat1
acetyl-Coenzyme A acetyltransferase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [iron(II)-ascorbic acid complex results in decreased activity of ACAT1 protein]
CTD
PMID:10656290
NCBI chr 9:53,491,822...53,521,650
Ensembl chr 9:53,491,822...53,521,682
G
Ache
acetylcholinesterase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Streptozocin results in increased activity of ACHE protein] [alpha-Tocopherol co-treated with Paraoxon] results in decreased activity of ACHE protein; ALB protein inhibits the reaction [alpha-Tocopherol binds to and results in decreased activity of ACHE protein]; alpha-Tocopherol binds to and results in decreased activity of ACHE protein; alpha-Tocopherol promotes the reaction [2-(2-cresyl)-4H-1-3-2-benzodioxaphosphorin-2-oxide results in decreased activity of ACHE protein]
CTD
PMID:19464315 PMID:34506764
NCBI chr 5:137,286,516...137,292,728
Ensembl chr 5:137,285,781...137,292,728
G
Acvrl1
activin A receptor, type II-like 1
increases expression
ISO
alpha-Tocopherol results in increased expression of ACVRL1 mRNA
CTD
PMID:16908007
NCBI chr15:101,026,403...101,043,217
Ensembl chr15:101,026,403...101,043,217
G
Agt
angiotensinogen
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]; alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]
CTD
PMID:17532611
NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445
G
Akr1b1
aldo-keto reductase family 1 member B
increases expression
ISO
alpha-Tocopherol results in increased expression of AKR1B1 mRNA
CTD
PMID:16908007
NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413
G
Akt1
thymoma viral proto-oncogene 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased phosphorylation of and results in decreased activity of AKT1 protein] alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of AKT1 protein]
CTD
PMID:19351882 PMID:22343715
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
G
Alad
aminolevulinate, delta-, dehydratase
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [[Streptozocin results in increased abundance of Blood Glucose] which results in decreased expression of ALAD protein]
CTD
PMID:7728901
NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155
G
Alas1
aminolevulinic acid synthase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of ALAS1 protein]
CTD
PMID:12180188
NCBI chr 9:106,110,654...106,125,153
Ensembl chr 9:106,110,654...106,125,853
G
Alb
albumin
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]; sodium-4,5-dihydroxy-1,3-benzene disulfonate promotes the reaction [alpha-Tocopherol inhibits the reaction [beryllium nitrate results in decreased expression of ALB protein]] [alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in increased secretion of ALB protein; ALB protein inhibits the reaction [alpha-Tocopherol binds to and results in decreased activity of ACHE protein]
CTD
PMID:17429802 PMID:34506764 PMID:36372912
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Ano6
anoctamin 6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of ANO6 mRNA]
CTD
PMID:27886375
NCBI chr15:95,688,724...95,873,353
Ensembl chr15:95,688,724...95,872,632
G
Apex2
apurinic/apyrimidinic endonuclease 2
multiple interactions decreases expression
ISO
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of APEX2 mRNA] alpha-Tocopherol results in decreased expression of APEX2 mRNA
CTD
PMID:26332274
NCBI chr X:149,286,625...149,371,175
Ensembl chr X:149,302,515...149,372,864
G
Apoa1
apolipoprotein A-I
decreases expression decreases activity
ISO
alpha-Tocopherol results in decreased expression of APOA1 mRNA; alpha-Tocopherol results in decreased expression of APOA1 protein alpha-Tocopherol results in decreased activity of APOA1 promoter
CTD
PMID:16423621
NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764
G
Apob
apolipoprotein B
multiple interactions
ISO
alpha-Tocopherol promotes the reaction [APOB protein results in increased reduction of Copper]
CTD
PMID:11368321
NCBI chr12:8,027,629...8,066,839
Ensembl chr12:8,027,648...8,066,835
G
App
amyloid beta precursor protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein]
CTD
PMID:12684028
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Atf2
activating transcription factor 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of ATF2 protein]
CTD
PMID:14645110
NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983
G
Bace1
beta-site APP cleaving enzyme 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Oxygen deficiency results in increased expression of BACE1 mRNA]
CTD
PMID:19196431
NCBI chr 9:45,749,878...45,775,694
Ensembl chr 9:45,749,878...45,775,697
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
alpha-Tocopherol results in increased expression of BAD mRNA
CTD
PMID:26332274
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bax
BCL2-associated X protein
multiple interactions increases expression
ISO
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in increased expression of BAX protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of BAX protein] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of BAX protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of BAX protein] alpha-Tocopherol results in increased expression of BAX mRNA
CTD
PMID:11805214 PMID:26332274 PMID:32134168 PMID:36058301 PMID:38242491
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bche
butyrylcholinesterase
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Endosulfan results in decreased activity of BCHE protein]
CTD
PMID:24299906
NCBI chr 3:73,543,138...73,615,767
Ensembl chr 3:73,543,141...73,615,748
G
Bcl2
B cell leukemia/lymphoma 2
multiple interactions decreases expression
ISO
alpha-Tocopherol affects the reaction [Lipopolysaccharides results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; TNFRSF10B mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein] alpha-Tocopherol analog results in decreased expression of BCL2 mRNA; alpha-Tocopherol analog results in decreased expression of BCL2 protein [alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2 mRNA]; alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of BCL2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of BCL2 protein]
CTD
PMID:11805214 PMID:16005924 PMID:16135673 PMID:20686688 PMID:29297235 PMID:36058301 More...
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
decreases expression multiple interactions
ISO
alpha-Tocopherol results in decreased expression of BCL2L1 protein alpha-Tocopherol inhibits the reaction [Acrylamide results in decreased expression of BCL2L1 protein]
CTD
PMID:18942769 PMID:38242491
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Bdnf
brain derived neurotrophic factor
multiple interactions
EXP
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased expression of BDNF protein]
CTD
PMID:30776390
NCBI chr 2:109,505,045...109,557,388
Ensembl chr 2:109,505,045...109,557,352
G
Bpifb1
BPI fold containing family B, member 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of BPIFB1 protein
CTD
PMID:36372912
NCBI chr 2:154,032,738...154,062,263
Ensembl chr 2:154,032,738...154,062,289
G
Canx
calnexin
affects localization increases expression
ISO
alpha-Tocopherol affects the localization of CANX protein alpha-Tocopherol results in increased expression of CANX mRNA; alpha-Tocopherol results in increased expression of CANX protein
CTD
PMID:16908007
NCBI chr11:50,184,784...50,216,500
Ensembl chr11:50,184,788...50,216,500
G
Casp3
caspase 3
multiple interactions decreases activity
ISO EXP
[alpha-Tocopherol co-treated with beta-ionone] results in increased activity of CASP3 protein; [alpha-Tocopherol co-treated with Tretinoin] results in increased activity of CASP3 protein; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Acetaldehyde results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased cleavage of and results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Vitamin A results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [beta Carotene metabolite results in decreased activity of CASP3 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in increased cleavage of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP3 protein] [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Diclofenac results in increased activity of CASP3 protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of CASP3 protein] alpha-Tocopherol results in decreased activity of CASP3 protein
CTD
PMID:12450566 PMID:14599462 PMID:14722101 PMID:15095415 PMID:17618090 PMID:17874176 PMID:17936189 PMID:21869839 PMID:22389237 PMID:23042730 PMID:29065513 PMID:29129777 PMID:30776390 PMID:31712109 PMID:32134168 PMID:36058301 More...
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp7
caspase 7
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [S-(1,2-dichlorovinyl)cysteine results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [Amiodarone results in increased activity of CASP7 protein]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]
CTD
PMID:23042730 PMID:29129777
NCBI chr19:56,382,640...56,430,780
Ensembl chr19:56,385,561...56,430,776
G
Casp8
caspase 8
increases cleavage
ISO
alpha-Tocopherol analog results in increased cleavage of CASP8 protein
CTD
PMID:20686688
NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662
G
Casp9
caspase 9
increases cleavage multiple interactions
ISO EXP
alpha-Tocopherol analog results in increased cleavage of CASP9 protein alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of CASP9 protein] alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of CASP9 protein] alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of CASP9 protein]; alpha-Tocopherol results in increased cleavage of and results in increased activity of CASP9 protein
CTD
PMID:20686688 PMID:21869839 PMID:31712109 PMID:36058301 PMID:38242491
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
multiple interactions increases activity increases expression
ISO
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of CAT protein]; [Curcumin co-treated with alpha-Tocopherol] inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of CAT protein]; [Sodium Selenite co-treated with alpha-Tocopherol] inhibits the reaction [bisphenol A results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [Copper Sulfate results in decreased activity of CAT protein]; alpha-Tocopherol affects the reaction [flubendiamide results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Camptothecin results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Chlorpyrifos results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [cholestane-3,5,6-triol results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Streptozocin results in decreased expression of CAT protein] alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of and results in decreased activity of CAT protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of CAT mRNA] alpha-Tocopherol results in increased activity of CAT protein alpha-Tocopherol results in increased expression of CAT protein alpha-Tocopherol results in increased expression of CAT mRNA; alpha-Tocopherol results in increased expression of CAT protein
CTD
PMID:9306888 PMID:16979807 PMID:18547560 PMID:19083475 PMID:19464315 PMID:19941068 PMID:20194575 PMID:21322096 PMID:22732938 PMID:25233897 PMID:25304969 PMID:26365763 PMID:27823922 PMID:30057697 PMID:31022331 PMID:36058301 More...
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav1
caveolin 1, caveolae protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Lysophosphatidylcholines results in increased expression of CAV1 mRNA]
CTD
PMID:27257344
NCBI chr 6:17,306,387...17,341,323
Ensembl chr 6:17,306,334...17,341,451
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of CCL2 protein] alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCL2 mRNA]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]
CTD
PMID:19735175 PMID:24333275 PMID:26332274
NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279
G
Ccnd1
cyclin D1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND1 mRNA]
CTD
PMID:26332274
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd2
cyclin D2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CCND2 mRNA]
CTD
PMID:26332274
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Cd36
CD36 molecule
affects expression multiple interactions
ISO
alpha-Tocopherol affects the expression of CD36 mRNA alpha-Tocopherol inhibits the reaction [[troglitazone co-treated with Ethanol] results in increased expression of CD36 protein]
CTD
PMID:16407258
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
multiple interactions decreases expression
ISO
alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of CDKN1A mRNA] alpha-Tocopherol results in decreased expression of CDKN1A mRNA
CTD
PMID:26332274
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cftr
cystic fibrosis transmembrane conductance regulator
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Cadmium results in decreased expression of CFTR protein]
CTD
PMID:20363832
NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767
G
Chat
choline O-acetyltransferase
multiple interactions
ISO
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein; Tobacco Smoke Pollution inhibits the reaction [[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in increased expression of CHAT protein]
CTD
PMID:25891525
NCBI chr14:32,130,160...32,187,866
Ensembl chr14:32,130,160...32,187,946
G
Clcn3
chloride channel, voltage-sensitive 3
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Ozone results in increased expression of CLCN3 mRNA]
CTD
PMID:27886375
NCBI chr 8:61,363,423...61,436,351
Ensembl chr 8:61,363,423...61,436,334
G
Cldn2
claudin 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Potassium Dichromate affects the localization of CLDN2 protein]
CTD
PMID:19766176
NCBI chr X:138,701,552...138,712,135
Ensembl chr X:138,701,577...138,712,135
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CPT1A mRNA]; alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA] alpha-Tocopherol results in increased expression of CPT1A mRNA
CTD
PMID:17936189
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Crabp2
cellular retinoic acid binding protein II
multiple interactions
ISO
[Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 mRNA; [Tretinoin co-treated with alpha-Tocopherol] results in increased expression of CRABP2 protein
CTD
PMID:15225641
NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683
G
Creb1
cAMP responsive element binding protein 1
multiple interactions
EXP
[alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in decreased phosphorylation of CREB1 protein]
CTD
PMID:30776390
NCBI chr 1:64,571,963...64,643,707
Ensembl chr 1:64,571,804...64,643,707
G
Crp
C-reactive protein, pentraxin-related
multiple interactions
ISO
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein
CTD
PMID:18191645
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Cryaa
crystallin, alpha A
increases expression
ISO
alpha-Tocopherol results in increased expression of CRYAA mRNA
CTD
PMID:16908007
NCBI chr17:31,896,905...31,900,704
Ensembl chr17:31,896,781...31,900,707
G
Ctsd
cathepsin D
increases expression
ISO
alpha-Tocopherol results in increased expression of CTSD protein
CTD
PMID:18942769
NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775
G
Cxcl1
C-X-C motif chemokine ligand 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL1 mRNA]
CTD
PMID:24333275
NCBI chr 5:91,039,104...91,040,980
Ensembl chr 5:91,039,100...91,040,974
G
Cxcl15
C-X-C motif chemokine ligand 15
multiple interactions
ISO
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased expression of CXCL8 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of CXCL8 protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]
CTD
PMID:19135038 PMID:25551565 PMID:26270818
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Cxcl2
C-X-C motif chemokine ligand 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL2 mRNA]
CTD
PMID:24333275
NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797
G
Cxcl3
C-X-C motif chemokine ligand 3
multiple interactions
EXP
[alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of CXCL1 mRNA]]
CTD
PMID:29284473
NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression multiple interactions
ISO
alpha-Tocopherol results in increased expression of CYP1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]; alpha-Tocopherol results in increased expression of and results in increased activity of CYP1A1 protein
CTD
PMID:15665910 PMID:22389237
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Cyp1a2
cytochrome P450, family 1, subfamily a, polypeptide 2
increases activity multiple interactions
ISO EXP
alpha-Tocopherol results in increased activity of CYP1A2 protein alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP1A2 mRNA]
CTD
PMID:15665910 PMID:26102010
NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986
G
Cyp2b10
cytochrome P450, family 2, subfamily b, polypeptide 10
decreases expression
EXP
alpha-Tocopherol results in decreased expression of CYP2B10 mRNA
CTD
PMID:26102010
NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049
G
Cyp2b9
cytochrome P450, family 2, subfamily b, polypeptide 9
decreases expression
EXP
alpha-Tocopherol results in decreased expression of CYP2B9 mRNA
CTD
PMID:26102010
NCBI chr 7:25,872,775...25,910,086
Ensembl chr 7:25,872,836...25,910,086
G
Cyp2c29
cytochrome P450, family 2, subfamily c, polypeptide 29
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP2C29 protein]
CTD
PMID:26102010
NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression multiple interactions
ISO
alpha-Tocopherol results in increased expression of CYP2E1 mRNA [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased activity of CYP2E1 protein]; [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP2E1 mRNA]; alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of CYP2E1 mRNA]
CTD
PMID:26332274 PMID:27919644 PMID:28062356
NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
increases expression multiple interactions
EXP ISO
alpha-Tocopherol results in increased expression of CYP3A11; alpha-Tocopherol results in increased expression of CYP3A11 mRNA; alpha-Tocopherol results in increased expression of CYP3A11 protein [Methionine co-treated with Thiamine co-treated with Niacinamide co-treated with alpha-Tocopherol co-treated with Zinc] inhibits the reaction [[Isoniazid co-treated with Rifampin co-treated with Ethambutol co-treated with Pyrazinamide] results in increased expression of CYP3A2 mRNA] alpha-Tocopherol results in increased expression of CYP3A4 mRNA alpha-Tocopherol inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of CYP3A4 mRNA]; Galactosamine inhibits the reaction [alpha-Tocopherol results in increased expression of CYP3A4 mRNA] alpha-Tocopherol inhibits the reaction [[Dietary Fats co-treated with Fructose] results in increased expression of CYP3A11 mRNA]
CTD
PMID:15649653 PMID:16008107 PMID:17936189 PMID:26102010 PMID:27919644 PMID:31102695 More...
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
increases expression multiple interactions
EXP ISO
alpha-Tocopherol results in increased expression of CYP3A13 mRNA; alpha-Tocopherol results in increased expression of CYP3A13 protein alpha-Tocopherol inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]
CTD
PMID:26102010 PMID:31102695
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions increases expression
ISO
alpha-Tocopherol inhibits the reaction [Cadmium Chloride results in increased expression of DDIT3 mRNA] alpha-Tocopherol analog results in increased expression of DDIT3 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]; DDIT3 mRNA affects the reaction [alpha-Tocopherol analog results in decreased expression of BCL2 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased expression of DDIT3 protein]
CTD
PMID:20459685 PMID:20686688
NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157 Ensembl chr10:127,126,643...127,132,157
G
Diablo
diablo, IAP-binding mitochondrial protein
affects localization
EXP
alpha-Tocopherol affects the localization of DIABLO protein
CTD
PMID:15582575
NCBI chr 5:123,649,393...123,664,825
Ensembl chr 5:123,647,828...123,662,239
G
Eif2a
eukaryotic translation initiation factor 2A
increases phosphorylation multiple interactions
ISO
alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of EIF2A protein]
CTD
PMID:20686688
NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Fasl
Fas ligand
increases expression
ISO
alpha-Tocopherol results in increased expression of FASLG mRNA
CTD
PMID:26332274
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fbl
fibrillarin
decreases expression
ISO
alpha-Tocopherol deficiency results in decreased expression of FBL protein
CTD
PMID:15247049
NCBI chr 7:27,868,293...27,878,701
Ensembl chr 7:27,869,135...27,878,694
G
Fmo1
flavin containing monooxygenase 1
increases expression
ISO
alpha-Tocopherol results in increased expression of FMO1 mRNA
CTD
PMID:16908007
NCBI chr 1:162,657,130...162,694,170
Ensembl chr 1:162,657,130...162,694,179
G
Fn1
fibronectin 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in increased expression of and results in increased secretion of FN1 protein]
CTD
PMID:9225831
NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359
G
Fyn
Fyn proto-oncogene
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of FYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of FYN protein]
CTD
PMID:14572611
NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
increases expression
ISO
alpha-Tocopherol results in increased expression of GADD45A mRNA
CTD
PMID:26332274
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLC mRNA
CTD
PMID:24530478
NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767
G
Gclm
glutamate-cysteine ligase, modifier subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA] [alpha-Tocopherol co-treated with Paraquat] results in increased expression of GCLM mRNA
CTD
PMID:22389237 PMID:24530478
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gfap
glial fibrillary acidic protein
increases expression
ISO
alpha-Tocopherol results in increased expression of GFAP protein
CTD
PMID:18942769
NCBI chr11:102,778,162...102,791,368
Ensembl chr11:102,778,162...102,791,738
G
Gnai2
G protein subunit alpha i2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI2 protein]
CTD
PMID:18441196
NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566
G
Gnai3
G protein subunit alpha i3
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of GNAI3 protein]
CTD
PMID:18441196
NCBI chr 3:108,014,591...108,053,468
Ensembl chr 3:108,014,596...108,053,462
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [beryllium nitrate results in increased activity of GPT protein]
CTD
PMID:17429802
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
Gpx1
glutathione peroxidase 1
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of GPX1 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of GPX1 mRNA] [alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ovalbumin promotes the reaction [Ozone results in increased activity of GPX1 protein]]
CTD
PMID:26365763 PMID:29284473 PMID:36058301
NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542
G
Gpx4
glutathione peroxidase 4
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Sodium Selenite results in increased expression of GPX4 mRNA]
CTD
PMID:14642406
NCBI chr10:79,883,000...79,892,273
Ensembl chr10:79,883,000...79,892,273
G
Gsr
glutathione reductase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Camptothecin results in decreased activity of GSR protein]; alpha-Tocopherol inhibits the reaction [Chlorodiphenyl (54% Chlorine) results in decreased activity of GSR protein]
CTD
PMID:16979807 PMID:25304969
NCBI chr 8:34,143,266...34,188,190
Ensembl chr 8:34,142,551...34,188,191
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gstt1
glutathione S-transferase, theta 1
increases expression
ISO
alpha-Tocopherol results in increased expression of GSTT1 protein
CTD
PMID:9855024
NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418
G
Gusb
glucuronidase, beta
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in decreased uptake of GUSB protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of GUSB protein]
CTD
PMID:19135433
NCBI chr 5:130,011,278...130,031,890
Ensembl chr 5:130,017,852...130,031,890
G
Hal
histidine ammonia lyase
increases expression
ISO
alpha-Tocopherol results in increased expression of HAL mRNA
CTD
PMID:16908007
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
multiple interactions
ISO
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in increased activity of HMGCR protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein]
CTD
PMID:19595682 PMID:21535577
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hmox1
heme oxygenase 1
affects expression multiple interactions
ISO
alpha-Tocopherol affects the expression of HMOX1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Paraquat results in increased activity of HMOX1 protein] alpha-Tocopherol inhibits the reaction [benzo(a)pyrene-7,8-dione results in increased expression of HMOX1 protein]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of HMOX1 protein]
CTD
PMID:8743975 PMID:12180188 PMID:22053912 PMID:22389237 PMID:36058301
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Hp
haptoglobin
affects activity multiple interactions
ISO EXP
alpha-Tocopherol affects the activity of HP protein polymorphism Ascorbic Acid inhibits the reaction [alpha-Tocopherol affects the activity of HP protein polymorphism]
CTD
PMID:19769483
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hsd17b3
hydroxysteroid (17-beta) dehydrogenase 3
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of HSD17B3 mRNA]
CTD
PMID:32134168
NCBI chr13:64,206,088...64,237,076
Ensembl chr13:64,206,080...64,237,044
G
Hspa1b
heat shock protein 1B
increases expression
ISO
alpha-Tocopherol results in increased expression of HSPA1B mRNA
CTD
PMID:16908007
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Icam1
intercellular adhesion molecule 1
multiple interactions
ISO
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of ICAM1 protein]
CTD
PMID:22313677 PMID:25551565
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifng
interferon gamma
multiple interactions
ISO EXP
[alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IFNG mRNA; alpha-Tocopherol results in decreased susceptibility to [IFNG protein co-treated with lipopolysaccharide, Escherichia coli O111 B4] alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IFNG protein]]
CTD
PMID:16307444 PMID:24333275 PMID:29284473
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Igfbp5
insulin-like growth factor binding protein 5
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of IGFBP5 mRNA
CTD
PMID:23859036
NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043
G
Ikbkb
inhibitor of kappaB kinase beta
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased phosphorylation of IKBKB protein]
CTD
PMID:34310962
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Il10
interleukin 10
multiple interactions
ISO
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] [alpha-Tocopherol co-treated with Lipopolysaccharides] results in increased expression of IL10 mRNA
CTD
PMID:24333275 PMID:25551565
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il13
interleukin 13
multiple interactions
EXP
[alpha-Tocopherol co-treated with SB 239063] inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL13 protein]]
CTD
PMID:29284473
NCBI chr11:53,522,150...53,525,529
Ensembl chr11:53,522,151...53,525,529
G
Il17a
interleukin 17A
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL17A mRNA]]
CTD
PMID:29284473
NCBI chr 1:20,801,129...20,804,720
Ensembl chr 1:20,801,129...20,804,720
G
Il1a
interleukin 1 alpha
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of IL1A protein]
CTD
PMID:15025948
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of IL1B protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of IL1B mRNA] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of IL1B protein]; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of IL1B mRNA]
CTD
PMID:19135433 PMID:19735175 PMID:26332274 PMID:31712109 PMID:38242491
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il5
interleukin 5
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL5 mRNA]]
CTD
PMID:29284473
NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933
G
Il6
interleukin 6
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of and results in increased secretion of IL6 protein] alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of IL6 protein] alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein]; alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of IL6 protein]]
CTD
PMID:15630180 PMID:24296301 PMID:29284473 PMID:32134168
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Ins1
insulin I
multiple interactions
ISO
[Lutein co-treated with alpha-Tocopherol] results in decreased expression of INS1 protein
CTD
PMID:12949374
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Jun
jun proto-oncogene
multiple interactions increases expression
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased phosphorylation of JUN protein] alpha-Tocopherol results in increased expression of JUN mRNA; alpha-Tocopherol results in increased expression of JUN protein
CTD
PMID:14645110 PMID:19000923 PMID:20025956
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kcnh2
potassium voltage-gated channel, subfamily H (eag-related), member 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Glucose results in decreased activity of KCNH2 protein]
CTD
PMID:12531891
NCBI chr 5:24,524,583...24,556,671
Ensembl chr 5:24,524,587...24,556,602
G
Keap1
kelch-like ECH-associated protein 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of KEAP1 protein]
CTD
PMID:36058301
NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
ISO
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Cadmium results in decreased activity of LCAT protein]; [Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]
CTD
PMID:19595682 PMID:21535577
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lck
lymphocyte protein tyrosine kinase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LCK protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LCK protein]
CTD
PMID:14572611
NCBI chr 4:129,442,142...129,467,415
Ensembl chr 4:129,442,137...129,467,434
G
Ldha
lactate dehydrogenase A
multiple interactions
ISO
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHA protein] [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased secretion of LDHA protein]
CTD
PMID:21322096 PMID:26270818
NCBI chr 7:46,491,698...46,505,051
Ensembl chr 7:46,490,899...46,505,051
G
Ldhb
lactate dehydrogenase B
multiple interactions
ISO
[Quercetin co-treated with alpha-Tocopherol] inhibits the reaction [Isoproterenol results in increased expression of LDHB protein]
CTD
PMID:21322096
NCBI chr 6:142,435,975...142,453,683
Ensembl chr 6:142,435,975...142,453,683
G
Lgals3bp
lectin, galactoside-binding, soluble, 3 binding protein
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of LGALS3BP protein
CTD
PMID:36372912
NCBI chr11:118,283,573...118,292,787
Ensembl chr11:118,283,577...118,292,918
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [bis(2-hydroxy-2-ethylbutanoato)oxochromate(V) results in increased phosphorylation of LYN protein]; alpha-Tocopherol inhibits the reaction [Potassium Dichromate results in increased phosphorylation of LYN protein]
CTD
PMID:14572611
NCBI chr 4:3,676,865...3,791,613
Ensembl chr 4:3,678,115...3,813,122
G
Mapk1
mitogen-activated protein kinase 1
multiple interactions affects activity
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK1 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK1 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK1 protein] [alpha-Tocopherol affects the activity of MAPK1 protein] which results in decreased susceptibility to Potassium Dichromate
CTD
PMID:17011908 PMID:19766176 PMID:30776390
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
multiple interactions
ISO EXP
alpha-Tocopherol inhibits the reaction [[4-hydroxy-2-nonenal co-treated with Hydrogen Peroxide] results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK14 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK14 protein] alpha-Tocopherol inhibits the reaction [[Ovalbumin co-treated with Ozone] results in increased phosphorylation of MAPK14 protein]
CTD
PMID:12684028 PMID:14645110 PMID:29284473
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk3
mitogen-activated protein kinase 3
multiple interactions affects activity
ISO EXP
alpha-Tocopherol inhibits the reaction [Tamoxifen results in decreased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK3 protein] [Nimodipine co-treated with alpha-Tocopherol] inhibits the reaction [Dibutyl Phthalate results in increased expression of and results in increased phosphorylation of MAPK3 protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of MAPK3 protein] [alpha-Tocopherol affects the activity of MAPK3 protein] which results in decreased susceptibility to Potassium Dichromate
CTD
PMID:14645110 PMID:17011908 PMID:19766176 PMID:30776390
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
alpha-Tocopherol inhibits the reaction [APP protein results in increased activity of MAPK8 protein]; alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased activity of MAPK8 protein]; benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK8 protein]
CTD
PMID:12684028 PMID:14645110 PMID:20686688
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mapk9
mitogen-activated protein kinase 9
increases phosphorylation multiple interactions
ISO
alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]; salubrinal inhibits the reaction [alpha-Tocopherol analog results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20686688
NCBI chr11:49,737,558...49,777,248
Ensembl chr11:49,737,578...49,777,248
G
Mb
myoglobin
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [MB modified form results in decreased secretion of very low density lipoprotein triglyceride]
CTD
PMID:17478120
NCBI chr15:76,899,687...76,934,868
Ensembl chr15:76,899,687...76,934,870
G
Mbp
myelin basic protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased expression of MBP protein]
CTD
PMID:14645110
NCBI chr18:82,492,883...82,603,762
Ensembl chr18:82,493,271...82,603,762
G
Mgat3
mannoside acetylglucosaminyltransferase 3
increases expression
ISO
alpha-Tocopherol results in increased expression of MGAT3 mRNA
CTD
PMID:16908007
NCBI chr15:80,057,852...80,099,720
Ensembl chr15:80,057,922...80,099,720
G
Mki67
antigen identified by monoclonal antibody Ki 67
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of MKI67 mRNA
CTD
PMID:23859036
NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090
G
Mpo
myeloperoxidase
multiple interactions
ISO
[Ascorbic Acid co-treated with beta Carotene co-treated with alpha-Tocopherol co-treated with Sodium Selenite] inhibits the reaction [Galactosamine results in increased activity of MPO protein]
CTD
PMID:31022331
NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239
G
Muc4
mucin 4
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of MUC4 protein
CTD
PMID:36372912
NCBI chr16:32,555,089...32,602,786
Ensembl chr16:32,555,015...32,602,754
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of MUC5AC mRNA]
CTD
PMID:24333275
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Myc
myelocytomatosis oncogene
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [mancozeb results in decreased expression of MYC protein]
CTD
PMID:16005924
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Nefh
neurofilament, heavy polypeptide
increases expression
ISO
alpha-Tocopherol results in increased expression of NEFH protein modified form
CTD
PMID:18942769
NCBI chr11:4,888,754...4,898,064
Ensembl chr11:4,888,754...4,898,064
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]; [alpha-Tocopherol co-treated with Hydrogen Peroxide] affects the localization of NFE2L2 protein; alpha-Tocopherol inhibits the reaction [Arsenic Trioxide results in decreased expression of NFE2L2 mRNA]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of NFE2L2 protein] [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] promotes the reaction [[Ozone co-treated with Oxygen] results in increased localization of NFE2L2 protein]; alpha-Tocopherol promotes the reaction [Hydrogen Peroxide affects the localization of NFE2L2 protein]
CTD
PMID:22389237 PMID:26270818 PMID:29297235 PMID:31412289 PMID:32134168 PMID:36058301 More...
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkb1
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105
multiple interactions increases activity
ISO
alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of NFKB1 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [NFKB1 protein binds to NFKB1 protein]]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol results in increased activity of NFKB1 protein
CTD
PMID:15025948 PMID:16135673 PMID:17936189 PMID:19083475
NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [AGT protein results in increased phosphorylation of NFKBIA protein]; alpha-Tocopherol inhibits the reaction [DCD protein results in increased phosphorylation of NFKBIA protein] [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased phosphorylation of NFKBIA protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased phosphorylation of NFKBIA protein]
CTD
PMID:16135673 PMID:17532611 PMID:25551565 PMID:38242491
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP ISO
alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased expression of NOS2 protein] alpha-Tocopherol inhibits the reaction [Galactosamine results in increased expression of NOS2 mRNA]
CTD
PMID:17936189 PMID:19135433
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nos3
nitric oxide synthase 3, endothelial cell
increases expression
ISO
alpha-Tocopherol results in increased expression of NOS3 mRNA; alpha-Tocopherol results in increased expression of NOS3 protein
CTD
PMID:16949522
NCBI chr 5:24,569,772...24,589,472
Ensembl chr 5:24,569,808...24,589,472
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein] alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NQO1 protein]
CTD
PMID:22389237 PMID:36058301
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
alpha-Tocopherol promotes the reaction [NR1I2 results in increased expression of CPT1A mRNA]
CTD
PMID:17936189
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Ogdh
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide)
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [sodium arsenite results in decreased activity of OGDH protein]
CTD
PMID:12915223
NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642
G
Orm1
orosomucoid 1
increases expression
EXP
alpha-Tocopherol results in increased expression of ORM1 mRNA; alpha-Tocopherol results in increased expression of ORM1 protein
CTD
PMID:19000923 PMID:20025956
NCBI chr 4:63,262,793...63,266,400
Ensembl chr 4:63,262,797...63,266,400
G
Park7
Parkinson disease (autosomal recessive, early onset) 7
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Rotenone affects the localization of PARK7 protein]
CTD
PMID:16439141
NCBI chr 4:150,981,590...150,994,378
Ensembl chr 4:150,981,590...150,998,894
G
Parp1
poly (ADP-ribose) polymerase family, member 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Tamoxifen results in increased cleavage of PARP1 protein] alpha-Tocopherol inhibits the reaction [nickel chloride results in increased cleavage of PARP1 protein]
CTD
PMID:14645110 PMID:24448832
NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819
G
Pawr
PRKC, apoptosis, WT1, regulator
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR mRNA]; alpha-Tocopherol inhibits the reaction [Nerve Growth Factors deficiency results in increased expression of PAWR protein]
CTD
PMID:10428045
NCBI chr10:108,168,050...108,250,708
Ensembl chr10:108,167,982...108,250,101
G
Pax3
paired box 3
multiple interactions increases expression
EXP
alpha-Tocopherol inhibits the reaction [Glucose results in decreased expression of PAX3 mRNA] alpha-Tocopherol results in increased expression of PAX3 mRNA
CTD
PMID:12739027
NCBI chr 1:78,077,904...78,173,773
Ensembl chr 1:78,077,904...78,173,771
G
Pck1
phosphoenolpyruvate carboxykinase 1, cytosolic
decreases expression
ISO
alpha-Tocopherol results in decreased expression of PCK1 mRNA
CTD
PMID:11597575
NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB mRNA; [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of PDGFRB protein
CTD
PMID:23859036
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pgk1
phosphoglycerate kinase 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of PGK1 protein]
CTD
PMID:18603805
NCBI chr X:105,230,706...105,247,305
Ensembl chr X:105,230,706...105,247,305
G
Plg
plasminogen
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Arsenic promotes the reaction [Humic Substances results in decreased activity of PLG protein]]; alpha-Tocopherol inhibits the reaction [Humic Substances results in decreased activity of PLG protein]
CTD
PMID:11419606
NCBI chr17:12,597,496...12,638,271
Ensembl chr17:12,597,495...12,638,272
G
Pltp
phospholipid transfer protein
decreases abundance
EXP
PLTP mutant form results in decreased abundance of alpha-Tocopherol
CTD
PMID:16675720
NCBI chr 2:164,681,441...164,699,564
Ensembl chr 2:164,681,438...164,699,631
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions increases expression
ISO EXP
alpha-Tocopherol inhibits the reaction [Galactosamine results in decreased expression of PPARA mRNA] alpha-Tocopherol inhibits the reaction [7-ketocholesterol results in decreased expression of PPARA mRNA] alpha-Tocopherol results in increased expression of PPARA mRNA
CTD
PMID:17936189 PMID:29065513
NCBI chr15:85,619,112...85,691,052
Ensembl chr15:85,619,184...85,687,020
G
Pparg
peroxisome proliferator activated receptor gamma
increases expression multiple interactions increases activity
ISO
alpha-Tocopherol results in increased expression of PPARG mRNA; alpha-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein] alpha-Tocopherol results in increased activity of PPARG protein
CTD
PMID:11752099 PMID:14521714 PMID:19083475 PMID:22389237 PMID:28062356
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppia
peptidylprolyl isomerase A
increases expression
ISO
alpha-Tocopherol results in increased expression of PPIA mRNA
CTD
PMID:16908007
NCBI chr11:6,365,867...6,369,817
Ensembl chr11:6,365,443...6,369,817
G
Prl2c3
prolactin family 2, subfamily c, member 3
increases expression
EXP
alpha-Tocopherol results in increased expression of PRL2C3 protein
CTD
PMID:20025956
NCBI chr13:12,805,705...12,814,982
Ensembl chr13:12,805,705...12,814,968
G
Psmc6
proteasome (prosome, macropain) 26S subunit, ATPase, 6
multiple interactions
EXP
alpha-Tocopherol inhibits the reaction [AGT protein results in increased expression of PSMC6 protein]
CTD
PMID:17532611
NCBI chr14:45,567,285...45,587,150
Ensembl chr14:45,567,245...45,587,162
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity multiple interactions
ISO
alpha-Tocopherol metabolite results in decreased activity of PTGS2 protein; alpha-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:15225597 PMID:22389237
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
affects localization multiple interactions
ISO
alpha-Tocopherol affects the localization of RELA protein [Ascorbic Acid co-treated with alpha-Tocopherol co-treated with ferulic acid] inhibits the reaction [[Ozone co-treated with Oxygen] results in increased localization of RELA protein]; alpha-Tocopherol affects the reaction [[manganese chloride results in increased abundance of Manganese] which affects the localization of RELA protein]; alpha-Tocopherol inhibits the reaction [Galactosamine results in increased activity of [RELA protein binds to NFKB1 protein]] alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased activity of RELA protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased activity of [NFKB1 protein binds to RELA protein]]
CTD
PMID:15025948 PMID:16135673 PMID:16882165 PMID:17936189 PMID:26270818 PMID:34310962 More...
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rps6
ribosomal protein S6
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [28-O-acetylbetulin-3-ylglucopyranoside results in decreased phosphorylation of RPS6 protein]
CTD
PMID:22343715
NCBI chr 4:86,772,336...86,775,604
Ensembl chr 4:86,772,897...86,775,649
G
Rxra
retinoid X receptor alpha
multiple interactions
ISO
[Tretinoin co-treated with alpha-Tocopherol co-treated with Okadaic Acid] results in decreased phosphorylation of RXRA protein; [Tretinoin co-treated with alpha-Tocopherol] results in decreased phosphorylation of RXRA protein
CTD
PMID:15225641
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Sele
selectin, endothelial cell
multiple interactions
ISO
[Ascorbic Acid co-treated with lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of SELE protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA]
CTD
PMID:12566129 PMID:25551565
NCBI chr 1:163,867,200...163,886,056
Ensembl chr 1:163,875,773...163,885,246
G
Slc1a2
solute carrier family 1 (glial high affinity glutamate transporter), member 2
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 mRNA]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in decreased expression of SLC1A2 protein]
CTD
PMID:34310962
NCBI chr 2:102,488,584...102,621,129
Ensembl chr 2:102,489,004...102,621,129
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
multiple interactions
ISO
[alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 mRNA; [alpha-Tocopherol co-treated with Paraquat] results in increased expression of SLC7A11 protein
CTD
PMID:24530478
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Slpi
secretory leukocyte peptidase inhibitor
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in decreased secretion of SLPI protein
CTD
PMID:36372912
NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015
G
Smad4
SMAD family member 4
multiple interactions
ISO
SMAD4 results in decreased susceptibility to [Fluorouracil co-treated with alpha-Tocopherol]
CTD
PMID:20562578
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Snca
synuclein, alpha
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Rotenone results in increased expression of SNCA protein]
CTD
PMID:16439141
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sod1
superoxide dismutase 1, soluble
multiple interactions increases expression
ISO
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of SOD1 protein]; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD1 protein] alpha-Tocopherol inhibits the reaction [Hexachlorobenzene results in increased activity of SOD1 protein] alpha-Tocopherol results in increased expression of SOD1 mRNA; alpha-Tocopherol results in increased expression of SOD1 protein
CTD
PMID:19083475 PMID:20194575 PMID:21344382 PMID:22732938 PMID:26365763
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sod2
superoxide dismutase 2, mitochondrial
decreases expression increases expression multiple interactions
ISO
alpha-Tocopherol results in decreased expression of SOD2 protein alpha-Tocopherol results in increased expression of SOD2 mRNA; alpha-Tocopherol results in increased expression of SOD2 protein [alpha-Tocopherol co-treated with beta Carotene co-treated with Ascorbic Acid co-treated with Zinc co-treated with Sodium Selenite] results in decreased expression of SOD2 mRNA; alpha-Tocopherol inhibits the reaction [Malathion results in increased activity of SOD2 protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased expression of and results in increased activity of SOD2 protein]
CTD
PMID:16135673 PMID:18942769 PMID:20194575 PMID:22732938 PMID:23859036
NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950
G
Srsf2
serine and arginine-rich splicing factor 2
decreases expression
ISO
alpha-Tocopherol deficiency results in decreased expression of SRSF2 protein
CTD
PMID:15247049
NCBI chr11:116,740,723...116,744,511
Ensembl chr11:116,740,727...116,743,920
G
Star
steroidogenic acute regulatory protein
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in decreased expression of STAR mRNA]
CTD
PMID:32134168
NCBI chr 8:26,298,502...26,306,010
Ensembl chr 8:26,296,583...26,306,010
G
Stat3
signal transducer and activator of transcription 3
increases expression
ISO
alpha-Tocopherol results in increased expression of STAT3 mRNA
CTD
PMID:16908007
NCBI chr11:100,777,632...100,830,447
Ensembl chr11:100,775,924...100,830,366
G
Tert
telomerase reverse transcriptase
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in decreased activity of TERT protein]
CTD
PMID:20112180
NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962
G
Tgfa
transforming growth factor alpha
decreases response to substance
ISO
alpha-Tocopherol results in decreased susceptibility to TGFA protein
CTD
PMID:7593635
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
G
Tgfb1
transforming growth factor, beta 1
multiple interactions decreases expression
ISO
alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of TGFB1 protein]; alpha-Tocopherol inhibits the reaction [TGFB1 protein results in increased abundance of Reactive Oxygen Species] alpha-Tocopherol results in decreased expression of TGFB1 mRNA
CTD
PMID:9608545 PMID:14732287 PMID:38242491
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Th
tyrosine hydroxylase
multiple interactions
ISO
[Ascorbic Acid co-treated with alpha-Tocopherol co-treated with Acetylcysteine] results in decreased expression of TH protein; alpha-Tocopherol inhibits the reaction [Rotenone results in decreased expression of TH protein]
CTD
PMID:15790535 PMID:25891525
NCBI chr 7:142,446,516...142,453,732
Ensembl chr 7:142,446,489...142,484,865
G
Tnf
tumor necrosis factor
multiple interactions affects expression decreases response to substance decreases expression
ISO EXP
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; [Ascorbic Acid co-treated with Lycopene co-treated with alpha-Tocopherol] promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased abundance of Reactive Oxygen Species]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of CXCL8 protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of CXCL8 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of NFKBIA mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of SELE mRNA]; alpha-Tocopherol inhibits the reaction [TNF protein results in increased expression of TNF mRNA]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP3 protein]]; alpha-Tocopherol promotes the reaction [TNF protein promotes the reaction [Amiodarone results in increased activity of CASP7 protein]]; alpha-Tocopherol promotes the reaction [TNF protein results in increased expression of and results in increased secretion of IL10 protein] alpha-Tocopherol inhibits the reaction [Acrylamide results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Acrylonitrile results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF mRNA]; alpha-Tocopherol inhibits the reaction [Hexachlorocyclohexane results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Mercuric Chloride results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Triiodothyronine, Reverse results in increased secretion of TNF protein] alpha-Tocopherol affects the expression of TNF protein alpha-Tocopherol results in decreased susceptibility to TNF protein [alpha-Tocopherol co-treated with Nimodipine] inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [cumene hydroperoxide results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Dibutyl Phthalate results in increased expression of TNF protein]; alpha-Tocopherol inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; alpha-Tocopherol inhibits the reaction [Ozone promotes the reaction [Ovalbumin results in increased expression of TNF mRNA]]; alpha-Tocopherol inhibits the reaction [Vitamin E deficiency results in increased expression of TNF mRNA] alpha-Tocopherol results in decreased expression of TNF protein
CTD
PMID:10588948 PMID:11805214 PMID:12195823 PMID:15025948 PMID:15630180 PMID:16135673 PMID:16750838 PMID:18191645 PMID:19135038 PMID:19135433 PMID:19735175 PMID:23042730 PMID:25551565 PMID:26332274 PMID:29284473 PMID:30776390 PMID:31712109 PMID:32134168 PMID:34310962 PMID:38242491 More...
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Trf
transferrin
multiple interactions
ISO
[alpha-Tocopherol co-treated with hempseed oil co-treated with Glycerol co-treated with Propylene Glycol] results in increased secretion of TF protein
CTD
PMID:36372912
NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643
G
Trp53
transformation related protein 53
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 mRNA]; alpha-Tocopherol inhibits the reaction [arsenite results in increased expression of TP53 protein]
CTD
PMID:12126965
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Txn1
thioredoxin 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with Ascorbic Acid] inhibits the reaction [arsenite results in increased expression of TXN1 protein]
CTD
PMID:21344382
NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [Hydrogen Peroxide results in increased expression of VCAM1 protein]; alpha-Tocopherol inhibits the reaction [Vehicle Emissions results in increased expression of VCAM1 protein]
CTD
PMID:12566129 PMID:22313677
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Xbp1
X-box binding protein 1
increases expression
ISO
alpha-Tocopherol analog results in increased expression of XBP1 mRNA
CTD
PMID:20686688
NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893
G
Xrcc6
X-ray repair complementing defective repair in Chinese hamster cells 6
multiple interactions
ISO
alpha-Tocopherol promotes the reaction [Acrylonitrile results in increased expression of XRCC6 mRNA]
CTD
PMID:26332274
NCBI chr15:81,868,805...81,924,286
Ensembl chr15:81,872,036...81,924,286
G
Yy1
YY1 transcription factor
multiple interactions
ISO
alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 mRNA]; alpha-Tocopherol inhibits the reaction [[manganese chloride results in increased abundance of Manganese] which results in increased expression of YY1 protein]
CTD
PMID:34310962
NCBI chr12:108,758,841...108,786,074
Ensembl chr12:108,758,899...108,786,074
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
increases expression
ISO
tocotrienol, alpha results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
multiple interactions increases expression
ISO
tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, alpha results in increased expression of CYP3A4
CTD
PMID:15269186 PMID:31102695
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
multiple interactions affects response to substance
ISO
tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, alpha inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid] CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, alpha
CTD
PMID:31102695
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
GSTM1 gene polymorphism affects the susceptibility to [Ascorbic Acid co-treated with tocotrienol, alpha]
CTD
PMID:15668500
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, alpha binds to and results in increased activity of NR1I2 protein; tocotrienol, alpha inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression
ISO
tocotrienol, alpha results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Casp3
caspase 3
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] beta-Tocopherol affects the reaction [7-ketocholesterol results in increased activity of CASP3 protein]; beta-Tocopherol affects the reaction [cholest-5-en-3 beta,7 alpha-diol results in increased activity of CASP3 protein]
CTD
PMID:12450566 PMID:22389237
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Gclm
glutamate-cysteine ligase, modifier subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:22389237
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:22389237
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:22389237
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:22389237
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
increases expression
ISO
tocotrienol, beta results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
increases expression
ISO
tocotrienol, beta results in increased expression of CYP3A4
CTD
PMID:15269186
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, beta binds to and results in increased activity of NR1I2 protein; tocotrienol, beta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression
ISO
tocotrienol, beta results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Abcg8
ATP binding cassette subfamily G member 8
affects expression
ISO
Corn Oil affects the expression of ABCG8 mRNA
CTD
PMID:16360708
NCBI chr17:84,983,730...85,007,761
Ensembl chr17:84,983,730...85,007,761
G
Acaca
acetyl-Coenzyme A carboxylase alpha
increases expression
ISO
Corn Oil results in increased expression of ACACA mRNA
CTD
PMID:1973097
NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477
G
Acly
ATP citrate lyase
affects expression
ISO
Corn Oil affects the expression of ACLY mRNA
CTD
PMID:16360708
NCBI chr11:100,367,178...100,418,826
Ensembl chr11:100,367,179...100,418,826
G
Acot2
acyl-CoA thioesterase 2
affects expression
ISO
Corn Oil affects the expression of ACOT2 mRNA
CTD
PMID:16360708
NCBI chr12:84,034,635...84,040,651
Ensembl chr12:84,034,635...84,040,647
G
Adipoq
adiponectin, C1Q and collagen domain containing
multiple interactions
ISO
Corn Oil promotes the reaction [Glucose results in increased expression of ADIPOQ protein]
CTD
PMID:29165388
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Akr1b7
aldo-keto reductase family 1, member B7
affects expression
ISO
Corn Oil affects the expression of AKR1B7 mRNA
CTD
PMID:16360708
NCBI chr 6:34,389,297...34,400,072
Ensembl chr 6:34,389,269...34,400,077
G
Aldh1a1
aldehyde dehydrogenase family 1, subfamily A1
affects expression
ISO
Corn Oil affects the expression of ALDH1A1 mRNA
CTD
PMID:16360708
NCBI chr19:20,469,947...20,620,827
Ensembl chr19:20,470,079...20,620,829
G
Angptl4
angiopoietin-like 4
affects expression
ISO
Corn Oil affects the expression of ANGPTL4 mRNA
CTD
PMID:16360708
NCBI chr17:33,993,874...34,000,549
Ensembl chr17:33,992,724...34,000,804
G
Areg
amphiregulin
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of AREG mRNA
CTD
PMID:32186404
NCBI chr 5:91,287,458...91,296,291
Ensembl chr 5:91,287,458...91,296,291
G
Bad
BCL2-associated agonist of cell death
increases expression
ISO
Corn Oil results in increased expression of BAD mRNA
CTD
PMID:22760963
NCBI chr19:6,919,229...6,929,273
Ensembl chr19:6,919,229...6,929,267
G
Bdkrb1
bradykinin receptor, beta 1
multiple interactions
ISO
Corn Oil inhibits the reaction [Glucose results in increased expression of BDKRB1 protein]
CTD
PMID:29165388
NCBI chr12:105,570,350...105,571,770
Ensembl chr12:105,569,344...105,571,687
G
Bhlhe40
basic helix-loop-helix family, member e40
affects expression
ISO
Corn Oil affects the expression of BHLHE40 mRNA
CTD
PMID:16360708
NCBI chr 6:108,637,590...108,643,886
Ensembl chr 6:108,637,590...108,643,886
G
Bhmt
betaine-homocysteine methyltransferase
affects expression
ISO
Corn Oil affects the expression of BHMT mRNA
CTD
PMID:16360708
NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469
G
Birc3
baculoviral IAP repeat-containing 3
increases expression
EXP
Corn Oil results in increased expression of BIRC3 mRNA
CTD
PMID:33263755
NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187
G
Bmp1
bone morphogenetic protein 1
affects expression
ISO
Corn Oil affects the expression of BMP1 mRNA
CTD
PMID:16360708
NCBI chr14:70,711,998...70,758,280
Ensembl chr14:70,711,998...70,757,674
G
Bmp2
bone morphogenetic protein 2
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of BMP2 mRNA
CTD
PMID:32186404
NCBI chr 2:133,394,079...133,404,816
Ensembl chr 2:133,394,079...133,404,805
G
Cadm1
cell adhesion molecule 1
affects expression
ISO
Corn Oil affects the expression of CADM1 mRNA
CTD
PMID:16360708
NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413
G
Calca
calcitonin/calcitonin-related polypeptide, alpha
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of CALCA mRNA
CTD
PMID:32186404
NCBI chr 7:114,225,223...114,236,145
Ensembl chr 7:114,230,713...114,235,592
G
Car6
carbonic anhydrase 6
increases expression
EXP
Corn Oil results in increased expression of CAR6 mRNA
CTD
PMID:33263755
NCBI chr 4:150,271,472...150,285,592
Ensembl chr 4:150,271,472...150,285,789
G
Card9
caspase recruitment domain family, member 9
increases expression
EXP
Corn Oil results in increased expression of CARD9 mRNA
CTD
PMID:33263755
NCBI chr 2:26,242,199...26,250,957
Ensembl chr 2:26,242,188...26,250,930
G
Cat
catalase
decreases expression multiple interactions
EXP
Corn Oil results in decreased expression of CAT protein [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in decreased expression of CAT protein
CTD
PMID:36432690
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Cav3
caveolin 3
decreases expression
EXP
Corn Oil results in decreased expression of CAV3 mRNA
CTD
PMID:33263755
NCBI chr 6:112,436,466...112,449,833
Ensembl chr 6:112,436,466...112,449,833
G
Ccl3
C-C motif chemokine ligand 3
increases expression decreases expression
EXP ISO
Corn Oil results in increased expression of CCL3 mRNA Corn Oil results in decreased expression of CCL3 mRNA
CTD
PMID:22760963 PMID:23409006
NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181
G
Ccnd1
cyclin D1
affects expression
ISO
Corn Oil affects the expression of CCND1 mRNA
CTD
PMID:16360708
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cd36
CD36 molecule
decreases expression
ISO
Corn Oil results in decreased expression of CD36 mRNA
CTD
PMID:22760963
NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799
G
Cdhr1
cadherin-related family member 1
increases expression
ISO
Corn Oil results in increased expression of CDHR1 mRNA
CTD
PMID:22760963
NCBI chr14:36,799,806...36,820,304
Ensembl chr14:36,799,814...36,820,304
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
increases expression affects expression
ISO
Corn Oil results in increased expression of CDKN1A mRNA Corn Oil affects the expression of CDKN1A mRNA
CTD
PMID:16360708 PMID:22760963
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cenpt
centromere protein T
increases expression
ISO
Corn Oil results in increased expression of CENPT mRNA
CTD
PMID:22760963
NCBI chr 8:106,571,297...106,581,678
Ensembl chr 8:106,571,305...106,579,910
G
Cfb
complement factor B
increases expression
ISO
Corn Oil results in increased expression of CFB mRNA
CTD
PMID:22760963
NCBI chr17:35,075,350...35,081,492
Ensembl chr17:35,075,350...35,081,494
G
Cldn1
claudin 1
decreases expression
EXP
Corn Oil results in decreased expression of CLDN1 mRNA
CTD
PMID:33263755
NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591
G
Cldn9
claudin 9
increases expression
EXP
Corn Oil results in increased expression of CLDN9 mRNA
CTD
PMID:33263755
NCBI chr17:23,901,558...23,903,000
Ensembl chr17:23,901,558...23,903,000
G
Cox7a1
cytochrome c oxidase subunit 7A1
decreases expression
EXP
Corn Oil results in decreased expression of COX7A1 mRNA
CTD
PMID:23409006
NCBI chr 7:29,883,596...29,885,455
Ensembl chr 7:29,883,569...29,885,503
G
Cox8b
cytochrome c oxidase subunit 8B
decreases expression
EXP
Corn Oil results in decreased expression of COX8B mRNA
CTD
PMID:23409006
NCBI chr 7:140,478,855...140,480,359
Ensembl chr 7:140,478,858...140,480,359
G
Cpt1a
carnitine palmitoyltransferase 1a, liver
affects expression multiple interactions increases expression
ISO EXP
Corn Oil affects the expression of CPT1A mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT1A mRNA Corn Oil results in increased expression of CPT1A mRNA
CTD
PMID:16360708 PMID:22760963 PMID:36432690
NCBI chr19:3,372,328...3,435,735
Ensembl chr19:3,372,334...3,435,733
G
Cpt2
carnitine palmitoyltransferase 2
multiple interactions
EXP
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CPT2 mRNA
CTD
PMID:36432690
NCBI chr 4:107,761,179...107,780,786
Ensembl chr 4:107,761,178...107,780,807
G
Crot
carnitine O-octanoyltransferase
affects expression multiple interactions
ISO EXP
Corn Oil affects the expression of CROT mRNA [bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of CROT mRNA
CTD
PMID:16360708 PMID:36432690
NCBI chr 5:9,016,033...9,047,926
Ensembl chr 5:9,016,033...9,047,324
G
Ctsg
cathepsin G
increases expression
ISO
Corn Oil results in increased expression of CTSG mRNA
CTD
PMID:22760963
NCBI chr14:56,337,342...56,340,031
Ensembl chr14:56,337,338...56,340,031
G
Cyp17a1
cytochrome P450, family 17, subfamily a, polypeptide 1
affects expression
ISO
Corn Oil affects the expression of CYP17A1 mRNA
CTD
PMID:16360708
NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611
G
Cyp7a1
cytochrome P450, family 7, subfamily a, polypeptide 1
affects expression
ISO
Corn Oil affects the expression of CYP7A1 mRNA
CTD
PMID:16360708
NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633
G
Cyp8b1
cytochrome P450, family 8, subfamily b, polypeptide 1
affects expression
ISO
Corn Oil affects the expression of CYP8B1 mRNA
CTD
PMID:16360708
NCBI chr 9:121,743,422...121,745,371
Ensembl chr 9:121,743,422...121,745,371
G
Ephx2
epoxide hydrolase 2, cytoplasmic
affects expression
ISO
Corn Oil affects the expression of EPHX2 mRNA
CTD
PMID:16360708
NCBI chr14:66,321,821...66,361,971
Ensembl chr14:66,321,823...66,361,949
G
Ets1
E26 avian leukemia oncogene 1, 5' domain
decreases expression
ISO
Corn Oil results in decreased expression of ETS1 mRNA
CTD
PMID:22760963
NCBI chr 9:32,547,501...32,669,116
Ensembl chr 9:32,547,517...32,669,116
G
Fabp1
fatty acid binding protein 1, liver
multiple interactions
ISO
[Ethanol co-treated with Corn Oil] results in decreased expression of FABP1 mRNA
CTD
PMID:15016835
NCBI chr 6:71,176,863...71,182,018
Ensembl chr 6:71,176,811...71,182,007
G
Fabp2
fatty acid binding protein 2, intestinal
affects expression
ISO
Corn Oil affects the expression of FABP2 mRNA
CTD
PMID:16360708
NCBI chr 3:122,688,721...122,693,155
Ensembl chr 3:122,688,721...122,693,155
G
Fabp7
fatty acid binding protein 7, brain
affects expression
ISO
Corn Oil affects the expression of FABP7 mRNA
CTD
PMID:16360708
NCBI chr10:57,661,019...57,664,546
Ensembl chr10:57,660,977...57,664,546
G
Fasn
fatty acid synthase
affects expression
ISO
Corn Oil affects the expression of FASN mRNA
CTD
PMID:16360708
NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373
G
Fcgrt
Fc fragment of IgG receptor and transporter
decreases expression
ISO
Corn Oil results in decreased expression of FCGRT mRNA
CTD
PMID:22760963
NCBI chr 7:44,742,417...44,753,246
Ensembl chr 7:44,742,414...44,753,275
G
Fgb
fibrinogen beta chain
affects expression
ISO
Corn Oil affects the expression of FGB mRNA
CTD
PMID:16360708
NCBI chr 3:82,949,553...82,957,170
Ensembl chr 3:82,947,448...82,957,170
G
Fgf21
fibroblast growth factor 21
affects expression
ISO
Corn Oil affects the expression of FGF21 mRNA
CTD
PMID:16360708
NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914
G
Fst
follistatin
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of FST mRNA
CTD
PMID:32186404
NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487
G
G0s2
G0/G1 switch gene 2
affects expression
ISO
Corn Oil affects the expression of G0S2 mRNA
CTD
PMID:16360708
NCBI chr 1:192,954,468...192,955,496
Ensembl chr 1:192,954,469...192,955,525
G
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
affects expression
ISO
Corn Oil affects the expression of GADD45A mRNA
CTD
PMID:16360708
NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441
G
Gal
galanin and GMAP prepropeptide
increases expression
ISO
Corn Oil results in increased expression of GAL mRNA
CTD
PMID:22760963
NCBI chr19:3,459,915...3,464,544
Ensembl chr19:3,459,915...3,464,544
G
Gck
glucokinase
affects expression
ISO
Corn Oil affects the expression of GCK mRNA
CTD
PMID:16360708
NCBI chr11:5,850,816...5,900,081
Ensembl chr11:5,850,820...5,900,081
G
Gjd2
gap junction protein, delta 2
increases expression
EXP
Corn Oil results in increased expression of GJD2 mRNA
CTD
PMID:33263755
NCBI chr 2:113,840,086...113,844,555
Ensembl chr 2:113,840,082...113,844,100
G
Gm7030
predicted gene 7030
increases expression
ISO
Corn Oil results in increased expression of RT1-CE5 mRNA
CTD
PMID:22760963
NCBI chr17:36,438,501...36,440,317
Ensembl chr17:36,420,611...36,440,317
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
affects expression
ISO
Corn Oil affects the expression of GOT1 mRNA
CTD
PMID:16360708
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Got2
glutamatic-oxaloacetic transaminase 2, mitochondrial
decreases expression
ISO
Corn Oil results in decreased expression of GOT2 mRNA
CTD
PMID:34987138
NCBI chr 8:96,590,761...96,615,029
Ensembl chr 8:96,590,762...96,615,175
G
Gpd2
glycerol phosphate dehydrogenase 2, mitochondrial
affects expression
ISO
Corn Oil affects the expression of GPD2 mRNA
CTD
PMID:16360708
NCBI chr 2:57,127,690...57,260,731
Ensembl chr 2:57,127,647...57,260,731
G
Gpt
glutamic pyruvic transaminase, soluble
multiple interactions
ISO
[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein; Dactinomycin inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]; Orlistat inhibits the reaction [[Corn Oil co-treated with (5'-(4-amino-7,7-dimethyl-2-trifluoromethyl-7H-pyrimido(4,5-b)(1,4)oxazin-6-yl)-2',3'-dihydrospiro(cyclohexane-1,1'-inden)-4-yl)acetic acid] results in increased activity of GPT protein]
CTD
PMID:29479035
NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886
G
H2-Ab1
histocompatibility 2, class II antigen A, beta 1
increases expression
ISO
Corn Oil results in increased expression of RT1-BB mRNA
CTD
PMID:22760963
NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393
G
H2-Q1
histocompatibility 2, Q region locus 1
increases expression
ISO
Corn Oil results in increased expression of RT1-CE16 mRNA
CTD
PMID:22760963
NCBI chr17:35,539,503...35,547,118
Ensembl chr17:35,539,381...35,544,075
G
H2ac25
H2A clustered histone 25
affects expression
ISO
Corn Oil affects the expression of H2A mRNA
CTD
PMID:16360708
NCBI chr11:58,845,511...58,846,018
Ensembl chr11:58,845,511...58,847,656
G
Hal
histidine ammonia lyase
affects expression
ISO
Corn Oil affects the expression of HAL mRNA
CTD
PMID:16360708
NCBI chr10:93,324,630...93,352,623
Ensembl chr10:93,324,630...93,355,166
G
Hamp
hepcidin antimicrobial peptide
affects expression
ISO
Corn Oil affects the expression of HAMP mRNA
CTD
PMID:16360708
NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457
G
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase
affects expression
ISO
Corn Oil affects the expression of HMGCR mRNA
CTD
PMID:16360708
NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444
G
Hoxa11
homeobox A11
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of HOXA11 mRNA
CTD
PMID:32186404
NCBI chr 6:52,219,086...52,222,784
Ensembl chr 6:52,219,086...52,222,790
G
Hp
haptoglobin
increases expression
ISO
Corn Oil results in increased expression of HP mRNA
CTD
PMID:22760963
NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804
G
Hsp90aa1
heat shock protein 90, alpha (cytosolic), class A member 1
increases expression
EXP
Corn Oil results in increased expression of HSP90AA1 mRNA
CTD
PMID:33263755
NCBI chr12:110,657,470...110,662,829
Ensembl chr12:110,657,039...110,669,162
G
Idi1
isopentenyl-diphosphate delta isomerase
affects expression
ISO
Corn Oil affects the expression of IDI1 mRNA
CTD
PMID:16360708
NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487
G
Igf2bp2
insulin-like growth factor 2 mRNA binding protein 2
increases expression affects expression
ISO
Corn Oil results in increased expression of IGF2BP2 mRNA Corn Oil affects the expression of IGF2BP2 mRNA
CTD
PMID:22760963
NCBI chr16:21,877,759...21,982,049
Ensembl chr16:21,877,759...21,982,049
G
Igfbp1
insulin-like growth factor binding protein 1
affects expression
ISO
Corn Oil affects the expression of IGFBP1 mRNA
CTD
PMID:16360708
NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546
G
Ihh
Indian hedgehog
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of IHH mRNA
CTD
PMID:32186404
NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831
G
Il12b
interleukin 12b
increases secretion
ISO
Corn Oil results in increased secretion of IL12B protein
CTD
PMID:33263755
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il18
interleukin 18
increases expression
EXP
Corn Oil results in increased expression of IL18 mRNA
CTD
PMID:33263755
NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140
G
Il1a
interleukin 1 alpha
increases secretion
ISO
Corn Oil results in increased secretion of IL1A protein
CTD
PMID:33263755
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
increases secretion
ISO
Corn Oil results in increased secretion of IL1B protein
CTD
PMID:33263755
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
increases expression
ISO
Corn Oil results in increased expression of IL1RN mRNA
CTD
PMID:22760963
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il4
interleukin 4
decreases expression increases expression increases secretion
EXP ISO
Corn Oil results in decreased expression of IL4 mRNA Corn Oil results in increased expression of IL4 mRNA Corn Oil results in increased secretion of IL4 protein
CTD
PMID:23409006 PMID:33263755
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il6ra
interleukin 6 receptor, alpha
increases expression
ISO
Corn Oil results in increased expression of IL6R mRNA
CTD
PMID:22760963
NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503
G
Il9
interleukin 9
increases secretion
ISO
Corn Oil results in increased secretion of IL9 protein
CTD
PMID:33263755
NCBI chr13:56,627,090...56,630,070
Ensembl chr13:56,627,090...56,630,059
G
Inhbe
inhibin beta-E
affects expression
ISO
Corn Oil affects the expression of INHBE mRNA
CTD
PMID:16360708
NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280
G
Ins1
insulin I
multiple interactions
ISO
Corn Oil inhibits the reaction [Glucose results in increased expression of INS1 protein]
CTD
PMID:29165388
NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914
G
Irak1
interleukin-1 receptor-associated kinase 1
increases expression
EXP
Corn Oil results in increased expression of IRAK1 mRNA
CTD
PMID:33263755
NCBI chr X:73,057,520...73,067,527
Ensembl chr X:73,057,520...73,067,524
G
Irf5
interferon regulatory factor 5
increases expression
EXP
Corn Oil results in increased expression of IRF5 mRNA
CTD
PMID:33263755
NCBI chr 6:29,526,129...29,541,874
Ensembl chr 6:29,526,624...29,541,870
G
Irf7
interferon regulatory factor 7
increases expression
EXP
Corn Oil results in increased expression of IRF7 mRNA
CTD
PMID:33263755
NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394
G
Jun
jun proto-oncogene
increases expression
EXP
Corn Oil results in increased expression of JUN mRNA
CTD
PMID:33263755
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Klf2
Kruppel-like transcription factor 2 (lung)
affects expression
ISO
Corn Oil affects the expression of KLF2 mRNA
CTD
PMID:16360708
NCBI chr 8:73,072,906...73,075,498
Ensembl chr 8:73,072,877...73,075,500
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of LCAT mRNA
CTD
PMID:36432690
NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014
G
Lcn2
lipocalin 2
increases expression
ISO
Corn Oil results in increased expression of LCN2 mRNA
CTD
PMID:22760963
NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264
G
Lep
leptin
multiple interactions
ISO
Corn Oil inhibits the reaction [Glucose results in increased expression of LEP protein]
CTD
PMID:29165388
NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876
G
Lgals1
lectin, galactose binding, soluble 1
increases expression
ISO
Corn Oil results in increased expression of LGALS1 mRNA
CTD
PMID:22760963
NCBI chr15:78,810,925...78,814,665
Ensembl chr15:78,810,925...78,814,665
G
Lox
lysyl oxidase
multiple interactions
EXP
Corn Oil results in increased activity of and results in increased cleavage of LOX protein
CTD
PMID:26240151
NCBI chr18:52,649,132...52,662,939
Ensembl chr18:52,649,139...52,662,939
G
Ly75
lymphocyte antigen 75
increases expression
ISO
Corn Oil results in increased expression of LY75 mRNA
CTD
PMID:22760963
NCBI chr 2:60,122,447...60,213,617
Ensembl chr 2:60,122,447...60,213,647
G
Map2k1
mitogen-activated protein kinase kinase 1
increases expression
EXP
Corn Oil results in increased expression of MAP2K1 mRNA
CTD
PMID:33263755
NCBI chr 9:64,093,066...64,160,887
Ensembl chr 9:64,093,052...64,160,913
G
Map2k3
mitogen-activated protein kinase kinase 3
increases expression
EXP
Corn Oil results in increased expression of MAP2K3 mRNA
CTD
PMID:33263755
NCBI chr11:60,822,880...60,843,637
Ensembl chr11:60,822,859...60,843,637
G
Map2k6
mitogen-activated protein kinase kinase 6
affects expression
ISO
Corn Oil affects the expression of MAP2K6 mRNA
CTD
PMID:16360708
NCBI chr11:110,289,928...110,416,348
Ensembl chr11:110,289,948...110,416,348
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
increases expression
EXP
Corn Oil results in increased expression of MAP3K7 mRNA
CTD
PMID:33263755
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk1
mitogen-activated protein kinase 1
increases expression
EXP
Corn Oil results in increased expression of MAPK1 mRNA
CTD
PMID:33263755
NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317
G
Mapk14
mitogen-activated protein kinase 14
increases expression
EXP
Corn Oil results in increased expression of MAPK14 mRNA
CTD
PMID:33263755
NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380
G
Mapk3
mitogen-activated protein kinase 3
increases expression
EXP
Corn Oil results in increased expression of MAPK3 mRNA
CTD
PMID:33263755
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mdm2
transformed mouse 3T3 cell double minute 2
decreases expression
ISO
Corn Oil results in decreased expression of MDM2 mRNA
CTD
PMID:22760963
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Mgmt
O-6-methylguanine-DNA methyltransferase
increases expression
ISO
Corn Oil results in increased expression of MGMT mRNA
CTD
PMID:22760963
NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
G
Mgst2
microsomal glutathione S-transferase 2
increases expression
ISO
Corn Oil results in increased expression of MGST2 mRNA
CTD
PMID:22760963
NCBI chr 3:51,544,179...51,590,096
Ensembl chr 3:51,567,781...51,590,098
G
Mlycd
malonyl-CoA decarboxylase
decreases expression
ISO
Corn Oil results in decreased expression of MLYCD mRNA
CTD
PMID:22760963
NCBI chr 8:120,121,591...120,148,577
Ensembl chr 8:120,121,617...120,137,841
G
Msmo1
methylsterol monoxygenase 1
affects expression
ISO
Corn Oil affects the expression of MSMO1 mRNA
CTD
PMID:16360708
NCBI chr 8:65,171,157...65,186,822
Ensembl chr 8:65,171,173...65,186,826
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions
EXP
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of MTR mRNA
CTD
PMID:36432690
NCBI chr13:12,196,217...12,273,090
Ensembl chr13:12,197,598...12,272,999
G
Myd88
myeloid differentiation primary response gene 88
increases expression
EXP
Corn Oil results in increased expression of MYD88 mRNA
CTD
PMID:33263755
NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
decreases activity
EXP
Corn Oil results in decreased activity of NFE2L2 protein
CTD
PMID:30203046
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nfkbia
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha
increases expression
EXP
Corn Oil results in increased expression of NFKBIA mRNA
CTD
PMID:33263755
NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432
G
Nlrc4
NLR family, CARD domain containing 4
increases expression
EXP
Corn Oil results in increased expression of NLRC4 mRNA
CTD
PMID:33263755
NCBI chr17:74,733,254...74,766,140
Ensembl chr17:74,732,433...74,766,137
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
affects expression
ISO
Corn Oil affects the expression of NR1H4 mRNA
CTD
PMID:16360708
NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447
G
Nr4a2
nuclear receptor subfamily 4, group A, member 2
increases expression
ISO
Corn Oil results in increased expression of NR4A2 mRNA
CTD
PMID:22760963
NCBI chr 2:56,996,845...57,014,152
Ensembl chr 2:56,996,842...57,014,015
G
Nsmce3
NSE3 homolog, SMC5-SMC6 complex component
affects expression
ISO
Corn Oil affects the expression of NSMCE3 mRNA
CTD
PMID:16360708
NCBI chr 7:64,521,430...64,522,788
Ensembl chr 7:64,516,800...64,522,745
G
Oat
ornithine aminotransferase
affects expression
ISO
Corn Oil affects the expression of OAT mRNA
CTD
PMID:16360708
NCBI chr 7:132,159,204...132,178,127
Ensembl chr 7:132,159,207...132,178,127
G
Osgin1
oxidative stress induced growth inhibitor 1
affects expression
ISO
Corn Oil affects the expression of OSGIN1 mRNA
CTD
PMID:16360708
NCBI chr 8:120,160,874...120,172,996
Ensembl chr 8:120,160,863...120,172,995
G
P2rx5
purinergic receptor P2X, ligand-gated ion channel, 5
affects expression
ISO
Corn Oil affects the expression of P2RX5 mRNA
CTD
PMID:16360708
NCBI chr11:73,029,164...73,063,509
Ensembl chr11:73,051,247...73,063,511
G
Pax8
paired box 8
affects expression
ISO
Corn Oil affects the expression of PAX8 mRNA
CTD
PMID:16360708
NCBI chr 2:24,310,563...24,365,611
Ensembl chr 2:24,310,572...24,365,611
G
Pdgfa
platelet derived growth factor, alpha
affects expression
ISO
Corn Oil affects the expression of PDGFA mRNA
CTD
PMID:16360708
NCBI chr 5:138,961,761...138,986,336
Ensembl chr 5:138,961,769...138,983,125
G
Pdgfrb
platelet derived growth factor receptor, beta polypeptide
increases expression
ISO
Corn Oil results in increased expression of PDGFRB mRNA
CTD
PMID:22760963
NCBI chr18:61,178,194...61,218,139
Ensembl chr18:61,178,222...61,218,133
G
Pdlim1
PDZ and LIM domain 1 (elfin)
affects expression
ISO
Corn Oil affects the expression of PDLIM1 mRNA
CTD
PMID:16360708
NCBI chr19:40,210,683...40,260,060
Ensembl chr19:40,209,617...40,260,286
G
Pdlim2
PDZ and LIM domain 2
affects expression
ISO
Corn Oil affects the expression of PDLIM2 mRNA
CTD
PMID:16360708
NCBI chr14:70,401,667...70,415,140
Ensembl chr14:70,401,667...70,415,130
G
Pgf
placental growth factor
increases expression
ISO
Corn Oil results in increased expression of PGF mRNA
CTD
PMID:22760963
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pgrmc2
progesterone receptor membrane component 2
affects expression
ISO
Corn Oil affects the expression of PGRMC2 mRNA
CTD
PMID:16360708
NCBI chr 3:41,020,772...41,037,443
Ensembl chr 3:41,020,761...41,037,481
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha
increases expression
EXP
Corn Oil results in increased expression of PIK3CA mRNA
CTD
PMID:33263755
NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635
G
Plin2
perilipin 2
affects expression
ISO
Corn Oil affects the expression of PLIN2 mRNA
CTD
PMID:16360708
NCBI chr 4:86,545,147...86,588,518
Ensembl chr 4:86,566,623...86,588,297
G
Prlr
prolactin receptor
affects expression
ISO
Corn Oil affects the expression of PRLR mRNA
CTD
PMID:16360708
NCBI chr15:10,177,324...10,349,276
Ensembl chr15:10,177,324...10,349,266
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
EXP
[Estradiol co-treated with Progesterone co-treated with Corn Oil] results in increased expression of PTGS2 mRNA
CTD
PMID:32186404
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptprf
protein tyrosine phosphatase receptor type F
affects expression
ISO
Corn Oil affects the expression of PTPRF mRNA
CTD
PMID:16360708
NCBI chr 4:118,065,410...118,148,602
Ensembl chr 4:118,065,410...118,148,602
G
Pycard
PYD and CARD domain containing
increases expression
EXP
Corn Oil results in increased expression of PYCARD mRNA
CTD
PMID:33263755
NCBI chr 7:127,590,545...127,593,039
Ensembl chr 7:127,588,880...127,593,039
G
Rac1
Rac family small GTPase 1
increases expression
EXP
Corn Oil results in increased expression of RAC1 mRNA
CTD
PMID:33263755
NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
G
Ripk1
receptor (TNFRSF)-interacting serine-threonine kinase 1
increases expression
EXP
Corn Oil results in increased expression of RIPK1 mRNA
CTD
PMID:33263755
NCBI chr13:34,181,072...34,219,153
Ensembl chr13:34,186,346...34,221,130
G
Ripk2
receptor (TNFRSF)-interacting serine-threonine kinase 2
increases expression
EXP
Corn Oil results in increased expression of RIPK2 mRNA
CTD
PMID:33263755
NCBI chr 4:16,122,740...16,163,674
Ensembl chr 4:16,122,733...16,163,647
G
S100a8
S100 calcium binding protein A8 (calgranulin A)
increases expression
ISO
Corn Oil results in increased expression of S100A8 mRNA
CTD
PMID:22760963
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
G
S100a9
S100 calcium binding protein A9 (calgranulin B)
increases expression
ISO
Corn Oil results in increased expression of S100A9 mRNA
CTD
PMID:22760963
NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028
G
Scd1
stearoyl-Coenzyme A desaturase 1
affects expression
ISO
Corn Oil affects the expression of SCD1 mRNA
CTD
PMID:16360708
NCBI chr19:44,382,889...44,396,148
Ensembl chr19:44,382,894...44,396,318
G
Scn1b
sodium channel, voltage-gated, type I, beta
affects expression
ISO
Corn Oil affects the expression of SCN1B mRNA
CTD
PMID:16360708
NCBI chr 7:30,815,949...30,826,436
Ensembl chr 7:30,815,949...30,826,428
G
Sds
serine dehydratase
affects expression
ISO
Corn Oil affects the expression of SDS mRNA
CTD
PMID:16360708
NCBI chr 5:120,614,612...120,621,997
Ensembl chr 5:120,614,591...120,621,997
G
Sfrp2
secreted frizzled-related protein 2
decreases expression
ISO
Corn Oil results in decreased expression of SFRP2 mRNA
CTD
PMID:22760963
NCBI chr 3:83,673,628...83,681,621
Ensembl chr 3:83,673,628...83,681,623
G
Slc25a20
solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
multiple interactions
EXP
[bisphenol A co-treated with Resveratrol co-treated with Corn Oil] results in increased expression of SLC25A20 mRNA
CTD
PMID:36432690
NCBI chr 9:108,539,335...108,561,841
Ensembl chr 9:108,539,287...108,561,840
G
Slc25a25
solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 25
affects expression
ISO
Corn Oil affects the expression of SLC25A25 mRNA
CTD
PMID:16360708
NCBI chr 2:32,304,499...32,341,482
Ensembl chr 2:32,304,499...32,341,457
G
Sod1
superoxide dismutase 1, soluble
multiple interactions decreases activity
EXP
[Corn Oil co-treated with Iron, Dietary] results in decreased activity of SOD1 protein; [Corn Oil co-treated with Iron] results in decreased activity of SOD1 protein; Iron promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]; Iron, Dietary promotes the reaction [Corn Oil results in decreased activity of SOD1 protein]
CTD
PMID:17194920
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Sparc
secreted acidic cysteine rich glycoprotein
increases expression
ISO
Corn Oil results in increased expression of SPARC mRNA
CTD
PMID:22760963
NCBI chr11:55,284,985...55,310,906
Ensembl chr11:55,285,326...55,314,009
G
Sqle
squalene epoxidase
affects expression
ISO
Corn Oil affects the expression of SQLE mRNA
CTD
PMID:16360708
NCBI chr15:59,186,941...59,203,042
Ensembl chr15:59,186,926...59,203,041
G
Srebf1
sterol regulatory element binding transcription factor 1
affects expression
ISO
Corn Oil affects the expression of SREBF1 mRNA
CTD
PMID:16360708
NCBI chr11:60,089,910...60,113,407
Ensembl chr11:60,089,915...60,113,407
G
Sstr3
somatostatin receptor 3
decreases expression
ISO
Corn Oil results in decreased expression of SSTR3 mRNA
CTD
PMID:22760963
NCBI chr15:78,421,214...78,433,565
Ensembl chr15:78,421,208...78,428,885
G
Sugt1
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae)
increases expression
EXP
Corn Oil results in increased expression of SUGT1 mRNA
CTD
PMID:33263755
NCBI chr14:79,825,100...79,868,237
Ensembl chr14:79,825,131...79,872,636
G
Syk
spleen tyrosine kinase
increases expression
EXP
Corn Oil results in increased expression of SYK mRNA
CTD
PMID:23409006
NCBI chr13:52,736,670...52,802,828
Ensembl chr13:52,737,209...52,802,828
G
Tac1
tachykinin 1
decreases expression
ISO
Corn Oil results in decreased expression of TAC1 mRNA
CTD
PMID:22760963
NCBI chr 6:7,555,061...7,562,978
Ensembl chr 6:7,554,879...7,565,834
G
Tat
tyrosine aminotransferase
affects expression
ISO
Corn Oil affects the expression of TAT mRNA
CTD
PMID:16360708
NCBI chr 8:110,712,710...110,726,436
Ensembl chr 8:110,717,069...110,726,435
G
Tbc1d14
TBC1 domain family, member 14
affects expression
ISO
Corn Oil affects the expression of TBC1D14 mRNA
CTD
PMID:16360708
NCBI chr 5:36,647,948...36,743,611
Ensembl chr 5:36,647,948...36,750,620
G
Tgfa
transforming growth factor alpha
decreases expression
ISO
Corn Oil results in decreased expression of TGFA mRNA
CTD
PMID:22760963
NCBI chr 6:86,172,020...86,252,726
Ensembl chr 6:86,172,205...86,252,701
G
Ticam1
TIR domain containing adaptor molecule 1
increases expression
EXP
Corn Oil results in increased expression of TICAM1 mRNA
CTD
PMID:33263755
NCBI chr17:56,576,462...56,583,767
Ensembl chr17:56,576,319...56,583,786
G
Tjp2
tight junction protein 2
increases expression
EXP
Corn Oil results in increased expression of TJP2 mRNA
CTD
PMID:33263755
NCBI chr19:24,071,860...24,202,492
Ensembl chr19:24,071,869...24,202,394
G
Tjp3
tight junction protein 3
increases expression
EXP
Corn Oil results in increased expression of TJP3 mRNA
CTD
PMID:33263755
NCBI chr10:81,109,022...81,127,415
Ensembl chr10:81,109,041...81,127,415
G
Tnfrsf1a
tumor necrosis factor receptor superfamily, member 1a
increases expression
EXP
Corn Oil results in increased expression of TNFRSF1A mRNA
CTD
PMID:33263755
NCBI chr 6:125,326,686...125,339,446
Ensembl chr 6:125,326,325...125,339,447
G
Tollip
toll interacting protein
increases expression
EXP
Corn Oil results in increased expression of TOLLIP mRNA
CTD
PMID:33263755
NCBI chr 7:141,435,317...141,456,198
Ensembl chr 7:141,428,550...141,472,244
G
Tpcn2
two pore segment channel 2
affects expression
ISO
Corn Oil affects the expression of TPCN2 mRNA
CTD
PMID:16360708
NCBI chr 7:144,735,370...144,837,743
Ensembl chr 7:144,740,261...144,837,748
G
Tpt1
tumor protein, translationally-controlled 1
increases expression
ISO
Corn Oil results in increased expression of TPT1 mRNA
CTD
PMID:22760963
NCBI chr14:76,082,771...76,085,743
Ensembl chr14:76,082,533...76,085,965
G
Vegfb
vascular endothelial growth factor B
decreases expression
ISO
Corn Oil results in decreased expression of VEGFB mRNA
CTD
PMID:22760963
NCBI chr19:6,959,840...6,965,019
Ensembl chr19:6,959,841...6,965,019
G
Vnn1
vanin 1
affects expression
ISO
Corn Oil affects the expression of VNN1 mRNA
CTD
PMID:16360708
NCBI chr10:23,770,586...23,781,242
Ensembl chr10:23,770,586...23,781,241
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
EXP
Corn Oil results in decreased expression of XIAP mRNA
CTD
PMID:33263755
NCBI chr X:41,148,483...41,198,541
Ensembl chr X:41,148,556...41,198,533
G
Xpnpep2
X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound
affects expression
ISO
Corn Oil affects the expression of XPNPEP2 mRNA
CTD
PMID:16360708
NCBI chr X:47,195,790...47,225,859
Ensembl chr X:47,197,602...47,225,858
G
Zdhhc23
zinc finger, DHHC domain containing 23
affects expression
ISO
Corn Oil affects the expression of ZDHHC23 mRNA
CTD
PMID:16360708
NCBI chr16:43,785,396...43,800,295
Ensembl chr16:43,785,396...43,800,154
G
Casp3
caspase 3
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein]
CTD
PMID:22389237
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Crabp2
cellular retinoic acid binding protein II
multiple interactions
ISO
[Tretinoin co-treated with delta-tocopherol] results in increased expression of CRABP2 mRNA
CTD
PMID:15225641
NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Gclm
glutamate-cysteine ligase, modifier subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gstm1
glutathione S-transferase, mu 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:22389237
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Hmox1
heme oxygenase 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:22389237
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:22389237
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Pcna
proliferating cell nuclear antigen
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein]
CTD
PMID:22389237
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pparg
peroxisome proliferator activated receptor gamma
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:22389237
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:22389237
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:22389237
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Abcb1a
ATP-binding cassette, sub-family B member 1A
increases expression
ISO
tocotrienol, delta results in increased expression of ABCB1
CTD
PMID:15269186
NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575
G
Abcc1
ATP-binding cassette, sub-family C member 1
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA] tocotrienol, delta results in increased expression of ABCC1 mRNA
CTD
PMID:22185406
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Abcd2
ATP-binding cassette, sub-family D member 2
decreases expression
EXP
tocotrienol, delta results in decreased expression of ABCD2 mRNA
CTD
PMID:22185406
NCBI chr15:91,029,874...91,076,013
Ensembl chr15:91,030,074...91,076,002
G
Actl6b
actin-like 6B
increases expression
EXP
tocotrienol, delta results in increased expression of ACTL6B mRNA
CTD
PMID:22185406
NCBI chr 5:137,551,784...137,567,844
Ensembl chr 5:137,551,779...137,567,844
G
Atp2a2
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
multiple interactions increases expression
EXP
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of ATP2A2 mRNA] tocotrienol, delta results in increased expression of ATP2A2 mRNA
CTD
PMID:22185406
NCBI chr 5:122,591,576...122,640,288
Ensembl chr 5:122,591,576...122,640,288
G
Ccl8
C-C motif chemokine ligand 8
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CCL8 mRNA] tocotrienol, delta results in decreased expression of CCL8 mRNA
CTD
PMID:22185406
NCBI chr11:82,006,011...82,007,625
Ensembl chr11:82,006,011...82,007,625
G
Ccnd1
cyclin D1
decreases expression
ISO
tocotrienol, delta results in decreased expression of CCND1 protein
CTD
PMID:21453743
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd2
cyclin D2
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CCND2 mRNA] tocotrienol, delta results in increased expression of CCND2 mRNA
CTD
PMID:22185406
NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156
G
Cd40
CD40 antigen
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD40 mRNA] tocotrienol, delta results in increased expression of CD40 mRNA
CTD
PMID:22185406
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cd69
CD69 antigen
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of CD69 mRNA] tocotrienol, delta results in increased expression of CD69 mRNA
CTD
PMID:22185406
NCBI chr 6:129,244,287...129,252,332
Ensembl chr 6:129,244,288...129,252,399
G
Cox7b2
cytochrome c oxidase subunit 7B2
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of COX7B2 mRNA] tocotrienol, delta results in decreased expression of COX7B2 mRNA
CTD
PMID:22185406
NCBI chr 5:71,600,166...71,705,548
Ensembl chr 5:71,600,167...71,705,548
G
Crp
C-reactive protein, pentraxin-related
multiple interactions
ISO
[resveratrol co-treated with pterostilbene co-treated with Quercetin co-treated with tocotrienol, delta co-treated with Niacin] results in decreased expression of CRP protein
CTD
PMID:24319627
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Ctnnb1
catenin beta 1
decreases expression
ISO
tocotrienol, delta results in decreased expression of CTNNB1 protein
CTD
PMID:21453743
NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573
G
Cyp3a11
cytochrome P450, family 3, subfamily a, polypeptide 11
multiple interactions increases expression
ISO
tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A4 protein results in increased oxidation of Lithocholic Acid] tocotrienol, delta results in increased expression of CYP3A4
CTD
PMID:15269186 PMID:31102695
NCBI chr 5:145,791,417...145,816,664
Ensembl chr 5:145,791,236...145,816,774
G
Cyp3a13
cytochrome P450, family 3, subfamily a, polypeptide 13
multiple interactions affects response to substance
ISO
tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased hydroxylation of Testosterone]; tocotrienol, delta inhibits the reaction [CYP3A5 protein results in increased oxidation of Lithocholic Acid] CYP3A5 gene polymorphism affects the susceptibility to tocotrienol, delta
CTD
PMID:31102695
NCBI chr 5:137,891,195...137,923,872
Ensembl chr 5:137,891,194...137,919,881
G
Gimap1
GTPase, IMAP family member 1
multiple interactions decreases expression
EXP
tocotrienol, delta promotes the reaction [Lipopolysaccharides results in decreased expression of GIMAP1 mRNA] tocotrienol, delta results in decreased expression of GIMAP1 mRNA
CTD
PMID:22185406
NCBI chr 6:48,715,981...48,720,729
Ensembl chr 6:48,715,988...48,720,729
G
Icam1
intercellular adhesion molecule 1
decreases expression multiple interactions
EXP
tocotrienol, delta results in decreased expression of ICAM1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of ICAM1 mRNA]
CTD
PMID:22185406
NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113
G
Ifnb1
interferon beta 1, fibroblast
multiple interactions
EXP
tocotrienol, delta inhibits the reaction [[IFNB1 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
CTD
PMID:22185406
NCBI chr 4:88,440,253...88,441,083
Ensembl chr 4:88,440,262...88,441,011
G
Ifng
interferon gamma
multiple interactions
EXP
tocotrienol, delta inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
CTD
PMID:22185406
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Ifngr1
interferon gamma receptor 1
decreases expression multiple interactions
EXP
tocotrienol, delta results in decreased expression of IFNGR1 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of IFNGR1 mRNA]
CTD
PMID:22185406
NCBI chr10:19,467,697...19,485,977
Ensembl chr10:19,467,697...19,485,977
G
Il12b
interleukin 12b
decreases expression multiple interactions
EXP
tocotrienol, delta results in decreased expression of IL12B mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA]
CTD
PMID:22185406
NCBI chr11:44,290,890...44,305,504
Ensembl chr11:44,290,890...44,304,860
G
Il1a
interleukin 1 alpha
increases expression
EXP
tocotrienol, delta results in increased expression of IL1A mRNA
CTD
PMID:22185406
NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892
G
Il1b
interleukin 1 beta
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] tocotrienol, delta results in increased expression of IL1B mRNA
CTD
PMID:22185406
NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059
G
Il1rn
interleukin 1 receptor antagonist
increases expression multiple interactions
EXP
tocotrienol, delta results in increased expression of IL1RN mRNA tocotrienol, delta promotes the reaction [Lipopolysaccharides results in increased expression of IL1RN mRNA]
CTD
PMID:22185406
NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506
G
Il6
interleukin 6
increases expression multiple interactions
EXP
tocotrienol, delta results in increased expression of IL6 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]
CTD
PMID:22185406
NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979
G
Jun
jun proto-oncogene
decreases expression
ISO
tocotrienol, delta results in decreased expression of JUN protein
CTD
PMID:21453743
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Mmp7
matrix metallopeptidase 7
decreases expression
ISO
tocotrienol, delta results in decreased expression of MMP7 protein
CTD
PMID:21453743
NCBI chr 9:7,692,095...7,699,587
Ensembl chr 9:7,692,091...7,699,587
G
Ncor1
nuclear receptor co-repressor 1
multiple interactions
ISO
tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr11:62,207,132...62,348,200
Ensembl chr11:62,207,252...62,349,367
G
Nos2
nitric oxide synthase 2, inducible
multiple interactions
EXP
Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of NOS2]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:21356098 PMID:22185406
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Nr1i2
nuclear receptor subfamily 1, group I, member 2
multiple interactions
ISO
tocotrienol, delta binds to and results in increased activity of NR1I2 protein; tocotrienol, delta inhibits the reaction [NR1I2 protein binds to NCOR1 protein]
CTD
PMID:15269186
NCBI chr16:38,068,711...38,115,211
Ensembl chr16:38,068,685...38,115,186
G
Phka2
phosphorylase kinase alpha 2
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PHKA2 mRNA] tocotrienol, delta results in increased expression of PHKA2 mRNA
CTD
PMID:22185406
NCBI chr X:159,284,900...159,384,772
Ensembl chr X:159,285,162...159,381,874
G
Psmb2
proteasome (prosome, macropain) subunit, beta type 2
decreases expression
EXP
tocotrienol, delta results in decreased expression of PSMB2 mRNA
CTD
PMID:22185406
NCBI chr 4:126,571,460...126,603,503
Ensembl chr 4:126,571,423...126,603,507
G
Ptbp2
polypyrimidine tract binding protein 2
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of PTBP2 mRNA] tocotrienol, delta results in increased expression of PTBP2 mRNA
CTD
PMID:22185406
NCBI chr 3:119,512,390...119,578,296
Ensembl chr 3:119,512,391...119,578,115
G
Rasgrp1
RAS guanyl releasing protein 1
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of RASGRP1 mRNA] tocotrienol, delta results in increased expression of RASGRP1 mRNA
CTD
PMID:22185406
NCBI chr 2:117,110,464...117,173,358
Ensembl chr 2:117,110,474...117,173,482
G
Rasgrp3
RAS, guanyl releasing protein 3
decreases expression multiple interactions
EXP
tocotrienol, delta results in decreased expression of RASGRP3 mRNA tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of RASGRP3 mRNA]
CTD
PMID:22185406
NCBI chr17:75,742,849...75,836,049
Ensembl chr17:75,742,891...75,836,049
G
Socs3
suppressor of cytokine signaling 3
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of SOCS3 mRNA] tocotrienol, delta results in decreased expression of SOCS3 mRNA
CTD
PMID:22185406
NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873
G
Tnf
tumor necrosis factor
decreases expression multiple interactions
EXP
tocotrienol, delta results in decreased expression of TNF mRNA Lipopolysaccharides inhibits the reaction [tocotrienol, delta results in increased expression of TNF]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]
CTD
PMID:21356098 PMID:22185406
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnp1
transition protein 1
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of TNP1 mRNA] tocotrienol, delta results in decreased expression of TNP1 mRNA
CTD
PMID:22185406
NCBI chr 1:73,054,233...73,055,058
Ensembl chr 1:73,054,233...73,055,068
G
Traf1
TNF receptor-associated factor 1
multiple interactions increases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of TRAF1 mRNA] tocotrienol, delta results in increased expression of TRAF1 mRNA
CTD
PMID:22185406
NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784
G
Ube2d2a
ubiquitin-conjugating enzyme E2D 2A
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in decreased expression of UBE2D2A mRNA] tocotrienol, delta results in decreased expression of UBE2D2A mRNA
CTD
PMID:22185406
NCBI chr18:35,904,612...35,940,225
Ensembl chr18:35,904,611...35,942,547
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression
ISO
tocotrienol, delta results in increased expression of UGT1A1
CTD
PMID:15269186
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Vcam1
vascular cell adhesion molecule 1
multiple interactions decreases expression
EXP
tocotrienol, delta inhibits the reaction [Lipopolysaccharides results in increased expression of VCAM1 mRNA] tocotrienol, delta results in decreased expression of VCAM1 mRNA
CTD
PMID:22185406
NCBI chr 3:115,903,669...115,923,337
Ensembl chr 3:115,903,598...115,923,337
G
Wnt1
wingless-type MMTV integration site family, member 1
decreases expression
ISO
tocotrienol, delta results in decreased expression of WNT1 protein
CTD
PMID:21453743
NCBI chr15:98,687,738...98,691,711
Ensembl chr15:98,687,738...98,691,718
G
Abcc1
ATP-binding cassette, sub-family C member 1
decreases activity multiple interactions
ISO
Tocopherols results in decreased activity of ABCC1 protein Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide]
CTD
PMID:15617835
NCBI chr16:14,179,317...14,292,743
Ensembl chr16:14,179,422...14,293,601
G
Alb
albumin
multiple interactions
ISO
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA]
CTD
PMID:19389874
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
App
amyloid beta precursor protein
decreases abundance multiple interactions
ISO
APP protein modified form results in decreased abundance of Tocopherols resveratrol inhibits the reaction [APP protein modified form results in decreased abundance of Tocopherols]
CTD
PMID:25654502
NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654
G
Ar
androgen receptor
decreases activity decreases expression
ISO
Tocopherols results in decreased activity of AR protein [Tocopherols results in decreased expression of AR protein] which results in decreased expression of KLK3 protein; Tocopherols results in decreased expression of AR mRNA; Tocopherols results in decreased expression of AR protein
CTD
PMID:12032296 PMID:16302272
NCBI chr X:97,192,363...97,366,824
Ensembl chr X:97,192,375...97,366,821
G
Arf3
ADP-ribosylation factor 3
increases expression
EXP
Tocopherols results in increased expression of ARF3 mRNA
CTD
PMID:17654050
NCBI chr15:98,635,505...98,660,999
Ensembl chr15:98,634,515...98,661,095
G
Aspm
abnormal spindle microtubule assembly
increases expression
EXP
Tocopherols results in increased expression of ASPM mRNA
CTD
PMID:17056531
NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829
G
Atp1a2
ATPase, Na+/K+ transporting, alpha 2 polypeptide
increases expression
EXP
Tocopherols results in increased expression of ATP1A2 mRNA
CTD
PMID:17654050
NCBI chr 1:172,099,276...172,125,631
Ensembl chr 1:172,099,276...172,125,631
G
Atp1b2
ATPase, Na+/K+ transporting, beta 2 polypeptide
increases expression
EXP
Tocopherols results in increased expression of ATP1B2 mRNA
CTD
PMID:17654050
NCBI chr11:69,490,554...69,496,786
Ensembl chr11:69,490,562...69,496,768
G
Aurka
aurora kinase A
increases expression
EXP
Tocopherols results in increased expression of AURKA mRNA
CTD
PMID:17056531
NCBI chr 2:172,198,116...172,212,825
Ensembl chr 2:172,198,110...172,212,455
G
Bax
BCL2-associated X protein
increases response to substance increases expression multiple interactions
ISO
BAX protein results in increased susceptibility to Tocopherols gamma-Tocopherol results in increased expression of BAX mRNA [Fluorouracil co-treated with gamma-Tocopherol] results in increased expression of BAX mRNA
CTD
PMID:16001965 PMID:31587439
NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322
G
Bcl2
B cell leukemia/lymphoma 2
increases expression multiple interactions decreases expression decreases response to substance
EXP ISO
Tocopherols results in increased expression of BCL2 mRNA; Tocopherols results in increased expression of BCL2 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of BCL2 mRNA gamma-Tocopherol results in decreased expression of BCL2 mRNA BCL2 protein results in decreased susceptibility to Tocopherols
CTD
PMID:8970189 PMID:16001965 PMID:31587439
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Bcl2l1
BCL2-like 1
decreases response to substance
ISO
BCL2L1 protein results in decreased susceptibility to Tocopherols
CTD
PMID:16001965
NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
EXP
Tocopherols results in increased expression of BIRC5 mRNA
CTD
PMID:17056531
NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569
G
Camk2g
calcium/calmodulin-dependent protein kinase II gamma
increases expression
EXP
Tocopherols results in increased expression of CAMK2G mRNA
CTD
PMID:17654050
NCBI chr14:20,784,943...20,844,225
Ensembl chr14:20,784,943...20,844,156
G
Casp3
caspase 3
increases activity multiple interactions
ISO
gamma-Tocopherol results in increased activity of CASP3 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CASP3 protein] thermozymocidin inhibits the reaction [gamma-Tocopherol results in increased activity of CASP3 protein]
CTD
PMID:15596715 PMID:22389237
NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724
G
Casp9
caspase 9
increases activity
ISO
gamma-Tocopherol results in increased activity of CASP9 protein
CTD
PMID:15596715
NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287
G
Cat
catalase
increases expression
EXP
gamma-Tocopherol results in increased expression of CAT protein
CTD
PMID:19115203
NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505
G
Ccnb2
cyclin B2
increases expression
EXP
Tocopherols results in increased expression of CCNB2 mRNA
CTD
PMID:17056531
NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO
gamma-Tocopherol results in decreased expression of CCND1 mRNA; gamma-Tocopherol results in decreased expression of CCND1 protein; Tocopherols results in decreased expression of CCND1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCND1 mRNA
CTD
PMID:12368234 PMID:12504091 PMID:31587439
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Ccnd3
cyclin D3
decreases expression
ISO
Tocopherols results in decreased expression of CCND3 protein
CTD
PMID:12504091
NCBI chr17:47,815,976...47,910,614
Ensembl chr17:47,815,976...47,910,616
G
Ccne1
cyclin E1
decreases expression multiple interactions
ISO
gamma-Tocopherol results in decreased expression of CCNE1 mRNA; gamma-Tocopherol results in decreased expression of CCNE1 protein; Tocopherols results in decreased expression of CCNE1 mRNA; Tocopherols results in decreased expression of CCNE1 protein [Fluorouracil co-treated with gamma-Tocopherol] results in decreased expression of CCNE1 mRNA
CTD
PMID:12368234 PMID:12504091 PMID:31587439
NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959
G
Cdc6
cell division cycle 6
increases expression
EXP
Tocopherols results in increased expression of CDC6 mRNA
CTD
PMID:17056531
NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766
G
Cdk1
cyclin dependent kinase 1
increases expression
EXP
Tocopherols results in increased expression of CDK1 mRNA
CTD
PMID:17056531
NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768
G
Cdk2
cyclin dependent kinase 2
decreases expression
ISO
Tocopherols results in decreased expression of CDK2 protein
CTD
PMID:12504091
NCBI chr10:128,533,807...128,540,920
Ensembl chr10:128,533,808...128,540,900
G
Cdk4
cyclin dependent kinase 4
multiple interactions
ISO
Tocopherols results in decreased expression of and results in decreased activity of CDK4 protein
CTD
PMID:12504091
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cdk5r1
cyclin dependent kinase 5, regulatory subunit 1
increases expression
EXP
Tocopherols results in increased expression of CDK5R1 mRNA
CTD
PMID:17654050
NCBI chr11:80,367,849...80,372,010
Ensembl chr11:80,367,849...80,372,010
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN1A protein
CTD
PMID:12368234
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn1b
cyclin dependent kinase inhibitor 1B
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN1B protein
CTD
PMID:12368234
NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
decreases expression
ISO
gamma-Tocopherol results in decreased expression of CDKN2A protein
CTD
PMID:12368234
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Clec4e
C-type lectin domain family 4, member e
increases expression
EXP
Tocopherols results in increased expression of CLEC4E mRNA
CTD
PMID:17056531
NCBI chr 6:123,258,748...123,266,830
Ensembl chr 6:123,258,748...123,266,829
G
Cplx1
complexin 1
increases expression
EXP
Tocopherols results in increased expression of CPLX1 mRNA
CTD
PMID:17654050
NCBI chr 5:108,666,420...108,697,893
Ensembl chr 5:108,666,420...108,697,890
G
Cplx2
complexin 2
increases expression
EXP
Tocopherols results in increased expression of CPLX2 mRNA
CTD
PMID:17654050
NCBI chr13:54,455,447...54,531,736
Ensembl chr13:54,519,162...54,531,730
G
Crabp2
cellular retinoic acid binding protein II
multiple interactions
ISO
[Tretinoin co-treated with gamma-Tocopherol] results in increased expression of CRABP2 mRNA
CTD
PMID:15225641
NCBI chr 3:87,856,000...87,860,679
Ensembl chr 3:87,855,973...87,860,683
G
Crp
C-reactive protein, pentraxin-related
multiple interactions
ISO
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of CRP protein
CTD
PMID:18191645
NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598
G
Csf1r
colony stimulating factor 1 receptor
increases expression
EXP
Tocopherols results in increased expression of CSF1R mRNA
CTD
PMID:17056531
NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221
G
Csrp2
cysteine and glycine-rich protein 2
increases expression
EXP
Tocopherols results in increased expression of CSRP2 mRNA
CTD
PMID:17056531
NCBI chr10:110,756,037...110,775,375
Ensembl chr10:110,755,650...110,775,483
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of CYP1A1 mRNA]
CTD
PMID:22389237
NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107
G
Dnajc5
DnaJ heat shock protein family (Hsp40) member C5
increases expression
EXP
Tocopherols results in increased expression of DNAJC5 mRNA
CTD
PMID:17654050
NCBI chr 2:181,162,141...181,194,679
Ensembl chr 2:181,162,278...181,196,926
G
E2f1
E2F transcription factor 1
increases expression
ISO
Tocopherols results in increased expression of E2F1 protein
CTD
PMID:15883045
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Egr1
early growth response 1
decreases activity
ISO
Tocopherols results in decreased activity of EGR1 protein
CTD
PMID:15878867
NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037
G
Esr1
estrogen receptor 1 (alpha)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR1 protein]
CTD
PMID:22389237
NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614
G
Esr2
estrogen receptor 2 (beta)
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of ESR2 mRNA]
CTD
PMID:22389237
NCBI chr12:76,167,193...76,224,033
Ensembl chr12:76,167,193...76,224,033
G
Fcer1a
Fc receptor, IgE, high affinity I, alpha polypeptide
increases expression
EXP
Tocopherols results in increased expression of FCER1A mRNA
CTD
PMID:17056531
NCBI chr 1:173,048,836...173,054,799
Ensembl chr 1:173,048,851...173,054,781
G
Fes
feline sarcoma oncogene
increases expression
EXP
Tocopherols results in increased expression of FES mRNA
CTD
PMID:17056531
NCBI chr 7:80,027,506...80,037,702
Ensembl chr 7:80,027,504...80,037,694
G
Fgf1
fibroblast growth factor 1
decreases expression
ISO
Tocopherols results in decreased expression of FGF1 mRNA
CTD
PMID:15878867
NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525
G
Fgf2
fibroblast growth factor 2
decreases expression
ISO
Tocopherols results in decreased expression of FGF2 mRNA
CTD
PMID:15878867
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fgfr1
fibroblast growth factor receptor 1
decreases expression
ISO
Tocopherols results in decreased expression of FGFR1 mRNA
CTD
PMID:15144885
NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734
G
Fkbp9
FK506 binding protein 9
increases expression
EXP
Tocopherols results in increased expression of FKBP9 mRNA
CTD
PMID:17056531
NCBI chr 6:56,809,044...56,856,345
Ensembl chr 6:56,809,044...56,856,343
G
Fos
FBJ osteosarcoma oncogene
increases expression
EXP
Tocopherols results in increased expression of FOS mRNA; Tocopherols results in increased expression of FOS protein
CTD
PMID:8970189
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fpr-rs4
formyl peptide receptor, related sequence 4
increases expression
EXP
Tocopherols results in increased expression of FPR-RS4 mRNA
CTD
PMID:17056531
NCBI chr17:18,241,995...18,242,966
Ensembl chr17:18,241,995...18,242,966
G
Gclm
glutamate-cysteine ligase, modifier subunit
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GCLM mRNA]
CTD
PMID:22389237
NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381
G
Gria2
glutamate receptor, ionotropic, AMPA2 (alpha 2)
increases expression
EXP
Tocopherols results in increased expression of GRIA2 mRNA
CTD
PMID:17654050
NCBI chr 3:80,588,757...80,711,534
Ensembl chr 3:80,588,757...80,710,142
G
Grin1
glutamate receptor, ionotropic, NMDA1 (zeta 1)
increases expression
EXP
Tocopherols results in increased expression of GRIN1 mRNA
CTD
PMID:17654050
NCBI chr 2:25,181,189...25,209,199
Ensembl chr 2:25,181,193...25,209,199
G
Gstm1
glutathione S-transferase, mu 1
increases expression multiple interactions
EXP ISO
gamma-Tocopherol results in increased expression of GSTM1 mRNA; gamma-Tocopherol results in increased expression of GSTM1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of GSTM1 mRNA]
CTD
PMID:19115203 PMID:22389237
NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289
G
Gsto1
glutathione S-transferase omega 1
decreases activity
ISO
Tocopherols results in decreased activity of GSTO1 protein
CTD
PMID:16781109
NCBI chr19:47,843,412...47,853,229
Ensembl chr19:47,843,409...47,853,229
G
Haspin
histone H3 associated protein kinase
increases expression
EXP
Tocopherols results in increased expression of HASPIN mRNA
CTD
PMID:17056531
NCBI chr11:73,026,310...73,029,120
Ensembl chr11:73,026,311...73,029,120
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
EXP ISO
gamma-Tocopherol results in increased expression of HMOX1 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of HMOX1 protein]
CTD
PMID:19115203 PMID:22389237
NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217
G
Jun
jun proto-oncogene
increases expression
EXP
Tocopherols results in increased expression of JUN mRNA; Tocopherols results in increased expression of JUN protein
CTD
PMID:8970189
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Kif20a
kinesin family member 20A
increases expression
EXP
Tocopherols results in increased expression of KIF20A mRNA
CTD
PMID:17056531
NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330
G
Kif4
kinesin family member 4
increases expression
EXP
Tocopherols results in increased expression of KIF4 mRNA
CTD
PMID:17056531
NCBI chr X:99,669,693...99,770,878
Ensembl chr X:99,669,343...99,770,820
G
Mcl1
myeloid cell leukemia sequence 1
decreases response to substance
ISO
MCL1 protein results in decreased susceptibility to Tocopherols
CTD
PMID:16001965
NCBI chr 3:95,564,017...95,583,553
Ensembl chr 3:95,566,099...95,570,487
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
multiple interactions
ISO
gamma-Tocopherol inhibits the reaction [ALB protein results in increased expression of MUC5AC mRNA]
CTD
PMID:19389874
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Myc
myelocytomatosis oncogene
decreases activity decreases expression
EXP
Tocopherols results in decreased activity of MYC protein Tocopherols results in decreased expression of MYC mRNA
CTD
PMID:8970189
NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223
G
Napb
N-ethylmaleimide sensitive fusion protein attachment protein beta
increases expression
EXP
Tocopherols results in increased expression of NAPB mRNA
CTD
PMID:17654050
NCBI chr 2:148,535,905...148,574,396
Ensembl chr 2:148,535,905...148,574,387
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
increases expression multiple interactions
EXP ISO
gamma-Tocopherol results in increased expression of NFE2L2 mRNA; gamma-Tocopherol results in increased expression of NFE2L2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NFE2L2 protein]
CTD
PMID:19115203 PMID:22389237
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nqo1
NAD(P)H dehydrogenase, quinone 1
multiple interactions
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of NQO1 protein]
CTD
PMID:22389237
NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838
G
Nsf
N-ethylmaleimide sensitive fusion protein
increases expression
EXP
Tocopherols results in increased expression of NSF mRNA
CTD
PMID:17654050
NCBI chr11:103,712,608...103,844,882
Ensembl chr11:103,712,608...103,844,882
G
Pcna
proliferating cell nuclear antigen
multiple interactions decreases expression
ISO
[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PCNA protein] Tocopherols results in decreased expression of PCNA
CTD
PMID:17927505 PMID:22389237
NCBI chr 2:132,091,206...132,095,100
Ensembl chr 2:132,091,082...132,095,234
G
Pparg
peroxisome proliferator activated receptor gamma
increases expression multiple interactions
ISO
gamma-Tocopherol results in increased expression of PPARG mRNA; gamma-Tocopherol results in increased expression of PPARG protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]; [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]
CTD
PMID:14521714 PMID:22389237
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ppp3ca
protein phosphatase 3, catalytic subunit, alpha isoform
increases expression
EXP
Tocopherols results in increased expression of PPP3CA mRNA
CTD
PMID:17654050
NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488
G
Prtn3
proteinase 3
increases expression
EXP
Tocopherols results in increased expression of PRTN3 mRNA
CTD
PMID:17056531
NCBI chr10:79,715,499...79,719,008
Ensembl chr10:79,710,310...79,719,008
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases activity multiple interactions
ISO
gamma-Tocopherol results in decreased activity of PTGS2 protein [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PTGS2 protein]
CTD
PMID:15225597 PMID:22389237
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Ptpro
protein tyrosine phosphatase receptor type O
increases expression
EXP
Tocopherols results in increased expression of PTPRO mRNA
CTD
PMID:17056531
NCBI chr 6:137,229,189...137,440,251
Ensembl chr 6:137,229,317...137,440,231
G
Rab11b
RAB11B, member RAS oncogene family
increases expression
EXP
Tocopherols results in increased expression of RAB11B mRNA
CTD
PMID:17654050
NCBI chr17:33,961,458...33,979,460
Ensembl chr17:33,961,458...33,979,504
G
Rab3a
RAB3A, member RAS oncogene family
increases expression
EXP
Tocopherols results in increased expression of RAB3A mRNA
CTD
PMID:17654050
NCBI chr 8:71,207,258...71,211,276
Ensembl chr 8:71,207,328...71,211,323
G
Rab6b
RAB6B, member RAS oncogene family
increases expression
EXP
Tocopherols results in increased expression of RAB6B mRNA
CTD
PMID:17654050
NCBI chr 9:102,988,866...103,062,475
Ensembl chr 9:102,988,986...103,062,475
G
Rb1
RB transcriptional corepressor 1
decreases phosphorylation
ISO
Tocopherols results in decreased phosphorylation of RB1 protein
CTD
PMID:12504091
NCBI chr14:73,430,298...73,563,446
Ensembl chr14:73,421,113...73,563,262
G
Rrm1
ribonucleotide reductase M1
increases expression
EXP
Tocopherols results in increased expression of RRM1 mRNA
CTD
PMID:17056531
NCBI chr 7:102,090,902...102,118,978
Ensembl chr 7:102,090,902...102,118,978
G
Rrm2
ribonucleotide reductase M2
increases expression
EXP
Tocopherols results in increased expression of RRM2 mRNA
CTD
PMID:17056531
NCBI chr12:24,758,253...24,764,145
Ensembl chr12:24,758,240...24,764,145
G
Snca
synuclein, alpha
increases expression
EXP
Tocopherols results in increased expression of SNCA mRNA
CTD
PMID:17654050
NCBI chr 6:60,708,557...60,806,839
Ensembl chr 6:60,708,559...60,806,839
G
Sncb
synuclein, beta
increases expression
EXP
Tocopherols results in increased expression of SNCB mRNA
CTD
PMID:17654050
NCBI chr13:54,906,673...54,914,435
Ensembl chr13:54,906,673...54,914,408
G
Sod1
superoxide dismutase 1, soluble
increases expression
EXP
gamma-Tocopherol results in increased expression of SOD1 protein
CTD
PMID:19115203
NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217
G
Stx1a
syntaxin 1A (brain)
increases expression
EXP
Tocopherols results in increased expression of STX1A mRNA
CTD
PMID:17654050
NCBI chr 5:135,051,473...135,079,954
Ensembl chr 5:135,052,336...135,079,954
G
Stxbp1
syntaxin binding protein 1
increases expression
EXP
Tocopherols results in increased expression of STXBP1 mRNA
CTD
PMID:17654050
NCBI chr 2:32,677,619...32,737,249
Ensembl chr 2:32,677,614...32,737,257
G
Sv2a
synaptic vesicle glycoprotein 2a
increases expression
EXP
Tocopherols results in increased expression of SV2A mRNA
CTD
PMID:17654050
NCBI chr 3:96,088,543...96,102,499
Ensembl chr 3:96,088,467...96,102,837
G
Syn1
synapsin I
increases expression
EXP
Tocopherols results in increased expression of SYN1 mRNA
CTD
PMID:17654050
NCBI chr X:20,726,750...20,787,157
Ensembl chr X:20,726,750...20,787,243
G
Syn2
synapsin II
increases expression
EXP
Tocopherols results in increased expression of SYN2 mRNA
CTD
PMID:17654050
NCBI chr 6:115,111,863...115,259,587
Ensembl chr 6:115,111,863...115,258,967
G
Syngr1
synaptogyrin 1
increases expression
EXP
Tocopherols results in increased expression of SYNGR1 mRNA
CTD
PMID:17654050
NCBI chr15:79,975,537...80,003,702
Ensembl chr15:79,975,535...80,003,702
G
Syp
synaptophysin
increases expression
EXP
Tocopherols results in increased expression of SYP mRNA
CTD
PMID:17654050
NCBI chr X:7,504,819...7,519,495
Ensembl chr X:7,504,710...7,519,495
G
Syt11
synaptotagmin XI
increases expression
EXP
Tocopherols results in increased expression of SYT11 mRNA
CTD
PMID:17654050
NCBI chr 3:88,652,006...88,682,466
Ensembl chr 3:88,652,007...88,682,471
G
Syt13
synaptotagmin XIII
increases expression
EXP
Tocopherols results in increased expression of SYT13 mRNA
CTD
PMID:17654050
NCBI chr 2:92,745,446...92,786,403
Ensembl chr 2:92,745,443...92,786,403
G
Tnf
tumor necrosis factor
multiple interactions
ISO
[alpha-Tocopherol co-treated with gamma-Tocopherol] results in decreased expression of TNF protein Tocopherols inhibits the reaction [TNF protein results in decreased export of Potassium]
CTD
PMID:17337591 PMID:18191645
NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983
G
Tnfaip2
tumor necrosis factor, alpha-induced protein 2
increases expression
EXP
Tocopherols results in increased expression of TNFAIP2 mRNA
CTD
PMID:17056531
NCBI chr12:111,408,898...111,421,452
Ensembl chr12:111,408,903...111,421,452
G
Trp53
transformation related protein 53
increases activity
ISO
Tocopherols results in increased activity of TP53 protein
CTD
PMID:15883045
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Ttc3
tetratricopeptide repeat domain 3
increases expression
EXP
Tocopherols results in increased expression of TTC3 mRNA
CTD
PMID:17654050
NCBI chr16:94,171,479...94,270,081
Ensembl chr16:94,171,477...94,270,202
G
Ugt1a1
UDP glucuronosyltransferase 1 family, polypeptide A1
increases expression multiple interactions
EXP ISO
gamma-Tocopherol results in increased expression of UGT1A1 mRNA [alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of UGT1A1 mRNA]
CTD
PMID:19115203 PMID:22389237
NCBI chr 1:88,139,681...88,147,724
Ensembl chr 1:88,139,681...88,146,719
G
Vamp1
vesicle-associated membrane protein 1
increases expression
EXP
Tocopherols results in increased expression of VAMP1 mRNA
CTD
PMID:17654050
NCBI chr 6:125,192,544...125,199,269
Ensembl chr 6:125,192,514...125,222,927
G
Vamp2
vesicle-associated membrane protein 2
increases expression
EXP
Tocopherols results in increased expression of VAMP2 mRNA
CTD
PMID:17654050
NCBI chr11:68,979,354...68,983,207
Ensembl chr11:68,979,316...68,983,210
G
Vdr
vitamin D (1,25-dihydroxyvitamin D3) receptor
increases expression
ISO
Tocopherols results in increased expression of VDR mRNA
CTD
PMID:12032296
NCBI chr15:97,752,308...97,806,177
Ensembl chr15:97,752,306...97,808,511
G
Akt1
thymoma viral proto-oncogene 1
increases phosphorylation
ISO
Gamma-tocotrienol increases phosphorylation of AKT1 protein in PC-3 prostate gland cancer cells
RGD
PMID:17601486
RGD:408364950
NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all